Biochemical studies on gelsolin : actin complexes and experiments to form a minimal, defined-length actin filament by Wear, Martin Alexander
THE UNIVERSITY of EDINBURGH
Title Biochemical studies on gelsolin : actin complexes and experiments to
form a minimal, defined-length actin filament
Author Wear, Martin Alexander
Qualification PhD
Year 2000
Thesis scanned from best copy available: may
contain faint or blurred text, and/or cropped or
missing pages.
Scanned as part of the PhD Thesis Digitisation project
http://librarvblogs.is.ed.ac.uk/phddigitisation
Biochemical studies on gelsolin:actin complexes and




The University of Edinburgh
2000
Declaration
This thesis was composed and written by myself and I personally
carried out the work described.
Martin Wear
II
This thesis is dedicated to my wife Elaine for her love, support and a




I owe my supervisor, Dr. Paul McLaughlin, a very large debt of gratitude, for two
reasons. Firstly, for giving me the opportunity of gaining my Ph. D. and secondly
(and more importantly), for the unstinting patience and support he has furnished me
with, right from the very beginning. Without such understanding, completing my
thesis would have been a much more arduous and time-consuming endeavour.
I would also like to thank Dr. Sutherland Maciver for sharing his extensive
experience and knowledge of the actin cytoskeleton field, and for his numerous
invaluable and informative discussions. Similarly, my thanks are extended to Dr.
Steve Winder and Dr. Lindsay Sawyer for encouragement and helpful suggestions
during the course of my thesis.
I am further indebted to Dr. Holger Husi, and would like to acknowledge (with much
appreciation) the help and direction he supplied me with and also for the divulgence
of some priceless unwritten "tricks-of-the-trade" for survival in the lab.
Gratitude is also extended to a large number of other individuals (too numerous to
name) who gave me huge amounts of encouragement during my studies, and helped
keep me sane (especially Nathan Cowieson and Dr. Janice Bramham; cheers guys!).
Finally, thanks to all my family and friends who supported me throughout with lots
of love and encouragement.
IV
Abstract
A number of important eukaryotic cellular processes (including movement,
endocytosis and generation of cytokinetic forces) are mediated by the dynamic
turnover of the actin cytoskeleton. Many actin-binding proteins control this turnover
of actin filaments; e.g. gelsolin, a Ca2+ and PIP2 regulated actin filament severing and
capping protein.
In this thesis we report the formation of a putative "capped-actin-minifilament"
complex. This was created by combining the gelsolin:actin2 ternary (G:A2) and the
actimDNasel binary (A:D) complexes together (1:1 molar ratio) under polymerising
conditions (lOOmM KC1; 2mM MgCl2 in the presence of 0.2mM CaCl2). Size-
exclusion data indicates the formation of a significantly larger species (in relation to
G:A2), with an apparent stoichiometry of G:A3:D (gelsolin:actin:DNaseI,
respectively).
Kinetic and modelling evidence (Weber et al, 1994) suggests that the binding of two
DNasel molecules at the pointed-end of filaments is not possible due to a steric clash.
Using DNasel's ability to bind at the pointed-ends of actin monomers, we have
probed the disposition of the monomers in the G:A2 complex. Size-exclusion, native-
PAGE and fluorescence enhancement data (performed with NBD-Actin) indicate the
formation of a stable, co-operative complex with a stoichiometry of G:A2:D2
(gelsolin:actin:DNaseI, respectively). The apparent Kd of A:D binding to the
gelsolimactin binary complex (G:A) is ~ 50nM, and is equivalent to the binding of
G-Actin alone (Kd ~ 39nM). Our data are consistent with DNasel having no effect on
the interaction of actin monomers with gelsolin, and with the spatial orientation of
monomers in G:A2 being different to those at the barbed-end of filaments.
In contrast to this, data from fluorescence enhancement experiments with rhodamine-
phalloidin (an actin filament specific binding molecule) provide evidence for the
actin monomers, within the putative "minifilament", being in a filamentous-like
conformation. We observe a specific binding, with significant levels of fluorescence
enhancement (~ 3 - 4 fold), of rhodamine-phalloidin to the putative "minifilament",
with an apparent Kd of ~ 4.6pM.
We have also examined the possibility of replacing gelsolin (as the barbed-end
capping protein) with a cloned polypeptide fragment derived from tensin, a
component of focal adhesions. This polypeptide spans the region of tensin that
contains the sequence of "insertin", previously identified as possessing a
controversial high-affinity barbed-end capping activity (Ruhnau et al, 1989). Our
results are consistent with this polypeptide not binding to monomeric actin, and it
therefore not being a suitable alternative to gelsolin, for further analysis of the
putative "minifilament". However, we have studied its interaction with filamentous
actin. We report data that is consistent with the tight capping of the barbed-end (Kcap
of ~ 6 - 8nM). Our construct causes a shift in the steady-state critical monomer
concentration towards that of the pointed-end, consistent with it possessing a non-
"insertin-like" activity. We also report a novel F-Actin side-binding activity for this
polypeptide, with an apparent of ~ 10|iM.
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Our knowledge of the structure of actin filaments is only at low resolution and the
details of the intermolecular contacts at the atomic level are, at best, only
approximate. We consider here approaches to form a minimal stable unit,
representative of these contacts, using well defined actin monomer-binding proteins
as tools in the controlled definition of this minimal complex, with the ultimate aim
being to crystallise such a complex. Development of this argument is discussed in the
proceeding sections; we first introduce the biochemistry and cell biology of actin in
order to clarify why knowledge of the filament structure (at atomic detail) is an
important biological problem; we further describe the properties of the actin-binding
proteins (ABPs) we use; finally we describe our hypothesis and rationale to attempt
to produce a mono-disperse molecular complex representative of the subunit:subunit
contacts within an actin filament.
1.2 An introduction to actin
Actins comprise a highly conserved family of cytoplasmic proteins found in all
eukaryotes and can constitute upwards of ~ 10 - 15% of the total cellular protein. No
actin has been found, so far, in any prokaryotes. Large numbers of isoforms have
been identified and purified from animal, plant, protozoan and fungal sources and are
often differentially expressed in tissue specific as well as specific intracellular
locations (Vandekerckhove and Weber, 1979; Herman, 1993; Sheterline et al, 1995).
Early experiments analysing the various aspects of eukaryotic cell motility, and the
role actin played in this function, utilised potent actin-binding toxins isolated from
several sources including fungi (e.g. the cytochalasins and phalloidin) and marine
sponges (the latrunculins) (Cooper, 1987; Sampath and Pollard, 1991; Faulstich and
Wieland, 1996; Ayscough, 1998). It was clear from the action of these drugs on the
actin cytoskeleton, that the actin structures within the cell were highly dynamic,
1-1
(cycling between populations of polymers and monomers), and played central roles
in a number important cellular processes, e.g. maintaining cell size and shape,
motility, cytokinesis, competent vesicular traffic (Sheterline et al, 1995; Stossel et at
al 1999; Goode et al, 2000; Rogers and Gelfand, 2000; Borisy and Svitkina, 2000).
The functional form of actin in vivo is a non-covalent filamentous polymer (F-Actin).
Under physiological ionic conditions (~ 50 - lOOmM KC1, pH ranging from 7.0-8.0
and 1 - 2mM free Mg2+) F-Actin assembles spontaneously in vitro from pools of the
monomer (G-Actin), a globular protein of approximately 42kDa.
1.3 Actin polymerisation
The first steps of the spontaneous polymerisation process for actin can be described
as indicated in fig. 1.1. Polymerisation is initiated by the activation of actin
monomers. This probably takes place by the binding of Mg2+ at a high-affinity site
(see fig. 1.5) and also by the binding of mono- and divalent cations to several low
affinity sites on the monomer. This activated monomer appears to undergo subtle
conformational changes that result in nucleation and then subsequent polymerisation
(Rich and Estes, 1976; Rouayrenc and Travers, 1981; Frieden, 1982; Shu et al,
1992). The nucleus for polymerisation is usually defined as the smallest actin
oligomer that is more likely to remain stable long enough for another monomer to
add than to dissociate into monomers. Kinetic analysis of polymerisation curves
(Frieden, 1985; Pollard and Cooper, 1986) and solution scattering studies
(Matsudaira et al, 1987) appear to indicate that this nucleus is a trimer.
Nucleation is the rate-limiting step in the spontaneous polymerisation of actin.
Diffusion limited association rate constants (107M_1 .s"1) and dissociation rate
constants in the range of 106 - 10V mean that the intermediates of the nucleation
stage are very unstable, and this energetically unfavourable stage gives rise to the lag
phase seen during polymerisation (Pollard and Cooper, 1986). During spontaneous
polymerisation of 10 - 20pM actin, the concentrations of dimers and trimers is
expected to be very low («nM) and their lifetimes very short (Freiden, 1985).
1-2
A + nM ^ AMn = A' (1). monomer activation
mi
A' + A' 7* A'
+2
A'2 + A' ^ A'3 (nucleus) W (2). nucleation
A',
Fi+1 (i > 3) (3). elongation
Fig. 1.1. Kinetic scheme describing the first steps of the polymerisation
process. The polymerisation of actin can be divided into four steps (steps 1 - 3 are
illustrated above): 1. activation (the actin monomer is "activated" probably by the
binding of Mg-ATP at the tight nucleotide binding-site and the binding of mono- or
divalent cations to several low affinity sites; Carlier, 1991); 2. nucleation (the
formation of oligomers that have a higher probability of growing into filaments rather
than dissociating into monomers); 3. elongation (the end-wise addition of monomers
onto both ends of polymers); 4. annealing (the end-to-end joining of two filaments).
A' represents the "activated" monomer (either Ca-ATP-Actin or Mg-ATP-Actin) and M
represents the various cations (e.g. Na+, Mg2+, K+, Ca2+), that bind to several low
affinity sites, resulting in "activation" of that monomer. Activation is followed by the
formation of an energetically unfavourable trimer nucleus. This is then subsequently
followed by elongation of the nuclei by end-wise addition of actin monomers onto
both ends of the polymer. The association rate constants for the formation of the
trimer nucleus appear to be diffusion limited (e.g. k+1 and k+2 ~ 107M"1.s"1) with the
dissociation rate constants in the range of 106 - 107s"1. Thus, nucleation is the rate-
limiting step in the spontaneous polymerisation of actin because the reactions are so
unfavourable, with dissociation constants of - 0.1 - 1.0M. (Kd1 = k.1/k+1 ~ 0.1 M; Kd2 =
k.2/k+2 - 0.1 M, Frieden, 1985; Pollard and Cooper, 1986). These large dissociation
rates emphasise the instability of the intermediates of nucleation, and the formation
of these trimer-nuclei is responsible for the lag-phase at the outset of polymerisation.
In vitro under physiological ionic conditions (~ lOOmM KC1, pH ~ 7.0 - 8.0, ~ 2mM
free Mg2+) the critical concentration (below which filaments dissociate or do not
form) of the Mg2+-ATP bound monomer is ~ O.ljlM or greater (Pollard, 1986;
Carlier, 1991; Sheterline et al, 1995). The ionic composition of the buffer solution
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(variations in salt concentration, the type and concentration of mono- and divalent
cations present, and pH) used to initiate actin polymerisation, has very marked
effects on the kinetics of assembly and disassembly and on the monomer critical
concentration (Frieden, 1982; Brenner and Korn, 1983; Gershman et al, 1984; Coue
and Korn, 1985; Pollard, 1986; Zimmerle and Frieden, 1988a/b/c; Wang et al, 1989;
Kinosian et al, 1993; Sheterline et al, 1995). Typical purification procedures, usually
involving the extraction of actin from rabbit muscle acetone powders (Spudich and
Watt, 1971), take advantage of the higher critical concentration of Ca2+-ATP-Actin
to aid recovery of the monomeric form (G-Actin).
Actin filaments in non-muscle cells undergo rapid turnover, with cycles of assembly
and disassembly occurring over a period of minutes. Actins possess an intrinsic
ATPase activity and bound ATP (under physiological conditions Mg2+-ATP is bound
at the high affinity site) becomes hydrolysed after incorporation into the filament
(Korn et al, 1987; Pollard et al, 1992). Hydrolysis lags behind polymerisation and as
a result elongating filaments possess an evolving population of monomers. Typically
this involves a cap of ATP-Actin at the barbed-end (see section 1.5 and fig. 1.4), a
section of ADP.Pi-actin (due to the relatively slow release of the hydrolysed
phosphate), followed by a pointed-end consisting only of ADP-Actin (Carlier, 1991;
Sheterline et al, 1995). The net result of ATP hydrolysis is a difference in the kinetics
of association and disassociation at either end of the actin filament; actin filaments
therefore possess polarity (see fig. 1.4). ATP hydrolysis acts as a chemical switch
that maintains the dynamic nature of F-Actin.
Due to the differences in the kinetics of monomer addition and dissociation at each
end filament growth is unidirectional, with overall elongation occurring by the rapid
addition of ATP-Actin to the faster growing barbed-end and loss of ADP-Actin from
the slower growing pointed-end (Frieden, 1985; Pollard and Cooper, 1986; Pollard,
1986; Korn et al, 1987; Carlier, 1991; Sheterline et al, 1995). At steady-state the
phenomenon of "treadmilling" occurs (Wanger et al, 1985). During treadmilling the
net length of the filaments remains constant but a cycling of actin subunits occuring,
essentially with the loss of ADP-Actin from the pointed-ends and addition of ATP-
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Actin to the barbed-ends. It appears that the main consequence of ATP hydrolysis in
F-actin is to destabilise actimactin interactions in the filament and facilitate
depolymerisation. This destabilisation probably occurs due to slight changes in the
actin monomer structure conformation, thus causing loss of binding energy (Bremer
et al, 1991; Orlova and Egelman, 1992).
1.4 The cortical actin cytoskeleton
In eukaryotic cells the actin cytoskeleton consists of a gel-like cortex of actin
filaments that underlies the plasma membrane. Dynamic changes in the organisation
of this actin cytoskeleton have been closely linked to a large number of important
cellular processes, including changes in the size and shape of cells, the formation and
regulation of focal contacts (see below), generation of cytokinetic forces (a process
mediated by myosin in an ATP dependent manner; Sellers and Goodson, 1995) and
the mobility of cells in response to signalling events (Burridge and Chrzanowska-
Wodnicka, 1996; Taylor et al, 1998; Stossel et al, 1999; Critchley, 2000; Rogers and
Gelfand, 2000; Borisy and Svitkina, 2000).
Within this cytoplasmic cortex individual arrays of assembled actin filaments are
further organised into three-dimensional networks by a large collection (~ 80) of
Actin-Binding Proteins (ABPs) (Pollard, 1993; Sheterline et al, 1995; Van Troys et
al, 1999). Several broad (and sometimes over-lapping) groups of ABPs have been
defined depending on the type of interaction they exhibit with actin filaments. The
major categories of ABP function include; motor proteins (myosins, see section 1.5),
filament-stabilising proteins (tropomyosins), filament de-stabilising proteins
(cofilins), cross-linking proteins (e.g. villin, fimbrin and a-Actinin; Matsudaira,
1991), anchorage proteins that link the actin cytoskeleton to the plasma membrane
(e.g. talin, tensin; Taylor et al, 1998), end-binding proteins (capping protein; Schafer
and Cooper, 2000) and severing proteins (gelsolin and the numerous member of the
gelsolin family; Maciver and Weeds, 1993). Actin filaments, along with the
unpolymerised cytosolic actin - associated with monomer sequestering proteins in
the cytoplasm, principally |34-thymosin and profilin (Theriot and Mitchison, 1993;
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Sun et al, 1996) - are in a constant state of flux in response to interaction and
regulation by these ABPs, and ultimately signal transduction pathways initiated at
the surface of the cell. It is these ABPs that allow non-muscle cells to transmit force
per se and exert spatial and temporal control over the three-dimensional actin
cytoskeleton. This allows for vesicle translocation along the filaments, cytoplasmic
streaming and the generation of movement and the associated myosin mediated
forces involved in cytokinesis (Stossel et al, 1999; Rogers and Gelfand, 2000).
Although this actin cortex lacks the highly ordered structure of the acto-myosin array
in muscle (see section 1.5), it nevertheless presents several characteristic higher-
order actin structures that arise due to the interaction of numerous ABPs with the
actin filaments (Sheterline et al, 1995). These higher-order actin structures include
focal contacts (complex multi-protein arrays that act as attachment sites and mediate
signals between the actin cytoskeleton and the plasma membrane; Critchley, 2000),
anti-parallel arrays of actin filaments that form stress fibres (the cytoplasmic
homologue of myofibrils) and less obvious bundles and parallel arrays of F-actin that
form dynamic protrusive structures (e.g. microspikes or filopodia) at the surface of
the cell, see fig. 1.2 (Furukawa and Fechheimer, 1997).
The actin cytoskeleton also attaches to transmembrane proteins in the bilayer (e.g.
a(3 integrins and the EGFR; epidermal growth factor receptor) often via the adapter¬
like mediation of ABPs in specialised areas of the cell called focal contacts (see
below) that allow the cells to initiate myosin mediated movement. Focal contacts
(also called adhesion plaques or focal adhesions) are specialised areas of the plasma
membrane where cells (especially cultured cell-lines like fibroblasts) attach to the
underlying substratum (see fig. 1.3). These areas are of great interest because of their
roles in actin:membrane association, cell-substrate adhesion, and in signal
transduction, both internally and externally directed, that regulate cell growth and
apoptosis (Burridge et al, 1988; Geiger, 1989; Luna and Hitt, 1992; Hynes, 1992;
Jockusch et al 1995; Burridge and Chrzanowska-Wodnicka, 1996; Gilmore and
Burridge, 1996; Lauffenberger and Horwitz, 1996; Yamada and Geiger, 1997; Taylor
et al, 1998; Stossel et al, 1999; Critchley, 2000).
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Fig. 1.2. Actin structures in a moving Fibroblast. (A) Scanning EM micrograph of
a motile cultured fibroblast. At the cell front, filopodia, lamellipodia, and ruffles project
from the cell membrane, while at the rear of the cell the tail is firmly attached to the
substratum. (B) A Fluorescence micrograph of a fibroblast stained with Rhodamine-
Phalloidin (a fluorescent F-Actin specific binding molecule) showing some of the
higher-order actin structures of the cortical cytoskeleton in a moving fibroblast.
(Figure was reproduced from Darnell et al, 1995).
The number of proteins that have been identified and localised at focal contacts is
growing rapidly. These include vinculin (Geiger, 1979; Feramisco and Burridge,
1980), a-Actinin (Lazarides and Burridge, 1975), talin (Burridge and Connell, 1983),
paxillin (Turner et al, 1990), zyxin (Crawford and Beckerle, 1991), radixin (Sato et
al, 1991), Src (Rorschneider, 1980), focal adhesion kinase (FAK) (Schaller et al,
1992), tensin (Tsukita and Itoh, 1989), fimbrin/APB120 (Feramisco and Burridge,
1980), vasodilator-stimulated phosphoprotein (Reinhard et al, 1992), fibronectin, and
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integrin (Chen et al, 1986; Horwitz et al, 1990), see fig. 1.3. The roles for many of
these proteins are relatively unknown. However, the identification of the components
of focal contacts that are involved in the linkage of actin filaments to the integral
constituents of the plasma membrane (e.g. tensin) has proved critical in elucidating
the function of both the proteins themselves and also the function, composition and
regulation of focal contacts as dynamic multimeric protein complexes.
Fibronectin
Fig. 1.3. Schematic diagram of a focal adhesion. The figure above shows a model
of the structural arrangements for some of the components of a focal adhesion.
Many of the known protein:protein interactions are illustrated, based on in vitro
binding (see Taylor et al, 1998 for review). The putative tensin-dimer is also shown.
Abbreviations: PKC, protein kinase C; FAK, focal adhesion kinase; SH2, Scr
homology domain; Src, non-receptor tyrosine kinase; Ptyr, phosphotyrosine; a5p1,
integrin receptor (cell-matrix adhesion molecule). This figure was reproduced from
Lo et al, (1994b).
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1.5 The acto-myosin interaction
Most of our knowledge of the structure of the actin filament and the structure of
myosin has arisen from a huge body of work performed on skeletal muscle, mainly
due to the highly ordered structure and the ease of purification of both actin and
myosin from such specialised tissue (Sellers and Goodson, 1995). The a-skeletal
isoform of actin (in invertebrate muscle it constitutes ~ 20% of the total cellular
protein) and myosin are the two major constituents found in myofibrils and form part
of the interlocking parallel array of stable thin actin filaments and thick myosin II
fibrils that gives rise to the characteristic light and dark bands seen by EM at low
magnification (Amos, 1985). These basic components mediate the shortening of the
sarcomere, the contractile unit of muscle fibre, by sliding over each other in an ATP
dependent manner.
Myosins form a large and very diverse super-family of proteins that act as ATP
dependent molecular motors. These motors are capable of translocating actin
filaments or of the polar translocation of vesicles and other cargo along fixed
"tracks" of filamentous actin (Sellers and Goodson, 1995; Rogers and Gelfand,
2000). The most familiar and well-studied member of this family is the myosin II
from skeletal muscle. There are now ~ 15 distinct classes of myosin based on
sequence homology (Goodson and Spudich, 1993; Cheney et al, 1993; Sellers and
Goodson, 1995; Cope et al, 1996). These myosin II molecules form thick filaments at
low ionic strength and become soluble at high ionic strength. This feature is utilised
in the purification of vertebrate skeletal myosin II, most commonly from rabbit
skeletal muscle.
All myosins examined to date have the ability to bind actin and hydrolyse Mg-ATP.
There are very large differences in the hydrolysis activities of different classes of
myosin and the myosin II (from skeletal muscle) appears to have an unregulated
ATPase activity when assayed in the presence of purified actin filaments in vitro
(Sellers and Goodson, 1995). The regulation of myosin II in vivo (in skeletal muscle
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fibres) appears to result solely from the action of the troponin-tropomyosin system
on the thin actin filaments.
All types of myosin purified to date are multimeric complexes and appear to possess
at least three functional domains, a head, neck and tail. Members of the class II
myosins are hexameric complexes, comprised of two heavy chains (Mr. — 171 —
241kDa) and two pairs of light chains (Mr. ~ 14 - 30kDa). The N-terminal sequence
of the heavy chain forms the head region of the molecule, while the C-terminal
sequences of the heavy chains form an elongated coiled-coil a-helical rod structure.
Between these two regions are the binding sites for the two light chains and each
head of myosin is associated with an essential and a regulatory type light chain.
Myosin II can be cleaved into separate and functional fragments using controlled
proteolysis. Various proteases cleave the myosin at a site that is typically ~ 130kDa
from the N-terminus and produce two fragments, heavy meromyosin (HMM) and
light meromyosin (LMM). HMM can be further divided by proteolysis, which occurs
just after the regulatory chain-binding region of the neck, to generate sub-fragments
S-l and S-2. The S-l fragment is enzymatically active and is associated with either
both of the light chains or just the essential light chain (under some conditions the
regulatory light chain is lost), dependent on the type of protease used in the cleavage.
The S-l head has been used extensively in kinetic and actin-binding studies and most
of the knowledge of the kinetic cycle of myosin has been performed using the
soluble S-l head fragment (see Sellers and Goodson, 1995; Vale and Milligan, 2000
and Volkmann and Hanein, 2000 for reviews of the structural and kinetic
considerations of the acto-myosin interaction). Actin filaments typically activate the
Mg-ATPase activity of myosin by a factor of 50 - 100 (depending on the solution
ionic conditions). In the absence of ATP, actin and myosin are tightly complexed
(the association constant, in the absence of ATP is ~ 107 - 108 M~' for acto-Sl,
Marston and Weber, 1975; Margossian and Lowey, 1978). ATP binds rapidly to the
S-l head, as it does with myosin alone, and has the resultant effect of lowering the
affinity of actin for myosin to about 104 - 105 M"1 (Chalovich et al, 1984).
1-10
The three-dimensional structure of the S-l head region, from chicken fast skeletal
muscle, has been solved to a resolution of 2.8A (Rayment et al, 1993b). Myosin S-l
has a very asymmetric structure; ~ 165A long, ~ 65A wide and up to 40A thick. The
globular head (also referred to as the motor region) contains a nucleotide-binding site
and the actin-binding site, oriented on opposite sides of the globular head domain
(Rayment et al, 1993a/b).
It is important to know the structure of the acto-mysoin complex, both to elucidate
the molecular details of this reaction and also to provide data at the molecular level
for the interaction that take place between actin monomers in the filament. A low
resolution structure of the acto-myosin complex has been obtained by helical
reconstruction of electron micrographs of actin filaments completely decorated with
the S-l myosin heads, see fig. 1.4 (Milligan and Flicker, 1987; Milligan et al, 1990;
Schroder et al, 1993). These images indicated and highlight the polar nature of the
actin filament, supporting the kinetic observations. I.e. polymerising filaments have
fast- and slow-growing ends, defined as the barbed- and pointed-ends, respectively,
(see fig. 1.4)
A model for the interaction of myosin with the actin filament was constructed by
computer fitting of the electron density of the S-l myosin head and the F-Actin
model (Rayment et al, 1993a/b). Overall, this fit was good but it was clear that there
were subtle changes in the actin monomer structure, upon incorporation into the
filament, as well as for the structure of the S-l head and its interaction with the
filament (Rayment et al, 1993a/b). In a similar manner the crystal structure of the G-
Actin:DNaseI complex (Kabsch et al, 1990) was used to build a model of the actin
filament (Holmes et al, 1990). However, the data used in the construction of these
models extend to only ~ 7A. As a result we have limited knowledge of the molecular
details of the numerous proteimprotein interactions involved in both actin filaments
and the acto-myosin complex at the atomic level, and given the importance of the
actin cytoskeleton in eukaryotic cells knowing the structure of the actin filament at
atomic resolution is necessary to further our understanding of how the actin
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cytoskeleton is controlled and modulated. The model of the actin filament (Holmes et
al, 1990) is described in more detail in section 1.6.
Pointed-end
Barbed-end
Fig. 1.4. The actin filament has a polar nature. The figure above shows an
image reconstruction from EM micrographs of an actin filament decorated with the
myosin S-1 head, bound along the long axis of the filament (Milligan and Flicker,
1987; Milligan et al, 1990; Schroder et al, 1993). This image accentuates the polar
nature of the filament - the fast growing barbed-end and the slower growing
pointed-end - demarcated by the arrow head appearance of the structure.
1.6 G- and F-Actin structure
F-actin is not amenable to crystallisation and subsequent determination to atomic
resolution, due to the uncontrollable distribution of polymer lengths and their relative
flexibility. However, the atomic structure of monomeric actin (G-Actin) has been
determined, in 3 separate complexes: bovine DNasel (Kabsch et al, 1990; see fig.
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1.10) and gelsolin segment 1 (McLaughlin et al, 1993, see fig. 1.8) in complex with
rabbit skeletal muscle actin, while the structure of bovine profilin was solved
complexed with Bovine p-actin (Schutt et al, 1993). From the three dimensional
o
structures, the actin monomer resembles a "box" of dimensions 67x40x37A and is
divided into two roughly equal domains separated by a cleft containing the high-
affinity nucleotide and divalent-cation binding site (see fig. 1.5). Each of these
domains can be further split into two domains (termed subdomains I, II, III, IV) with
a hinge region that runs below the cleft, connecting the domains I and III via two
strands of the polypeptide chain (Kabsch et al, 1990).
Fig. 1.5. Actin monomer structure. Schematic view of the chain trace of G-Actin
(375 residues, Mr. ~ 42kDa) highlighting the subdomains (I - IV, numbered 1 - 4,
respectively) of the monomer, and Ca +-ATP bound at the high affinity site (as
described by Kabsch et al, 1990 and McLaughlin et al, 1993). (The figure was
created using MOLSCRIPT, Kraulis, 1991).
The crystal structure of the G-Actin:DNaseI complex (Kabsch et al, 1990) has been
used to build a model of the actin filament using data from X-ray diffraction patterns
of oriented F-Actin gels (Holmes et al, 1990; Lorenz et al, 1993). The fibre
symmetry has two descriptions. One is of a single start, left handed helix with a 13
subunit repeating every 6 turns in roughly 360A up the long axis. The orientation that
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relates subsequent monomers is a then rotation of -166° and a translation of 27.5A,
half the height of the monomer along the axis. Two such operations give the third
subunit lying on top of the first, related to each other by a rotation of 28° in the
opposite sense. This gives the alternate description; a right handed, two-strand helix
with a half pitch of 360A (see fig. 1.6).
The major problem with this model is that the experimental observations extend to
only 7-8 A, at best (Holmes et al, 1990; Lorenz et al, 1993; Schmid et al, 1993).
Although a unique solution was found, the Pointed end
resolution of the experimental data were
insufficient to allow further refinement of the
input model. Thus, if there had been any
conformational changes in surface loops, or
even rigid rotations of subdomains within the
monomer, the observation to parameter ratio
was insufficient to reliably estimate these by
least squares fitting of the model to the data.
Furthermore, low-resolution data is more
susceptible to bias towards the input model.
Thus difference map techniques, such as
those used in high-resolution
crystallography, less reliably show
differences between the input model and the
true structure. At low resolution the input
model is reinforced and the differences are
down weighted.
Fig. 1.6. Model of the actin filament. The
figure to the right shows eight actin subunits
oriented in the filament as described by
Holmes et al (1990). The differential
shading indicates the two strands of the
right-handed, two-start helix description of




However, in its favour, the model is consistent with crosslinking and esr-spin probe
data and both the low resolution EM reconstruction (Milligan et al, 1990) and X-ray
models (Holmes et al, 1990; Lorenz et al, 1993) agree (Mendelson and Morris,
1994). Nevertheless, despite this agreement, due to the low resolution of the current
model we are far from understanding the atomic contacts that hold the filament
together, the interactions involved when myosin uses the actin polymer as a track
during muscle contraction, and also how the many ABPs that control the actin
cytoskeleton, bind to and interact with the filament at the atomic level. Thus, given
the pivotal role that actin plays in a host of important cellular processes, knowledge
of the structure of the actin filament at the atomic level is crucial to aid our
understanding of the molecular details of the subunit:subunit contacts within the
filament, but also in elucidating the interactions between the filament and the
numerous actin binding protein at the atomic level.
If some form of control could be placed on the length of the filament, attempts could
be made to crystallise, and determine the atomic interactions of F-actin and bound
proteins. Several actin-binding proteins, gelsolin, DNasel and tensin, present us with
an opportunity to control the two ends of the filament. We propose a different
approach in an attempt to solve the resolution problem of the current F-Actin model;
this is to form a capped-actin-"minifilament", utilising the actin-binding properties
of these three proteins (see below).
Before describing this proposal in detail, it is necessary to explain the properties of
these ABPs (gelsolin and DNasel) and the details of their interaction with actin. The
actin-binding properties of tensin are described separately in chapter 5.
1.7 Gelsolin, a Ca2+ activated, PIP? regulated actin filament severing and
barbed-end capping protein
Gelsolin severs actin filaments and remains tightly bound to the severed-end. It also
forms a ternary complex with two actin monomers under depolymerising conditions.
This gelsolin:actin ternary complex (G:A2) may represent a cap between gelsolin and
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two actin subunits, one from each strand in the filament. Kinetic evidence suggests
that the complex is at the faster growing barbed-end of the actin filament.
Gelsolin was first identified as a calcium-dependent actin filament destabilising
protein found as a component of blood plasma (with an additional 25-residue leader
sequence) and in the cytoplasm of macrophages (Chaponnier et al, 1979; Yin and
Stossel, 1979; Harris et al, 1980; Kwiatkowski et al, 1986). The cytosolic form of
gelsolin (Mr. ~ 82kDa) is one of the primary candidates implicated in the regulation
of the cortical F-actin network in response to a wide range of extra- and intracellular
signals (Sun et al, 1999 and Kwiatkowski, 1999). While gene knockout experiments
(Witke et al, 1995) have shown that gelsolin is not essential, it is required for the
rapid movement of dynamic cell like fibroblasts. Over expression of gelsolin in
fibroblasts results in increased motility (Cunningham et al, 1991).
Gelsolin is a ubiquitous actin filament-severing, -capping and nucleating protein, and
these multiple activities allow gelsolin to regulate the architecture and mobility of
cells (Yin, 1987). Gelsolin is a member of a family of proteins that is defined by
either a three (e.g. fragmin, severin) or a six (e.g. gelsolin, villin and adsevrin) repeat
sequence motif that spans 125 - 150 residues, see fig. 1.7 (Vandekerckhove, 1990;
Hartwig and Kwiatkowski, 1991; Weeds and Maciver, 1993). The crystal structures
of whole, Ca2+-free gelsolin (Burtnick et al, 1997) and the actin:G4 - 6 complex
(Robinson et al, 1999) have shown that this motif folds up into functionally distinct
domains with the same basic fold topology (originally identified on the basis of their
sequence homology; Kwiatkowski et al, 1986; Way and Weeds, 1988; Way et al,
1989), and conserved residues present in all segments of the gelsolin family
contribute to the apolar core of the molecule, possibly indicating the selective
evolutionary pressures involved in maintaining a tightly folded globular domain
(Matsudaira, 1988). See figs. 1.7, 1.8 and 1.9 for details.
From these studies it is apparent that the segments G1 and G4 are the most similar
and the X-ray crystal structures of the GLactin complex (McLaughlin et al, 1993)
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Fig. 1.7. Gelsolin structure-function domains. (A) A schematic diagram
illustrating the segmental boundaries of the six-fold domain repeat of gelsolin (as
defined by the Ca2+-free structure, described by Burtnick et al, 1997), with the
amino acid residues (shown at the boundary of each of the individual domains)
numbered as in human plasma gelsolin (Kwiatkowski et al, 1986) is shown
above. The sequences of the putative PIP2-binding sites are also illustrated
(Janmey et al, 1992; Yu et al, 1992; see Janmey, 1995 for review). (B) A
schematic diagram correlating the actin-binding and functional activities (Ca2+
dependence, F-Actin-binding, severing and capping) with the six-fold segmental
repeat of gelsolin (Way and Weeds, 1988; Way et al, 1989; see Weeds and
Maciver, 1993 and Sun et al, 1999 for reviews).
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Fig. 1.8. The actin:gelsolin segment 1 binary complex. A schematic representation of
the actin:gelsolin segment 1 (G1 is shaded) binary complex is shown (the Ca2+ ions are
shown as spheres) as described by McLaughlin et al (1993). G1 forms a globular domain
of dimensions 13x26x25A and is composed of a 3 layered structure. A central 4 stranded
(3-sheet is sandwiched between a 4-turn a-helix (termed the long helix) roughly parallel to
the strands and a second a-helix perpendicular to the strands. This figure clearly shows
the binding interaction between the long a-helix from G1 at the cleft between the
subdomains I and III of the actin monomer. (The figure was produced using MOLSCRIPT;
Kraulis, 1991).
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the interaction between the two monomer-binding domains in gelsolin, G1 and G4,
and the actin monomer (see fig. 1.8). This association involves the long a-helix
present in the gelsolin domains binding in a cleft (between subdomains I and III) at
the barbed-end of the actin monomer (see fig. 1.8).
The activation of gelsolin requires calcium ions. The levels of calcium, reported in
the literature, required for activation, nucleation, filament severing and actin
monomer (G-Actin) binding show a large amount of variation (Bryan and Kurth,
1984; Weeds et al, 1986; Pope et al, 1986; Janmey and Stossel, 1986; Selve and
Wegner, 1986; Patkowski et al, 1991; McLaughlin et al, 1993; Hellweg et al, 1993;
Lamb et al, 1993; Ditsch and Wegner, 1995; Pope et al, 1995). However, it appears
that while gelsolin has several high affinity binding sites for calcium (K^ in the nM
range) in the C-terminal half, that may be involved in the activation and the
subsequent large scale conformational changes associated with the opening of the
molecule, calcium concentrations in the |lM range are required for actin binding,
severing and nucleation activities (Weeds et al, 1986; Way et al, 1989; Way et al,
1992; Hellweg et al, 1993; Sun et al, 1994; Ditsch and Wegner, 1995; Pope et al,
1995; Pope et al, 1997; Burtnick et al, 1997; Robinson et al, 1999).
In response to elevated calcium concentrations gelsolin severs actin filaments, and
remains tightly bound to the barbed-end of the filament, capping it and preventing
further monomer addition at that end (Kcap ~ lOpM; Selve and Wegner, 1986). PIP2
dissociates the gelsolin cap in vitro, and its severing ability is inhibited (Janmey and
Stossel, 1987; Janmey and Stossel, 1989; Janmey et al, 1992; Yu et al, 1992). The
barbed-end of the actin filament is the preferred end to which monomers bind as new
filaments extend during re-arrangement of the actin cytoskeleton in response to
signalling events (Cooper and Schafer, 2000). Thus, it has been proposed that as the
levels of polyphosphoinositides (PIP2) are altered at the plasma membrane (by
activation of receptors and signalling cascades) such interactions would localise the
growth of new filaments close to the site of action of these extra-cellular signals.
This model provides a possible means for the rapid control of severing and
nucleation of F-actin (Janmey, 1995; Stossel et al, 1999).
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Much of the work that has ascribed functional properties to the six domains of
gelsolin was performed by studies on truncated domains of the protein (following
limited proteolysis or using expressed recombinant constructs) and chimeric
constructs (Bryan and Hwo, 1986; Bryan, 1988; Yin et al, 1988; Kwiatkowski et al,
1989; Way et al, 1989; Way et al, 1990; Pope et al, 1991; Weber et al, 1991; Way et
al, 1992; McLaughlin et al, 1993; Sun et al, 1994; Pope et al, 1995; Pope et al, 1997;
McGough et al, 1998; Robinson et al, 1999; Puius et al, 2000). This body of work
has established that there are three distinct actin-binding sites, unevenly distributed,
within the six-fold segmental repeat of gelsolin (see below and fig. 1.7 for a
summary of the current picture of gelsolins domain structure-function relationships).
In summary: gelsolin has two binding sites for monomeric actin, a high-affinity
calcium-independent monomer-binding site in G1 (K^ ~ 5pM) and a calcium-
dependent site in G4 (BG ~ 1.8|lM in G4 alone, but ~ 25nM in the G4 - 6 construct;
Bryan, 1988; Pope et al, 1995). G2 contains the calcium independent F-Actin binding
site (BG ~ 5pM; Way et al, 1992; Sun et al, 1994; Puius et al, 2000). While it is
apparent that the F-Actin binding domain of gelsolin (G2) localises the protein to the
sides of actin filaments, it also contributes to the severing activity of G1 (Sun et al,
1994). The severing and capping activity of gelsolin are both highly dynamic
processes that require the participation and co-operation of several domains (if not all
six). The minimal actin severing domain is G1 - 2 (Way et al, 1992; Sun et al,
1994), while full nucleating ability requires the two actin binding sites in G2 - 6
(Way et al, 1989). The former construct is calcium independent while the latter is
calcium dependent, indicating the calcium regulation of actin binding, of all three of
the sites is mediated via the C-terminal half of gelsolin. Calcium regulation of whole
gelsolin appears to be modulated by several sites in the C-terminal (G4 - 6) domains,
with a high affinity Ca2+-binding site located in G6 (Hellweg et al, 1993; Ditsch and
Wegner, 1995; Pope et al, 1995; Pope et al, 1997).
Despite the extensive functional analysis of the various domains of gelsolin and the
structural information these crystal structures have provided, the molecular details of
the modulation and regulation of the cellular F-Actin architecture by gelsolin are still
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relatively unclear. However, the formation of a ternary complex between gelsolin
and two actin monomers may provide a tool to address some of these problems.
Gelsolin forms two complexes with monomeric actin (in a calcium dependent
manner), a binary (G:A) complex and a ternary (G:A2) complex (Weeds et al, 1986).
G:A2 caps the barbed-end (Kcap ~ 20nM; Coue and Korn, 1985) and also nucleates
the rapid polymerisation of actin, in the pointed-end direction. Data from cross-
linking studies (Doi et al, 1991; Doi, 1992) has indicated that the two monomers,
bound by G1 and G4 in the G:A2 ternary complex, are related to one another across
the short-pitch helix of the filament (akin to the two terminal, laterally related
monomers at the barbed-end of the filament) and not longitudinally up the long axis.
The chelation of the Ca2+ ions with EGTA results in the dissociation of only one of
the actin monomers, leaving a binary complex that has lost the nucleating ability
(Bryan and Kurth, 1984; Bryan, 1988; Way et al, 1989). Dissociation of the G:A
binary complex can be induced by PIP2 (Janmey et al, 1987; Janmey and Stossel,
1989), with the binding sites for this interaction located to G2 (Yu et al, 1992;
Janmey et al, 1992).
Gelsolins ability to form a very tight cap at the barbed-end of an actin filament, and
its ability to form a stable ternary complex with two actin monomers, provides us
with a tool to control the definition of one end (the barbed-end) of the actin filament.
GA2 ternary complexes could be combined with a pointed-end capped actin species
to give a larger complex, hopefully with the actin in an F-conformation. A candidate
pointed-end capping species is the actin:DNaseI (A:D) binary complex, used in the
co-crystallisation and determination of the actin monomer structure (Kabsch et al,
1990).
1.8 The actincDNasel binary complex
Bovine pancreatic deoxyribonuclease I (DNasel) is a glycoprotein that binds to, and
subsequently cleaves double stranded DNA to yield 5'-oligonucleotides (Moore,
1981). As well as possessing these enzymatic activities DNasel is also a high-affinity
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actin-sequestering protein (Lazarides and Lindberg, 1974; Mannherz et al, 1975;
Hitchcock et al, 1976; Hitchcock, 1980) which forms a 1:1 binary complex (A:D)
with actin. DNasel binds to subdomains II and IV of monomeric actin (Kabsch et al,
1990; see fig. 1.10) with a ~ 0.1 - l.OnM (Mannherz et al, 1980). It has also been
reported to bind with similar affinity (Kd ~ InM) to the pointed-ends of actin
filaments (Podolski et al, 1988; Weber et al, 1994), and this leads to a blockage of
filament elongation. This inhibition is conferred by the binding of only one DNasel
molecule to the pointed-end of a single strand of the F-Actin two-start helix. (One
DNasel molecule bound per filament; Podolski et al, 1988). The binding of this
DNasel appears to have no significant effect on the affinity of the attached actin for
the pointed-end of the filament (Weber at al, 1994). DNasel has also filament side-
binding activity (Hitchcock et al, 1976) but this is of much lower affinity (Kd ~
O.lmM; Mannherz et al, 1980). It is agreed that this interaction is probably not
physiological; nevertheless it has been used extensively as a tool in the study of
actin.
Work carried out by Weber and co-workers (Weber et al, 1994) indicated that the
binding of two DNasel molecules was not possible at the pointed-ends of gelsolin-
capped actin filaments. At higher concentrations of DNasel, 1 - 100pM (three orders
of magnitude higher than that required for the blockage of elongation), an increase in
the rate of depolymerisation from the pointed-ends of gelsolin-capped filaments was
observed. The K50% for this effect was ~ 5|lM DNasel (Weber et al, 1994). The
explanation proposed for this was a steric clash between two DNasel molecules at
the pointed-end. This prevented the stable binding of both DNasel molecules and
resulted in an increase in the k0ff rate for the actin monomer, as a 1:1 binary complex
with DNasel (Weber et al, 1994). Modelling of DNasel molecules onto the pointed-
ends of two subunits in the Holmes filament model (Holmes et al, 1990) indicates
that DNasel would sterically interfere with each other.
In a similar manner to the G:A2 ternary complex, the tight, stable and easily purified
A:D binary complex provides us with a tool that allows us to define and control the
pointed-end of the actin filament.
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1.9 A capped-actin-"minifilament" presents a different approach to attempt to
address the resolution problem of the current filament model
We propose to take a different approach to attempt to address the resolution problem
of the current actin filament model: this is to form a capped-actin-"minifilament",
with a view to crystallographic studies. This species has a defined length and
composition, and contains three actin subunits forming a "minifilament", blocked at
both ends by specific binding proteins with gelsolin binding at the barbed-end and
DNasel at the pointed-end of the filament (see fig. 1.10).
sj»|p
A B
Fig. 1.10. G-Actin in complex with two opposite end-opposed binding
proteins. (A) A schematic view of the actin-gelsolin segment 1 (shaded) complex
(the Ca2+ ions are shown as spheres) as described by McLaughlin et al (1993). (B)
A schematic view of the actin-DNasel (shaded) complex as described by Kabsch
et al (1990). This side-by-side orientation clearly indicates the binding of the two
proteins at opposite ends of the actin monomer. (Diagrams were created using
MOLSCRIPT; Kraulis, 1991).
Combining the G:A2 ternary complex and the A:D binary complex under
polymerising conditions may result in an association between the free ends of the
actin monomers, hopefully giving rise to a larger species with the actin monomers
oriented as they are in a filament. As described above, two actin:DNaseI binary
complexes (A:D) cannot be accommodated at the pointed-ends of filaments due to a
significant steric clash consistent with modelling and kinetic data (Weber et al,
1994). Our proposed "minifilament" model (see fig. 1.11) with the actin monomers
oriented in a filamentous conformation (as described by the Holmes filament model;
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Holmes et al, 1990) acknowledges this argument. It is not possible to accommodate
two DNasel molecules at the pointed-ends of the putative "minifilament", giving our
model a predicted stoichiometry of G:A3tD (see fig. 1.11).
Pointed-end
Barbed-end
Fig. 1.11. Model of the putative "minifilament". A schematic representation of a
putative model of the capped-actin-"minifilament", with stoichiometry of G:A3:D
(gelsolin:actin3:DNasel), is shown. DNasel is coloured grey, the three actin
monomer subunits, oriented as described by the Holmes filament model (Holmes
et al, 1990), are coloured red, green and blue. Only segment 1 (G1) and a
putatively positioned segment 4 (G4) - by analogy - from gelsolin are shown,
coloured yellow. Kinetic and modelling evidence suggests that only one DNasel
molecule can be bound at the pointed-end (Weber et al, 1994). (The diagram was
created using MOLSCRIPT; Kraulis, 1991).
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1.10 Thesis rationale
This thesis is primarily concerned with the analysis of the formation of a putative
"minifilament". As we are proposing to use the G:A2 ternary complex as the barbed-
end capping species in our analysis of the formation of a putative "minifilament" we
first address the question of whether the actin subunits within this complex are held
in a filamentous conformation, akin to that for those at the barbed-end of the
filament, or in an alternative orientation (chapter 3). The G:A2 complex is a potent
nucleator of actin polymerisation and tightly caps the barbed-end, but the spatial
orientation of the actin subunits is still unknown. We propose to use the ability of
DNasel to bind at the pointed-ends of actin monomers to probe the actin subunits in
G:A2. Acknowledging the kinetic and modelling arguments that indicate that two
DNasel molecules cannot be accommodated at the pointed-end of actin filament, we
similarly propose that two DNasel molecules cannot be accommodated at the
pointed-end of the actin monomers within G:A2 if they are bound with a filamentous
orientation.
We then address the possibility of forming a putative "minifilament" complex by
combining G:A2 and A:D together under polymerising conditions (chapter 4). As
part of this analysis we also examine the possibility of using the protein tensin (an
actin-binding protein localised to focal contacts, discussed in chapter 5) as an
alternative to gelsolin as the barbed-end capping molecule due to its smaller size.
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2. Materials and methods
2.1 Rabbit muscle actin acetone powder preparation
The method for the preparation of rabbit muscle acetone powder is based on that
described by Spudich and Watt (1971). Modifications are described below.
Stock solutions








Made up to 4 L with dH2Q, adjusted to pH 6.5.
0.1mM CaCl2.




(The above solution was stored at 4°C).
Solution (i): 50mM NaHC03;
Solution (ii): lOmM NaHC03;
Solution (iii): Analar acetone, stored at 4°C.
The soleus and upper leg muscles from a large (~ 3kg) newly killed rabbit were
excised as quickly as possible. The tissue was placed on ice immediately, to preserve
the endogenous ATP, and left to cool for 30min. Following cooling, the fat and
connective tissue were removed and the remaining muscle tissue minced. 3 volumes
of Guba Straub buffer were added to the minced tissue and left stirring for 15min at
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room temperature. The tissue extract was then centrifuged at 3000 xg, for 20min at
4°C, to pellet the residue. The tissue residue pellet is used for the preparation of
actin, while the supernatant is used for the preparation of myosin (see section 2.1.2).
2.1.1 Actin preparation
The tissue residue pellet was re-suspended in 10 volumes of solution (i), and stirred
for 15min at 4°C. The tissue residue was then filtered through cheesecloth.
This filtered residue was re-suspended in one volume of solution (ii), and stirred for
lOmin at 4°C. The residue was again filtered through cheesecloth, and the residue
then diluted into 10 volumes of dH20. This suspension was thoroughly mixed,
quickly filtered through cheesecloth and then re-suspended in 2.5L of cold acetone.
This was mixed and left to stand at room temperature for 15min. Rounds of filtration,
through cheesecloth, and washing with cold acetone were repeated until the
supernatant became clear. The residue was then left over-night to dry in a fume hood.
Typical yields of acetone powder were 0.5 - 2.0% (w/w) of the starting muscle
tissue.
2.1.2 Myosin preparation
The supernatant fraction (see section 2.1) was filtered through a bed (15cm x 3cm) of
3MM filter paper in Guba Straub buffer. Myosin was then precipitated by the
addition of 10 volumes of dH20, at 4°C, while stirring. The precipitated myosin was
left to settle overnight, at 4°C, and then the clear supernatant carefully decanted off.
The settled myosin precipitate was then subjected to centrifugation at 1000 xg for
30min at 4°C.
The resulting pellet was re-dissolved in lOmM NaPCU, pH 7.0 and 0.6M NaCl and
stirred for 30min, at 4°C. (The pellet was weighed and NaCl was added to exactly
0.6M). The resultant suspension was then carefully diluted to 0.3M NaCl at pH 6.5 -
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6.8, and subjected to centrifugation to pellet any remaining acto-myosin. (Myosin is
less soluble at lower pH, but denatures below pH 5.5).
The myosin was re-precipitated in 10 volumes of dP^O, at 4°C. This mixture was
then centrifuged immediately at 15,000 xg, for 15min at 4°C. The resultant pellet was
re-dissolved in lOmM NaP04, pH 7.0; 0.6M NaCl as before and subjected to high¬
speed centrifugation at 35,000 xg, for 2hrs at 4°C, in a preparative Beckman
XL100/70Ti rotor. The supernatant was carefully removed and the concentration of
myosin recorded; A280 of a l%(w/v) solution of myosin = 5.6. NaCl, NaP04, NaN3,
and glycerol were added to give a final buffer composition of lOmM NaP04, pH 7.0;
0.6M NaCl; ImM NaN3; 50% glycerol. The protein was stored in the above buffer at
minus 20°C, at a concentration of ~ lOmg.ml"1.
2.1.2.1 Myosin sub-fragment 1 preparation
Myosin (~ lOmg.ml"1) stored in lOmM NaP04, pH 7.0; 0.6M NaCl; ImM NaN3;
50% glycerol, at minus 20°C, was rapidly thawed and dialysed overnight against
lOmM imidazole, pH 6.5; 20mM NaCl; 5mM MgCB, at 4°C. (Myosin forms
filaments at low ionic strength. In these myosin filaments, the rods are protected
from cleavage, with only the heads, which stick out, being cut. Glycerol is removed,
as it tends to reduce the size of the myosin aggregates that form at low ionic strength,
and makes them difficult to spin down). The dialysed myosin solution was diluted 2
- 3 times with dialysis buffer and subjected to centrifugation at 50,000 xg, for 30min
at 4°C. The resultant pellet was then resuspended in 120mM NaP04, pH 7.0; 120mM
NaCl; 2mM MgCl2; ImM DTT.
Prior to proteolysis the myosin solution was incubated at 25°C. Papain (a cysteine
protease, made up as a lOOmM stock solution in 200mM NaP04, pH 7.0) was added
at 1:700 - 800 (w/w) to the myosin solution and the mixture incubated for 7min. The
reaction was quenched by the addition of iodoacetamide to ImM. (Iodoacetamide
reacts covalently with the cysteine group at the active site and irreversibly inhibits
the enzyme).
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This reaction mixture was immediately subjected to dialysis against 50mM Tris, pH
6.8; 2mM MgCl2; 2mM DTT, for 2hrs at 4°C. (This reduces the salt to 20 - 30mM).
The sample was then centrifuged at 40,000 xg, for 30min at 4°C, to clarify the
myosin solution (rod sections and undigested heads remain insoluble, and so
sediment) leaving essentially only the soluble S-l head in the supernatant fraction.
Prior to storage or use in further experiments, myosin is frequently subjected to
further purification by anion-exchange chromatography, on DEAE-Sepharose
columns equilibrated in lOmM imidazole, pH 6.8; 2mM MgCE; 2mM DTT. Elution
is typically achieved with a gradient of 0 - lOOmM NaCl, in the same buffer, over 6
column volumes.
The appropriate fractions were then dialysed against 50mM Tris, pH 6.8; 2mM
MgCl2; 2mM DTT prior to use. Myosin was stored in 50mM Tris, pH 6.8; 2mM
MgCl2; 2mM DTT; 20% sucrose (w/v) at minus 80°C.
2.2 Extraction and purification of G-Actin using 1M Tris, pH 8.0: ATP-G-
Buffer
The G-Actin extraction and purification protocol was adapted from those of Spudich
and Watt (1971) and Pinder at al (1995). Modifications are as follows.
ATP-G-Buffer
5mM Tris, pH 8.0; 0.5mM DTT; 0.2mM CaCl2; 0.2mM ATP; l.OmM NaN3.
1.0M Tris, pH 8.0; ATP-G-Buffer
1.0M Tris, pH 8.0; 0.5mM DTT; 0.2mM CaCl2; 0.2mM ATP; l.OmM NaN3.
40ml of ATP-G-Buffer, at 4°C, was added to each gram of rabbit muscle acetone
powder. The mixture was stirred gently for IVz - 2hrs at 4°C. The extract was then
filtered sequentially, under suction, through Whatman No. 54 filter paper, 8|im
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cellulose membranes and finally 0.22pm cellulose membranes. (The filtrate should
be clear at this stage). KC1 was then added to 0.8M, while gently stirring. When most
of the KC1 had dissolved MgCl2 and EGTA were added to 2mM and 0.1mM,
respectively. This mixture was left to polymerise for lhr at room temperature.
The polymerised solution was then subjected to high-speed centrifugation at
160,000xg, for 2hrs at 4°C, in a preparative Beckman XL100/70Ti rotor. This pellets
essentially only F-actin. The supernatant was discarded and the gelatinous F-Actin
pellet removed and homogenised in ~ 20ml of 1.0M Tris, pH 8.0; ATP-G-Buffer, at
4°C. Following homogenisation the suspension was diluted with 1.0M Tris, pH 8.0;
ATP-G-Buffer, at 4°C, so the final actin concentration was ~ 0.5 - 1.0 mg.mr1. (We
worked on the assumption that we extract ~ 30mg of actin from every gram of
acetone powder). This solution was dialysed overnight against 1L of 1.0M Tris, pH
8.0; ATP-G-Buffer, at 4°C. The dialysate was then clarified by high-speed
centrifugation at 160,000 xg, for 2hr at 4°C, in a preparative Beckman XL100/70Ti
rotor, and the supernatant carefully removed. The depolymerised G-Actin was stored
in this solution, at 4°C, until required. Every 2 weeks the G-Actin solution was
dialysed against 1L of 1.0M Tris, pH 8.0; ATP-G-Buffer, at 4°C, and then filtered
through a 0.22pm filter.
Prior to use in other experiments ~ 10 - 15ml of the 1M Tris-G-Actin solution was
filtered through a 0.22pm filter and concentrated to ~ 2ml (~ 5mg.mr'). This sample
was then subjected to gel-filtration chromatography on an S200 size-exclusion
column (Vt ~ 135ml; 65cm x 1.6cm), pre-equilibrated in ATP-G-Buffer, with a flow
rate of 0.5ml.min"'. Proteins were detected by A280nm and analysis by SDS-PAGE.
The relevant fractions were pooled and the G-Actin concentrated to ~ 1mg.mr1,
(based on the absorption coefficient of 0.63 at 290nm for a lmg-ml"1 solution with a
lcm path-length).
This high concentration Tris buffer enabled us to store G-actin in native and an
active state for over 4 months, in comparison to 2 - 3 weeks for conventional ATP-
G-Buffer. See appendix A for details of the viability of 1.0M Tris, pH 8.0; ATP-G-
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Buffer, at 4°C, for the long term storage of G-Actin with native activity, as judged by
critical concentration ([Cc]) assay with 5% pyrene labelled actin.
2.3 Pyrene-actin preparation
Pyrene-actin was prepared from pre-purified G-Actin and modified by the coupling
of N-pyrenyl iodoacetamide (Molecular Probes Inc.) to residue Cys-374, based on
the method of Kouyama and Mihashi (1981). Modifications are described below.
Approximately 15mg of G-actin, concentrated to ~ 2mg.mr1 was dialysed over night,
at 4°C, against 25mM Tris, pH 8.0; 0.2mM ATP; ImM NaN3; lOOmM KC1; 2mM
MgCh, at a 1:100 volume ratio for sample:dialysis buffer, respectively. The
concentration of polymerised actin was then adjusted to lmg.mr1 (based on the
absorption coefficient of 0.63 at 290nm for a lmg.mr1 solution with a 1cm path-
length). This solution was then transferred to a suitable container (~ 25ml volume)
and N-pyrenyl iodoacetamide (stock solution of lOmM in Dimethylformamide,
DMF) was added at a molar ratio of 7:1 N-pyrenyl iodoacetamide:actin, while gently
stirring. Following addition of N-pyrenyl iodoacetamide, the solution is covered in
foil and left overnight at 4°C.
The sample was then subjected to low speed centrifugation at 3000 xg, for 5min at
4°C, to pellet any precipitated dye. The clarified supernatant was carefully removed
and subjected to centrifugation at 160,000 xg, for 2hrs at 4°C, in a preparative
Beckman XL100/70Ti rotor, to precipitate the filamentous actin. The supernatant
was discarded and the gelatinous F-Actin pellet removed and homogenised in ~ 10ml
of ATP-G-Buffer. The sample was subjected to dialysis against ATP-G-Buffer, at a
1:100 volume ratio for sample:dialysis buffer, respectively, for 48 hrs in the dark, at
4°C, with several buffer changes.
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Following exhaustive dialysis the G-Actin solution was clarified by centrifugation at
160,000 xg, for 2hrs at 4°C, in a preparative Beckman XL100/70Ti rotor. The
resulting supernatant was then concentrated to ~ 2ml (~ Smg.ml"1) and then subjected
to size-exclusion chromatography on an S200 column, (Vt ~ 135ml; 65cm x 1.6cm),
pre-equilibrated in ATP-G-Buffer, with a flow rate of O.Sml.min"1. The relevant
fractions were pooled, concentrated to ~ lmg.mT1, and either used immediately or
0.5ml aliquots were flash frozen with liquid nitrogen, in ATP-G-Buffer, and stored at
minus 70°C until needed. Prior to use the pyrene-actin aliquots were rapidly thawed
and then centrifuged at 160,000 xg, for 30min at 4°C, in a preparative Beckman
XL100/70Ti rotor. The supernatant was carefully removed and the extent of labelling
measured.
The extent of pyrene labelling was calculated using the extinction coefficients listed
below:
%Label = [Pyrene-Actin] / [Actin]totai
[Pyrene-Actin] = A344nm / 2.2 x 104 (M"1)
[Actin] total = (A290nm - ((A344nm X 0- 127))/2.66 x 104(M"1)




NEM/NBD-Actin was prepared from pre-purified G-Actin based on the method of
Detmers et al (1981). Modifications are described below.
Modified ATP-G-Buffer for NEM labelling
5mM Tris, pH 8.0; 0.2mM CaCl2; 0.2mM ATP.
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N-ethylmaleimide (NEM) labelling of Cys-374. Approximately 15mg of G-actin (~
2mg.mr1) was dialysed over night, at 4°C, against 5mM Tris, pH 8.0; 0.2mM CaCl2;
0.2mM ATP; 0.2mM DTT, at a 1:100 volume ratio for sample:dialysis buffer,
respectively. The dialysate was filtered through a 0.22pm filter and NEM, (stock
solution of lOOmM in dH20), was added to a final concentration of l.OmM.
Immediately following NEM addition NaCl and MgCl2 were added to lOOmM and
2mM, respectively. The mixture was left to polymerise at room temperature for
30min and then DTT was added to ImM, to quench the reaction. The sample was
then subjected to high-speed centrifugation at 160,000 xg, for 2hr at 4°C, in a
preparative Beckman XL100/70Ti rotor. The supernatant was discarded and the
gelatinous E-actin pellet rcsuspended in --10ml of modified ATP-G-Buffer. The
sample was subjected to dialysis against modified ATP-G-Buffer, at a 1:100 volume
ratio for sample:dialysis buffer, respectively, for 48 hrs in the dark at 4°C, with
several buffer changes.
4-chloro-7-nitro-2,l,3-benzoxadiazole (NBD) labelling of Lys-373. Following
exhaustive dialysis the NEM-G-Actin solution was clarified by high-speed
centrifugation at 160,000 xg, for lhr at 4°C, in a preparative Beckman XL100/70Ti
rotor and the concentration then adjusted to lmg.mT1 (based on the absorption
coefficient of 0.63 at 290nm for a lmg.mP1 solution with a 1cm path-length). NBD
was then added to the supernatant to 0.6mM, (stock solution of 20mM in 95%
ethanol), and NaCl and MgCl2 immediately added to lOOmM and 2mM respectively.
This mixture was left for 5hrs, at room temperature, in the dark, while gently stirring.
Following this the F-Actin solution was centrifuged at 160,000 xg, for 2hrs at 4°C, in
a preparative Beckman XL100/70Ti rotor. The supernatant was discarded and the
gelatinous F-actin pellet resuspended in ~10ml of modified ATP-G-Buffer. The
sample was subjected to dialysis ATP-G-Buffer, at a 1:100 volume ratio for
sample:dialysis buffer, respectively, for 48 hrs in the dark at 4°C, with several buffer
changes. Finally, the NBD-G-Actin was filtered through a 0.22|im filter before use.
The shelf life of NBD-Actin is ~ 2 - 3 weeks, and all experiments carried out with
NBD-Actin were performed within this time.
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The extent of labelling was calculated using the extinction coefficients listed below:
% labelling = [NBD-Lys-373] / [Actin]totai
[NBD-Lys-373] = A48onm / 26,000 (M"1)
[Actin]total = A290nm / 26,000 (M )
Typical labelling was between 40 - 70% with a ~ 40 - 60% yield of the total actin
initially used.
2.5 Actin critical concentration assay (TCrl)
The protocol used was based on that described by Kouyama and Mihashi (1981).
Modifications are described below.
Pre-purified G-Actin and pyrene-actin are required. A dilution series of actin (5%
pyrene labelled) was set up, with actin concentrations typically ranging from 0.1, 0.2,
0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 1.0, 1.2, 1.5, 1.8, 2.0jiM. One dilution series was incubated
under depolymerising conditions (ATP-G-Buffer) while the other was incubated
under polymerising conditions (ATP-F-Buffer). Upon incorporation of pyrene actin
into the filament, a ~ 20 - 25 fold fluorescence enhancement (linearly dependent on
the actin concentration), over that of a similar concentration of 5% pyrene labelled
G-actin, is observed. Linear extrapolation of the G and F-Actin series, to the
intersection point, gives the [Cc] for that particular actin preparation, or set of
conditions, (see example in fig. 2.1).
Method
Typically, a 12jiM/5% pyrene G-Actin stock solution was first prepared. From this, a
6pM/5% pyrene F-Actin solution was prepared by the addition of KC1 and MgCL to
lOOmM and 2mM, respectively. This was left for 2hrs, at 20°C in the dark, to
polymerise. Following polymerisation, the sample was subjected to brief
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ultrasonication (a single 20sec burst, at 4°C). Each individual sample in the F-Actin
dilution series was then prepared by diluting the appropriate amount of 6p,M/5%
pyrene F-Actin to the appropriate concentration with ATP-F-Buffer, to a final
reaction volume of 500|il. A similar dilution series was also prepared using the
12jiM/5% pyrene G-Actin stock solution and ATP-G-Buffer. Both the F and G-Actin
dilution series were then incubated for 24hrs, at 20°C in the dark.
pM Actin
Fig. 2.1 Actin critical concentration ([Cc]) assay. [Cc] assay performed after a
24hr incubation, at 20°C in the dark. Closed squares indicate the fluorescence
intensity of the G-Actin dilution series. Open squares indicate the fluorescence
intensity enhancement of the F-Actin dilution series, under polymerising
conditions; 100mM KCI; 2mM MgCI2. The solid lines represent a linear regression
and the intersect of the two series reports the [Cc] of the actin; 0.11pM in this
particular preparation. The excitation wavelength was 366nm, the emission
wavelength was 384nm, with a 5nm slit for both.
Following this incubation, the fluorescence of each sample was measured.
Fluorescence measurements were carried out in a Perkin-Elmer LS50B
spectrofluorimeter at 20°C, with a Grant LTD6 temperature control unit. The
excitation wavelength for pyrene actin was 366nm and the emission wavelength was
384nm, using a 5nm slit width for both. A quartz fluorimeter cuvette with a lcm-path
length and a 400|il working volume was used. F-Actin containing samples were
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removed from the incubation tubes, and added to the cuvette using a truncated tip, to
prevent breakage of the filaments due to shearing forces. The fluorescence intensity
is reported in arbitrary units.
2.6 Actin polymerisation/depolymerisation assays
The ability of proteins to influence actin assembly/disassembly was determined by
their effect on the initial rate and extent of the fluorescence intensity increase, caused
by polymerisation of pyrene labelled actin monomers. The basis of this assay is
described by Kouyama and Mihashi (1981) and Walsh et al (1984). Modifications
are as follows.
2.6.1 Polymerisation assay
G-Actin (20% pyrene labelled) was prepared at a concentration of 1 .OjiM in ATP-G-
Buffer. F-Actin, used as seeds for nucleation, was prepared by polymerising 20 -
30(tM actin (unlabelled), in ATP-G-Buffer, by the addition of KC1 and MgC^ to
lOOmM and 2mM, respectively. This mixture was left for 30min at room
temperature, and then ATP-F-Buffer was used to dilute the polymerised actin to
3.0pM. The F-Actin solution was equilibrated at 20°C for 2hrs before subsequent
use.
Method
The final reaction volume was 500pl. A solution containing 2M KC1, 40mM MgC^
("20x salt") was added to 250pl of 1.0|lM G-Actin so the final concentrations were
lOOmM KC1 and 2mM MgC^. This was incubated for 60sec, at 20°C, before the
addition of F-Actin seeds (0. lpM) to nucleate polymerisation. Aliquots of 3.0|lM F-
Actin were vortexed for 20sec, then mixed with the appropriate amount/volume of
protein (T-cap-protein or Gelsolin, in ATP-F-Buffer). Following a subsequent 20sec
incubation ATP-F-Buffer was added to a final volume of 250(il. The F-Actin seeds
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were then added to the G-Actin solution, to nucleate polymerisation, and following a
further 20sec incubation, 400|il of the reaction mixture was removed and placed in a
quartz fluorescence cuvette (1cm path length) and the rate of polymerisation
measured. (The total incubation time was 90sec. This includes ~ lOsec for the
transfer of the reaction mixture into the cuvette and the transfer of the cuvette into
the holding cell of the fluorimeter). The initial rate of polymerisation was measured
by monitoring the increase in the fluorescence intensity of pyrene actin. Fluorescence
measurements were carried out in a Perkin-Elmer LS50B spectrofluorimeter at 20°C,
with a Grant LTD6 temperature control unit. The excitation wavelength for pyrene
actin was 366nm and the emission wavelength was 384nm, using a 5nm slit width for
both. The fluorescence signal was typically measured for 400, 800 or 1000 sec.
The initial rate of polymerisation can be directly measured from the initial increase in
the fluorescence intensity of pyrene labelled actin, which is proportional to the rate
of incorporation of monomers into filaments. d[F-Actin] / dt can be calculated from
the relationship:
d[F-Actin] / dt = df / dt*{[total actin] / (fF-fG)},
where fF is the fluorescence of the pyrene-actin when it is all polymerised, fG is the
fluorescence when all the pyrene-actin is monomeric and df / dt is the time
dependent fluorescence, df / dt can be calibrated, from the mean fluorescence
intensity values from a range of concentrations of G-Actin and F-Actin, obtained
from critical concentration assays, to give d[F-actin] / dt in nM.s"1.
2.6.2 Depolymerisation assay
Method
20 - 30jlM G-Actin (20% pyrene), in ATP-G-Buffer, was polymerised by the
addition of KC1 and MgCh to lOOmM and 2mM, respectively. This mixture was left
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for 30min at room temperature, and then further diluted to 3.0pM by the addition of
ATP-F-Buffer. The F-Actin solution was equilibrated at 20°C for 2hrs before
subsequent use.
Aliquots of F-Actin were vortexed for 20sec and then the appropriate amount/volume
of protein (T-cap-protein or Gelsolin) was added and mixed and incubated for a
further lOsecs. ATP-G-Buffer or ATP-F-Buffer was then added to give a final
concentration of actin of 0.5jlM, in a total reaction mixture volume of 500pil. 4-OOpl
of the reaction mixture was then removed and placed in a quartz fluorescence cuvette
(lcm path length) and the rate of polymerisation measured. The initial rate of
polymerisation was measured by monitoring the increase in the fluorescence
intensity of pyrene actin. Fluorescence measurements were carried out in a Perkin-
Elmer LS50B spectrofluorimeter at 20°C, with a Grant LTD6 temperature control
unit. The excitation wavelength for pyrene actin was 366nm and the emission
wavelength was 384nm, using a 5nm slit width for both. The fluorescence signal was
typically measured for 400, 800 or 1000 sec.
2.7 Actin co-sedimentation assay
The protocol used was based on that described by Winder and Walsh (1990).
Modifications are described below.
The assay volume used was 50 or lOOjil (the amount of available protein dictates the
actual volume used). 20 - 30jlM G-Actin, in ATP-G-Buffer, was polymerised by the
addition of KC1 and MgCh to lOOmM and 2mM, respectively. This was left to
incubate at room temperature for lhr before use in the co-sedimentation assays. The
protein under examination (e.g. T-cap-protein) was concentrated to ~ 1000(lM, in
ATP-F-Buffer. A dilution series of the F-Actin binding protein under examination,
was then set up (typically with the range of concentrations of 0, 2, 5, 10, 20, 50, 80,
100, 200, 400, 1000|lM). Additionally an incubation containing the highest
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concentration of ligand alone and 10pM F-Actin alone were also set up. The
appropriate amount of the F-Actin binding protein was then diluted to the appropriate
final concentration, in a final volume of 50 or lOOjil, with ATP-F-Buffer, and gently
mixed. The final concentration of actin was lOpM in every reaction mixture. The
samples were then incubated for 15min at room temperature, and then subsequently
centrifuged at 386,000 xg, in a TL100 Ultracentrifuge rotor (Beckman), for 15min at
4°C.
Following the high-speed centrifugation, the supernatant was carefully removed and
added to an equal volume of 2x SDS-PAGE sample buffer. 50 or 100pil (whatever
the assay volume used) of 2x SDS-PAGE sample buffer was then added to the F-
Actin pellet fraction. This was incubated at room temperature for 30min, to allow the
pellet to completely dissolve. The pellet fraction was then transferred to a fresh tube
and the original washed with an equal volume of ATP-F-Buffer. This was then added
to the pellet fraction. Equal volumes of the supernatant and pellet fractions were then
subjected to SDS-PAGE analysis. Typically 10% (w/v) polyacrylamide gels were
used and run as described. The gels were stained with SYPRO™ Red protein stain
and the intensities of the bands analysed as described in ImageQuant™, performed as
described. Following analysis in ImageQuant™ the gels were re-stained with R250
Coomassie Blue to visualise the proteins normally.
Typically the amount of ligand bound to the F-Actin fraction is calculated from the
difference between the two intensities of the supernatant and pellet fractions (where
the sum of the two intensities corresponds to the total ligand concentration used in
the incubation). Corrections need to be made to the values obtained for the band
intensities. The amount of ligand that pellets in the absence of any actin (% of
insoluble material) is obtained from the incubation tube containing the highest
concentration of ligand alone, in the absence of F-Actin. This value was typically 1 -
2% of the concentration added. The amount of ligand "trapped" by the F-Actin
filament network, in a non-specific way also needs to be determined empirically,
with a protein of similar size that does not bind to actin (e.g. ovalbumin was used for
T-cap-protein). Typically this value was ~ 1%. The corrections reduced the mean
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apparent ligand in the pellet by ~ 2%. The 10pM F-Actin incubation tube provide a
reference for the quality of the actin and provides a monitor for any change in the
critical concentration due to ligand binding (any change in the amount of actin
recovered in the supernatant fractions).
Typically the binding data is analysed by Scatchard plots, plotting:
[Bound ligand] / [Free ligand] vs [Bound ligand] / [F-Actin]
The Kd can be derived from 1/gradient and maximum ligand bound per F-Actin
monomer (i.e. the stoichiometry of binding) from the intersection on the x-axis.
Alternatively, non-linear least squares fitting of the data to equation below can be
performed;
[Bound ligand] = Bmax*[ligand]/([ligand]+Kd),
where Bmax is equal to the maximal amount of ligand bound and is equilibrium
dissociation constant.
2.8 Recipes for E. coli growth media
The recipes used were based on those described by Sambrook et al (1989), in
Molecular Cloning. A laboratory manual.
Stock solutions
Ampicillin (AMP), 50mg.mr' in dH20.
Streptomycin (STREP), 40mg.mr', in dFEO.
Thiamine (THI), lmg.mf', in dH20.
20% Glucose.
Isopropyl-P-D-thio-galactopyranside (IPTG), 1M in dH20.
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(All of the above were autoclaved separately).
2xTY agar plates
15g.L"' Bacto-Agar;
31g.L 1 2x yeast-tryptone powder (2xTY).
The media was autoclaved in a suitable sterile vessel, and cooled to below 50°C
before the addition of any antibiotic/heat sensitive compound.
2xTY/Ampicillin (AMP) agar plates
Ingredients are identical to those listed above, except with the addition of ampicillin
to 50p,g.mr'.
M9 minimal media agar plates
6g Bacto-Agar;
100ml of x4 M9 salts;
0.8ml of 1M MgS04;
40pl of 1M CaCl2;
dH20 added to final volume of 400ml.
The media was autoclaved in a suitable sterile vessel, and cooled to below 50°C.
After cooling the following were added:
THI, to liig.ml"1;
8ml of 20% glucose;
STREP, to 25|i,g.mT1.
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2xTY liquid growth media
3 lg.L"1 2x yeast-tryptone powder (2xTY).
The media was autoclaved in a sterile 2L conical shaker flask, and cooled to below
50°C before the addition of any antibiotic/heat sensitive compound.
2xTY/AMP liquid growth media




Strain (E. coli) Genotype Use/Reference





















expression from the tac
promoter (trp - lac hybrid),
with induction by addition
of IPTG. (Yanisch-Perron
et al, 1985).
BL21(DE3) hsdS, gal, (Xc\ts857, indl,
Sam 7, nin5, lacUV5-T7
gene 1)
Recombinant gene
expression from the T7
promoter, with induction




2.10 Over-night bacterial cultures
20ml of 2xTY growth media (either minus antibiotic or with AMP added to 50(ig.mr
'), in a 250ml conical shaker flask, was inoculated with a single colony of a given
bacterial strain. The cells were then grown, shaking at 37°C, until Agoonm ~ 0.6 - 1.0.
The cells were decanted into a sterile 50ml Falcon tube and placed on ice for 15min.
Following this, the cells were stored overnight at 4°C. The cells were then pelleted
by centrifugation at 3000 xg, for 5min at 4°C. The cells were re-suspended in 20ml
of fresh 2xTY media and aliquots of this overnight culture were then used to
inoculate larger volumes of growth media for protein expression, plasmid
amplification and extraction or for the preparation of Ca2+ competent cells.
2.11 Ca2+ competent if. coli
The protocol used was based on that described by Sambrook et al (1989), in
Molecular Cloning. A laboratory manual.
5ml from an over-night culture of a given E. coli strain, (grown in 2xTY minus
antibiotic), was used to inoculate 100ml of 2xTY in a 250ml conical shaker flask.
Cells were grown, shaking at 37°C, until Agoonm reached ~ 0.6 - 1.0. The cells were
then transferred to two sterile, 50ml Falcon tubes, and left on ice for lOmin. The cells
were centrifuged at 3000 xg, for 5min at 4°C, the supernatant carefully removed, and
then the cell pellets gently re-suspended in ~ 10ml of lOOmM CaCl2 at 4°C. The
suspension was left at 4°C for lhr. Following this incubation the cells were subjected
to centrifugation at 3000 xg, for 5min at 4°C, the supernatant removed, and the cell
pellets gently re-suspended in ~ 2ml of lOOmM CaCl2 4°C. Ca2+ competent cells
were stored at 4°C and either used immediately or within 5 days.
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2.12 Transformation of E. coli
The protocol used is a heat shock method, based on that described by Sambrook et al
(1989), in Molecular Cloning. A laboratory manual.
lOOpl of Ca2+ competent cells were transferred to a sterile 0.5ml Eppendorf tube at
4°C. 3.0pl of plasmid DNA was added, the solution mixed very gently, and left for
Ihr, at 4°C. The cells were then placed in a water bath, at 42°C, and heat shocked for
lmin. Following heat shock, the cells were placed on ice for 5min. 500pl of 2xTY
media was then added, and the cells were incubated, shaking at 37°C, for 15min.
50pl of the recovered E. coli, were transferred onto a 2xTY/AMP (50pg/ml) agar
plate and spread using a sterile glass spreader. The agar plate was left for 5min to
allow the cell suspension to soak into the media, and then incubated overnight, at
37°C, in an inverted position. Successful transformants were used immediately or
stored at 4°C until needed (no longer than 4 weeks).
2.13 Alkali lysis plasmid mini prep
The protocol used was based on that described by Sambrook et al (1989), in
Molecular Cloning. A laboratory manual.
Stock solutions
SET: 20% (w/w) sucrose;
50mM Tris, pH 8.0;
50mM EDTA.
(The above solution was stored at 4°C).
Alkali lysis: 0.2M NaOH;
1% (w/v) SDS.
(The above solution was made up fresh before use).
3M NaAcetate, pH 4.8 (acetic acid), stored at 4°C.
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RNase A: lOmg.ml"1 in dH20. (The enzyme was heated to 80°C to
inactivate any trace of DNasel present. It was subsequently
stored at minus 20°C).
TE: lOmM Tris, pH 8.0;
O.lmMEDTA.
(The above solution was stored at room temperature).
70% (v/v) Ethanol.
Isopropanol.
A high plasmid copy E. coli strain (e.g. JM101, JM109) was transfected with the
appropriate plasmid DNA. An overnight culture, (with the appropriate antibiotic
added), was grown containing transfected bacteria. 1ml aliquots of the re-suspended
cells were then centrifuged at 13,000 xg, for 5min at 4°C. The supernatant was
carefully removed and 150jil of SET buffer and 5(il of RNasel was then added. The
mixture was vortexed vigorously and 350(0.1 of alkali lysis solution was added. The
solution was gently mixed, by several inversions, until the mixture cleared. The
solution was placed on ice for 5min at 4°C. Following this incubation, 250(ll of cold
3M NaAcetate, pH 4.8, was added, the solution mixed well, and then placed back on
ice for a further lOmin. The mixture was then subjected to centrifugation at 13,000
xg, for lOmin at 4°C, and the supernatant, containing plasmid DNA, carefully
removed to a new tube. This new tube was filled with isopropanol, mixed well and
subjected to centrifugation at 13,000 xg, for 5min at room temperature. The
supernatant was again carefully removed and 0.5ml of 70% (v/v) EtOH, at room
temperature, was added to the precipitate. (A precipitate may not be actually seen as
"clean" plasmid DNA is often transparent). The sample was vortexed and
centrifuged at 13,000 xg, for 5min at room temperature. The EtOH was then
removed and the plasmid DNA pellet re-suspended in 50|il of TE buffer. Plasmid
DNA was stored at minus 70°C.
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2.14 Recombinant mutant DNaseI/H134Q purification protocol
2.14.1 Optimisation of expression
Ca2+ competent JM105 E. coli were successfully transformed with pkk223-
3[DNaseI/H134Q] and maintained on 2xTY/AMP (SOjlg.mr1) agar plates. 5ml from
an overnight culture was used to inoculate 100ml of 2xTY/AMP (SOqg.mr1). The
cells were grown, shaking at 37°C, until the Aeoonm ~ 0.6 - 1.0 and induction of
synthesis of DNasel was carried out by addition of IPTG to l.OmM. 5ml aliquots
were removed at various time intervals and the percentage of DNasel in the soluble
protein fraction was analysed.
The cell pellets obtained at each time point were resuspended in lOmM Tris, pH 7.6;
2mM CaCF; l.OmM NaN3; 100|iM PMSF; 100pM benzamidine, and subjected to
lysis by ultrasonication (3 x 20sec bursts at 4°C). The resulting cell lysate was then
centrifuged at 18,000 xg, for 5min at 4°C. The soluble supernatant fraction was
removed and the insoluble pellet fraction was resuspended in the same volume of
lOmM Tris, pH 7.6; 2mM CaCl2; l.OmM NaN3; lOOjlM PMSF; 100pM
benzamidine. 5(il of 5x SDS-sample buffer was added to 20pl samples of soluble,
insoluble and pre-lysis whole-cell fractions. These samples were then subjected to
SDS-PAGE. The appearance and relative percentage of DNasel in the soluble and
insoluble fractions was subsequently analysed by gel densitometry, performed as
described.
2.14.2 Purification protocol
(All purification was performed on Pharmacia Gradifrac™ or FPLC™ systems).
Calcium competent JM105 E. coli were successfully transformed with pkk223-
3[DNaseFH134Q] and maintained on 2xTY/AMP (SOilg.ml"1) agar plates. 10ml
from an overnight culture was used to inoculate 1 L of 2xTY/AMP (SOjig.mF1). The
cells were grown, shaking at 37°C, until the Aeoonm ~ 0.6 - 1.0 and induction of
synthesis of DNasel was carried out by addition of IPTG to l.OmM. The cells were
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grown for a further 4hrs and then harvested by centrifugation at 3000 xg, for 10 min
at 4°C. The cell pellets were either processed immediately or were flash-frozen with
liquid nitrogen in 10ml of 30mM Tris, pH 8.0; 4mM EDTA; l.OmM NaN3; 5ml of
bacterial cell extract inhibitor cocktail (Sigma), per litre of original bacterial cell
culture, and stored at minus 70°C until needed.
Cell pellets were re-suspended at 10% (w/v) of cells, in 30mM Tris, pH 8.0; 4mM
EDTA; 1 .OmM NaN^; 5ml.L"1 of bacterial cell extract inhibitor cocktail (Sigma). The
cell suspension was then lysed by ultrasonication, (5 x 20sec bursts at 4°C).
Following centrifugation at 50,000 xg, for lhr at 4°C, the clarified, soluble cell
extract was dialysed overnight against iOmM Tris, pEl 7.6; 2mM CaCl2; l.OmM
NaN3; lOOpM PMSF; lOOpM benzamidine at a 1:100 volume ratio for
sample:dialysis buffer, respectively. The dialysate was then filtered through a
0.22pm filter and loaded onto a DEAE-Sepharose column (Vt ~ 50 ml; 2.6cm x
9.5cm) pre-equilibrated in the same buffer. Unbound proteins were washed through
with this buffer and bound proteins were eluted by a gradient of 0 - 0.3M NaCl, over
6 column volumes (300ml), with a flow rate of 1.0ml.min"1. Proteins were detected
by A280nm and analysis by SDS-PAGE.
Relevant fractions were pooled, concentrated and dialysed overnight against lOmM
Tris, pH 7.6; 2mM CaCl2; l.OmM NaN2; lOOpM PMSF; lOOpM benzamidine, at a
1:100 volume ratio for sample:dialysis buffer, respectively. The dialysate was then
filtered through a 0.22pm filter and loaded onto a Cibacron F3GA Blue column (Vt ~
5.0ml; 1.0cm x 6.5cm), pre-equilibrated in the same buffer. Unbound proteins were
washed through with this buffer and specific elution of DNasel from the resin was
achieved with a ImM - lOmM ATP gradient, over 10 column volumes, with a flow
rate of 0.3ml.min"1. Proteins were detected by A280nm and analysis by SDS-PAGE.
Relevant fractions were pooled, concentrated and dialysed overnight against lOmM
Tris, pH 7.6; 2mM CaCl2; l.OmM NaN3; lOOpM PMSF; lOOpM benzamidine, at a
1:100 volume ratio for sample:dialysis buffer, respectively. The dialysate was
filtered through a 0.22pm filter, concentrated to ~ 2ml, and subjected to size-
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exclusion chromatography on a Sephacryl-200 (S200) column (Vt ~ 135ml; 65cm x
1.6cm), pre-equilibrated in the same buffer, with a flow rate of 0.5ml.min"'. Proteins
were detected by A280nm and analysis by SDS-PAGE, and the relevant fractions
pooled and concentrated and stored at 4°C, in the above buffer, until needed. (See
appendix B for details of alternative storage conditions and assay of the activity of
DNasel purified by this protocol).
2.15 Human cytoplasmic gelsolin (HGS) purification protocol
(All purification was performed on Pharmacia Gradifrac™ or FPLC™ systems).
Ca2+ competent BL21(DE3) E. coli were successfully transformed with
pMW172[HGS] and maintained on 2xTY/AMP (50jig.mr'). 10ml from an overnight
culture was used to inoculate 1 L of 2xTY/AMP (SOpg.mr1). The cells were grown,
shaking at 37°C, until the Agoonm ~ 0.6 - 1.0 and induction of synthesis of gelsolin
was carried out by addition of IPTG to l.OmM. The cells were grown for a further
3hrs and then harvested by centrifugation at 3000 xg, for 10 min at 4°C. The cell
pellets were either processed immediately or were flash-frozen with liquid nitrogen,
in 10ml of 30mM Tris, pH 8.0; 4mM EDTA; l.OmM NaN3; 5ml of bacterial cell
extract inhibitor cocktail (Sigma), per litre of original bacterial cell culture, and
stored at minus 70°C until needed.
The cell pellets were resuspended at 10% (w/v) of cells, in 30mM Tris, pH 8.0; 4mM
EDTA; l.OmM NaN3; 5ml.L"1 of bacterial cell extract inhibitor cocktail (Sigma). The
cell suspension was then lysed by ultrasonication, (5 x 20sec bursts at 4°C).
Following centrifugation at 50,000 xg, for lhr at 4°C, the clarified soluble cell
extract was dialysed overnight against 25mM Tris, pH 8.0; O.lmM DTT; l.OmM
NaN3; 0.2mM EGTA; 100|iM PMSF; 100|iM Benzamidine, at 4°C. The dialysate
was then filtered through a 0.22|im filter and loaded onto a Cibacron F3GA Blue
column (V, ~ 10.0ml; 1.6cm x 5.0cm), pre-equilibrated in the same buffer. Unbound
proteins were washed through with this buffer and gelsolin was specifically eluted
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with a wash of ImM ATP, in the above buffer, over 3 column volumes (15ml), with
a flow rate of 0.5ml.min~'. Proteins were detected by A280nm and analysis by SDS-
PAGE.
For samples from greater than 500ml of original bacterial cell culture, a second
round of chromatography, on a Cibacron F3GA Blue column in the presence of
calcium, was routinely carried out. Relevant fractions from the first column were
pooled, concentrated and dialysed overnight against 25mM Tris, pH 8.0; O.lmM
DTT; ImM Azide; l.OmM CaCL; lOOpM PMSF; 100|iM Benzamidine, at 4°C, at a
1:100 volume ratio for sample:dialysis buffer, respectively. The dialysate was
filtered through a 0.22|im filter and loaded onto a Cibacron F3GA Blue column (Vt ~
5.0ml; 1.0cm x 6.5cm), pre-equilibrated in the same buffer. Elution of gelsolin from
the resin was achieved with a 0.4 - 1.0M NaCl gradient, over 4 column volumes, or a
0.6mM NaCl wash, over 5 column volumes, with a flow rate of O.Sml.min1. Proteins
were detected by A280nm and analysis by SDS-PAGE.
Relevant fractions were pooled, concentrated and dialysed overnight against 25mM
Tris, pH 8.0; O.lmM DTT; ImM Azide; 0.2mM EGTA; lOOpM PMSF; 100|lM
Benzamidine, at 4°C, at a 1:100 volume ratio for sample:dialysis buffer, respectively.
The dialysate was filtered through a 0.22pm filter, concentrated to ~ 2ml, and
subjected to size-exclusion chromatography on a Sephacryl-200 (S200) column (Vt ~
135ml; 65cm x 1.6cm), pre-equilibrated in the same buffer, with a flow rate of
0.5ml.min"'. Proteins were detected by A28onm and analysis by SDS-PAGE, and the
relevant fractions pooled and concentrated and stored at 4°C, in the above buffer,
until needed. Gelsolin was routinely stored in a buffer containing EGTA. Long term
storage of gelsolin in Ca2+ containing buffers has been shown to result in a loss of the
Ca2+ sensitive actin binding activity (Pope et al, 1989).
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2.16 Purification protocol for recombinant full-length T-cap-protein
(All purification was performed on Pharmacia Gradifrac™ or FPLC™ systems).
Ca2+competent BL21(DE3) E. coli were successfully transformed with pMW172[T-
cap-protein/R861-A1223] and maintained on 2xTY/AMP (50pg.mr') agar plates.
10ml from an overnight culture was used to inoculate 1 L of 2xTY/AMP (SOpg.mP1).
The cells were grown, shaking at 37°C, until the Agoonm ~ 0.6 - 1.0 and induction of
synthesis of the T-cap-protein construct was carried out by addition of IPTG to
l.OmM. The cells were grown for a further 3hrs and then harvested by centrifugation
at 3000 xg, for 10 min at 4°C. The cell pellets were processed immediately.
Cell pellets were re-suspended at 10% (w/v) of cells, 20mM Bis-Tris, pH 6.1;
0.25mM EDTA; 5mM NaCl; ImM NaN3; 5ml of bacterial cell extract inhibitor
cocktail (Sigma) per litre of original cell culture. The cell suspension was then lysed
by ultrasonication, (5 x 20sec bursts at 4°C). Following centrifugation at 50,000 xg,
for lhr at 4°C, the clarified, soluble cell extract was dialysed overnight against
20mM Bis-Tris, pH 6.1; 0.25mM EDTA; 5mM NaCl; ImM NaN3; 5ml of bacterial
cell extract inhibitor cocktail (Sigma) per litre of dialysis buffer, at a 1:100 volume
ratio for sample:dialysis buffer, respectively. The dialysate was then filtered through
a 0.22pm filter and loaded onto a DEAE-Sepharose column (Vt ~ 50 ml; 2.6cm x
9.5cm) pre-equilibrated in the same buffer. Unbound proteins were washed through
with this buffer and bound proteins were eluted by a gradient of 5 - 300mM NaCl,
over 6 column volumes (300ml), with a flow rate of 1.0ml.min"1. Proteins were
detected by A280nm and analysis by SDS-PAGE.
Relevant fractions were pooled, concentrated and dialysed overnight against 50mM
MES, pH 5.50; 0.25mM EDTA; 5mM NaCl; ImM NaN3; 5ml of bacterial cell
extract protease inhibitor cocktail (Sigma) per litre of dialysis buffer, at a 1:100
volume ratio for sample:dialysis buffer, respectively. The dialysate was filtered
through a 0.22pm filter and loaded onto a Mono-S/(30pm) column (Vt ~ 6.0ml;
1.6cm x 2.0cm), pre-equilibrated in the same buffer. Unbound proteins were washed
through with this buffer and elution of T-cap-protein from the resin was achieved
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with a 5mM - lOOmM NaCl gradient, over 6 column volumes (36ml), with a flow
rate of 0.5ml.min"1. Proteins were detected by A280nm and analysis by SDS-PAGE.
Depending on the degree of proteolytic degradation and the relative yields of full-
length T-cap-protein and the major degraded fragment, several further rounds of
cation-exchange on Mono-S/(30|im) resins were performed. The gradient parameters
used were varied to maximise the purity and yield of the full-length T-cap-protein.
However, the final ion exchange step was always that described below.
Relevant fractions were pooled, concentrated and dialysed overnight against, 50mM
MES, pH 5.50; 0.25mM EDTA; 5mM NaCl; ImM NaN3; 5ml of bacterial cell
extract protease inhibitor cocktail (Sigma) per litre of dialysis buffer, at a 1:100
volume ratio for sample:dialysis buffer, respectively. The dialysate was then filtered
through a 0.22|im filter and loaded onto a HR 5/5 Mono-S/(15|im)/FPLC column (Vt
~ 1.0ml; 1.0cm x 1.30cm), pre-equilibrated in the same buffer. Unbound proteins
were washed through with this buffer and elution of T-cap-protein from the resin was
achieved with a 60mM - 80mM NaCl gradient, over 15 column volumes (15ml),
with a flow rate of 0.25ml.min"1. Proteins were detected by A280nm and analysis by
SDS-PAGE.
Relevant fractions were pooled and concentrated to ~ 200pl. The sample was then
subjected to size exclusion chromatography on an FPLC/Superose-12™ (Pharmacia)
size exclusion column (Vt ~ 24ml; 1.0cm x 32cm), pre-equilibrated in either ATP-F-
Buffer or lOOmM Tris, pH 8.0; ATP-G-Buffer, with a flow rate of 0.5ml.min"1.
Proteins were detected by A280nm and analysis by SDS-PAGE, and the relevant
fractions were pooled and concentrated and stored at 4°C, in the above buffer until
needed.
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2.17 Determination of protein concentration
2.17.1 Individual proteins
For the individual proteins, gelsolin, actin, DNasel, full-length T6-potein and myosin
S-l head, concentrations were calculated using the extinction coefficients listed
below:
Actin1, £290nm = 24.9 mM"1.cm"1.
Gelsolin1, £280nm = 150 mM"1.cm"1.
'Webber et al, 1994; 2Gill and von Hippel, 1989; 3Combeau et al, 1992.
2.17.2 Protein complexes
The concentrations of the various protein complexes, actin:DNaseI binary complex
(A:D), gelsolin:actin binary complex (G:A), gelsolin:actin2 ternary complex (G:A2)
were determined by using the Bicinchoninic acid (BCA) protein assay (Pierce®)
protocol, usually with a primary TCA precipitation step to avoid any interfering
substances (e.g. DTT, EGTA, EDTA). Bovine serum albumin (BSA) or a sample of
known concentration of the individual proteins was used as the reference standard.
Reagents were as described for the standard Bicinchoninic acid (BCA) protein assay
(Pierce®), with the method modified as described below.
Trichloroacetic acid (TCA) precipitation reagents
0.15% (w/v) Sodium Deoxycholate
72% (w/v) TCA
DNasel , £280nm = 34.4 mM"1.cm"1.
Full length T-cap-protein2 £280nm= 19.2 mM'.cm"1
Myosin S-l head3 £280nm = 88.8 mM"1.cm"1.
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5% (w/v) SDS in 0.1M NaOH
Method
50pl of the protein sample to be assayed (either unknown or standard) was added to a
1.5ml Eppendorf tube. 950pl of dH20 was then added followed by lOOpl of 0.15%
(w/v) sodium deoxycholate. The solution was mixed by inversion and incubated at
room temperature for 15min. 1OOptl of 72% (w/v) TCA was then added, the solution
vortexed and subjected to centrifugation at 3000 xg for 15min at room temperature.
The supernatant was carefully removed and the insoluble protein pellet solubilised in
50pl 5% (w/v) SDS; 0.1M NaOH. 1.0ml of working BCA reagent was then added to
the tube, the sample vortexed and incubated at 37°C for 30min. Following this
incubation the samples were quickly removed and the absorbance at 562nm
measured for all the samples.
Typically, the range of standards used was 100, 75, 50, 25, 12.5, 6.25pg. A dilution
series of 1:1, 1:2, 1:4, 1:8, 1:16 of the unknown protein solution was used, treated in
the manner described above. Plots of A562nm against |ig of standard protein, and pi of
unknown sample were performed. To try and minimise the errors inherent in this
method of protein concentration determination, the ratio of the gradients from the
two plots (AbS562nm-pl1 / AbS562nm-ftg 1 = Itg.pf1) was used to calculate the
unknown sample concentration.
2.18 Sodium dodecylsulphate polyacrylamide gel electrophoresis (SDS-PAGE)
SDS-PAGE was performed as described by Laemmli (1970). Modifications are
described below. The BioRad Mini-PROTEAN II™ gel system was used, with gels





made up to dH20 to 500ml.
(The above solution was filtered through a Whatman
No. 1 filter, and stored at room temperature).
1.5M Tris, pH 8.8.
0.5M Tris, pH 6.8.
10% SDS (w/v).
10% (w/v) Ammonium persulphate (APS) made up fresh before use.
TEMED, stored at 4°C.
dH20 saturated isobutanol.
0.1% (w/v) bromophcnol blue in dH20, stored at 4°C.
Running buffers
1Ox running buffer: 30g Tris-base;
144g Glycine;
lOg SDS;
made up to 1L with dH20.
5x SDS-Sample buffer: 4ml dH20;
lml 0.5M Tris, pH 6.8;
lml glycerol;
1.6ml 10% (w/v) SDS;
0.4ml (3-mercoptoethanol or lOOmM DTT;
0.2ml 0.1% (w/v) bromophenol blue.
(Non-reducing sample buffer contained the same ingredients minus the DTT or P~
mercoptoethanol).
Separating gel mixtures.
7.5% 10% 12% 15% 18% 20%
dH20 4.85ml 4.05ml 3.35ml 2.35ml 1,35ml 0.75ml
1.5M Tris, pH 8.8 2.5ml 2.5ml 2.5ml 2.5ml 2.5ml 2.5ml
10% SDS 100pl 100pl 100pl 100M-I 100pl 100pl
acrylamide 2.5ml 3.3ml 4ml 5ml 6ml 6.6ml
10% APS 50p! 50pl 50pl 50pl 50pl 50pl
TEMED 5pl 5pl 5pl 5pl 5pl 5pl
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Stacking gel mixture; 4% (w/v) acrylamide.
dH20 3.05ml





Running conditions: 45min at a constant 200V.




The dye was dissolved in the above solutions, while gently stirring, and was then
filtered through a Whatman No. 1 filter. Gels were typically stained for 20min and
then subjected to exhaustive destain.
Destain: 100ml Methanol, (10% v/v);
100ml Acetic acid, (10% v/v);
made up to 1L with dH20.
2.19 Non-denaturing polyacrylamide gel electrophoresis
2,19.1 First dimension native-PAGE.
The protocol used was based on an electrophoretic procedure for detecting actin-
binding proteins described by Safer (1989). Modifications for the BioRad Mini-




lOx native gel buffer: 250mM Tris, pH 9.0;
1.94M Glycine.
Running buffer: 50ml lOx native gel buffer;
0.2mM ATP (lOOmM stock in dH20);
0.5mM DTT (1M stock in dH20);
made up to 500ml with dH20.




0.2 - 2.0mM MgCl2.
Sample buffer: 50% (v/v) Glyerol in running buffer (with appropriate
additions).








(CaCI2, EGTA, and MgCI2 were added to the appropriate concentrations and the
volume of dH20 adjusted accordingly).
Running conditions: Constant 200V for various times (see below).
Method
Double sets of 0.75mm spacers were used during gel set up. A four well, 50|il
sample volume, comb was also used during the gel set up. Samples were first
incubated under the appropriate conditions, then a 25pl sample was mixed 1:1 with
the appropriate sample buffer. This was incubated for 5min at room temperature, and
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then loaded carefully into the sample wells of the gels. A tracking dye containing
Xylene cyanol and bromophenol blue was also added to an unused sample well to
follow the electrophoretic progress. Gels were typically run until the green Xylene
cyanol band had migrated to the bottom, ~ 40 - 50min. This gave a migration
distance for G-Actin of ~ 60% (with respect to the bottom of the gel). The conditions
for each given set of individual proteins/protein complexes were determined
empirically, and adjusted accordingly.
2.19.2 Second dimension SDS-PAGE
After the first dimension native-gel had been run, the entire lane of interest was
excised from the gel, using a razor blade. The edges of the lane were trimmed to
remove the "smile" section of the gel that commonly appeared during running of the
native gels (see results for examples). The gel lane was then placed horizontally ~
5mm from the top of a clean glass gel plate. The gel lane was then incubated in ~ 5 -
10ml of SDS-PAGE lx running buffer, and ~ 1ml of 10% SDS, for 15min at room
temperature.
The excess liquid was carefully removed, (with a tissue and thin pasteur), and the gel
piece was then clamped between two glass plates and an 11% (w/v) acrylamide SDS-
separating gel carefully poured underneath. After this had set, a 4% (w/v) acrylamide
SDS-stacking gel was poured round the gel piece, completely covering it. A protein
standards lane was placed in the stacking gel. Following acrylamide polymerisation
second dimension SDS-PAGE, staining and destaining were performed as described.
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2.20 SYPRO™ Red (Molecular Probes Inc.) fluorescent protein stain protocol
2.20.1 Staining protocol
The SYPRO™ Red protein stains are a set of fluorescent protein stains developed for
the detection of low levels of protein (~ 2ng, Molecular Probes Inc.) on SDS or non-
denaturing polyacrylamide gels. The SYPRO™ Red protein stain is supplied as a
5000x stock solution in dimethylsulphoxide, (DMSO).
Method
SDS-PAGE/Native-PAGE were carried out as normal. Gels were placed in clean gel
boxes (R250 Coomassie Blue binds to the proteins and masks SYPRO™ Red
staining) and rinsed for 5min in dPEO. Following this 50 ml of a 1:5000 dilution, in
7.5% (v/v) acetic acid, of SYPRO™ Red protein stain was added, per gel. The gels
were then incubated for lhr, at room temperature in the dark. (The staining solution
can be used for up to five times if protected from light).
The gel was then rinsed several times with dH20 to remove any excess stain. The gel
was then visualised on a Molecular Dynamics Chemifluorescence imager set to Blue
fluorescence, 100 micron pixel size, 800 PTM Voltage. The image was saved to disc
and subsequently analysed in ImageQuant™. Following analysis in ImageQuant™
the gels were be re-stained with R250 Coomassie Blue to visualise the proteins
normally.
2.20.2 Gel densitometry using SYPRO™ Red (Molecular Probes Inc.) fluorescent
protein stain
SDS-PAGE was carried out as described. Gels were stained with SYPRO™ Red as
described. The gel was then visualised on a Molecular Dynamics Chemifluorescence
imager set to Blue fluorescence, 100 micron pixel size, 800 PTM Voltage. The image
was saved to disc and subsequently analysed in ImageQuant™ v. 1.1 for the
Macintosh. The gel was displayed in inverted false colour to make the band
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boundaries easier to see. Rectangular scan profiles were then placed around the
protein bands of interest and the integrated volume intensity calculated using the
Local Background setting in ImageQuant™.
The intensity responses were calibrated. SDS-PAGE was performed with 11% (w/v)
polyacrylamide gels loaded with 0, 0.1, 0.25, 0.5, 1.0, 1.5, 2.0, 3.0, 4.0, 5.0, 6.0, 7.0,
8.0, lO.Opg of each respective protein, either applied separately or together. The gels
were stained and the intensity analysed. The colour-intensity response was linear for
all proteins (DNasel, G-Actin, gelsolin and T-cap-protein), in the concentration range
of 0 - 6|lg, and amounts of protein within this level (typically 2 - 3.0jlg) were used
as internal reference standards for stoichiometric analysis of complex components.
The SYPRO™ Red stain intensity showed less protein to protein variability than
R250 Coomassie Blue. However, the limit detection level for protein that we
observed, (for DNasel, G-Actin, gelsolin and T-cap-protein), with SYPRO™ Red,
was not significantly better than R250 Coomassie Blue (~ O.ljlg). Nevertheless, the
mechanics and logistics of the quantification procedures for SYPRO™ Red were
very much better than those available for R250 Coomassie Blue staining analysis.
2.21 Size-exclusion chromatography
2.21,1 FPLC/Superose-12 size-exclusion chromatography
An FPLC/Superose-12™ (Pharmacia) size exclusion column (Vt ~ 24ml; 1.0cm x
32cm) was used extensively during experiments performed to analyse complex
formation between gelsolin and G-Actin, G-Actin and DNasel, that between G:A2




5mM Tris, pH 8.0; 0.5mM DTT; 0.2mM CaCl2; 0.2mM ATP; l.OmM NaN3; lOOmM
KC1; 2mM MgCl2.
ATP-G-Buffer
5mM Tris, pH 8.0; 0.5mM DTT; 0.2mM CaCl2; 0.2mM ATP; l.OmM NaN3.
lOOmM Tris, pH 8.0; ATP-G-Buffer
lOOmM Tris, pH 8.0; 0.5mM DTT; 0.2mM CaCl2; 0.2mM ATP; l.OmM NaN3.
The column was equilibrated in either ATP-F-Buffer, ATP-G-Buffer, lOOmM Tris,
pH 8.0; ATP-G-Buffer (modified by the further addition of 0.6mM EGTA and/or
0.2mM CaCl2). Calcium was added to the buffers to ensure the activation and
subsequent actin binding activity of gelsolin. Due to interactions between the resin
and proteins, in buffers with low ionic strengths, ATP-G-Buffer was not used
extensively. Instead under conditions where depolymerising conditions were
required, lOOmM Tris, pH 8.0; ATP-G-Buffer was substituted. Proteins were applied
to the column in a sample volume, up to a maximum of 200|ll, with an automated
injection valve/sample loop. The column was run at O.Sml.min"1 and the elution
profiles monitored by A28onm and subsequent analysis by SDS-PAGE. Fraction size
was typically 400|il over the dynamic range of the column. The column was
calibrated, in the appropriate buffer, with protein standards (see table 2.1 and fig.
2.2).
Protein Theoretical Mr. Retention Vol. o CO o m
(kDa.) (ml)
Ribonuclease A 13.7 15.37 4.14
DNasel 29 14.36 4.46
Ovalbumin 43 12.95 4.63
BSA 67 11.98 4.83
Aldolase 158 11.68 5.2
Catalase 232 11.2 5.37
Ferritin 443 9.91 5.65
Table 2.1. Calibration standards for FPLC/Superose-12 column, in ATP-F-Buffer;
0.2mM CaCI2■ The column was calibrated with the proteins indicated. ~ 200pg of each
protein was applied and the column run with ATP-F-Buffer; 0.2mM CaCI2, with a flow
rate of 0.5ml.min"1. Vt = 24ml; 30.7cm x 1.0cm. Void volume - 7.25ml (calculated from
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Fig. 2.2 Calibration standard curve for FPLC/Superose-12 column, in ATP-F-
Buffer; 0.2mM CaCI2■ The retention volume for the proteins was plotted against the
log-io of the proteins Mr. and a linear regression performed on the data. The inset
indicates the equation of calibration, with the R2 value listed below. The column was
calibrated with the proteins indicated in table 2.1.
2.21,2 Preparative Sephacryl-200 (S200) size-exclusion chromatography
(All purification was performed on Pharmacia Gradifrac™ or FPLC™ systems). A
Sephacryl-S200 (S200) size exclusion column (Vt ~ 135ml; 65cm x 1.6cm) was used
for the purification of large amounts (~ 5 - lOmg) of the gelsolin:actin2 ternary
complex, (G:A2), the gelsolin:actin binary complex (G:A), and the actin:DNaseI
binary complex, (A:D) for use in further binding experiments.
The column was calibrated with protein standards in ATP-G-Buffer, with a flow rate
of 0.5ml.min"'. Protein standards used: Ferritin (Mr. = 443kDa), Catalase (232kDa),
Aldolase (158kDa), BSA (67kDa), Ovalbumin (43kDa), and Ribonuclease A
(13.7kDa). Plots of logio Mr. against elution volume were linear throughout this
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range. Proteins were detected by A280nm and subsequent analysis by SDS-PAGE,
performed as described.
Protein samples were concentrated to ~ 2ml and then applied to the S200 column,
pre-equilibrated in ATP-G-Buffer. No more than ~ lOmg of total protein applied to
the column during any given chromatographic run. The column was run with a flow
rate of 0.5ml.min"1. Fraction size was typically 1.0ml over the dynamic range of the
column.
2.21.3 Gelsolimactin complex formation and purification.
For large scale preparation of G:A2, typical concentrations used were ~ 6|lM gelsolin
and 12pM G-Actin, with ~ 5 - lOmg of total protein. Such incubations were carried
out in ATP-G-Buffer, to avoid any actin polymerisation. (At such actin
concentrations, well in excess of the monomer critical concentration, the presence of
salt results in the initiation of polymerisation). The complex mixture was then
concentrated to ~ 2ml and subjected to size exclusion on an S200 column, (Vt ~
135ml; 65cm x 1.6cm), in ATP-G-Buffer.
2.21.4 Purification of the gelsolimactin binary complex, (G:A)
Due to problems with an incomplete dissociation of G:A2, in the presence of EGTA,
to form G:A complex and free G-Actin we used an alternative method for the large
scale production of G:A, (amounts ~ 3 - 5mg).
The protocol used was based on that described by Selve and Wegner (1986).
Modifications are described below.
Method
(All purification was performed on Pharmacia Gradifrac™ or FPLC™ systems).
DNasel was used to prepare a DNasel-Sepharose affinity column. ~ 5mg of pre-
purified DNasel was concentrated to ~ 5mg.mr' and then applied to a Sephadex-G25
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(Coarse) desalt column, (Vt ~ 80ml; 2.6cm x 15cm), pre-equilibrated in lOOmM
NaHCCE, pH 8.3; 150mM NaCl, with a flow rate of lml.min"1. Elution was
monitored by A280nm and the relevant fractions pooled and concentrated to
approximately 5mg.mr'. This protein solution was added to an 80% slurry of NHS-
activated Sepharose 4® (N-hydroxysuccinamide-Sepharose 4, Pharmacia), in the
same buffer, at a ratio of 0.5:1 (coupling media:protein solution, respectively). The
mixture was then incubated, with gentle agitation, at room temperature for 4hrs, to
allow coupling of DNasel to the Sepharose resin via the activated NHS group and
free primary amino groups.
Following this incubation, excess 200mM Tris, pH 8.0 buffer was added (~ 20
volumes) to quench the reaction, and the mixture left for a further 2hrs. The resin
was then washed extensively with ATP-G-Buffer (~ 50 volumes), at 4°C, and the
media then loaded into a C 10/10 column® (Pharmacia) (Vt ~ 2 - 3ml; 1.0cm x
4.0cm). The column was then loaded with excess monomeric actin, in ATP-G-Buffer
at 4°C, to saturate the coupled DNasel with actin.
EGTA and MgCE were added to 0.6mM and 0.2mM, respectively, to ~ 5mg of G:A2
ternary complex in ATP-G-Buffer, purified as described. This mixture was left to
incubate for lhr, at 4°C, and then concentrated to ~ 2ml and subjected to size-
exclusion chromatography on a S200 column, pre-equilibrated in ATP-G-Buffer;
0.6mM EGTA; 0.2mM MgCl2. The fractions corresponding to G:A were pooled and
concentrated to ~ 1ml. CaCl2 was added to l.OmM and the protein sample then
applied to the Actin:DNaseI-Sepharose column, in ATP-G-Buffer. The G:A binary
complex, in the presence of Ca2+, re-binds to the actin, complexed 1:1 with the
immobilised DNasel, to form immobilised G:A2 ternary complex. The column was
washed with ~ 10 column volumes of the same buffer and elution of the G:A
complex from the affinity column, was achieved by 5.0mM EGTA in ATP-G-Buffer,
additionally with l.OmM CaC^and l.OmM MgCl2.
This protocol gave a much more homogeneous population of G:A (~ 95%) than gel-
filtration ofG:Ai complex in the presence of EGTA.
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2.21.5 Large scale actin:DNaseI binary complex purification
DNasel and G-Actin were mixed together, (in a molar ratio of 1:1) in ATP-G-Buffer,
and incubated for 30min at room temperature. Typical concentrations used were ~
6(iM G-Actin and 6|iM DNasel (the addition of 3 - 15 % excess DNasel was
included to account for the amount of inactive protein in a given preparation), with ~
5 - lOmg of total protein. The mixture was then concentrated to ~ 2ml and subjected
to size exclusion chromatography on an S200 column, (Vt ~ 135ml; 65cm x 1.6cm),
in ATP-G-Buffer.
The same procedure was performed with NBD-Actin for the creation and purification
of the Anbd'D binary complex.
2.22 NBD-Actin fluorescence binding assays
Two types of experiments were performed, (a) Gelsolin solutions of fixed
concentration were mixed with variable amounts of NBD-Actin or Anbd:D complex,
(b) The proportions of the two proteins/complexes, in a series of mixtures, were
continuously varied at a constant total protein concentration (the "continuous
variation" experiments). Fluorescence measurements were carried out in a Perkin-
Elmer LS50B spectrofluorimeter at 20°C, with a Grant LTD6 temperature control
unit. The excitation wavelength for both NBD-Actin and the Anbd:D binary complex
titration experiments was 475nm and the emission wavelength was 520nm, using a
5nm slit width for both. A quartz fluorescence cuvette with a lcm-path length and a
400pl working volume was used. The fluorescence intensity is reported in arbitrary
units.
Complex formation was studied in both calcium and EGTA. The proteins/complexes
were initially mixed together, in the appropriate concentrations, in ATP-G-Buffer or
ATP-F-Buffer, containing 0.2mM CaC^. For conditions containing Ca2+, the
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proteins were incubated for lhr at 20°C, in the dark and then the fluorescence
intensity measured.
For conditions in EGTA, the proteins/complexes were mixed together, in the
appropriate concentrations, in ATP-G-Buffer or ATP-F-Buffer, containing 0.2mM
CaCl2. Following a 5min incubation at 20°C in the Ca2+containing buffer, EGTA and
MgCl2 were added to 0.6mM and 0.2mM, respectively. The protein/complex
mixtures were incubated for a further lhr, at 20°C, and then the fluorescence
intensity measured.
2.23 Creation of nucleotide-free solutions for use in experiments probing the
"minifilament" conformation with the S-l head.
The protocol used was based on that described by Pollard et al (1992) and De la Cruz
and Pollard (1994). Modifications are described below.
200pl of strong anion exchange Dowex 1 resin (Bio-Rad AG1-X2) was extensively
washed (15 times 20 volumes) with 5mM Tris, pH 8.0; 0.5mM DTT; 0.2mM CaCl2;
lOOmM KC1; 2mM MgCl2. The final preparation of washed resin was stored as a
50% slurry in the same buffer at 4°C.
G:A2 ternary complex and A:D binary complex were added together at a 1:1 molar
ratio and incubated for 30min at room temperature, in modified ATP-F-Buffer;
50nM ATP; 0.2mM CaCl2. Myosin S-l, in nucleotide-free-ATP-F-Buffer (5mM Tris,
pH 8.0; 0.5mM DTT; 0.2mM CaCl2; lOOmM KC1; 2mM MgCl2), was then added at
a molar ratio of 1:1 (S-l:putative "minifilament" complex). The final concentrations
of G:A2, A:D and S-l were 3.0|lM. Removal of free nucleotide (both ADP and ATP)
from this mixture was performed by gently mixing 25|il (50% slurry in nucleotide-
free-ATP-F-Buffer) of Dowex 1 beads (Bio-Rad AG1-X2) with the protein solution,
followed by an incubation of 5min at 4°C. The Dowex 1 beads were then pelleted by
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centrifugation at 18,000 xg, for 5min at 4°C. Following centrifugation the
supernatant was carefully removed and the protein mixture was incubated at room
temperature for a further 30min, and then subjected to size-exclusion
chromatography on an FPLC/Superose-12 column, pre-equilibrated in nucleotide-
free ATP-F-Buffer.
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3. Probing the disposition of the actin subunits in ternary complex
with gelsolin
3.1 Overview
We have used decoration of the gelsolin:actin2 ternary complex (G:A2) with DNasel
to probe the disposition of the actin monomers in this complex. We have also
determined the stoichiometry of the components within this new complex. This new
complex has stoichiometry of G:A2:D2. Furthermore, we have studied the interaction
of the actin:DNaseI (A:D) binary complex with gelsolin.
The results are consistent with the actin monomers within G:A2 having a different
spatial orientation to those in a filament, or at least, the tight-binding association with
DNasel is sufficient to change that conformation.
3.1.1 Introduction
Gelsolin was first identified as calcium-dependent actin filament destabilising protein
found in blood plasma and in the cytoplasm of macrophages (Chaponnier et al, 1979;
Yin and Stossel, 1979; Harris et al, 1980). It is a member of a ubiquitous family of
severing proteins that is defined by either a three (e.g. fragmin, severin) or a six (e.g.
gelsolin, villin and adsevrin) repeat sequence motif spanning 125 - 150 residues that
fold up into functionally distinct domains (Weeds and Maciver, 1993; Sun et al,
1999). The six segments of gelsolin (G1 - 6), originally identified on the basis of
their sequence homology (Kwiatkowski et al, 1986; Way and Weeds, 1988; Way et
al, 1989) have been shown to contain the same basic fold (McLaughlin et al, 1993;
Burtnick et al, 1997). (See chapter 1 and figs. 1.7, 1.8 and 1.9 for details).
The activation of gelsolin requires calcium ions and it appears that while gelsolin has
several high affinity binding sites for calcium (Kd in the nM range) in the C-terminal
half, that may be involved in the activation and opening of the molecule, calcium
concentrations in the pM range are required for actin binding, severing and
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nucleation activities (Weeds et al, 1986; Way et al, 1989; Hellweg et al, 1993; Ditsch
and Wegner, 1995; Pope et al, 1997; Burtnick et al, 1997; Robinson et al, 1999).
Gelsolin has two binding sites for monomeric actin, a calcium-independent site in G1
(IQ ~ 5pM) and a calcium-dependent site in S4 (Kj ~ 1.8p.M for G5 alone, but ~
25nM as the G4 - 6 construct; Pope et al, 1995) and one F-Actin binding site located
in G2 (K<j ~ 1 - 5pM; Bryan, 1988; Way et al, 1992). The minimal actin severing
domain is G1 - 2 (Way et al, 1992; Sun et al, 1994), while full nucleating ability
requires the two actin binding sites in G2 - 6 (Way et al, 1989). The former construct
is calcium independent while the latter is calcium dependent, indicating the calcium
regulation of actin binding, of all three of the sites is mediated via the C-terminal half
of gelsolin. However, it is becoming increasingly clear that the interactions of whole
gelsolin, with both filamentous and monomeric actin, compared to the analogous
interactions of its various truncated domains and constructs, are probably subtly
different (Yin et al, 1988; Way et al, 1989; Pope et al, 1991; Way et al, 1992; Sun et
al, 1994; Pope et al, 1995; McGough et al, 1998).
Gelsolin also forms two complexes with monomeric actin (in a calcium dependent
manner); a binary (G:A) complex and a ternary (G:A2) complex. However, The
spatial orientation of the actin monomers in ternary complex with gelsolin is
unknown. It is still unclear whether the actin monomers bound in G:A2 are held in an
F-actin like conformation, akin to those found at the barbed-end of the filament (as
described by Holmes et al, 1990), or in an altogether different conformation.
Kinetic analysis of polymerisation nucleated in the presence of gelsolin or G:A2
appears to be inconsistent with models where the nucleating species act like the
pointed-ends of already formed filaments (Coue and Korn, 1985; Pollard and
Cooper, 1986; Ditsch and Wegner, 1994). Evidence has been reported to suggest that
G:A2 (at least at low actin or low G:A2 concentrations) does not act like a "true"
nucleus, with regard to the nucleation of actin polymerisation in the pointed-end
direction (Coue and Korn, 1985). The inference is that G:A2 executes nucleating
activity in a manner slightly different to normal actin nucleation and polymerisation,
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possibly due to a difference in the disposition of the actin monomers within G:A2, in
relation to those at the barbed-end of a filament. Other evidence from cross-linking
studies has also suggested that the actin monomer topography within the G:A2
ternary complex is similar, but not identical, to the monomer orientation at the
barbed-end of the filament (Doi et al, 1991; Doi, 1992).
We proposed to use DNasel, binding at the pointed-ends of actin monomers, to probe
the disposition of the monomers within the G:A2 ternary complex.
Deoxyribonuclease I (DNasel) is a high-affinity actin-sequestering protein
(Lazarides and Lindberg, 1974; Mannherz et al, 1975; Hitchcock et al, 1976;
Hitchcock, 1980) which forms a 1:1 binary complex (A:D) with actin. DNasel binds
to subdomains II and IV of monomeric actin (Kabsch et al, 1990) with a IQ ~ 0.1 -
l.OnM (Mannherz et al, 1980). It has also been reported to bind with similar affinity
(Kd ~ InM) to the pointed-ends of actin filaments (Podolski et al, 1988; Weber et al,
1994), and this leads to a blockage of filament elongation. This inhibition is
conferred by the binding of only one DNasel molecule to the pointed-end of a single
strand of the F-Actin two-start helix. (One DNasel molecule bound per filament,
Podolski et al, 1988). The binding of this DNasel appears to have no significant
effect on the affinity of the attached actin for the pointed-end of the filament (Weber
at al, 1994). DNasel has also filament side-binding activity (Hitchcock et al, 1976)
but this is of much lower affinity (K<j ~ O.lmM; Mannherz et al, 1980).
Work carried out by Weber and co-workers (Weber et al, 1994) indicated that the
binding of two DNasel molecules was not possible at the pointed-ends of gelsolin
capped actin filaments. At higher concentrations of DNasel, 1 - 100|lM (which are
three orders of magnitude higher than that required for the blockage of elongation),
an increase in the rate of depolymerisation from the pointed-ends of gelsolin capped
filaments was observed. The Kso% for this effect was ~ 5|lM DNasel (Weber et al,
1994). The explanation proposed for this was a steric clash between two DNasel
molecules at the pointed-end. This prevented the stable binding of both DNasel
molecules and resulted in an increase in the k0ff rate for the actin monomer, as a 1:1
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binary complex with DNasel (Weber et al, 1994). Modelling of DNasel molecules
onto the pointed-ends of two subunits in the Holmes filament model (Holmes et al,
1990) indicates that DNasel would sterically interfere with each other.
Assuming the actin monomers within the G:A2 ternary complex are held in an F-like
conformation, akin to that orientation found at the barbed-end of the actin filament,
we should not expect to be able to accommodate the binding of two DNasel
molecules onto the pointed-ends of the actin monomers within this complex. Thus,
we propose to use ability of DNasel to bind at the pointed-ends of actin monomers,
to probe the disposition of the monomers within the G:A2 ternary complex.
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3.2 Formation and verification of the G:A? ternary, G:A binary and A:D binary
complexes
We designed experiments to add DNasel to G:A2 ternary complex, and to add the
A:D binary complex to gelsolin. This involved the formation and pre-purification of
a variety of complexes: A:D, G:A and G:A2. It also involved the analysis and
verification of the stoichiometry of the individual components within these
complexes. The three separate proteins (DNasel, actin and gelsolin) used in the
formation of these various complexes were also purified. DNasel was purified by a
novel protocol.
3.2.1 Purification of individual proteins
3.2.1.1 DNasel protocol
A partial purification protocol for an inactive DNasel mutant (H134Q) has been
reported (Worrall and Connolly, 1990; Doherty et al, 1993). This gave purity of
between 60% and 90%, with variable yields. Professor Bernard Connolly kindly
supplied us with ~ 2p,g of the recombinant mutant DNasel, in the pkk223-3™
Pharmacia vector. When this protocol was followed, using JM105[pkk223-
3/DNaseI/H134Q], we were unable to obtain purity better than ~ 65%.
We have developed a novel purification protocol that routinely gives >95% purity
for DNasel preparations, with yields of 10 - 15mg.L_1 of original bacterial cell
culture.
3.2.1.1.1 Optimisation of expression
JM105 E. coli were successfully transformed with pkk223-3[DNaseI/H134Q] and
the induction of synthesis of high levels of recombinant DNasel was obtained upon
addition of IPTG to l.OmM. The appearance of a protein band that migrates at
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approximately 30kDa on SDS-polyacrylamide gels corresponded to recombinant
DNasel, see fig. 3.1.
Fig. 3.1. SDS-polyacrylamide gel of induction of synthesis of recombinant
DNasel from JM105[pkk223-2/DNasel/H134Q] by addition of IPTG to 1.0mM.
Lane a. pre-induction; b. 3hrs post IPTG addition. JM105[pkk223-
3/DNasel/H134Q] in 100ml of 2xTY/AMP (50pg/ml) were grown at 37°C until the
A6oonm ~ 0.6, and synthesis of DNasel was induced by addition of IPTG to 1.0mM.
Cells were grown for a further 3hrs. 1.0ml aliquots from pre- and post-induction
conditions were taken and the resultant cell pellet was resuspended in 10Optl of 5 x
SDS-sample buffer (see methods) and boiled for 5mins. A 20pl sample was loaded
onto the gel, following centrifugation at 15,000 xg for 2min. Mr. of protein
standards is given in kilodaltons. (SDS-PAGE was performed as described in
methods).
The expression of the protein was optimised. (For protocol details see methods). The
time course for the optimisation of expression of recombinant DNasel is indicated in
fig. 3.2(A). The synthesis of this protein increased as a function of time after
induction with IPTG. The optimum time for production of soluble protein was 4hrs,
see figs. 3.2(A) and (B) at which time it constituted ~ 10 - 15% of the total cellular
protein, as judged by densiometric scanning of SDS-polyacrylamide gels (data not
shown). Fig. 3.2(B) shows SDS-PAGE analysis of the optimal 4hrs induction time
point. The vast percentage of DNasel is present in the soluble fraction, lane c. After ~
4 - 5hrs the protein begins to appear in inclusion bodies and the percentage of protein
present in the soluble fraction steadily decreases with time, see fig. 3.2(A). After
20hrs the majority of protein was present in inclusion bodies in a non-recoverable
form. (Other time point data are not shown for clarity).
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a b c
Fig. 3.2. Optimisation of induction. (A) Graph showing the time course for the
optimisation of induction of recombinant DNasel from JM105[pkk223-
2/DNasel/H134Q] by addition of IPTG to 1.0mM. (B) SDS-polyacrylamide gel
analysis of the 4hrs post IPTG addition time point in A. Lane a. 4hrs post IPTG
addition, pre-lysis; b. Insoluble fraction, post-lysis; c. Soluble fraction, post-lysis.
JM105[pkk223-3/DNasel/H134Q] in 100ml of 2xTY/AMP (50pg/ml) were grown at
37°C until the A60onm ~ 0.6, and synthesis of DNasel was induced by addition of
IPTG to 1.0mM. 5ml aliquots were removed at various time intervals and the
percentage of DNasel in the soluble protein fraction was analysed. Cell pellets
obtained at each time point were resuspended in 10mM Tris, pH 7.6; 2mM CaCI2;
100mM PMSF; 100mM benzamidine, subjected to ultrasonication (3 x 20 sec bursts
at 4°C) and the resulting cell lysate centrifuged at 18,000 xg (5min at 4°C). The
appearance and relative percentage of DNasel in the soluble and insoluble fractions
was analysed by SDS-PAGE and gel densitometry. (See methods for details).
3.2.1.1.2 Protein purification
JM105[pkk223-3/DNaseI/H134Q] were grown at 37°C in 2xTY/AMP, and protein
synthesis induced by the addition of IPTG to l.OmM. Cells were grown for a further
4hrs and then harvested and processed for purification (see methods for details).
Figs. 3.3(A) and (B) show the results of the DEAE-Sepharose anion-exchange
chromatography step. Bound proteins were eluted by a gradient of 0 - 0.3M NaCl
with DNasel eluting at ~ 0.1M NaCl, as indicated by the hatched area in fig. 3.3(A).




































Fig. 3.3. DEAE-Sepharose chromatography of recombinant DNasel. (A) Abs280nm monitored
elution profile from a DEAE-Sepharose column showing the elution of DNasel at - 0.1 M NaCI,
indicated by the hatched area. (B) SDS-PAGE analysis of the elution profile in A. (SN50; soluble
fraction resulting from centrifugation of cell lysate at 50,000 xg). JM105[pkk223-
3/DNasel/H134Q] were grown at 37°C in 2xTY/AMP (50p.g/ml) until A600nm ~ 0.6 and protein
synthesis induced by the addition of IPTG to 1 .OmM. Cells were grown for a further 4hrs and then
harvested by centrifugation at 3000 xg for 10 min at 4°C. Cells were lysed and following an
overnight dialysis against 10mM Tris, pH 7.6; 2mM CaCI2; 100pM PMSF; 100pM benzamidine,
the soluble clarified fraction was loaded onto a DEAE-Sepharose column (V, ~ 50 ml; 2.6cm x
9.5cm) pre-equilibrated in the same buffer. Bound proteins were eluted by a gradient of 0 - 0.3M
NaCI, over 6 column volumes, and proteins detected by A280nm and analysis by SDS-PAGE. Mr. of
protein standards are given in kilodaltons. (SDS-PAGE and chromatography were performed as
described in methods).
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against lOmM Tris, pH 7.6; 2mM CaCl2; lOOmM PMSF; lOOmM benzamidine, they
were loaded onto a Cibacron Blue F3GA column.
Cibacron Blue F3GA dye is a highly conjugated ligand that shows structural
similarities with the co-factors NAD+, NADP+ and has been used to purify enzymes
and proteins that utilise and bind adenyl containing co-factors/ligands (Scopes,
1987). Some proteins combine in a bio-specific way with the ligand. We proposed to
attempt to bind DNasel to the dye - DNasel binds to DNA so is a possible candidate
for specific interaction with the ligand - and attempt specific elution with ATP.
Fig. 3.4(A) shows a typical A28onm monitored elution profile of the purification. The
protein bound to the matrix, and specific elution with ATP was achieved only with
concentrations above ImM. Accordingly a gradient of ATP, from ImM - lOmM was
used and this successfully partitioned the protein from its major contaminants, see
fig. 3.4(B). Relevant fractions were pooled, concentrated and then subjected to size-
exclusion chromatography on a Sephacryl-200 (S200) column. Densiometric
scanning of the relevant pooled and concentrated fractions gave final purity for the
recombinant protein of > 95%. See figs. 3.5(A) and (B). Typical yields of between
10 - 15mg.L"' of original bacterial cell culture were obtained using this protocol.
3.2.1.2 Actin extraction and purification
Actin was extracted from rabbit muscle acetone powder utilising a modified version
of a widely used protocol (Spudich and Watt, 1971). (See methods and appendix A
for details). Fig. 3.6 indicates the typical purity of G-Actin (as analysed by SDS-
PAGE) obtained using this method. Assay of the competence of G-actin, to undergo
polymerisation, prepared by this method was carried out by critical concentration
assay ([Cc]) using 5% pyrene-actin. Incorporation of pyrene-actin into the filament
produces an enhancement in the fluorescence intensity; - 20 - 25 times that of
monomeric actin. The [Cc] of this particular preparation was O.lljiM. [Cc] values
routinely obtained with this method of extraction and purification compare
















Fig. 3.4. Cibacron F3GA Blue chromatography of recombinant DNasel. (A) Abs280nm
monitored elution profile from a Cibacron F3GA Blue column showing specific elution of
DNasel by an ATP gradient. (B) SDS-PAGE analysis of the elution profile in A. (The first lane
represents the pooled fractions from the DEAE-Sepharose column). Relevant fractions from
the DEAE-Sepharose chromatography step were pooled (illustrated by the first lane of the gel)
and subjected to an over night dialysis against 10mM Tris, pH 7.6; 2mM CaCI2; 100pM PMSF;
100pM benzamidine. The dialysate was filtered through a 0.22pm filter and loaded onto a
Cibacron F3GA Blue column (V, ~ 5.0ml; 1.0cm x 6.5cm), pre-equilibrated in the same buffer.
Specific elution of DNasel from the resin was achieved with a 1mM - 10mM ATP gradient, over
10 column volumes. (SDS-PAGE and chromatography were performed as described in
methods).
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Fig. 3.5. Final purity of DNasel obtained by novel purification protocol. (A) Densiometric scan
profile, performed on SDS-polyacrylamide gels (similar to that shown in B, lane c) illustrating the final
purity of DNasel preparations. (B) SDS-polyacrylamide gel illustrating the purity of DNasel at various
stages in the purification protocol. Lane a. SN50 fraction (soluble fraction resulting from centrifugation
of cell lysate at 50,000 xg); b. pooled fractions from DEAE-Sepharose chromatography; c. final purity,
following Cibacron F3GA Blue and S200 size-exclusion chromatography. Final purity of >95% was
obtained regularly; see table inset in A. Mr. of protein standards are given in kilodaltons. (SDS-PAGE
and gel densitometry were performed as described in methods).
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Sheterline et al, 1995). Typical yields were 12 - 15mg of purified G-Actin per g of
acetone powder. See methods and appendix A for details of methodology and the
assay of the viability of 1M Tris, pH8.0; ATP-G-Buffer for the long-term storage of
G-Actin in a stable and active state.
pM Actin
Fig. 3.6. Extraction and purification of G-Actin using 1M Tris, pH 8.0; ATP-
G-Buffer. Critical concentration ([Cc]) assay for actin (5% pyrene-labelled)
prepared by 1M Tris, pH 8.0; ATP-G-Buffer protocol, performed at 20°C. The
excitation wavelength was 366nm, the emission wavelength was 384nm, and a
5nm slit width was used for both. Open squares represent the fluorescence
intensity of actin incubated in ATP-F-Buffer; closed squares represent actin
incubated in ATP-G-Buffer. Inset indicates the purity of the G-Actin obtained
following extraction and S200 size-exclusion chromatography, as judged by
SDS-polyacrylamide gel analysis. 1.0M Tris, pH 8.0; ATP-G-Buffer. 1,0M Tris, pH
8.0; 0.2mM CaCI2; 0.2mM ATP; 0.5mM DTT; 1.0mM NaN3. ATP-G-Buffer. 5mM
Tris, pH 8.0; 0.2mM CaCI2; 0.2mM ATP; 0.5mM DTT; 1.0mM NaN3. ATP-F-
Buffer. 5mM Tris, pH 8.0; 0.2mM CaCI2; 0.2mM ATP; 0.5mM DTT; 1.0mM NaN3;
100mM KCI; 2mM MgCI2. (SDS-PAGE and [Cc] assays were performed as
described in methods).
3.2.1.3 Gelsolin Purification Protocol.
Several well-established and documented protocols exist for the purification and
over-expression of gelsolin, both from plasma and as recombinant proteins from E.
coli. Various procedures utilise gelsolins affinity for the Cibacron Blue F3GA ligand
(Yamamoto et al, 1989; Ito et al, 1990; Pope et al, 1997). Gelsolin binds to the resin
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in the absence of divalent cations, especially Ca2+. Specific elution with ImM ATP is
only achieved in the presence of 0.25mM EGTA. This gives pure gelsolin, after the
removal of the ATP by passing the protein down a Sephadex-G25 (coarse) desalt
column or long-term dialysis (ca. 48hrs). For larger preparations - over 500ml of
original cell culture - a second round of chromatography on a Cibacron Blue F3GA
column, in the presence of Ca2+ is routinely carried out. Ca2+ displaces bound ATP
from gelsolin and gelsolin re-binds to the resin. Elution can be achieved by NaCl
gradients or salt washes at ~ 0.6M NaCl. These procedures appear to exploit a non-
physiological ATP binding site on gelsolin as the ATP is not, as it normally the case,
bound co-ordinated with a divalent cation e.g. Mg2+, Ca2+, Mn2+, (Yamamoto et al,
1990; Kambe et al, 1992).
BL21(DE3) E. coli were successfully transformed with pMW172[GHS], Cells were
grown in 2xTY/AMP, and the induction of synthesis of high levels of gelsolin was
obtained upon addition of IPTG to l.OmM. Cells were grown for a further 3hrs and
then harvested and processed for purification (see methods for protocol details).
Fig. 3.7(A) shows a typical A280nm monitored elution profile from the first round of
Cibacron F3GA Blue column chromatography. Gelsolin bound to the matrix and
eluted in ImM ATP, see figs. 3.7(A) and (B). The protein band corresponding to
gelsolin migrated with an apparent molecular weight of ca. 86 - 90 kDa on SDS-
polyacrylamide gels, see fig. 3.7(B). Fig. 3.7(C) illustrates the purity of gelsolin
following processing on the second Cibacron column and an S200 size-exclusion
column. Typical purity obtained was >95% (as determined by densiometric scanning
of appropriate lanes on SDS-polyacrylamide gels similar to that shown in C, lane c,
data not shown). Typical yields obtained were between 12 - 18mg.L_1 of original
bacterial cell culture.
3.2.2 Complex formation between Gelsolin and Actin
Complex formation between gelsolin and actin, in a calcium dependent manner, was
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Fig. 3.7. Cibacron F3GA Blue chromatography of human cytoplasmic gelsolin. (A) A280nm
monitored elution profile showing the specific elution of gelsolin by 1mM ATP. (B) SDS-PAGE analysis
of the elution profile in A. (C) SDS-polyacrylamide gel illustrating the purity of gelsolin at various
stages in the purification protocol. Lane a. SN50 fraction (soluble fraction resulting from centrifugation
of cell lysate at 50,000 xg); b. pooled fractions from Cibacron F3GA Blue chromatography performed
in 0.6mM EGTA; c. final purity of gelsolin following subsequent purification on a second Cibacron
F3GA Blue column (in 0.2mM CaCI2) and an S200 size-exclusion column. >95% purity was regularly
obtained. Mr. of protein standards are given in kilodaltons. (SDS-PAGE and chromatography were
performed as described in methods).
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(G:A) formation was analysed by gel-filtration chromatography. Densitometry
confirmed the stoichiometry of the protein components within these complexes.
3.2.2.1 Gel-filtration of complexes.
Complexes between gelsolin and actin were formed by mixing gelsolin and actin in
molar ratios between 2:1 and 1:4 (gelsolin:actin, respectively) in buffers containing
either 0.2mM CaCl2 (.ATP-G-Buffer. 5mM Tris, pH8.0; 0.2mM ATP; 0.5mM DTT;
0.2mM CaCl2; l.OmM NaN3), 2mM MgCl2 and lOOmM KC1 (ATP-F-Buffer 5mM
Tris, pH8.0; 0.2mM ATP; 0.5mM DTT; 0.2mM CaCl2; l.OmM NaN3; 2mM MgCl2;
lOOmM KC1) or modified G-Buffer containing additionally 0.6mM EGTA; 2mM
MgCl2. During the analysis of complex formation in EGTA, gelsolin and actin were
first incubated in the calcium-containing buffer for 5min, followed by the addition of
EGTA and MgCl2 to 0.6mM and 2mM, respectively. The resultant complex
formation was analysed by FPLC/Superose-12 size-exclusion chromatography,
performed in ATP-F-Buffer; 0.2mM CaCl2 (see methods for details).
Fig. 3.8(A) shows the elution profiles of the complexes formed in 0.2mM CaCl2
(peak 1) and 0.6mM EGTA (peak 2) compared to those of gelsolin and actin alone
(peaks 3 and 4 respectively). The retention volumes (see table 3.1) of these two
species give mean apparent Mr. values of 209,kDa (theoretical Mr. 166,kDa) and
149,kDa (theoretical Mr. 124,kDa) for the complexes at peaks 1 and 2, respectively.
The stoichiometry of the components was analysed by densiometric scanning of
SDS-polyacrylamide gels, using known amounts of pure actin and gelsolin as
internal standards. Fig. 3.8(B) shows the components of peaks 1 and 2 as analysed by
SDS-PAGE. The stoichiometry of gelsolin and actin (from several experiments)
within these complexes is illustrated in table 3.2. The results gave mean molar ratios
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Fig. 3.8. Gelsolin:actin complex formation analysed by size-exclusion. (A) A280nm monitored
elution profiles of G-Actin, gelsolin and gelsolin:actin complexes from an FPLC/Superose-12 size-
exclusion column, in ATP-F-Buffer; 0.2mM CaCI2 . (B) SDS-PAGE analysis of the peak compositions
from A. (G:A and G:A2 correspond to the binary and ternary complexes respectively). For comparison
of different profiles the absorbance values have been normalised to the maximum at the peak. The
arrows mark the elution positions of (1) G:A2 (0.2mM CaCI2); (2) G:A (0.6mM EGTA; 0.2mM CaCI2);
(3) gelsolin; (4) G-Actin. (SDS-PAGE and chromatography were performed as described in methods).
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Table 3.1. Retention volumes (ml) of individual proteins and those of the A:D, G:A and
G:A2 complexes. Data obtained from FPLC/Superose-12 size-exclusion chromatography
experiments. The value given for the apparent Mr. is a mean value calculated from the
calibration curve using the corresponding mean retention volume. (See methods for details).
Protein complex Stoichiometry of components
actin:DNasel (A:D) 1:1.1 (±0.15 SD, n=5)
gelsolin:actin binary complex (G:A) 1:1.2 (± 0.084 SD, n=6)
gelsolin:actin2 ternary complex (G:A2) 1:2.1 (±0.13 SD, n=11)
Table 3.2. Stoichiometry of the protein components within the A:D, G:A and G:A2
complexes. Data obtained from SDS-PAGE analysis of FPLC/Superose-12 size-exclusion
chromatography experiments. (See methods for details).
Complexes that were prepared in 0.2mM CaCl2 eluted at values corresponding to that
of the ternary complex even up to molar ratios of actimgelsolin of 1:2. Uncomplexed
gelsolin, in these experiments, eluted at the peak position 3, see fig. 3.8(A). (See
discussion for importance and relevance to co-operative binding). In buffers
containing EGTA (0.6mM EGTA in the presence of 0.2mM CaC^ and 0.2mM
MgCh to prevent the denaturation of the actin) only the binary complex was formed.
Even when a molar excess of G-Actin was present in the incubation mix, there was
no evidence of ternary complex formation. The excess free G-actin, in such
experiments, eluted at the peak position 4, fig. 3.8(A). However, when EGTA was
added to preparations of G:A2, and the resultant mixture re-chromatographed in the
presence of EGTA, an incomplete dissociation to form G:A and free G-actin was
sometimes observed (results similar to Weeds et al, 1986). The G:A binary complex
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does not disproportionate into G:A2 and free gelsolin when pre-purified G:A
complex (see methods for details of the alternative purification protocol), is re-
chromatographed in the presence of Ca2+. Elution volumes give a corresponding Mr.
of 149kDa. In contrast, when excess G-actin was added to pre-purified G:A binary
complex, in the presence of Ca2+ the elution volume of the resultant complex shifted
to the higher value corresponding to the molecular weight G:A2 ternary complex.
If gelsolin and actin were mixed together under conditions where the Ca2+
concentration is below nM levels no complex formation was observed (results not
shown). Similar results have been reported by other workers (Bryan and Kurth, 1984;
Coue and Korn, 1985; Wanger and Wegner, 1985; Weeds et al, 1986; Selve and
Wegner, 1986; Bryan, 1988; Way et al, 1989; Pope et al, 1997). Calcium
concentrations of ~ 5 - 3nM are required for the structural rearrangements that occur
upon the activation of gelsolin (Hellweg et al, 1993; Pope et al, 1997; Burtnick et al,
1997; Robinson et al, 1999). Once activated, the Ca2+ levels need to be elevated to
the pM level (~ lpM) to allow the binding of actin monomers (Selve and Wegner,
1986; Selve and Wegner, 1987; Schoepper and Wegner, 1991; Lamb et al, 1993;
Hellweg et al, 1993; Pope et al, 1995; Ditsch and Wegner, 1995; Pope et al, 1997).
Similar experiments were performed using lOOmM Tris, pH 8.0; ATP-G-Buffer as
the column running-buffer. (This buffer is essentially the same as ATP-G-Buffer -
i.e. low salt - except that the Tris concentration has been increased to raise the ionic
strength of the media. Superose resins are prone to interactions with protein samples
with low ionic strength buffers). The results obtained were very similar to those
carried out in ATP-F-Buffer. The apparent Mr. values obtained during
chromatographic runs with this buffer, were in good agreement with the ones
described above (data not shown).
For obtaining larger amounts of protein complex, for use in further experiments,
size-exclusion chromatography was carried out on a preparative S200 column (Vt ~
135ml, see methods for details). Similar results to those obtained on the
FPLC/Superose-12 column were obtained. Due to the problems with the incomplete
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dissociation of G:A2, to give G:A and free actin in EGTA, an alternative method was
used for the preparation of the G:A binary complex (see methods for details).
These results confirm that gelsolin and actin specifically form a ternary complex
(G:A2), in Ca2+, and a binary complex (G:A) in EGTA.
3.2.2.2 Native-gel complex formation
Non-denaturing PAGE showed complex formation for each of the G:A2 and G:A
complexes and second dimension analysis by SDS-PAGE confirmed the identity and
stoichiometry of the protein components within each of the complexes.
All densitometry was carried out using SYPRO™-Red (Molecular Probes Inc.)
fluorescent stain and a Molecular Dynamics chemi-luminescence imager. Complex
formation was further analysed using non-denaturing gels. The proteins to be tested
were mixed together in ATP-G-Buffer, in similar ratios as those used in the gel-
filtration experiments (see methods for details). F-Buffer was not used routinely to
avoid the associated problems that occurred with native-PAGE, due to the presence
of high salt (lOOmM KC1) concentrations in this buffer.
Fig. 3.9(A) shows the migration pattern for G-Actin, gelsolin and the two complexes,
G:A2 and G:A, on a 7% acrylamide (w/v) Native gel (see methods for details). Clear
shifts in electrophoretic mobility were seen upon formation of the two complexes.
The gel running conditions have to be altered slightly for each individual complex or
set of proteins, e.g. Gelsolin alone runs as a broad smear near the top of the gel when
Ca2+ is included in the gel running buffer. This is not an unexpected feature, as the
binding of calcium produces large conformational rearrangements in the tertiary
structure of gelsolin (Hellweg at al, 1993; Pope et al, 1997; Burtnick et al, 1997;
Robinson et al, 1999). The structural rearrangements and the additional effect of
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binding Ca ions, with the coupled changes in the charge distribution of the
molecule, would result in mobility shifts on such non-denaturing gels. Gel running
conditions: 0.2mM CaCl2; 0.2mM ATP; 0.5mM DTT were used for G:A2 complex
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Fig. 3.9. Gelsolin:actin complex formation analysed by non-denaturing PAGE. (A) Native gel
showing the electrophoretic mobilities of G-Actin, gelsolin and gelsolin:actin complexes. (G:Acomp.
and G:A2comp. correspond to the binary and ternary complexes respectively). (B) SDS-PAGE
analysis, in a second dimension, of the components of the protein bands in A. Standard migration
positions of G-Actin and gelsolin are indicated between the two gels. Gel running conditions; 0.2mM
CaCI2; 0.2mM ATP; 0.5mM DTT were used for G-Actin and G:A2 complex formation; 0.2mM ATP;
0.5mM DTT were used for gelsolin; 0.2mM CaCI2; 0.2mM ATP; 0.5mM DTT; 0.6mM EGTA; 1.0mM
MgCI2 were used for G:A complex formation. (SDS-PAGE and native-PAGE were performed as
described in methods).
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formation. These were changed to 0.2mM CaCl2; 0.2mM ATP; 0.5mM DTT; 0.6mM
EGTA; lmM MgCl2 for G:A complex formation.
SDS-PAGE in a second dimension and subsequent analysis of the components of the
protein bands from the native gels, by densiometric scanning, was carried out. Fig.
3.9(B) clearly illustrates the components of the two gelsolimactin complexes. The
stoichiometric values of the respective complex components are shown in table 3.3.
Mean values for the molar ratios of gelsolimactin indicate the formation of the G:A
binary complex in EGTA and the formation of the G:A2 ternary complex in Ca2+.
Protein complex Stoichiometry of components
actin:DNasel (A:D) 1:1.3 (± 0.06 SD, n=4)
gelsolimactin binary complex (G:A) 1:1.3 (=t 0.05 SD, n=4)
gelsolin:actin2 ternary complex (G:A2) 1:2.1 (±0.18 SD, n=6)
Table 3.3. Stoichiometry of the protein components within the A:D, G:A and G:A2
complexes. Data obtained from non-denaturing-PAGE experiments. SDS-PAGE and
stoichiometric analysis was performed as described in methods.
Similarly to experiments performed on size-exclusion columns, incubation mixtures
performed in the presence of calcium, that contained an excess of gelsolin (molar
ratios of actimgelsolin of 1:2) the formation of the ternary complex predominated.
Very little, if any, binary complex was detected. The uncomplexed gelsolin, in these
experiments, migrated at its normal position. (See discussion for importance and
relevance of this result to the co-operativity of actin monomer binding for the
formation of the G:A2 ternary complex).
In buffers containing EGTA (0.6mM EGTA in the presence of 0.2mM CaCl2 and
1 .OmM MgCl2 to prevent the denaturation of the actin) only the binary complex was
formed. Even when a molar excess of G-Actin was added to the incubation mix,
there was little evidence of ternary complex formation. The excess free G-actin, in
such experiments, migrated with a mobility characteristic of free G-Actin, see fig.
3.9(A).
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3.2.2.3 Complex formation analysis by fluorescence enhancement measurement
Fluorescence enhancement of NBD-Actin, upon binding to gelsolin, confirmed the
stoichiometry of G:A2 and G:A.
Several workers (Bryan & Kurth, 1984; Doi & Frieden, 1984; Weeds et al, 1986;
Way et al, 1989; Way et al, 1990; Pope et al, 1995; Pope et al, 1997) have reported
the use of fluorescence enhancement measurements from two fluorescently labelled
actin derivatives to follow complex formation with gelsolin; NBD-Actin (Lys - 373)
and Pyrene-Actin (Cys - 374) (see methods for protocol details). The maximum
fluorescence enhancement observed when NBD-Actin binds to gelsolin (formation of
G:Ai) is approximately 110 - 130 % (Weeds et al, 1986; Way et al, 1989; Pope et al,
1997). Several experiments were carried out using NBD-Actin to follow complex
formation with gelsolin. Experiments were carried out in ATP-G-Buffer, containing
0.2mM CaCl2 or 0.6mM EGTA; 0.2mM CaCl2; 0.2mM MgCl2 or in ATP-F-Buffer;
0.2mM CaCl2, (see methods for details).
Fig. 3.10(A) shows the titration of NBD-Actin in the absence or presence of a
constant amount of gelsolin, 80nM, in 0.2mM CaCl2 (ATP-G-Buffer).
Fig. 3.10. Fluorescence titration at constant gelsolin concentration with NBD-
Actin, in 0.2mM CaCI2 (ATP-G-Buffer). (A) Closed squares indicate the
fluorescence intensity of NBD-Actin alone; open squares indicate the fluorescence
intensity of NBD-Actin with added 80nM gelsolin. (B) Difference between
fluorescence intensities in (A). (A,ex=475nm, A,em=520nm; 5nm slit for both). The
solid line is a linear regression and gives maximum enhancement at 2.1








Each data point represents a separate reaction mixture and not serial additions of
titrant. Fig. 3.10(B) shows the difference between the two fluorescence profiles, in A,
which is due to the enhancement in fluorescence intensity of NBD-Actin upon
complex formation with gelsolin. Fig. 3.10(B) clearly indicates that the fluorescence
rises linearly as the concentration of NBD-Actin increases, up to an inflexion point.
At this point there is an abrupt transition to a plateau level. The position of this
inflexion point occurs at a stoichiometry of gelsolin:actin of 1:2 respectively. Mean
values for gelsolin:actin were 1:2.1 (± 0.15 SD, n=5) indicating the formation of the
G:A2 ternary complex, in Ca2+.
These data also demonstrate that both binding sites on gelsolin contribute equally to
the fluorescence signal enhancement. Fig. 3.11 shows the emission spectra of NBD-
Actin alone and those with the addition of gelsolin in the presence or absence of
Ca2+. An enhancement of ca. 60 - 70% is seen over NBD-actin alone in the presence
of gelsolin and EGTA. A further 60 - 70% enhancement is seen in 0.2mM CaCE.
Binding of NBD-Actin to each site on gelsolin contributes equally to the
fluorescence enhancement signal.
Fig. 3.12(A) shows the fluorescence measurements from a continuous variation
experiment performed in 0.2mM CaCl2 (see methods for details). The total protein
concentration is maintained at 400nM and both gelsolin and NBD-Actin are varied in
a continuous fashion (Blake et al, 1967; Weeds et al, 1986; Way et al, 1989). The
fluorescence shows a very sharp discontinuity at a molar ratio that corresponds to
that stoichiometry of the component proteins within the resultant complex. The
inflexion point has a mean molar ratio for gelsolimactin of 1:2.1 (± 0.17 SD, n=9).
Similar continuous variation experiments were carried out in the presence of 0.6mM
EGTA. The EGTA fluorescence profile is shown in fig. 3.12(B). This biphasic
profile also has a sharp inflexion point that corresponds to a mean stoichiometry for
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Fig. 3.11. The effect on the emission spectra of NBD-Actin upon complex
formation with gelsolin. The emission spectra (the excitation wavelength used was
475nm, with a 5nm slit width for both excitation and emission) of 400nM NBD-Actin,
in 0.2mM CaCI2, and those with added 195nM gelsolin, in the presence or absence
of calcium, are shown. (Molar ratio is ~ 2:1 for actin:gelsolin). The equal contribution
by each actin-binding site on gelsolin to the fluorescence enhancement is illustrated
by two equivalent step-wise increases in fluorescence. Proteins were mixed
together, at the appropriated concentrations, in the calcium containing buffer and
incubated at RT for 30min, and then the emission spectra measured. For
experiments in EGTA the protein mixture was first incubated at RT for 5min, in the
calcium-containing buffer, and MgCI2 and EGTA were then added to the appropriate
concentrations. Solution conditions for calcium containing buffers: ATP-G-Buffer,
5mM Tris, pH8.0; 0.5mM DTT; 0.2mM ATP; 0.2mM CaCI2; 1.0mM NaN3. Solution
conditions for EGTA containing buffers: 5mM Tris, pH8.0; 0.5mM DTT; 0.2mM ATP;
0.2mM CaCI2; 1.0mM NaN3; 0.2mM MgCI2; 0.6mM EGTA.
Similar experiments were performed in ATP-F-Buffer (additionally contains lOOmM
KC1 and 2mM MgCl2). The results obtained were very similar to those carried out in
ATP-G-Buffer (data not shown). However, care has to be taken to make sure that the
free G-Actin concentration is below the [Cc] when using ionic conditions that induce
actin polymerisation. NBD-Actin gives a fluorescence enhancement of -100% when
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the monomer becomes incorporated into the filament (Detmers et al, 1981). This can
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Fig. 3.12. Fluorescence titration at constant total protein concentration with
continuous variation of both NBD-Actin and gelsolin. (A) Experiment using
400nM total protein in 0.2mM CaCI2 (ATP-G-Buffer) with the transition point at
139nM gelsolin and 261 nM NBD-Actin (the solid line is a linear regression; inflection
point at actin/gelsolin = 1.9). (B) Experiment with 300nM total protein concentration
in 0.6mM EGTA (in the presence of 0.2mM MgCI2) with the transition point at 158nM
gelsolin and 141nM NBD-Actin (the solid line is a linear regression; inflection point at
actin/gelsolin = 0.9). (Titrations were performed as described in methods).
The data obtained from the fluorescence analysis provides further supportive
evidence - by a third and completely different physical method - for the formation of
G:A2 ternary and G:A binary complexes between gelsolin and actin in Ca2+ and
EGTA, respectively.
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3.2.3 Complex formation between DNasel and G-Actin.
3.2.3.1 Gel-filtration analysis of complex formation.
In the analysis of the orientation of the actin monomers within the G:A2 ternary
complex we wanted to add A:D binary complex to gelsolin to test the binding of this
complex to gelsolin. We purified the A:D binary complex and confirmed its
stoichiometry.
Actin and DNasel were mixed together at molar ratios of 1:1, in ATP-F-Buffer or
lOOmM ATP-G-Buffer, and then subjected to size-exclusion chromatography. Fig.
3.13(A) shows the elution profile from an FPLC/Superose-12 size-exclusion run of
the actin:DNaseI complex (peak 1) compared to G-actin and DNasel alone, peaks 2
and 3 respectively. The retention volume of peak 1 has a mean apparent Mr. of
92kDa (theoretical Mr. = 71kDa) corresponding to the formation of the actin:DNaseI
binary complex (see table 3.1).
SDS-PAGE analysis of the elution profile of peak 1 in fig. 3.13(A) is shown in fig.
3.13(B). It confirmed the presence of both proteins (actin and DNasel) in peak 1.
The stoichiometric analysis of this complex, by densiometric scanning of appropriate
gel lanes, is illustrated in table 3.3. The results indicate a molar ratio for
actin:DNaseI is 1:1 within this complex.
3.2.3.2 Native-gel analysis of actin:DNaseI binary complex formation.
Formation of complex was similarly analysed using non-denaturing gels (see
methods for details). Fig. 3.14(A) shows the protein band migration pattern of
DNasel, G-actin and the A:D complex on a 7% (w/v) acrylamide native gel. Gel
running conditions were carried out in the absence of Ca2+, for DNasel samples.
DNasel binds Ca2+ ions - the cation helps to stabilise the molecule and protects
against proteolytic degradation (Price et al, 1969; Suck et al, 1984; Suck and Oefner,
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Fig. 3.13. Actin:Dnasel complex formation analysed by size-exclusion. (A) A280nm monitored
elution profiles of DNasel, G-Actin and the actin:DNasel complex from an FPLC/Superose-12 size-
exclusion column. (B) SDS-PAGE analysis of the peak composition from A. (A:D corresponds to the
actin:DNasel binary complex). For comparison of different profiles the absorbance values have been
normalised to the maximum at the peak. The arrows mark the elution positions of (1) A:D; (2) G-Actin;









Fig. 3.14. Actin:DNasel complex formation analysed by non-denaturing
PAGE. (A) Native gel showing the electrophoretic mobilities of DNasel, G-Actin,
and the actin:DNasel complex. (A:D corresponds to the actin:DNasel binary
complex). (B) SDS-PAGE analysis, in a second dimension, of the components of
the protein bands in A. Standard migration positions of G-Actin and DNasel are
indicated beside the gel. Gel running conditions: 0.2mM CaCI2; 0.2mM ATP;
0.5mM DTT were used for G-Actin and A:D complex formation; 0.2mM ATP;
0.5mM DTT were used for DNasel. (SDS-PAGE and native-PAGE were
performed as described in methods).
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1986) - and this sometimes resulted in strange mobility shifts and smearing of the
protein bands in DNasel samples, on the non-denaturing gels.
A distinct shift in the electrophoretic mobility of the 1:1 molar ratio incubation
sample of A:D was observed. Second dimension SDS-PAGE analysis of the band
confirmed the presence of both DNasel and Actin within this shifted complex band,
see fig. 3.14(B). Table 3.3 shows the stoichiometric analysis, by densitometry,
confirming the 1:1 molar ratios for actin:DNaseI in the binary complex.
3.2.3.3 Fluorescence analysis of the A:D complex
Fig. 3.15 shows the emission spectra of NBD-Actin alone and that of NBD-Actin
complexed 1:1 with DNasel. There is no significant difference between the two
spectra. A AFmax of minus 5% and a slight blue shift in the wavelength, ~ 1 - 2nm, at
490 540 590 640 690
Wavelength, nm
Fig. 3.15. The effect on the emission spectra of NBD-Actin upon complex
formation with DNasel. The emission spectra (the excitation wavelength was
475nm, with a 5nm slit width for both excitation and emission) of 400nM NBD-Actin,
in 0.2mM CaCI2, and that with added 400nM of active DNasel are shown. (Molar
ratio is ~ 1:1 for actin:DNasel). The two spectra are not significantly different from
each other demonstrating the spectral "silence" of the presence of DNasel bound to
the pointed-end of the NBD-Actin monomer. Proteins were mixed together, at the
appropriate concentrations, and incubated at RT for 30min in ATP-G-Buffer: 5mM
Tris, pH8.0; 0.5mM DTT; 0.2mM ATP; 0.2mM CaCI2; 1.0mM NaN3.
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maximal absorbance, upon formation of the binary complex, have been reported but
these spectral changes were not observed with every preparation of NBD-Actin or
Anbd:D complex (Detmers et al, 1981). The binding of DNasel to the pointed-end of
an NBD-actin monomer has little effect on the emission spectra of that actin. The
presence of DNasel is "silent" with respect to analysis of NBD-Actin by
fluorescence enhancement. Conformation of the formation of a tight binary complex,
between NBD-Actin and DNasel, was performed by size-exclusion chromatography
and non-denaturing gel analysis. Very similar results to those carried out with the
native proteins were obtained (data not shown).
3.2.4 Summary
The results from the preceding sections verify the formation of the G:A2, G:A and
A:D complexes. The techniques applied and the results obtained serve as an
illustration of the validity and sensitivity of these methods as sound and
complementary ways of elucidating the system of complex formation between
gelsolin, actin and DNasel. (Similar results have been reported by other workers,
Detmers et al, 1981; Bryan and Kurth, 1984; Coue and Korn, 1985; Weeds et al,
1986; Way et al, 1989; Way et al, 1990; Pope et al, 1991; Pope et al, 1997). A
combination of these three methods served as the basis of the approach to the
problem of trying to elucidate the spatial orientation of the actin monomers within
G:A2.
3-30
3.3 Probing the actin monomer conformation in the gelsolin:actin? complex
using DNasel.
3.3.1 Overview
We proposed to use DNasel as a tool to probe the spatial orientation of the two actin
monomers in G:A2. DNasel was added to pre-purified G:A2 and the resultant
complex analysed by gel-filtration, non-denaturing gel experiments. Such
experiments produced data indicate the formation of a complex, significantly larger
than G:A2, containing G:A2:D2, respectively. The binding of pre-purified A:D
complex (with NBD labelled actin monomers), to gelsolin was also studied. The
results also indicated the formation of a larger complex, with a stoichiometry of
G:(A:D)2.
3.3.2 Binding of DNasel to the pointed-ends of actin monomers within the G:A?
ternary complex.
G:A2 complex was purified: gelsolin and G-actin were incubated in the presence of
0.2mM CaCl2 at a molar ratio of 1:2 (gelsolimactin, respectively), and then subjected
to size-exclusion chromatography on an S200 gel-filtration column (see methods for
details)
3.3.2.1 Gel-filtration analysis of "GA?:D?" complex formation
Purified DNasel was added to a solution of G:A2 complex, in ATP-G-Buffer or ATP-
F-Buffer; 0.2mM CaCl2, at a molar ratio of 2:1 (3.0|iM G:A2; 6.0pM DNasel). This
incubation mix included + 3 - 15% DNasel, to account for the proportion of inactive
protein in DNasel preparations, assayed by a modified [Cc] assay, (see methods and
appendix B for details). The mixture was incubated for 30min at RT and any
subsequent complex formation analysed by size-exclusion chromatography on an
FPLC/Superose-12 column, pre-equilibrated in ATP-F-Buffer; 0.2mM CaCl2 or
lOOmM Tris, pH 8.0; ATP-G-Buffer.
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Fig. 3.16(A) shows the elution profile from FPLC/Superose-12 size-exclusion
column chromatography of a "GA2:D2" incubation (peak 1), compared to those of
G:A2 and DNasel alone (peaks 2 and 3 respectively). A significant shift (P<0.05) in
the retention volume of the "GA2:D2" incubation mixture sample mixture was
observed, see table 3.4.
The retention volumes for this species give an apparent mean Mr. of 251kDa. This
value suggests the formation of a complex between one G:A2 ternary complex and
two DNasel molecules, (GA2):D2. This is in good agreement with the theoretical
value of 224kDa (assuming that the complex has a globular shape).















"GA2:D2" complex 9.29 (+/- 0.057
SEM, n=4)
224 251
Table 3.4. Retention volumes (ml) of DNasel, G:A2 ternary complex and the "GA2:D2"
complex. Data obtained from FPLC/Superose-12 size-exclusion chromatography. The value
given for the apparent Mr. is a mean value calculated from the calibration curve using the
corresponding mean retention volume. The significance of the difference between the mean
retention volume of G:A2 and that of (G:A2):D2 is P<0.05. (See methods for details).
SDS-PAGE analysis of the components of the putative complex peak showed the
presence of all three proteins (gelsolin, actin and DNasel) in the shifted peak, see fig.
3.16(B). DNasel has shifted from its normal elution volume to that of a much higher
molecular weight species, indicative of it having bound to the larger G:A2 complex.
Stoichiometric analysis of the components of the new peak was carried out by
densiometric scanning of bands on SDS-polyacrylamide gels, using known amounts
of gelsolin, actin and DNasel as internal standards. Table 3.5 summarises the results
from four similar experiments. The stoichiometry of this new complex appears to be
G2:A2:D2.
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Fig. 3.16. Formation of a complex between the G:A2 ternary complex and DNasel as analysed
by size-exclusion. (A) A280nm monitored elution profiles of DNasel, G:A2 ternary complex and the
"GA2:D2" complex on an FPLC/Superose-12 size-exclusion column, run in ATP-F-Buffer; 0.2mM
CaCI2. (B) SDS-PAGE analysis of the peak composition for the "GA2:D2" sample from A. For
comparison of different profiles the absorbance values have been normalised to the maximum at the
peak. The arrows mark the elution positions of (1) "GA2:D2"; (2) G:A2; (3) DNasel. The "GA2:D2"
cpmplex is that formed from an incubation (30min at RT) of pre-purified G:A2 ternary complex and
DNasel in a molar ratio of 1:2 (3.0pM G:A2 and 6.0|iM DNasel) in ATP-F-Buffer; 0.2mM CaCI2. (SDS-






gelsolin:actin 1:2.2 1:2.07 1:2.17 1:2.34
actin:DNasel 1:1.05 1:1.03 1 :1.13 1:1.05
gelsolin:
DNasel
1:2.3 1:2.13 1:2.4 1:2.28
Native Gels Mole ratios
gelsolin:actin 1:1.94 1:2.3 1:2.1 1:2.3
actin:DNasel 1:1.02 1:0.81 1:1.08 1:0.95
gelsolin:
DNasel
1:1.97 1:1.81 1:2.1 1:1.90
Table 3.5. Stoichiometry of the individual component proteins within the "(GA2):D2"
complex. The values given in the upper half of the table represent data obtained from 4
similar experiments carried out on FPLC/Superose-12 size-exclusion chromatography
columns. Those in the lower half represent data obtained from 4 similar experiments carried
out on non-denaturing gels. The densitometry was carried out with the fluorescent SYPRO-
Red™ stain (Molecular Probes Inc.) and a chemi-luminescence imager. The gels were then
subsequently stained with Coomassie Blue-R250 for visual conformation of the results. (See
methods for details).
When 2:1 molar ratio incubations of (A:D):gelsolin (in ATP-F-Buffer; 0.2mM
CaCl2), were subjected to size-exclusion chromatography, on an FPLC/Superose-12
column the elution profile produced a peak corresponding to position 1 in fig.
3.16(A). The apparent Mr. of this species was ~ 251kDa indicating the formation of a
complex with an apparent stoichiometry of G:(A:D)2, see table 3.2 for the retention
volume details.
Similarly to the formation of G:A2, when excess gelsolin was included in incubation
mixtures of gelsolin and A:D (up to 2:1, respectively), the G:(AD)2 complex
preferentially forms with the excess gelsolin eluting at a position corresponding to
free uncomplexed gelsolin (peak position 3 in fig. 3.8).
Incubations of both, G:A2plus DNasel (molar ratio of 1:2, respectively), and those of
gelsolin plus pre-formed A:D binary complex (molar ratio 1:2, respectively), gave a
complex that eluted with the same retention volume, and with the same stoichiometry
for its protein components; G:A2:D2.
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3.3.2.2 Native-gel analysis of "(GA2): D?" complex formation
The use of non-denaturing gels provided additional evidence for the formation of a
complex between the G:A2 ternary complex and two DNasel molecules. Fig. 3.17(A)
shows the appearance of a band with a shifted electrophoretic mobility in lanes that
contained samples from an incubation (RT for 30min, in ATP-G-Buffer) of G:A2 and
DNasel at a 1:2 molar ratio (3.0|iM G:A2; 6.0|iM DNasel). (The incubation mix
contained additional DNasel to account for the 3 - 15% of inactive protein in that
preparation).
Second dimension analysis, by SDS-PAGE, of the "GA2:D2" lane was carried out.
As can be seen from the gel in fig. 3.17(B) the shifted band contains all three
proteins; gelsolin, actin and DNasel. The stoichiometry of these three proteins was
confirmed as being G:A2:D2, by densiometric scanning of stained SDS-
polyacrylamide gels, with pure samples of each protein included as internal reference
standards. Table 3.5 summarises the results from four similar experiments. Our data
indicate the formation of a complex with a stoichiometry of G:A2:D2.
3.3.2.3 Fluorescence enhancement analysis of "GA?:D?" complex formation
Several sets of experiments were conducted to investigate the binding of pre-purified
9-4-
actingDNasel complex to gelsolin in the presence of Ca (here after referred to as
Anbd-D). Experiments utilising the fluorescence enhancement of the binding of NBD-
Actin to gelsolin were designed to test the formation of the putative G:(A:D)2
complex. They also exploit the fact that the presence of DNasel bound to the
pointed-end of an NBD-Actin monomer is spectrally "silent" (see fig. 3.15).
Experiments were carried out in ATP-G-Buffer, containing 0.2mM CaCl2 or 0.6mM
EGTA; 0.2mM CaCl2; 0.2mM MgCl2 or in F-buffer additionally containing 0.2mM










Fig. 3.17. Formation of a complex between the G:A2 ternary complex and DNasel as analysed
by non-denaturing PAGE. (A) Native gel showing the electrophoretic mobilities of DNasel, G:A2and
the "GA2:D2" complex. (B) SDS-PAGE analysis, in a second dimension, of the components of the
protein bands in A. "GA2:D2" is the complex formed from an incubation (30min at RT) of pre-purified
G:A2 ternary complex and DNasel in molar ratio of 1:2 (3.0pM G:A2 and 6.0pM DNasel) in ATP-G-
Buffer. Standard migration positions are indicated beside the gel. Gel running conditions: 0.2mM
CaCI2; 0.2mM ATP; 0.5mM DTT was used for G:A2 and "GA2:D2"; 0.2mM ATP; 0.5mM DTT was used
for DNasel. (SDS-PAGE and non-denaturing PAGE were performed as described in methods).
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Fig. 3.18(A) shows the titration of pre-formed and pre-purified Anbd:D complex in
the absence or presence of a constant amount of gelsolin, 80nM, in 0.2mM CaCF.
(Similarly to those experiments carried out with gelsolin and NBD-Actin alone, each
data point represents a separate reaction mixture and not serial additions of titrant).
Fig. 3.18(B) shows the difference between the two fluorescence profiles in A. The
difference between the titration profiles is again due to the enhancement in
fluorescence intensity upon complex formation. Fig. 3.18(B) clearly indicates that
the fluorescence rises linearly as the concentration of Anbd:D increases, up to an
inflexion point. At this point there is an abrupt transition to a plateau level. The
position of this inflexion point occurs at a stoichiometry of 1:2 for gelsolin / Anbd:D
respectively. Mean values for the sloichiometry at the inflexion point are 1:2.12 (±
0.17 SD, n=7) apparently indicating the formation of a G:(Anbd:DF complex.
nM Anbd:D nM Anbd:D
Fig. 3.18. Fluorescence titration at constant gelsolin concentration with
Anbd:D in 0.2mM Cad2 (ATP-G-Buffer). (A) Closed squares indicate the
fluorescence intensity of Anbd:D alone; open squares indicate the fluorescence
intensity of Anbd:D with added 80nM gelsolin. (B) Difference between fluorescence
intensities in (A). The solid line is a linear regression and gives maximum
enhancement at 2.2 (Anbd:D):gelsolin. (A,ex=475nm, A,em=520nm, 5nm slit for
both). Titration was performed as described in methods.
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The assumption here is that, analogous to the situation of complex formation
between gelsolin and NBD-Actin alone, both binding sites on gelsolin contribute
equally to the fluorescence signal enhancement of Anbd:D. Fig. 3.19 shows the
emission spectra of the Anba:D binary complex alone (a different preparation of
NBD-Actin to that used in fig. 3.11) and those with the addition of gelsolin, in the
presence or absence of Ca2+. Very similar levels of enhancement were observed for
Wavelength, nm
Fig. 3.19. The effect on the emission spectra of Anbd:D upon complex
formation with gelsolin. The emission spectra (the excitation wavelength was
475nm, with a 5nm slit width for both excitation and emission) of 400nM Anbd:D, in
0.2mM CaCI2, and those with added 195nM gelsolin, in the presence or absence of
calcium are shown. (Molar ratio is ~ 2:1 for (Anbd:D) and gelsolin, respectively). The
equal contribution by each actin-binding site on gelsolin to the fluorescence
enhancement is illustrated by the two equivalent step-wise increases in
fluorescence. Proteins were mixed together, at the appropriated concentrations, in
the calcium-containing buffer and incubated at RT for 30min. Then the emission
spectra measured. For experiments in EGTA the sample was incubated at RT for
5min, in the calcium-containing buffer, and MgCI2 and EGTA were then added to
the appropriate concentrations. Solution conditions for calcium containing buffers:
ATP-G-Buffer, 5mM Tris, pH8.0; 0.5mM DTT; 0.2mM ATP; 0.2mM CaCI2; "I.OmM
NaN3. Solution conditions for EGTA containing buffers: 5mM Tris, pH8.0; 0.5mM
DTT; 0.2mM ATP; 0.2mM CaCI2; 1.0mM NaN3; 0.2mM MgCI2; 0.6mM EGTA.
complex formation between gelsolin and the A„bd:D complex. An enhancement of ~
60 - 70% was seen in the presence of gelsolin and EGTA, over that observed for
Anbd:D alone. A further ~ 60 - 70% enhancement was observed in 0.2mM Ca2+.
Similar results were obtained in ATP-F-Buffer (data not shown). The problem of
fluorescent enhancement due to spurious NBD-Actin polymerisation is negated by
the presence of DNasel, bound to the pointed-ends of the actin monomers in the A:D
binary complex. This prevents any association between the monomers, thus
preventing polymerisation.
Binding of Anbd:D to each site on gelsolin contributes equally to the fluorescence
enhancement signal observed upon complex formation. The levels of enhancement
are very similar to those obtained with NBD-actin alone. The results from several
binding experiments, analysing the interaction between gelsolin and NBD-Actin
were compared to those obtained with the Anbd:D binary complex; of which different
preparations of NBD-Actin, with different degrees of labelling (~ 40 - 70%) were
used. It was found that the two sets were not significantly different from each other,
(P>0.50). Compare the emission spectra in figs. 3.11 and 3.19.
Fig. 3.20 shows the fluorescence titration measurements from a continuous variation
experiment in 0.2mM CaCF (see methods for details). The total protein concentration
was maintained at 400nM and both gelsolin and the Anbd:D complex were varied in a
continuous fashion. The fluorescence again shows a very sharp discontinuity at a
molar ratio that corresponds to the stoichiometry of the component proteins within
the resultant complex. The inflexion point has a mean molar ratio of 1:2.0 (± 0.16
SD, n=5) for gelsolin:(Anbd:D) binary complex, respectively. A comparison of the
levels of fluorescence enhancement and the range of stoichiometries for the complex
components (at the inflection point), in experiments using Anbd:D or NBD-Actin
alone, indicated no statistically significant differences between them (P>0.30).
Similar experiments carried out in ATP-F-Buffer; 0.2mM CaCl2 produced very









0 100 200 300 400 [Anbd:D] nM
400 300 200 100 0 [Gelsolin] nM
Fig. 3.20. Fluorescence titration at constant protein concentration with
continuous variation of both gelsolin and Anbd:D. Experiment using 400nM total
protein in 0.2mM CaCI2 (ATP-G-Buffer) with the transition point at 146nM gelsolin
and 254nM Anbd:D (Solid line is a linear regression; Anbd:D/gelsolin = 1.8). (Titration
was performed as described in methods).
3.3.3 Summary
The data described in the preceding sections are consistent with the spatial
orientation of the two actin monomers in the G:A2 ternary complex being similar, but
not identical, to the orientation of those monomers at the barbed-end of a filament.
Our results provide good evidence for the formation of a larger complex between the
G:A2 ternary complex and two DNasel molecules. The association most likely
occurs via binding of the two DNasel molecules to the pointed-ends of the actin
2+
monomers. Gelsolin also binds two A:D binary complexes (in Ca ). The interaction
of A:D with gelsolin, resulting in the formation of the G:(A:D)2 complex, appears to
take place via a similar two-stage binding equilibrium, analogous to that for the
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formation of G:A2, with similar affinities (see section 3.5 for details). No
experimental evidence was found for an interaction between gelsolin and DNasel.
Data from size-exclusion experiments and non-denaturing gels of 1:1 molar ratio
incubations of the two proteins (gelsolin and DNasel), in a variety of conditions,
always produced two distinct and separate populations that corresponded to the two
individual uncomplexed proteins (data not shown).
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3.4 Analysis of the effect of DNasel on actin monomer binding to the G:A binary
complex
3.4.1 Overview
The results described in the preceding sections appear to indicate that the geometrical
arrangement of the two actin monomers in the G:A2 ternary complex was similar, but
not identical, to the orientation of those monomers at the barbed-end of a filament.
However, the binding of DNasel to the pointed-end of one monomer may have a
perturbatory effect on the geometrical arrangement of the two actin monomers within
the G:A2 ternary complex. The actin monomers within G:A2 may normally be held in
an F-like conformation, but the high-affinity association between DNasel and the
pointed-end of one of the actin monomer causes a conformational change within the
structure of that actin (with respect to uncomplexed actin) that results in a change in
the binding interactions with other monomer and/or with gelsolin. I.e. a DNasel
induced disruption to interactions between the actin monomers and/or between
gelsolin, may cause a loss of the normal F-like conformation of the actin monomers
within G:A2, and enable the binding of a second DNasel molecule
We have performed fluorescence enhancement experiments to analyse the interaction
between the G:A binary complex and NBD-Actin and also the interaction between
G:A binary complex and the Anb,pD complex, in the presence of Ca2+. The results
suggest that the equilibrium dissociation constant of A:D binary complex binding to
G:A (at the EGTA labile site - G4 - on gelsolin) is equivalent to that of G-Actin
alone binding to the G:A binary complex. Our data are consistent with the presence
of DNasel having no effect on the interaction of gelsolin and actin.
3.4.2 The presence of DNasel has no apparent effect on the dissociation constant of
actin monomer binding to the G:A binary complex
We have analysed the binding of NBD-Actin and Anba:D to the G:A binary complex
(in Ca2+) and determined the Kd for each reaction. We have used an alternative
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protocol for the purification of G:A binary complex to overcome problem of
incomplete dissociation of G:A2, upon addition of EGTA, to give G:A and free G-
Actin (see section 3.2.2.1).
3.4.2.1 DNasel-agarose column purification of G:A binary complex
The protocol used to purify G:A binary complex was based on that described by
Selve and Wegner (1986). It utilises the tight binding affinity of DNasel for the
pointed-ends of actin monomers (K<j ~ O.lnM), and dissociation of the G:A2 ternary
complex to give G:A and free G-Actin, upon the addition of excess EGTA (see
methods for protocol details).
DNasel was first covalently coupled to a sepharose matrix (via reaction with NHS-
Activated Sepharose 4® Pharmacia). This DNasel-sepharose column was then
equilibrated with G-Actin monomer, in ATP-G-Buffer, resulting in the formation of
immobilised A:D binary complex.
EGTA (0.6mM EGTA in the presence of 0.2mM MgCl2) was added to a preparation
of pre-formed and pre-purified G:A2 ternary complex. Following incubation (lhr at
4°C) this mixture was subjected to size-exclusion chromatography on an S200
column, pre-equilibrated in ATP-G-Buffer; 0.6mM EGTA; 0.2mM MgCl2. The
fractions that contained G:A binary complex were pooled and CaCl2 was then added
to 1 .OmM (in excess over EGTA), thus enabling G:A complex competent to rebind to
monomeric actin. This mixture was then loaded onto the DNasel-Actin-sepharose
column under depolymerising conditions. The G:A complex, in the presence of Ca2+,
rebinds to the actin monomers complexed 1:1 with DNasel on the column, to give
immobilised G:A2:D complexes. Specific elution of essentially only G:A binary
complex was achieved with a wash of 5mM EGTA in ATP-G-Buffer (in the presence
of l.OmM CaCl2; l.OmM MgCl2). This protocol gives a much more homogeneous
population of G:A (~ 95%) than gel-filtration of G:A2 in the presence of EGTA.
3-43
3.4.2.2 Binding of NBD-Actin by the G:A binary complex, in the presence of
calcium
Binding of NBD-Actin to G:A produces a fluorescence enhancement of 60 ~ 70% at
saturation (see fig. 3.11 and Weeds et al, 1986; Way et al, 1989; Pope et al, 1997).
Fig. 3.21 shows the titration of a constant amount of NBD-Actin (lOnM) with G:A
binary complex (purified as described). The level of enhancement in the fluorescence
signal is directly related to the amount of G:AAnbd ternary complex formed. A non¬
linear least squares fit of the data gave an apparent Kd of ~ 38nM for this interaction


















X Kd = 38nM
I ^^"max = 1.69 arb. units
50 100 150 200
nM G:A binary complex
250 300
Fig. 3.21. Binding of NBD-Actin to the G:A binary complex. Fluorescence titration of
G:A binary complex against a constant amount of NBD-Actin (10nM), in the presence of
0.2mM CaCI2. The solid line is a non-linear least squares fit of the equation AF =
AFmax*[G:A]/([G:A]+Kd). The apparent Kd for the interaction - 38nM (mean Kd ~ 39nM ±
6 SD, n=3), with a AFmax~ 1.69 arbitrary units, (R = 0.997). Titration was performed by
adding increasing amounts of G:A binary complex, in ATP-G-Buffer, to 10nM of NBD-
Actin in the same buffer, in a total volume of 500pl. Following a 1 hr incubation, at 20°C
in the dark, the fluorescence intensity was measured. The fluorescence values shown
are the mean values calculated after measurement for 90sec, (at 20°C), with a 1sec
reading interval. The error bars show 1 SD, calculated from three separate
experiments. The excitation wavelength was 475nm, the emission wavelength was
520nm, with a 5nm slit width for both. The level of fluorescence enhancement is directly
proportional to the amount of NBD-Actin bound (i.e. the amount of G:AAnbd ternary
complex). The fluorescence intensity value of 10nM NBD-Actin was subtracted from
each sample
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Similar experiments were performed to analyse the binding of Anbd:D to G:A binary
complex. Fig. 3.22 shows the titration of a constant amount of Anbd:D (lOnM) with
G:A binary complex. Similarly to fig. 3.21, the level of fluorescence enhancement is
directly related to the amount of GA:(Anbd:D) complex formed. A non-linear least
squares fit of the data gave an apparent Kd of ~ 49nM or this binding reaction {G:A
~t" Anbd-D ^ GA.(Anbd-D)}.
nM G:A binary complex
Fig. 3.22. Binding of Anbd:D to the G:A binary complex. Fluorescence titration of
G:A binary complex against a constant amount of Anbd:D (10nM), in the presence of
0.2mM CaCI2. The solid line is a non-linear least squares fit of the equation AF =
AFmax*[G:A]/([G:A]+Kd). The apparent Kd for the interaction - 49nM (mean Kd -
50nM ± 6.5 SD, n=3), with a AFmax~ 1.70 arbitrary units, (R = 0.998). Titration was
performed by adding increasing amounts of G:A binary complex, in ATP-G-Buffer,
to 10nM of Anbd:D in the same buffer, in a total volume of 500pl. Following a 1 hr
incubation, at 20°C in the dark, the fluorescence intensity was measured. The
fluorescence values shown are the mean values calculated after measurement for
90sec, (at 20°C), with a 1sec reading interval. The error bars show 1 SD, calculated
from three separate experiments. The excitation wavelength was 475nm, the
emission wavelength was 520nm, with a 5nm slit width for both. The level of
fluorescence enhancement is directly proportional to the amount of Anbd:D bound
(i.e. the amount of G:A(Anbd:D) complex). The fluorescence intensity value of 10nM
Anbd:D was subtracted from each sample
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The mean value for the dissociation constant for NBD-Actin binding to G:A was
38nM (± 6 SD, n=3) while that for Anbd:D binding to G:A was 50nM (± 6.5 SD,
n=3). A Kd of ~ 39nM for the binding of actin to the EGTA labile site on gelsolin
(G4) is in agreement with the ~ 25nM values reported by others (Bryan, 1988; Way
et al, 1989; Schoepper and Wegner, 1991; Pope et al, 1995).
The two Kd values show no significant difference from each other (P>0.15) and
suggests that the equilibrium dissociation constants are equivalent. The maximal
level of fluorescence enhancement reached at saturation was virtually identical for
both systems; AFmax ~ 1.69 arbitrary units for NBD-Actin compared to a AFmax ~ 1.70
arbitrary units for Anbd:D. The extent of enhancement was ~ 60 - 80% over that seen
for NBD-Actin and Anbd:D, alone in the absence of G:A binary complex. This data is
in good agreement with that reported in section 3.3.2.3.
The apparent equivalence of the two Kd values for the binding of G-Actin or A:D by
gelsolin is consistent with DNasel having no effect on the way G:A binary complex
interacts with actin monomers.
3-46
3.5 Discussion
3.5.1 DNasel purification protocol
DNasel is a highly toxic endonuclease, and as a result does not lend itself to high
levels of cytoplasmic expression in E. coli. However, the development of an inactive
mutant (H134Q; specific activity of the mutant is ~ 0.001% of the native enzyme;
Worrall and Connolly, 1990) led to subsequent high level expression in E. coli
(Doherty et al, 1993). Histidine 134 is essential to enzymatic activity and it plays an
integral part in the proposed DNA cleavage mechanism (Price et al, 1969; Suck and
Oefner, 1986). Several protocols for the purification of DNasel have been published
(Worrall and Connolly, 1990) but we were unable to achieve purity of >65% when
utilising these methods.
Commercially available DNasel (e.g. Sigma, Worthington, Fluka) has trace
contaminants of the proteolytic enzyme Chymotrypsin. Such preparations are
commonly pre-purified over hydroxyapatite resins before use, in attempts to avoid
further potential problems with protease degradation. However, this procedure does
not always remove all the protease activity and the subsequent use of DNasel in
actin:DNaseI binary complex formation and other experiments and assays involving
proteolytic sensitive proteins - e.g. gelsolin and actin - often still creates problems
with degradation. A further advantage of working with the recombinant protein is
that it is always available and cheaper than commercial preparations.
We have established a novel protocol for the purification of the recombinant mutant
DNaseI/H134Q, from JM105 E. coli. This protocol takes advantage of an apparent
specific interaction between the DNasel enzyme and the ligand Cibacron F3GA
Blue. We achieved elution from the Cibacron F3GA Blue resin with an ATP gradient
from ImM - lOmM. Elution could also be achieved with NaCl gradients of 0.15M -
0.5M; however the purity of the protein achieved by salt elution was ~ 85%.
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The difference in the ionic strengths between the concentration of ATP (~ 6mM), and
the equivalent NaCl concentrations (~ 0.2 - 0.3M) needed to achieve elution, coupled
with the extent of partitioning from major contaminants, suggests an apparent
specific interaction between DNasel and the resin. This affinity is possibly not a
surprise as the highly conjugated Cibacron F3GA ligand bears structural similarities
to the co-factors NAD+, NADH+ and adenyl containing co-factors and ligands.
Bovine pancreatic deoxyribonuclease I (DNasel) is a glycoprotein that binds to, and
subsequently cleaves double stranded DNA to yield 5'-oligonucleotides (Moore,
1981). DNasel is reported to interact with the DNA helix across the minor groove in
a sequence dependent manner (Suck et al, 1984), and its three-dimensional structure,
in complex with a fragment of DNA, has been solved to atomic resolution (Lahm and
Suck, 1991). The enzyme may be binding to the resin via some specific interaction
with the solid phase ligand that might resemble its native DNA substrate.
We routinely obtained purity of >95% for the recombinant mutant DNasel from
cultures of JM105 E. coli using this protocol and typical yields were 10 - 15mg.L_1
of original bacterial cell culture.
3.5.2 1.0M Tris, pH 8.0; ATP-G-Buffer actin extraction and purification protocol
We have developed an alternative method for the extraction and purification of G-
actin, altered from the widely used Spudich and Watt protocol, (Spudich and Watt,
1971). Actin was extracted from rabbit muscle acetone powder, in monomeric form,
in a low ionic strength buffer (ATP-G-Buffer). Polymerisation was then initiated by
addition of KC1 to 0.8M followed by very high-speed centrifugation. This pellets
essentially only actin in F-form. The pellet was then homogenised in a 1M Tris, pH
8.0 buffer (Pinder et al, 1995). This procedure induces rapid depolymerisation of the
actin filament, possibly as a result of the Tris acting as a chaotropic agent. Amine
salts have been reported to be effective dissociating agents for protein complexes
(Keen, 1979). This high Tris concentration buffer seems to perform this function
without denaturing the G-actin. 1.0M Tris, pH 8.0; ATP-G-Buffer also allowed us to
store G-actin for over 4 months in a stable and active form (compared to 2 -3 weeks
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for conventional ATP-G-Buffer). Details of the protocol and the assay of the viability
of the buffer for long term storage are given in the methods and appendix A,
respectively.
3.5.3 Confirming the formation of the G:A, G:At and A:D complexes
We have analysed the formation of complexes between actin and gelsolin and that
between actin and DNasel. Conformation of the existence of these various
complexes was performed by a variety of techniques: gel-filtration, non-denaturing
PAGE and by NBD-Actin fluorescence enhancement experiments. Additionally, the
stoichiometry of the complexes was verified by gel densitometry.
The experiments reported in the preceding sections show that gelsolin (recombinant
expressed human cytoplasmic gelsolin), binds to monomeric actin. No complex
formation was observed in the absence of calcium ions (i.e. at less than (iM
concentrations). G:A2 ternary complex was formed in the presence of Ca2+ and a
binary complex, G:A, was formed in EGTA (after first activating gelsolin by the
addition of 0.2mM CaCl2, followed by subsequent chelation by EGTA). Chelation of
Ca2+ results in the dissociation of the actin monomer from the G4 binding site on
gelsolin. This G4 binding site is totally calcium dependent. (The removal of calcium
only reduces the affinity of the binding site in G1 for actin. Kd in Ca2+ ~ 5pM; Kd in
the absence of Ca2+ ~ 1 - 2nM; Bryan, 1988).
Gel-filtration illustrated that even in the presence of a molar excess of gelsolin
(molar ratios of up to 1:2 for actimgelsolin), the ternary complex predominates in
Ca2+. Non-denaturing PAGE analysis of complex formation also confirmed these
results, indicating the preferential formation of G:A2 ternary complex, even in the
presence of a molar excess gelsolin (up to 1:2). Weeds and co-workers (Weeds et al,
1986), have reported very similar results and suggested that the two actin-binding
sites were coupled in strong co-operative way. The data we report here are in
agreement with this
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Our data also showed that the fluorescence increment per NBD-Actin monomer
21
bound is approximately the same. Formation of G:A2, in Ca , produces an
enhancement of ~ 120% (over that observed for NBD-Actin alone) in contrast to the
~ 60 - 70% enhancement observed upon formation of the binary complex, in EGTA,
(see fig. 3.11). Similar conclusions can be drawn from the continuous variation
experiments. The levels of enhancement upon ternary complex formation, in Ca2+,
are approximately twice those seen upon G:A formation in EGTA, see figs. 3.12(A)
and (B). Furthermore, the shape of the titration curve and the positions of the sharp
inflection point in these experiments, indicates a strong coupling of both sites with
tight binding (IQ at least in the nM range, Weeds et al, 1986), and an equal
contribution to the enhancement by both binding sites. (See Blake et al, 1967; Pinder
and Gratzer, 1982; Weeds et al, 1986, for details of the interpretation of data from
such experiments).
Our experiments have also confirmed the formation and stoichiometry of the tight
binary actin:DNaseI complex. This complex forms in the presence or absence of
Ca2+, with no apparent difference (Pinder and Gratzer, 1982; Weber et al, 1994).
Flowever, the addition of EGTA to A:D that had been pre-formed in the presence of
Ca2+ occasionally resulted in a partial dissociation of the complex. This was observed
as small amounts of free actin and DNasel appearing at the corresponding retention
volumes and electrophoretic migration positions for uncomplexed proteins, during
size-exclusion and native-PAGE experiments, respectively.
A possible explanation for this observation may be due to the chelation of several
Ca2+ ions (by EGTA), bound to the DNasel molecule at two distinct binding-sites.
One Ca2+ ion is bound at the catalytic site of the enzyme, but the other is found at a
site between the two major domains of the molecule (Suck and Oefner, 1986).
Binding of calcium at this second site confers a degree of protection against
proteolysis; cleavage occurs within a loop that lies between the two domains of
DNasel that form the DNA binding cleft (Suck and Oefner, 1986). Reconstitution of
native enzyme activity, in samples of protein cleaved at this site, is possible by the
addition of Ca2+.
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The removal of this Ca2+ from DNasel in the A:D complex may possibly result in a
local conformational change within the DNasel molecule that then induces a loss of
affinity for actin. This phenomenon gave some anomalous results, especially on
native gels, during the analysis of the formation of the G:A2:D2 and G:(A:D)2
complexes but the occurrence was limited and had little effect on our data.
The spectral "silence" of DNasel bound to NBD-Actin is in agreement with results
published by Detmers et al (1981). The protocol used to couple the NBD-probe to G-
Actin involves the linkage of NBD to Lys-373, after the Cys-374 residue has been
blocked by the action of N-ethylmaleimide (see methods for details). A decrease
(maximally 5%) in the fluorescence signal of NBD-Actin complexed with DNasel
(compared to uncomplexed NBD-Actin) is sometimes observed. However,
differences in the degree of NBD-labelling within a given preparation of NBD-Actin
(~ 40 - 70%) and some spectral interference by small amounts of NBD-Cys-374,
(NBD coupled to Cys-374 has a slightly different excitation and emission spectral
characteristics than that of NBD-Lys-373), mean this decrease in signal is not always
observed (Detmers et al, 1981).
Lys-373 lies at the surface of sub-domain I on the actin monomer (Kabsch et al,
1990). The fluorescence enhancement observed upon the binding of gelsolin to
NBD-Actin, is probably due to changes in the polar environment around the NBD
probe. The gelsolin:actin binding interaction takes place via a site located between
sub-domains I and III of the actin monomer (McLaughlin et al, 1993). This
interaction likely cause marked local changes in the solvent environment around the
NBD-Probe that lead to enhancement of the fluorescence signal. In contrast to this,
the binding of DNasel takes place via a loop located at the edge of sub-domain II, see
fig. 1.10 (Kabsch et al, 1990). This region is far from the site of coupling for NBD, ~
50A. There are essentially no changes in the structure of the actin monomer, upon
1:1 complex formation with DNasel that would affect the structural and/or solvent
environment around the NBD probe. This is consistent with the crystallographic data,
which suggests that DNasel does not significantly alter the actin conformation. The
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actin monomer has the same structure in the DNasel crystal (Kabsch et al, 1990) as
in the crystal with G1 of gelsolin (McLaughlin et al, 1993), see figs. 1.8 and 1.10.
3.5.4 Decoration of G:A? with DNasel suggests a non-filamentous disposition for the
actin monomers
The results from our size-exclusion experiments (performed under polymerising
conditions) in which DNasel was added to pre-formed G:A2 (at a molar ratio of 2:1,
respectively) showed the formation of a significantly larger complex (relative to
G:A2) with an apparent Mr. of 251kDa. The stoichiometry of this larger complex was
shown to be G:A2:D2. Similarly, in experiments in which we added pre-formed A:D
to gelsolin, in the presence of Ca2+ (0.2mM CaCl2), a larger complex with the same
apparent Mr. (251kDa), and stoichiometry, G:(A:D)2, was formed. Similar results
were obtained from non-denaturing gel experiments.
The fluorescence enhancement data also support the formation of the G:(A:D)2
complex. Titration of a constant amount of gelsolin with Anbd:D complex, in the
presence of Ca2+ (0.2mM CaCl2), indicated the formation of a tight complex
between gelsolin and Anbd:D, with a stoichiometry of G:(Anbd:D)2. Similarly, the
continuous variation fluorescence titration experiments with gelsolin with Anbd:D
indicated the formation of a complex with a stoichiometry of G:(Anbd:D)2. We found
no significant difference between these titration curves and those obtained for the
binding to gelsolin of NBD-Actin alone. (Compare the data in figs. 3.10, 3.11 and
3.12 with 3.18, 3.19 and 3.20).
The gel-filtration and native-PAGE experiments seem to illustrate a similar co¬
operative binding of the A:D binary complex by gelsolin, (analogous to the
formation of G:A2 ternary complex). Even in the presence of a molar excess of
gelsolin (molar ratios of up to 1:2 for (A:D):gelsolin), we observed the formation of a
complex with an apparent Mr. of 251kDa and a stoichiometry of G:(A:D)2. Non-
denaturing PAGE analysis of complex formation also confirmed this result. It seems
that the formation of the G:(A:D)2 complex predominates (up to a molar ratio of 1:2,
3-52
for A:D and gelsolin, respectively) in Ca2+ (0.2mM CaC^). This may imply that
gelsolin binds A:D by a similar method to the way it binds actin monomers to form
the G:A2 ternary complex, i.e. there is a strong positive coupling between both sites
binding sites on gelsolin, with tight binding (K<j at least in the nM range) at both
(Weeds et al, 1986; Schoepper and Wegner, 1991). This suggests that the presence of
DNasel, bound to the pointed-ends of the actin monomers in the A:D binary
complex, may have little effect on the interaction between the actin monomers and
gelsolin.
Our data from fluorescence enhancement experiments analysing the interaction
between the G:A binary complex and NBD-Actin and the interaction between G:A
binary complex and the Anbd:D complex (in the presence of Ca2+) further support this
notion. The mean value for the dissociation constant obtained for NBD-Actin
binding to G:A was 38nM (± 6 SD, n = 3) while that for Anbd:D binding to G:A was
50nM (± 6.5 SD, n = 3). A Kd of ~ 39nM for the binding of actin to the EGTA labile
site on gelsolin (G4) is in good agreement with the ~ 25nM values reported by others
(Bryan et al, 1988; Way et al, 1989; Schoepper and Wegner, 1991; Pope et al, 1995).
The dissociation constants show no significant difference from each other (P>0.15)
suggesting that the dissociation constants are equivalent. The final level of
fluorescence enhancement reached at saturation was virtually identical for both
systems. A AFmax of ~ 1.69 arbitrary units for NBD-Actin compared to a AFmax of ~
1.70 arbitrary units for Anbd."D, and the extent of enhancement was ~ 60 - 80% over
that observed for NBD-Actin or Anbd:D, in the absence of G:A binary complex. This
data is in good agreement with that reported in section 3.3.2.3.
The apparent equivalence of the two dissociation constants for the binding of G-
Actin or A:D by gelsolin (at the G4 binding site on gelsolin), is consistent with the
presence of DNasel (bound at the pointed-end of the actin monomer) having no
effect on the way G:A binary complex interacts with actin monomers.
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The formation of G:A2:(D)2 or G:(A:D)2 is consistent with the actin monomers
within G:A2 having a non-filamentous disposition.
Fig. 3.23 illustrates various possibilities for the disposition of the actin monomers in
G:A2. If G:A2 has a conformation like that described for condition (A), F-
conformation in fig. 3.23, we would not have expected to be able to bind two DNasel
molecules to the exposed pointed-ends of the actin monomers in the ternary complex.
This conformation, where the actin monomers are oriented as described in the
Holmes filament model (Holmes et al, 1990), prevents the binding of two DNasel
molecules due to a steric clash (Weber et al, 1994). However, our results clearly
indicate the formation of a complex between G:A2 and DNasel with a stoichiometry
of (G:A2):D2 and also the formation of a complex between gelsolin and two A:D
binary complexes, with a stoichiometry of G:(A:D)2. i.e. two DNasel molecules can
be bound to the actin monomers within the G:A2 ternary complex.
Any shift in the spatial disposition of the actin monomers bound to gelsolin, due to
the steric effects of DNasel bound/binding at the pointed-ends (in relation to their
disposition in G:A2 without DNasel bound), may produce changes in the
fluorescence spectra of NBD-Actin. The fluorescence emission spectra and
enhancement levels of the NBD moiety are very sensitive (significant shifts in the
wavelength of maximum absorbance and/or differences in the levels of
enhancement) to changes in the polar environment around the probe (Detmers et al,
1981; Way et al, 1989). However, our data showed that the fluorescence
enhancement levels for either NBD-Actin alone or the Anbd:D binary complex,
binding to gelsolin, are very similar. There was also no significant difference
between the fluorescence titration data for NBD-Actin alone binding to gelsolin, and
that for AnbtfD binding to gelsolin, (in 0.2mM CaCl2). Furthermore, the dissociation
constants for the binding of A:D or G-Actin alone, to G:A, are equivalent (50nM and
39nM, respectively).
This similarity may suggest that the binding of actin monomers by gelsolin takes







Fig. 3.23. Schematic diagram representing the possible conformational orientations of
the actin monomers in G:A2. (A) F-Conformation. The monomers have a spatial orientation
like those at the barbed-end of the filament, as described by the Holmes filament model (Holmes
et al, 1990). This conformation prevents the binding of two DNasel molecules to the exposed
pointed-ends, due a steric clash (Weber et al, 1994). (B) Non-F-Conformation. The actin
monomers are held in a non-filamentous conformation, but in close proximity to each other, by
gelsolin. In this orientation there are no steric constraints and two DNasel molecules could bind
to the pointed ends of the actin monomers. (C) Perturbation. The actin monomers are held in an
F-like conformation. However, the binding of DNasel to the pointed-end of one monomer
disrupts the interaction between the two monomers and/or between gelsolin and the monomers,
causing a loss of F-like conformation and enabling the binding of a second DNasel molecule.
This model suggests that the binding of DNasel to an actin monomer results in a conformational
change in the structure of that actin, with respect to uncomplexed actin, that results in a change
in it's binding interactions with other monomers and gelsolin. Such a change results in the actin
becoming non-viable for adoption of F-like conformation in the G:A2 complex. (D) Equilibrium. In
this case the G:A2 ternary complex is in equilibrium between the two conformations in (A) and
(B). The addition of DNasel to G:A2 may result in a shift of the equilibrium to favour the non
filamentous conformation. The binding of two DNasel molecules and the resulting steric
interference between them, may force the G:A2 complex to adopt a more open, non-filamentous
conformation. Actin-G1; the tight binding actin monomer, on the G1 site on gelsolin. Actin-G4;
the EGTA labile, actin monomer, on the G4 site on gelsolin.
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complex with DNasel or not, (analogous to that described below for ternary complex
formation between gelsolin and actin). We are proposing that the presence of DNasel
does not impose any steric and/or kinetic constraints on the monomer association
with gelsolin, due to the fact that the monomers are normally held in a non-
filamentous conformation.
Formation of the G:A2 ternary complex has been shown to have two distinct
reactions. The binding of the second monomer is ~ 100 - 1000 fold faster than the
first, upon activation of gelsolin with >|i,M levels of Ca2+. G + A <-> G:A. k+ ~ 104
M.s"1; G:A + A <-> G:A2, k+ ~ 2*107 M.s"1, k. ~ 0.02 s"1 (Schoepper and Wegner,
1991). The kinetic parameters of the two reactions mean that the reverse reaction for
the formation of G:A (Kj for G1 and actin is ~ 5pM) essentially does not occur and
the concentration of G:A compared to that of G:A2 is negligible. The fitting of
kinetic parameters to fluorescence enhancement data, very similar to ours obtained in
fig. 3.10, was best achieved by having two tight actin-binding sites (fQi ~ pM, and fQ
~ nM, for G1 and G4 respectively) with strong positive co-operatively between them
(Weeds et al, 1986; Selve and Wegner, 1986; Bryan, 1988; Schoepper and Wegner,
1991). As there is no significant difference between the results obtained with NBD-
Actin alone and those with Anbd:D then, by analogy, we propose a similar binding
scheme for the formation of G:(A:D)2 (see fig. 3.24).
As two DNasel molecules are bound to G:A2, and as the formation of G:(A:D)2 is
apparently indistinguishable from the formation of G:A2 (at least from our
fluorescence enhancement data) we suggest that the actin monomers may be held in
an open, non-filamentous conformation, but in close proximity to each other. This
orientation implies that there may be no steric constraints on the binding of these two
DNasel molecules, such as is illustrated by condition (B) Non-F-Conformation in fig.
3. 23.
Our results may also provide an explanation for why the G:A2 ternary complex does
not behave as a "true" nucleus for polymerisation, as judged by the kinetic analysis
of gelsolin and G:A2 nucleated actin polymerisation. Coue and Korn (1985), showed
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Fig. 3.24. Schematic diagram of the two step equilibrium binding scheme for the
formation of the G:A2 ternary complex and the putative (by analogy) binding scheme
for the formation of G:(A:D)2. (A) Formation of G:A2 ternary complex takes place via two
distinct reactions; A1 and A2. The binding of the second monomer is ~ 100 - 1000 fold faster
than the first, upon activation of gelsolin with >pM levels of Ca2+ (Schoepper and Wegner,
1991). The kinetic parameters of the two reactions mean that the reverse reaction for the
formation of G:A (Kd for G1 and actin ~ 5pM; Bryan, 1988) essentially does not occur (at
concentrations used in our experiments) and the concentration of G:A compared to that of
G:A2 is negligible. The fitting of fluorescence enhancement data, very similar to that illustrated
in fig. 3.10, was best achieved by having two tight actin-binding sites (Kd ~ pM, and Kd ~ nM,
for G1 and G4 respectively) with strong positive co-operatively between them (Weeds et al,
1986). (B) A similar two step (B1 and B2) binding scheme for the formation of G:(A:D)2 is
shown. We observed no significant difference between fluorescence enhancement data
obtained with NBD-Actin alone and those with Anbd:D (compare the data shown in figs. 3.10,
3.11 and 3.12 with that in figs. 3.18, 3.19 and 3.20). Furthermore, the Kd for the binding of A:D
by G:A is equivalent to the Kd of the binding of G-Actin alone by G:A (50nM and 39nM,
respectively). By analogy, we propose a similar binding scheme, with similar dissociation
constants, for the formation of G:(A:D)2. Actin-G1; the tight binding actin monomer, on the G1
site on gelsolin. Actin-G4; the EGTA labile, actin monomer, on the G4 site on gelsolin.
A:D/G1; A:D binary complex binding at the tight G1 site on gelsolin. A:D/G4; A:D binary
complex binding at EGTA labile G4 site on gelsolin.
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G:A2 greatly accelerated the rate of polymerisation and reduced the nucleation step,
but did not bypass it altogether, see fig. 3.25 for illustration of this effect. (The lag-
phase may be partly due to the exchange of Ca2+ for Mg2+ at the high affinity site).
Time, sec
Fig. 3.25. Illustration of the nucleating effect of G:A2 ternary complex on the
rate of actin polymerisation, in the presence of 0.2mM CaCI2. The time courses
of polymerisation of 10|aM actin alone (5% pyrene-labelled) or 10pM actin (5%
pyrene-labelled) in the presence of 0.1 pM F-actin seeds, or 5nM, 10nM or 20nM
G:A2 ternary complex is shown above. Polymerisation was induced by the addition
of KCI and MgCI2to 100mM and 2mM, respectively. Polymerisation was followed by
monitoring the increase in fluorescence intensity of pyrene actin. The excitation
wavelength was 366nm, the emission wavelength was 384nm, with a 5nm slit-width
for both. Buffer conditions: 5mM Tris, pH 8.0; 0.2mM CaCI2; 0.2mM ATP; 0.5mM
DTT; 1.0mM NaN3; 100mM KCI; 2mM MgCI2. The presence of G:A2 results in an
increase in the initial rate of polymerisation, over that of 10pM actin alone, However,
although the lag phase is greatly reduced it is not abolished completely. Contrast
this to the nucleation of polymerisation with 0.1 pM F-actin seeds. Under these
conditions there is no lag phase and the initial polymerisation rate is the maximum
(for these conditions).
Although the initial rate of actin polymerisation is linearly related to the
concentration of G:A2, at low concentrations the rate of polymerisation was less than
one would have predicted if all of the G:A2 present caused nucleated filament
growth, i.e. the concentration of the filaments (at least at low actin concentrations)
was less than the concentration of G:A2 used to nucleate polymerisation (Coue and
Korn, 1985). The affinity of ATP-G-Actin for G:A2 (at least at relatively low
concentrations of actin, or of G:A2) may be less than its affinity for an already
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formed pointed-end of an actin filament leading to the conclusion that G:A2 was not
acting as a "true" nucleus for actin polymerisation.
This observation could be explained by the actin monomers in G:A2 being oriented in
a non-filamentous conformation. As a result they may then present a different surface
for the addition of monomer than that presented by a pointed-end of an already
formed filament. In this non-filamentous conformation in G:A2 may just hold the
monomers in very close proximity to each other, whereby the energetics of the
nucleation phase is reduced, but it is not by-passed altogether.
However, the ionic conditions used during Coue and Korn's analysis were different
to those normally used to initiate and study actin polymerisation. The initiation of
actin polymerisation was performed solely by the addition of MgCl2 (to ImM), to
actin (in the presence of G:A2) in ATP-G-Buffer. In similar experiments where actin
polymerisation is induced by the addition of physiological concentrations of KC1 and
MgCh (~ 100 - 150mM and 2mM, respectively) to actin in ATP-G-Buffer, the
concentration of actin filaments, nucleated in the presence of gelsolin or G:A2, is
equal to the concentration of the nucleating species (Janmey and Stossel, 1986; Selve
andWegner 1986; Way et al, 1989; Weber et al, 1994).
The ionic composition of the buffer solution (variations in salt concentration, the
type and concentration of mono- and divalent-cations present, and pH) used to
initiate actin polymerisation, has very marked effects on the kinetics of assembly and
disassembly (Frieden, 1982; Brenner and Korn, 1983; Gershman et al, 1984; Pollard,
1986; Zimmerle and Frieden, 1988a/b/c; Wang et al, 1989; Kinosian et al, 1993;
Sheterline et al, 1995). Variations in salt concentration and the presence or absence
of the divalent-cations Ca2+ and Mg2+ have also been reported to alter the way
gelsolin interacts with both monomeric and filamentous actin (Way et al, 1988; Yin
et al, 1988; Way et al, 1989; Pope et al, 1991; Way et al, 1992; Laham et al, 1993;
Allen and Janmey, 1994). Thus, the different solution conditions used by Coue and
Korn may have caused or amplified the effect they observed for G:A2.
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More direct evidence that the actin subunits in G:A2 are not held in a filamentous
orientation comes from studies of the interaction between gelsolin and a cross-linked
actin dimer derived from filaments. Actin filaments can be covalently cross-linked
between Cys-374 from one subunit to Lys-191 of a neighbouring subunit, and the
actin dimer purified (Knight and Offer, 1978; Elzinga and Phelan, 1984). This cross¬
link is consistent with the Holmes filament model (Holmes et al, 1990) which
indicates that this linkage most likely occurs between two actin monomers that are
neighbours across the short-pitch helix. We would predict that gelsolin should bind
to both subunits in the dimer in a similar manner to its binding of the terminal actin
monomers at the barbed-end of filaments, during capping.
However, this appears not to be the case. Doi and colleagues (Doi et al, 1991; Doi,
1992) showed that although gelsolin did bind to the actin dimer (labelled with NBD)
this binding only produced fluorescence enhancement levels indicative of gelsolin
having only bound to one of the actin monomers. Attempts to covalently link the
crosslinked actin dimer to gelsolin, resulted in the linkage of the dimer to only the
Ca2+ insensitive G1 site in gelsolin and not to G4. While we would not expect the
crosslink to hold the dimer in a rigid and inflexible filament conformation, the
significance of this result is that when a filament "constraint" - the cross-link - is
imposed on actin subunits, gelsolin appears to not be able to bind both monomers.
This data is complementary to our own. Doi (Doi, 1992) imposed an F-Actin
constraint and did not observe the binding of both G1 and G4 actin-binding sites of
gelsolin; we have two binding sites but did not observe results that were consistent
with an F-Actin conformation.
A further possible model for actin monomers in ternary complex with gelsolin
complex is that illustrated in (C) Perturbation, in fig. 3.23. In this perturbation model
the actin monomers within G:A2 are normally in a filamentous conformation. The
binding of DNasel to one of the monomers in G:A2 may induce some form of
conformational change within that actin. This stmctural rearrangement may then
result in change in the way that monomer interacts with gelsolin and/or with the
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second neighbouring actin, causing a loss of F-like conformation and enabling the
binding of the second DNasel molecule.
Some support for the idea that DNasel binding may perturb normal gelsloin:actin
interactions comes from the work of Ballweber and colleagues (Ballweber et al,
1997). They have suggested that there is negative co-operativity between the binding
sites on G-Actin for DNasel and gelsolin segment-1 (Gl). In the presence of both G1
and DNasel, the increase in the steady-state critical monomer concentration (due to
the sequestration of actin monomers) was found not to be completely additive, unlike
the mutually exclusive binding of thymosin-[34 and Gl with actin (Ballweber et al,
1997). This kinetic data suggested a negatively co-operative linkage between the two
binding sites, implying that it prevented the formation of a stable ternary complex;
DNaseI:actin:Gl. DNasel and Gl bind to two oppositely spaced sub-domains of G-
Actin, that bridge an inter-domain cleft (see fig. 1.10 and McLaughlin and Weeds,
1995), and these sites are part of regions of the monomer that are involved in actin-
actin interfaces (Holmes et al, 1990; Lorenz et al, 1993). As a result Ballweber et al
(1997) suggest that this apparent negative co-operativity may explain the effect of
DNasel increasing the off rate, from the pointed-ends of gelsolin capped filaments
(Weber et al, 1994).
Nevertheless, The formation of a ternary complex between actin, DNasel, and Gl
could be demonstrated by gel-filtration and other binding experiments (Weeds et al,
1991). This implied that the affinity of these two proteins were significantly high
enough to give a stable ternary complex formation. Formation of the
Gl:actin:DNaseI ternary complex was also confirmed by us in gel-filtration
experiments (data not shown).
Indeed, other evidence suggests that the DNasel molecule has little, if any, effect on
the structure of the actin monomer. The A:D binary complex and G-actin alone
appear to have the same affinity for the pointed-ends of actin filaments; IQ in the
range of 0.3 - 0.8p.M for both species (Podolski et al, 1988; Weber et al, 1994).
Crystallographic data also suggests that DNasel does not significantly alter the
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conformation of the complexed actin monomer. Actin has the same structure in the
DNasel crystal, which binds at a loop on the surface of subdomain II (Kabsch et al,
1990), as in the crystal with G1 of gelsolin, which binds to a cleft between domains I
and III (McLaughlin et al, 1993). Furthermore, our own data indicates that the
dissociation constants for the binding of A:D or G-Actin by the G:A binary complex
are equivalent (see section 3.4). The presence of DNasel appears to have no effect on
the actin monomer with regards to its binding interaction with gelsolin. The close
similarity of our fluorescence data, for the binding of Anbd:D to gelsolin, compared to
that obtained with NBD-Actin alone binding to gelsolin, suggests a similar
equilibrium binding scheme. In that case, the presence of DNasel imposes no steric
or kinetic constraints on the binding interaction between gelsolin and actin
monomers, and suggests that condition (C) Perturbation (fig. 3.23) is unlikely.
The (D) equilibrium condition in fig. 3.23 suggests a model where the G:A2 ternary
complex in equilibrium between a closed "F-like" state and a more open "Non-
Filamentous" state. Addition of DNasel to the G:A2 complex may pull the
equilibrium towards the less constrained, and non-filamentous conformation, by
simply binding to the pointed-ends of the actin monomers when G:A2 is in the more
open "Non-F-conformation". If the equilibrium, between the open and F-like actin
subunit interactions of G:A2 is very rapid, we could not distinguish this model from
the (B) Non-F-Conformation model since the binding of actin by gelsolin is so tight.
All we can say is that the actimactin interactions that may exist between monomers
within G:A2 are not strong enough to prevent access of DNasel to both subunits, if
they are in a filamentous conformation.
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3.6 Conclusion
Our results are not inconsistent with the actin monomers within G:A2 having a
different conformation from those at the barbed-end of a filament. The actin
monomers are afforded a degree of flexibility, or at least, the tight-binding
association with DNasel is sufficient to change the normal conformation. These
results are in agreement with the model (B) Non-F-Conformation in fig. 3.23.
However, we have no direct evidence to support or discount the possibility of an
equilibrium between non- and filamentous conformations for the orientation of the
actin monomers in G:A2, like that illustrated in the (D) Equilibrium model in fig.
3.23.
Although our results suggest that the actin monomers within isolated G:A2
complexes are not oriented in an F-like conformation (adjacent to each other across
the short pitch helix of the filament; Holmes et al, 1990) addition of a third actin
subunit, resulting in the formation of a "trimer-nucleus", might stabilise the filament
conformation. Therefore, using the A:D binary complex as the third subunit (where
further monomer addition is blocked by DNasel bound at the pointed-end) suggested
a possible way in which we could test this idea by forming a defined molecular
complex.
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4. Towards a capped actin-"minifilament"
4.1 Overview
We have performed experiments to test for the formation of an actin-"minifilament",
of defined length and composition, capped at both ends by specific binding proteins;
with gelsolin binding at the barbed-end and DNasel at the pointed-end of the
filament. Formation of a putative "minifilament" complex, with a stoichiometry of
G:A3:D, is reported. This putative "minifilament" appears to bind rhodamine-
phalloidin but not the myosin S-l head (at least in the presence of ATP).
4.1.1 Introduction
F-actin is not amenable to crystallisation and subsequent determination to atomic
resolution, due to the uncontrollable distribution of polymer lengths and their relative
flexibility. The crystal structure of the actin:DNaseI binary complex (Kabsch et al,
1990) was used to build a model of the actin filament using data from X-ray
diffraction patterns of oriented F-Actin gels (Holmes et al, 1990; Lorenz et al, 1993).
The major problem with this model is that the experimental observations extend to
only 7-8 A, at best, see chapter 1 for details (Holmes et al, 1990; Lorenz et al, 1993;
Schmid et al, 1993). Although a unique solution was found, the resolution of the
experimental data were insufficient to allow refinement of the input model. Thus, if
there had been any conformational changes in surface loops, or even rigid rotations
of subdomains within the monomer, the observation to parameter ratio was
insufficient to reliably estimate these by least squares fitting of the model to the data.
In its favour, the model is consistent with crosslinking and esr-spin probe data and
both the EM (Milligan et al, 1990) and X-ray models (Holmes et al, 1990) agree
(Mendelson and Morris, 1994).
However, we are far from understanding the atomic contacts that hold the filament
together, the interactions involved when myosin uses the actin polymer as a track
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during muscle contraction and how the many proteins that control the actin
cytoskeleton bind to and interact with the filament.
We propose to take a different approach to attempt to address the resolution problem
of the current model: this is to form a capped-actin-"minifilament", with a view to
crystallographic studies. This species has a defined length and composition, and
contains three actin subunits forming a "minifilament", blocked at both ends by
specific binding proteins with gelsolin binding at the barbed-end and DNasel at the
pointed-end of the filament, with a stoichiometry of G:A3:D, see fig 4.1.
Gelsolins ability to form a cap at the barbed-end of an actin filament, and formation
of stable ternary complexes with two actin monomers, provides us with a tool to
control the definition of one end (the barbed-end) of the filament. The GA2 ternary
complex could be combined with a pointed-end capped actin species to give a larger
complex, hopefully with the actin monomers in F-conformation. A possible
candidate for the capping of the pointed-end is the G-Actin:DNasel binary complex
(A:D), see fig. 4.2.
DNasel forms a very tight and stable 1:1 binary complex (A:D) with actin (K^ ~ 0.1
- l.OnM, Mannherz et al, 1980). It also binds to the pointed-ends of actin filaments
with similar affinity (K<j ~ InM, (Podolski et al, 1988; Weber et al, 1994). This
binding leads to a blockage of filament elongation, conferred by the binding of one
DNasel molecule to the pointed-end of a single strand of the F-Actin two-start helix
(Podolski et al, 1988). The binding of this DNasel appears to have no significant
effect on the affinity of the attached actin for the pointed-end of the filament. Weber
and co-workers (Weber et al, 1994) indicated that the binding of two DNasel
molecules was not possible at the pointed-ends of gelsolin capped actin filaments. At
DNasel concentrations in the |iM range an increase in the rate of depolymerisation
from the pointed-ends of gelsolin capped filaments was observed (K50% ~ 5(lM,
Weber et al, 1994). The explanation proposed for this was a steric clash between two
DNasel molecules at the pointed-end. This prevented the simultaneous stable binding
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of both DNasel molecules and resulted in an increase in the koff rate for the actin
monomer, as a 1:1 binary complex with DNasel (Weber et al, 1994).
Pointed-end
Barbed-end
Fig. 4.1. Model of the putative "minifilament". A schematic representation of a
putative model of the capped-actin-"minifilament", with stoichiometry of G:A3:D
(gelsolin:actin3:DNasel), is shown. DNasel is coloured grey, the three actin
monomer subunits, oriented as described by the Holmes filament model (Holmes
et al, 1990), are coloured red, green and blue. Only segment 1 (G1) and a
putatively positioned segment 4 (G4) - by analogy - from gelsolin are shown,
coloured yellow. Kinetic and modelling evidence suggests that only one DNasel
molecule can be bound at the pointed-end (Weber et al, 1994). (The diagram was
created using MOLSCRIPT; Kraulis, 1991).
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Fig. 4.2. G-Actin in complex with two opposite end-opposed binding
proteins. (A) A schematic view of the actin-gelsolin segment 1 (shaded) complex
(the Ca2+ ions are shown as spheres) as described by McLaughlin et al (1993. (B)
A schematic view of the actin-DNasel (shaded) complex as described by Kabsch
et al (1990). This side-by-side orientation clearly indicates the binding of the two
proteins at opposite ends of the actin monomer. (Diagrams were created using
MOLSCRIPT; Kraulis, 1991).
Modelling evidence is consistent with this kinetic data. Two actin:DNaseI binary
complexes (A:D) cannot be accommodated at the pointed-ends of filaments due to a
significant steric clash. Our proposed "minifilament" model (fig. 4.1), with the actin
monomers oriented in a filamentous conformation (as described for the filament
model, Holmes et al, 1990) acknowledges this argument. It is not possible to
accommodate two DNasel molecules at the pointed-ends of the putative
"minifilament", giving our model a likely stoichiometry of G:A3:D.
Capping and nucleating proteins like gelsolin (and the G:A2 ternary complex) result
in an acceleration of the rate of polymerisation by shortening the lag phase (see
section 1.3 for details on actin polymerisation and see fig. 3.25 for an example of
G:A2 nucleation). The probable explanation for this activity is that the nucleation rate
is increased. Despite the apparent lack of F-like character of the orientation of the
actin monomers within the G:A2 ternary complex (see results reported in chapter 3),
it nevertheless still binds tightly to, and caps the barbed-end of actin filaments,
preventing further polymerisation. G:A2 also nucleates actin polymerisation, very
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efficiently, in the pointed-end direction. Although polymerisation tales place at the
slower growing pointed-end, the overall polymerisation rate is increased because the
rate-limiting nucleation step occurs faster; the nuclei are probably more stable and
more free pointed-ends are created during gelsolin and G:A2 nucleated
polymerisation (Pollard and Cooper, 1986; Ditsch and Wegner, 1994). The final
result is the production of large numbers of short filaments with gelsolin capped
barbed-ends.
Thus, the nucleating ability of G:A2 probably results in a reduction in the energetics
of nucleation (resulting in the formation of more nuclei and thus, more filament ends
onto which polymerisation can occur), due to the close proximity, and increased
stability of two actin monomers in ternary complex with gelsolin, compared to the
"true" actin trimer nuclei. However, the kinetic analysis of such nucleated
polymerisation is inconsistent with models where the capping proteins (in this case
G:A2 ternary complex) simply orient the actin subunits to be like the pointed-end of
an already formed actin filament (Coue and Korn, 1985; Pollard and Cooper, 1986;
Ditsch and Wegner, 1994). This is consistent with our results discussed in chapter 3,
where our data appear to indicate that the actin monomers in the G:A2 complex are
oriented in a different conformation to those at the barbed-end of a filament.
Although the kinetics of monomer addition, during nucleated polymerisation, onto
the pointed-end of such species is probably different to addition onto the pointed-end
of already formed filaments, it nevertheless still requires the formation of some form
of "trimer-nuclei" species before rapid elongation takes place. Hence this may be the
reason why gelsolin and G:A2 reduce the lag phase but do not bypass it altogether.
(The lag phase may also be partly due to the exchange of Ca2+ for Mg2+ at the high
affinity site).
The addition of further actin monomers to the system may alter the orientation of the
actin monomers in the G:A2 complex towards a conformation more like that of a
filament. Therefore, the addition of a third actin monomer, in the form of A:D binary
complex, may result in the formation of a stable G:A3:D "trimer-nucleus". Gelsolin
binds two of the actin monomers tightly, tethering them together preventing the rapid
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dissociation observed for the formation of actin dimers during "true" nucleation.
Thus, the energetics of formation of this capped actin-"minifilament" may be
significantly less, and its relative stability greater, than formation of the "true" actin
trimer nucleus.
We propose to use the G:A2 ternary and A:D binary complexes in an attempt to form
a capped "minifilament" with a stoichiometry of G:A3:D, see fig. 4.1. We also
propose to use molecules that specifically bind F-Actin and stabilise filaments to
probe the putative "minifilament" for filamentous-like conformation, e.g. binding
rhodamine-phalloidin or the myosin S-1 head.
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4.2 Formation of a putative "minifilament" from G:A? ternary and A:D binary
complexes
We have performed experiments to test for the formation of a putative capped actin-
"minifilament" from the G:A2 ternary complex and A:D binary complex under
polymerising conditions. Gel-filtration experiments appear to indicate the formation
of a significantly larger complex (as compared to G:A2), with stoichiometry of
G:A3:D.
4.2.1 Gel-filtration analysis of the formation of a putative "minifilament"
Complex formation between the G:A2 ternary complex and the A:D binary complex
was analysed by FPLC/Superose-12 size-exclusion chromatography (see methods for
details). The concentrations of the two complexes were calculated by BCA protein
assay (Pierce®). G:A2 and A:D were mixed together in ATP-F-Buffer; 0.2mM
CaCl2, at a molar ratio of 1:1 (at 3.0|lM for both complexes) and incubated at room
temperature for lhr. (Calcium was included in the buffers to ensure the activation
and to maintain the monomer binding activity of gelsolin). The sample was then
loaded onto an FPLC/Superose-12 column, pre-equilibrated in ATP-F-Buffer;
0.2mM CaCl2.
Fig. 4.3(A) shows the elution profile from a 1:1 molar ratio incubation of GA2 and
AD (peak 1) compared to those of G:A2 and A:D alone (peaks 2 and 3 respectively).
A significant shift (P<0.05) in the retention volume of the 1:1 GA2:AD sample was
observed, indicative of the formation of a larger species (as compared to G:A2). The
retention volumes of the various protein complexes are shown in table 4.1, and the
corresponding apparent Mr. value, 271kDa., suggests the formation of a complex
between one G:A2 ternary complex and one A:D complex (a complex with an
apparent stoichiometry of G:A3:D).
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Fig. 4.3. Formation of a complex between G:A2 ternary complex and A:D binary complex
analysed by size-exclusion. (A) A280nm monitored elution profiles of A:D, G:A2 ternary complexes and
the "GA2:AD" complex from an FPLC/Superose-12 size-exclusion column. (B) SDS-PAGE analysis of
the "GA2:AD" peak from A. For comparison of different profiles the absorbance values have been
normalised to the maximum at the peak. The arrows mark the elution positions of (1) "GA2:AD"; (2)
G:A2; (3) A:D. The "GA2:AD" sample represents the complex formed from an incubation of pre-purified
G:A2 ternary complex and A:D binary complex, mixed at a 1:1 molar ratio, in ATP-F-Buffer; 0.2mM
CaCI2. Proteins were mixed together (at 3.0pM for each complex), and incubated for 1 hr at RT, in
ATP-F-Buffer; 0.2mM CaCI2 before being loaded onto an FPLC/Superose-12 column, pre-equilibrated
in ATP-F-Buffer; 0.2mM CaCI2. (SDS-PAGE and chromatography were performed as described in
methods).
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Table 4.1. Retention volumes (ml) of the A:D, G:A and G:A2 complexes and that of the
putative "minifilament". Data obtained from FPLC/Superose-12 size-exclusion
chromatography experiments. The value given for the apparent Mr. is a mean value
calculated from the calibration curve using the corresponding mean retention volume. The
significance of the difference between the mean retention volume of G:A2 and that of
"GA2:AD" (the putative "minifilament") is P<0.05.
The peaks from such elution profiles were always very sharp and relatively
symmetrical, with only a slight trailing-edge (see peak 1, fig. 4.3A). The width of the
peak and the relative peak area for elution profiles of the putative "minifilament" did
not significantly alter when compared to those of G:A2 and A:D alone. The trailing-
edge appears primarily to contain small amounts of the A:D binary complex (see fig.
4.3B). This section of the elution profiles frequently represented less than 10% of the
total protein present in such experiments, and it never accounted for more than 15 %.
SDS-PAGE analysis of the components of the putative "minifilament" complex
indicated the presence of all three proteins (gelsolin, actin and DNasel) in the shifted
peak, see fig. 4.3(B). The A:D binary complex has shifted from its normal elution
position to one indicative of a much larger species. The stoichiometry of the
components of the new peak was determined by scanning of the densities of bands
on SDS-polyacrylamide gels, using known amounts of gelsolin, actin and DNasel as
internal standards. Table 4.2 summarises the results from 4 similar experiments. The





gelsolin:actin 1:2.7 1:3.1 1:2.7 1:3.2
DNasekactin 1:2.9 1:2.8 1:2.8 1:3.3
gelsolin:DNasel 1:1.1 1:1.25 1:1.3 1:1.3
Table 4.2. Stoichiometry of the individual component proteins within the putative
"minifilament" complex. The values given in the table represent data obtained from 4
similar experiments carried out on FPLC/Superose-12 size-exclusion columns. The central
fraction from the elution profile was subjected to SDS-PAGE, with standard amounts of each
of the three proteins added as internal references, and the relative amounts of each
determined by gel densitometry. (Chromatography, SDS-PAGE and stoichiometric analysis
were performed as described in the methods).
4.2.2 Native-gel analysis of putative "minifilament" formation
Non-denaturing PAGE was also used to analyse complex formation between G:A2
and A:D. Fig 4.4(A) shows the standard migration positions for the A:D binary, the
G:A binary, the G:A2 ternary complexes and that of a 1:1 molar ratio incubation of
G:A2 and A:D (under polymerising conditions). It should be noted, that this is a
composite figure, created from several different gels. This was necessary, due to the
differences in the running conditions used for each individual complex or set of
proteins (see legend to fig 4.4), in order to illustrate the standard migration positions
of the various protein complexes.
G:A2 and A:D were mixed together at a 1:1 molar ratio (5.2|oM), and incubated at
room temperature for lhr, in ATP-F-Buffer; 0.2mM CaCl2. Native-gel sample buffer
(50% glycerol; ATP-F-Buffer; 0.2mM CaCl2) was added 1:1 (v/v) to the incubated
sample prior to loading onto the gel. The electrophoretic pattern for the "GA2:AD"
sample contained multiple bands with a high degree of smudging, see fig. 4.4(A).
However, there appears to be a slight shift in the electrophoretic mobility of a major
band within the "GA2:AD" sample (in relation to the normal migration position of
the G:A2 complex).
SDS-PAGE in a second dimension of the "GA2:AD" sample lane is shown in fig.
4.4(B). The 1:1 incubation mix of GA2 and A:D always produced a smudged ladder



































Fig. 4.4. Native-PAGE analysis of putative "minifilament" formation. (A) Native gel showing the
electrophoretic mobilities of the A:D binary, G:A binary, G:A2 ternary complexes and the migration pattern
of "GA2:AD"comp. "GA2:AD"comp. represents the mobility pattern formed from an incubation of pre-
purified G:A2 ternary complex and A:D binary complex mixed at a molar ratio of 1:1, in ATP-F-Buffer;
0.2mM CaCI2. Proteins were mixed together at a concentration of 5.2pM (for each complex) and
incubated for 1 hr at RT before loading. (B) SDS-PAGE analysis, in a second dimension, of the
components of the protein bands in A. Standard migration positions of G-Actin, gelsolin and DNAsel are
shown beside the gel. The positions of several of the protein complexes are indicated below the gel. The
figure shown in A is a composite image created from several lanes from different gels (the running
conditions required for each complex/set of proteins are slightly different), however, G:A2 and
"G:A2:AD"comp. were run on the same gel. Gel running conditions: 0.2mM ATP; 0.5mM DTT were used
for A:D; 0.2mM CaCI2; 0.2mM ATP; 0.5mM DTT; 0.6mM EGTA; 1.0mM MgCI2 were used for G:A; and
0.2mM CaCI2; 0.2mM ATP; 0.5mM DTT; 2mM MgCI2 were used for G:A2 and "GA2:AD"comp. complex
formation. (SDS-PAGE and native-PAGE were performed as described in methods).
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within these bands was performed on similar lanes from native-gels (data not
shown). The major species within the shifted band from samples of 1:1 molar ratio
incubations of GA2 and A:D appears to be G:A2 ternary complex. However, a small
amount of DNasel was found within these shifted band/s, see the inset box in fig.
4.4(B). This may represent the formation of a small amount of the "minifilament"
complex, but we were unable to verify this due to the very small amounts of DNasel
present. However, it may also represent the formation of a small amount of a
complex with stoichiometry G:A2:D, formed due to the binding of A:D binary
complex, at the EGTA labile site on gelsolin (see discussion).
G:A binary and A:D binary complexes were also observed, as was a substantial
amount of free uncomplexed DNasel. Several other unidentified protein complexes
and small amounts of the individual uncomplexed proteins (gelsolin, actin, DNasel),
were also frequently observed on such native-gel lanes.
We observed little evidence of "minifilament" complex formation in native-PAGE
experiments. Several factors related to the limit of resolution of such native-gels,
may explain these observations. The resolving power of such non-denaturing gels
(where the electrophoretic mobility of a given protein or complex is resolved as a
well defined, narrow band) decreases both as a function of the amount of total
protein and with the number of individual proteins (or complexes) present in the
reaction sample (Safer, 1989). The resolution limit of total protein per gel lane was
typically observed to be 10 - 12|ig. Protein added in excess of this amount (even for
samples of a single protein, of very high purity), often gave ill-defined and broadly
smeared mobility profiles. Samples containing several different proteins and/or
protein complexes often showed reduced resolution and separation of the
components. The distance migrated during the run (under the same solution
conditions), compared to samples containing only the individual proteins/complexes,
was often altered. Evidence of significant amounts of complex dissociation and break
down was also a feature in such sample profiles.
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Changes in concentration and the ionic composition of the running buffers, sample
buffers and the initial incubation solution conditions, has very marked effects on the
electrophoretic mobility of proteins and protein complexes on such native-gels.
Addition or removal of the divalent cations Ca2+ and Mg2+ has drastic effects on the
resolution and migration positions of gelsolin and DNasel (see section 3.2.2.2 for an
example). The buffer conditions used in the 1:1 molar ratio incubation of G:A2 and
A:D were 5mM Tris, pH8.0; 0.5mM DTT; 0.2mM ATP; 2mM MgCl2; lOOmM KC1;
l.OmM NaNs; 0.2mM CaCl2. Native gel sample buffer (50% glycerol; ATP-F-
Buffer; 0.2mM CaCl2), possesses the same ionic conditions and buffer ingredients as
the incubation buffer. However, the running buffer does not (0.2mM CaCl2; 0.2mM
ATP; 0.5mM DTT; 2mM MgCl2). Attempts to run such non-denaturing gels under
polymerising conditions by the inclusion of salt (~50mM KC1) in the running and gel
buffers resulted in the generation of very high currents (~ 300 - 900mAmps). The
heat generated, as a consequence of the high current, leads to the rapid and severe
denaturation of the protein samples, the gel and damage to the electrophoresis
apparatus. The sudden changes in the ionic conditions and shifts in charge
distribution of the solution that may occur during the running of such "GA2:AD"
samples, may have compromised any complex formation.
The relatively harsh solution conditions experienced by proteins during
electrophoresis, rapid changes in the ionic constituents and the existence of multiple
equilibrium systems in the 1:1 incubation sample of G:A2 and A:D may explain the
electrophoretic profile seen in fig. 4.4(A).
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4.3 Testin2 the conformation of the actin monomers in the putative
"minifilament"
Using F-Actin specific binding molecules, rhodamine-phalloidin and the myosin S-l
head from rabbit skeletal muscle, we have tested the putative "minifilament" for
filament-like properties.
4,3.1 Rhodamine-phalloidin fluorescence enhancement binding assay
Phallotoxins are a family of toxic peptides from the mushroom Amanita phalloides.
Phalloidin (a bicyclic heptapeptide) and the closely related compound phallacidin,
are the two major representatives of this family (Faulstich and Wieland, 1996). The
toxic effect is due to a very tight (Kd ~ 4nM) and specific binding to actin filaments
(Wulf et al, 1979; Estes et al, 1981; Vandekerckhove et al, 1985). The binding of
phalloidin to actin filaments results in their stabilisation, and this stability is
conferred by the toxin preventing the dissociation of actin monomers from both the
pointed and barbed-ends of filaments (Estes et al, 1981; Coluccio et al, 1984;
Sampath and Pollard, 1991). Phalloidin also appears to decrease the rate of
association of monomers at the barbed-end by ~ 50% (Coluccio et al, 1984; Sampath
et al, 1991). The probable binding site for phalloidin lies at a subunit interface
between three actin monomers (Faulstich et al, 1993; Lorenz et al, 1993) and
provides a rationale for phalloidin's high F-Actin binding specificity and its ability to
stabilise actin filaments (Wieland et al, 1978; Le Bihan et al, 1991). There is also
evidence that phalloidin inhibits the dissociation of actin subunits from actin
filaments below the critical concentration (Cano et al, 1992).
A fluorescent derivative, rhodamine-phalloidin (Wulf et al, 1979: Faulstich et al,
1983) has been used to visualise and quantitate actin filaments in cells (Cooper,
1987). A 6 - 12 fold fluorescence enhancement is observed upon binding to actin
filaments and the dissociation equilibrium constant for this derivative binding to F-
actin ranges between 40 - 400nM (Huang et al, 1992; Cano et al, 1992).
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We have used a modified version of a fluorescence enhancement assay described by
Huang et al (1992) and attempted to use it to probe the actin monomer conformation
within the putative "minifilament". This assay is based on a titration of polymerised
actin against a constant concentration of rhodamine-phalloidin and measuring the
fluorescence enhancement. The fluorescence enhancement is directly proportional to
the amount of bound fluorophore and can be readily used in Scatchard analysis for
the binding stoichiometry and equilibrium dissociation constant (Huang et al, 1992).
Fig. 4.5 illustrates the fluorescence enhancement obtained upon the binding of
rhodamine-phalloidin to F-Actin (0.15pM rhodamine-phalloidin in the presence of
1.2|xM Actin, in ATP-F-Buffer; 0.2mM CaCl2). A 7 - 8 fold fluorescence
enhancement, over that of rhodamine-phalloidin alone, was observed. No
enhancement was seen when rhodamine-phalloidin and actin were incubated together
under depolymerising conditions (ATP-G-Buffer), or when either F-Actin or
rhodamine-phalloidin were incubated alone under polymerising conditions (ATP-F-
Buffer; 0.2mM CaCU), (data not shown).
Titration of F-actin against a constant concentration of rhodamine-phalloidin
(0.32(iM) is shown in fig. 4.6(A). Under our experimental conditions (0.32|lM
rhodamine-phalloidin in ATP-F-Buffer; 0.2mM CaCh, in a total volume of 500ptl,
with a lhr incubation at 22°C) the maximum fluorescence change we obtained was
189.5 units (arbitrary fluorescence units). This corresponds to the complete binding
of 0.32pM rhodamine-phalloidin, and gave a calibration factor of 592.2 units.pM"1,
which was then used to calculate the amount of rhodamine-phalloidin bound at any
level of fluorescence enhancement.
Fig. 4.6(B) illustrates the Scatchard analysis of the data presented in fig. 4.6(A). This
gave an apparent dissociation constant for rhodamine-phalloidin of ~ 43nM and a
binding stoichiometry of ~ 0.94 (phalloidin:actin monomer). The mean Kj values
obtained for rhodamine-phalloidin, from two different suppliers, are shown in table
4.3. Our values obtained for the dissociation constant (mean Kj ~ 57nM), and the
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Fig. 4.5. Fluorescence enhancement of rhodamine-phalloidin upon binding to F-Actin.
The fluorescence excitation and emission spectra of 0.15pM rhodamine-phalloidin {\x I and
X.£mI) and 0.15pM rhodamine-phalloidin in the presence of 1.2 pM F-Actin (A.ex II and 7emII), are
shown. A 7 - 8 fold enhancement in the fluorescence intensity was observed upon the
complete binding of rhodamine-phalloidin to actin filaments. 250pl of 0.3pM rhodamine-
phalloidin (100pM stock in ethanol), in ATP-F-Buffer; 0.2mM CaCI2 was added either to 250pl
of ATP-F-Buffer; 0.2mM CaCI2 or to 250pl of 2.4pM actin in the same buffer. The samples
were left for 1 hr at 22°C, in the dark, and then the fluorescence intensity measured. Spectra
were recorded in a 1cm cell with a total volume of 500pl. The excitation spectra were
recorded with an emission wavelength of 580nm and emission spectra with an excitation























DC 15 Kd ~ 43nM
Binding stoichiometry = 0.94
[Rh-Ph]/[Actin] x B
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Fig. 4.6. Equilibrium dissociation constant of rhodamine-phalloidin binding to
actin filaments, determined by a fluorescence enhancement assay. (A)
Fluorescence titration of actin against 0.32pM rhodamine-phalloidin. (B) Scatchard
analysis of the fluorescence data presented in A. The solid line is a linear regression
(R2 = 0.864) and gives an apparent Kd - 43nM. 250pl of 0.64pM rhodamine-phalloidin
(100pM stock in ethanol), in ATP-F-Buffer; 0.2mM CaCI2, was added to 250pl of
various amounts of actin in the same buffer. The samples were incubated for 1 hr, at
22°C in the dark, and then the fluorescence intensity of each sample was measured.
The excitation wavelength was 550nm, the emission wavelength was 580nm, with a
5nm slit width for both. The maximum value of fluorescence enhancement obtained for
0.32pM rhodamine-phalloidin (Molecular Probes Inc.), under our assay conditions was
189.5 units (arbitrary fluorescence units), corresponding to the complete binding of
rhodamine-phalloidin. This gave a calibration factor of 592.2 units.pM"1 which was
used to calculate the amount of rhodamine-phalloidin bound for any level of
enhancement.
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results reported by others (Huang et al, 1992; Cano et al, 1992; De la Cruz et al,
1994).
Kd (nM) of Rhodamine-Phalloidin
(Molecular Probes Inc.)








Mean Kd = 56.8nM ± 5.1 (SEM, n=5) Mean Kd = 94.7nM ± 9.0 (SEM, n=6)
Table 4.3. Equilibrium dissociation constant of Rhodamine-Phalloidin binding to F-
Actin. The Kd of rhodamine-phalloidin, (obtained from Molecular Probes Inc. and Sigma),
binding to F-Actin was determined using the fluorescence enhancement assay, similar to
that illustrated in 4.6(A) and (B). 250pJ of 0.64pM Rhodamine-Phalloidin (100jrM stock
solution, in ethanol) in ATP-F-Buffer; 0.2mM CaCI2 was added to 250pl of various amounts
of actin in the same buffer. The samples were left for 1 hr at 22°C, in the dark, and then the
fluorescence intensity of each sample was measured. The excitation wavelength was
550nm, the emission wavelength was 580nm, with a 5nm slit width for both. The Kd was
determined by Scatchard analysis of the fluorescence enhancement data. The AFmax values
obtained for 0.32|j.M rhodamine-phalloidin were 189.5 units and 41 units (arbitrary
fluorescence units), for the reagent supplied from Molecular Probes Inc. and Sigma,
respectively. This gave a calibration factor of 592.2 units.pM"1 and 128.1 units.pM"1,
respectively.
Rhodamine-phalloidin supplied by Molecular Probes Inc. was superior to that
obtained from Sigma, in all respects. Firstly, the Kd values obtained for rhodamine-
phalloidin from Sigma are almost double those obtained with reagent supplied from
Molecular Probes Inc. (~ 57nM compared to ~ 95nM, respectively). Secondly, the
variation and noise levels of the readings obtained during fluorescence measurements
were always much greater with the Sigma reagent. Thirdly, the enhancement levels
obtained with the Sigma reagent were ~ 3 - 4 fold, in contrast to the ~ 8 fold levels
seen with the Molecular Probes Inc. reagent. However, it should be noted that this
high quality is reflected by the slightly higher cost of a small amount of the reagent
from Molecular Probes, in comparison to that supplied by Sigma. Assays performed
on the putative "minifilament", described in the following sections, were carried out
using the higher quality reagent from Molecular Probes Inc.
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4.3.2 Rhodamine-phalloidin binding to the putative "minifilament"
We have performed experiments to investigate rhodamine-phalloidin binding to the
putative "minifilament".
Our postulated model of the "minifilament" contains three actin monomers (see fig.
4.1) oriented in a filamentous conformation. This "minifilament" model feasibly
contains a binding site for the phalloidin molecule. The model for the binding site for
phalloidin on the filament was constructed from a least squares fit of the monomer
crystal structure using X-ray diffraction pattern data of oriented F-Actin gels in the
presence of phalloidin (Lorenz, et al, 1993). Although a unique solution was found
for the binding site of phalloidin, similarly to the situation for the actin filament
model (Holmes et al, 1990) the experimental observations extend to only 7 - 8 A at
best (Lorenz, et al, 1993). Also, the orientation of the bound phalloidin was achieved
solely by rotations of its position so it did not penetrate into one of the actin
monomers and where it satisfied the biochemical constraints for the residues that
possibly contribute to the binding site. Such biochemical constraint data was
obtained from cross-linking analysis (Faulstich et al, 1993) and from the generation
of point mutants in yeast actin that do not bind rhodamine-phalloidin (Drubin et al,
1993).
These studies indicate that the binding site for phalloidin appears to lie between the
two strands of the filament. The small toxin molecule makes contacts with three
different actin subunits at this subunit interface site, see fig. 4.7. This multiple
subunit contact provides a rationale for the ability of phalloidin to stabilise these
monomer-monomer interactions and the resultant increase in the overall stability of
the filament. This stabilisation of the monomer-monomer interactions also provides a
possible explanation for the reduction in monomer dissociation from the filament
(Coluccio et al, 1984; Sampath and Pollard, 1991). Our proposed model of the
"minifilament" contains three monomers (compare figs. 4.1 and 4.7), oriented in a
filamentous conformation, and so feasibly contains one binding site for a phalloidin





Fig. 4.7. Putative model of the phalloidin binding site on F-Actin. A
schematic representation of the putative model of the phalloidin binding site on
the actin filament is shown (as described by Lorenz et al, 1993). Phalloidin
binds at a subunit interface and makes contacts with three actin monomers,
providing a rationale for the stabilising effects of phalloidin upon filaments.
Only three actin monomers are shown (coloured red, green and blue) and they
are oriented in a filamentous conformation, as described by the Holmes and
Lorenz models (Holmes et al, 1990; Lorenz et al, 1993). The three actin
monomers are coloured and oriented in the same way as those in our putative
"minifilament" model shown in fig. 4.1. The "minifilament" could theoretically
provide a binding site for phalloidin, and in a similar manner to actin filaments,
any binding may confer extra stability on the "minifilament".
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and help prevent the dissociation of the complex, similar to its stabilising effects on
actin filaments.
4,3.2.1 Binding of rhodamine-phalloidin to the putative "minifilament" as analysed
by size-exclusion chromatography.
G:A2 and A:D, in ATP-F-Buffer (in the presence of 0.2mM CaCl2) were added
together in a 1:1 molar ratio, at a concentration of 6.0|i,M for each complex. The
"GA2:AD" mixture was incubated at room temperature for 15min and then
rhodamine-phalloidin was added 1:1 (v/v), from a 6.0jiM stock in ATP-F-Buffer;
0.2mM CaCl2, giving a 1:1 molar ratio for GA2:AD/rhodamine-phalloidin, with a
final concentration of ~ 3.0|iM of each of G:A2, A:D and rhodamine-phalloidin.
Following a further 45min incubation at room temperature, the "GA2:AD" sample
was concentrated and then subjected to size-exclusion chromatography on an
FPLC/Superose-12 column, pre-equilibrated in ATP-F-Buffer; 0.2mM CaCl2.
We noted that a small, but significant, proportion of the added rhodamine-phalloidin
co-concentrated with the "GA2:AD" protein fraction (prior to the loading of samples
onto the Superose-12 size-exclusion column) in such experiments. The initial
concentration of the rhodamine-phalloidin added was 3.0|iM. We recovered
approximately 2.50 - 2.70|iM rhodamine-phalloidin from the flow-through after
concentration. (Similar levels of recovery were obtained in 3 other similar
experiments; mean concentration of the sample recovered from the flow-through was
~ 2.6|iM ± 0.1 SD, n = 4) Correspondingly, approximately 0.3 - 0.5pM rhodamine-
phalloidin appears to have co-concentrated with the "minifilament" (~ 10 - 16% of
the total rhodamine phalloidin added). The Mr. cut-off of the concentrator membrane
was ~ 15,kDa, compared to the Mr. of rhodamine-phalloidin, which is approximately
l,250Da. Thus, the small toxin molecule is unlikely to have been retained by the
concentrator membrane. In contrast, concentration of samples from experiments
performed with 1:1 molar ratio incubations of rhodamine-phalloidin and either
3.0(iM G:A2 or 3.0pM A:D individually, invariably resulted in the recovery of
almost all (~ 98%) of the added 3.0|iM rhodamine-phalloidin.
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This co-concentration was initially suggestive of a specific binding interaction
between rhodamine-phalloidin and a larger protein species containing actin in a
filamentous conformation; i.e. the putative "minifilament".
Fig. 4.8(A) shows the elution profile of a 1:1 molar ratio incubation of GA2:AD
(similar to that shown in fig. 4.3A), from a Superose-12 size-exclusion column,
compared to that of a similar incubation performed in the presence of rhodamine-
phalloidin. There is no apparent difference in the retention volumes for the two
samples; however, a slight leading-edge was observed in samples incubated in the
presence of rhodamine-phalloidin, see fig. 4.8. This leading-edge feature was only
observed in gel-filtration experiments performed on "GA2:AD" samples, in the
presence of rhodamine-phalloidin. Similar experiments performed on the G:A2 or
A:D complexes individually (at 3.0|aM), incubated under the same conditions in the
presence of 3.0|i,M rhodamine-phalloidin showed no evidence of co-purification (or
co-concentration) of the phalloidin ligand with the protein complexes. The proteins
used in the experiment shown in fig. 4.8 were obtained from different preparations to
those used in the experiments illustrated in fig. 4.3(A). The "GA2:AD" sample
contained the equivalent amount of ethanol, ~ 1% (v/v), present in the sample
containing rhodamine-phalloidin. A comparison of the elution profiles shown in figs.
4.3A and 4.8(A) indicated that the added ethanol (at least at a concentration of 1%,
v/v) was not the cause of the changes in the elution profile (the appearance of a
leading-edge) of the putative "minifilament".
SDS-PAGE analysis of the protein components of the elution profiles in fig. 4.8(A)
is shown in fig. 4.8(B). The upper gel illustrates the protein peak components from
the "GA2:AD" incubation sample while the lower gel shows the protein components
from a similar sample incubated in the presence of 3.0p,M rhodamine-phalloidin.
Rhodamine-phalloidin appears to have caused a change in the way protein species
partition during size-exclusion chromatography. In the presence of rhodamine-
phalloidin the leading-edge fractions 9, 10 and 11 (see lower gel in fig. 4.8B) appear
to contain relatively more of all three of the component proteins (gelsolin, actin and
DNasel), compared to the corresponding fractions in the upper gel profile. The
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g. 4.8. Rhodamine-phalloidin causes a change in the elution profile of the putative "minifilament"
ompiex. (A) A280nm monitored elution profiles of the putative "minifilament" complex in the absence or presence of
odamine-phalloidin, from an FPLC/Superose-12 size-exclusion column. (B) SDS-PAGE analysis of the two
ofiles shown in A. The upper gel shows the SDS-PAGE analysis of the "GA2:AD" complex profile while the lower
presents the "GA2:AD" complex profile in the presence of rhodamine-phalloidin. A leading-edge to the elution
ofile of the putative "minifilament" was observed in the presence of rhodamine-phalloidin. "GA2:AD" is the
implex formed from an incubation of pre-purified G:A2 ternary complex and A:D binary complex, mixed at a
olar ratio of 1:1 in ATP-F-Buffer; 0.2mM CaCI2. Proteins were mixed together at 3.0pM, incubated for 1 hr at RT
id concentrated before being loaded onto an FPLC/Superose-12 column, pre-equilibrated in the same buffer,
cubation in the presence of rhodamine-phalloidin was performed as follows; G:A2 and A:D, in the above buffer,
^re added together 1:1, (at a concentration of 6.0pM for each). The "GA2:AD" mixture was incubated at room
mperature for 15min and then rhodamine-phalloidin was added 1:1 (v/v) to give a final concentration for all
imponents of 3.0pM. Following a further 45min incubation, at room temperature, the sample was concentrated
id subjected to size-exclusion chromatography on an FPLC/Superose-12 column, pre-equilibrated in ATP-F-
jffer; 0.2mM CaCI2. (SDS-PAGE and chromatography were performed as described in methods).
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relative molar ratios of the proteins present in the peak, both in the absence and
presence of rhodamine-phalloidin, did not change. The stoichiometry (as analysed by
gel densitometry), of the proteins in both elution profile peaks was ~ 1:3:1, for








Table 4.4. Stoichiometry of the individual protein components in the putative
"minifilament" is not changed by the presence of rhodamine-phalloidin. The values
given in the table represent data obtained from gel densitometry (with standard amounts of
each of the three proteins added as internal references), performed on the SDS-
polyacrylamide gels of the FPLC/Superose-12 size-exclusion elution profiles illustrated in fig.
4.8. (Chromatography, SDS-PAGE and densitometry were performed as described in the
methods).
The apparent increase in the relative amounts of protein in the leading-edge fractions
of the "GA2:AD" sample, incubated in the presence of rhodamine-phalloidin, may
reflect a direct and specific interaction between the proteins/complexes and the F-
Actin binding ligand. The complex/es partitioning within this leading-edge section of
the elution profile possibly represent a sub-population of "minifilament" species that
has been stabilised by the binding of rhodamine-phalloidin. Our proposed model of
the "minifilament" contains three monomers and providing the actin monomers are
oriented in a filamentous conformation, phalloidin may bind to the complex (see figs.
4.1 and 4.7). This binding may confer extra stability upon the "minifilament"
complex and result in a "stiffening" of this stabilised species. This "stiffening" could
conceivably result in an increase in the apparent size and shape of the molecule, with
regard to the way the complex partitions during gel-filtration, producing the leading-
edge seen in such experiments.
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4.3.2.2 Assay of the binding of rhodamine-phalloidin to the putative "minifilament"
using fluorescence enhancement.
We have attempted to confirm the binding of rhodamine-phalloidin to the putative
"minifilament" and to quantify this interaction using fluorescence enhancement. As
described above, we noted that a small, but significant, proportion of the added
rhodamine-phalloidin co-concentrated with the "GA2:AD" protein fraction (prior to
the loading of samples onto the Superose-12 size-exclusion column) in experiments
similar to those described in fig. 4.8. Approximately 0.3 - 0.5|iM rhodamine-
phalloidin appeared to co-concentrate with the "minifilament" (~ 10 - 16% of the
total rhodamine phalloidin added) suggesting a specific binding interaction.
Fig. 4.9 illustrates the co-purification of rhodamine-phalloidin with the leading-edge
fractions of a 1:1 molar ratio incubation (3.0|0,M for each) of rhodamine-phalloidin
and "minifilament" following concentration and size-exclusion chromatography on a
Superose-12 column (see legend to fig. 4.8 for details).
Fig. 4.9. Co-purification of rhodamine-phalloidin with the leading-edge
fractions of the putative "minifilament" elution profile. The absorbance
intensities at 280nm measuring total protein (open squares) and 550nm measuring
rhodamine-phalloidin (closed squares), were measured for fractions 7-15, from a
Superose-12 size-exclusion column elution profile, of a 1:1 molar ratio incubation
(3.0gM for each), of "minifilament" and rhodamine-phalloidin. (For details see legend
to fig. 4.8A). Rhodamine-phalloidin co-purifies with the leading edge fractions. The
Mr. of the species present in this section of the elution profile is very much larger
than the ~ 1250Da for rhodamine-phalloidin. This implies a specific binding
interaction with a protein species containing actin monomers in a filamentous
conformation.
0.05 0.7
6 7 8 9 10 11 12 13 14 15
Fraction No.
4-25
We have used the absorbance at 550nm to follow the presence of rhodamine-
phalloidin in these leading-edge fractions. Unlike the assay described in section
4.3.1, we were unable to obtain a reliable estimate for the extent (if any) of the
fluorescence enhancement of the rhodamine-phalloidin putatively binding to the
"minifilament" in these leading-edge fractions. Thus, using fluorescence intensity
measurements may have resulted in an over estimation of the amount of binding. The
rhodamine-phalloidin peaks close to fraction 11 (see fig. 4.9) and this corresponds
well with increase in the amounts of protein observed in these leading-edge fractions,
as observed on SDS-polyacrylamide gel analysis performed on such elution profiles
(see fig. 4.8B, fraction Nos. 9, 10 and 11).
Table 4.5 shows the mean fluorescence enhancement levels obtained from several
experiments where we titrated a fixed amount of rhodamine-phalloidin (0.32U.M),
against 3.0|iM of G:A2 or 3.0|iM of A:D individually, or against increasing amounts
of putative "minifilament" complex, under polymerising conditions (ATP-F-Buffer;
0.2mM CaCU). Following incubation, at 22°C for lhr in the dark, the fluorescence
intensity was measured
Protein species AF580nm (arbitrary units)
3.0p,M G:A2 ternary complex 0.9 (± 0.28 SD, n=4)
3.0pJVI A:D binary complex 0.7 (±0.21 SD, n=3)
GA2:AD/"minifilament"
0.5pM 11.3 (±4.2 SD, n=3)
1.0pM 14.6 (±5.5 SD, n=4)
2.0pM 25.5 (±8.2 SD, n=4)
3.0pM 44.7 (±10.2 SD, n=3)
4.0pM 36.0 (± 10.4 SD, n=4)
6.0pM 49.2 (±11.1 SD, n=5)
7.5pM 66.2 (± 9.7 SD, n=4)
9.0pM 55.5 (±9.1 SD, n=3)
10.0pM 65.7 (± 9.4 SD, n=3)
Table 4.5. The G:A2 ternary and A:D binary complex alone do not give fluorescence
enhancement. The table shows the mean fluorescence enhancement values of 0.32pM
rhodamine-phalloidin with 3.0pM of G:A2 or 3.0gM of A:D individually, and those of 0.32|iM
rhodamine-phalloidin with increasing amounts of the putative "minifilament" complex
observed after a 1 hr incubation at 22°C, in ATP-F-Buffer; 0.2mM CaCI2. (The excitation
wavelength was 550nm, the emission wavelength was 580nm, with a 5nm slit width for
both).
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Significant amounts of fluorescence enhancement were observed only in the presence
of "GA2:AD" (compared to that for 0.32|iM rhodamine-phalloidin alone or in the
presence of G:A2 or A:D alone). Incubation of 3.0|iM G:A2 or 3.0|iM A:D
individually in the presence of 0.32|iM rhodamine-phalloidin (in ATP-F-Buffer;
0.2mM CaCl2), produced virtually no fluorescence enhancement. Mean AF values of
0.9 (± 0.28 SD, n = 4) for 3.0[iM G:A2 and 0.7 (± 0.21 SD, n = 3) for 3.0fiM A:D
alone were obtained, see table 4.5. We would postulate that neither of these two
individual species (G:A2 and A:D) would contain a binding site for phalloidin (see
fig. 4.11) and the results are consistent with there being no binding. The partial co-
purification and the significant levels of fluorescence enhancement for rhodamine-
phalloidin in the presence of "minifilament" (1:1 molar ratio incubation, under
polymerising conditions of G:A2 and A:D) is suggestive of a specific binding
interaction.
Using the fluorescence enhancement assay for the titration of 0.32|iM rhodamine-
phalloidin with F-Actin (see figs. 4.5, 4.6 and table 4.3) we were able to define an
enhancement calibration constant (592.2 arbitrary fluorescence units.|iM-l) and use
it to calculate the amount of binding for any level of enhancement (Huang et al,
1992). We were unable to determine an accurate calibration factor for the binding of
rhodamine-phalloidin to the putative "minifilament", and so were unable to employ
this specific method in the analysis of the apparent binding. Despite this and the fact
that the fluorescence intensity values obtained during the titration of rhodamine-
phalloidin with "minifilament" were prone to large levels of fluctuation and large
errors (see table 4.5), we have determined an approximate equilibrium dissociation
constant for the putative binding interaction between the "minifilament" and
rhodamine-phalloidin.
The general trend for the data presented in table 4.5 appears to be an increase in the
level of fluorescence enhancement as we increase the amount of added
"minifilament". Correspondingly we have assumed a concomitant increase in the
amount of bound rhodamine-phalloidin, analogous to that observed with actin
filaments (see fig. 4.6A). A non-linear least squares fit of the data presented in table
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4.5 is shown in fig. 4.10. An apparent IQ of ~ 4.6pM was obtained by this analysis
(assuming a 1:1 stoichiometric binding between rhodamine-phalloidin and the
"minifilament" at saturation). The calculated AFmax for this interaction is ~ 93
arbitrary units, corresponding to an enhancement of approximately 3-5 times. The
apparent dissociation constant of ~ 4.6|iM, for the binding of rhodamine-phalloidin
to the putative "minifilament", is very much weaker than the equivalent interaction
between rhodamine-phalloidin and F-Actin, (K^ ~ 57nM, see fig. 4.6 and table 4.3).
The affinity of the toxin has decreased by ~ 100 times (two orders of magnitude).
pM "GA2:AD"
Fig. 4.10. Probing the "minifilament" for F-like conformation using
rhodamine-phalloidin. Fluorescence titration of putative "minifilament" against
0.32pM rhodamine-phalloidin in ATP-F-Buffer, in the presence of 0.2mM CaCI2.
The solid line is a non-linear least squares fit of the equation AF =
AFmax*[GA2:AD]/([GA2:AD]+Kd). The apparent Kd for the binding of rhodamine-
phalloidin to the putative "minifilament" is - 4.6pM, (R = 0.973). Titration was
performed by adding 250pl of increasing amounts of "minifilament" (GA2:AD), in
ATP-F-Buffer; 0.2mM CaCI2, to 250pl of 0.64pM rhodamine-phalloidin (100pM
stock in ethanol), in the same buffer. The samples were incubated for 1hr, at 22°C
in the dark, and then the fluorescence intensity of each sample was measured. The
excitation wavelength was 550nm, the emission wavelength was 580nm, with a
5nm slit for both. The error bars indicate 1SD.
Our results are not inconsistent with the formation of a relatively tight and stable
"minifilament" complex with stoichiometry of G:A3:D. There also appears to be an
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apparently specific binding of rhodamine-phalloidin to the putative "minifilament".
We observed significant levels of fluorescence enhancement of rhodamine-phalloidin
only in the presence of "GA2:AD". The dissociation constant for this interaction is
approximately 4.6|iM. Although this is -100 weaker than that for rhodamine-
phalloidin and F-actin, our data suggest that there is an interaction between
rhodamine-phalloidin and a protein species that contains actin monomers oriented in
a filamentous conformation.
4.3.3 Myosin S-l head binding to the putative "minifilament"
We next wanted to test whether we could use the myosin S-l head's F-Actiri specific
binding activity to test the putative "minifilament" for filamentous character. We
proposed to use the S-l head and the tight, F-Actin specific binding (in an ATP
manner) to probe the conformation of the actin monomer in the putative
"minifilament". Binding of the S-l head to the putative "minifilament" would
provide a positive indication that the actin monomer conformation was indeed that of
F-Actin.
4.3.3.1 Probing the conformation of the putative "minifilament" with the myosin S-l
head
Dr. John Kendrick-Jones kindly supplied us with a preparation of the myosin S-l
head from rabbit muscle, prepared by papain digestion (see methods for details). This
treatment results in the generation of several polypeptide chains of varying lengths,
as analysed on SDS-PAGE. Polypeptides of 94kDa and 70kDa correspond to the
heavy chains while three polypeptides, with Mr. between 14- 30kDa, correspond to
fragments derived from the light chains. Fig. 4.11 shows the standard electrophoretic
mobilities of gelsolin, G-Actin, DNasel and the various polypeptide chains derived
from the myosin S-l head, on an SDS-polyacrylamide gel.
Fig. 4.12 shows the elution profile from an FPLC/Superose-12 size-exclusion
column, run in ATP-F-Buffer; 0.2mM CaCl2 of the S-l head alone (peak 2). Table
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4.6 displays the retention volume and the corresponding mean apparent Mr. of the S-
1 head compared to the A:D, G:A, G:A2 and putative GA2:AD/"minifilament"
complexes. The apparent Mr. value of the S-l head is ~ 180kDa. The substantial
difference between the apparent Mr. and the theoretical Mr. (180kDa compared to
120 - 130kDa) is probably due to the asymmetric non-globular shape of the S-l head























Fig 4.11. SDS-polyacrylamide gel showing the standard electrophoretic
mobilities of Gelsolin, G-Actin, DNasei and the polypeptides from the myosin S-1
head. The myosin S-1 head, prepared by papain cleavage, produces 5 protein bands
present. The two at ~ 94kDa and 70kDa correspond to the polypeptides derived from
the heavy chains (labelled S1-HC). Those corresponding to the fragments derived
from the light chains have Mr. between 14kDa and 30kDa (labelled S1-LC). Mr. of
protein standards are given in kilodaltons. (SDS-PAGE was performed as described in
the methods).
G:A2 ternary complex and A:D binary complex were added together at a 1:1 molar
ratio (6.0pM) and incubated for 30min at room temperature, in ATP-F-Buffer;
0.2mM CaCl2. Myosin S-l, in the same buffer was then added at a molar ratio of 1:1
(S-l:"minifilament"). The final concentrations of G:A2, A:D and S-l were 3.0|lM.
This S-l/"minifilament" mixture was then incubated for a further 30min at room
temperature, in ATP-F-Buffer; 0.2mM CaCl2. Following the incubation the mixture
was subjected to size-exclusion chromatography on an FPLC/Superose-12 column,
pre-equilibrated in ATP-F-Buffer; 0.2mM CaCl2.
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Fig. 4.12. Probing the conformation of the putative "minifilament" with the myosin S-1 head.
A280nm monitored elution profiles of the S-1 myosin head alone, and a 1:1 molar ratio incubation of S-1
and putative "minifilament" complex (GA2:AD), from an FPLC/Superose-12 size-exclusion column. For
comparison of different profiles the absorbance values have been normalised to the maximum at the
peak. The arrows mark the elution positions of (1) GA3:D + S-1: (2) myosin S-1 head. The GA3:D + S-
1 sample was formed in the following manner. G:A2 ternary complex and A:D binary complex were
added together at a 1:1 molar ratio (6.0|iM for each complex) and incubated for 30min at room
temperature, in ATP-F-Buffer; 0.2mM CaCI2. Myosin S-1, in the same buffer, was then added at a
molar ratio of 1:1 (S-1:"minifilament"). The final concentrations of G:A2, A:D and S-1 were ~ 3.0p.M.
This s-1 :"minifilament mixture was then incubated for a further 30min at room temperature, in ATP-F-
Buffer; CaCI2. Following incubation the mixture was concentrated and loaded onto an
FPLC/Superose-12 size-exclusion column, pre-equilibrated in ATP-F-Buffer; 0.2mM CaCI2. (SDS-
PAGE and chromatography were performed as described in methods).
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Table 4.6. Retention volumes (ml) of the myosin S-1 head, A:D, G:A and G:A2
complexes and that of the putative "minifilament". Data obtained from FPLC/Superose-
12 size-exclusion chromatography experiments, in ATP-F-Buffer; 0.2mM CaCI2. The value
given for the apparent Mr. is a mean value calculated from the calibration curve using the
corresponding mean retention volume. The significance of the difference between the mean
retention volume of G:A2 and that of "GA2:AD" (the putative "minifilament" peak) is P<0.05.
Myosin S-1 was produced by papain digestion. This protocol generates heavy-chains with
Mr. of 94kDa and 70kDa and three light chain derived fragments with Mr. ranging from 14 -
30kDa. (See methods for details).
Fig 4.12 shows the elution profile from an FPLC/Superose-12 size-exclusion column
(in ATP-F-Buffer; 0.2mM CaCB) of a 1:1 molar ratio incubation of myosin S-1 and
"minifilament", (peak 1) compared to that of myosin S-1 alone (peak 2). There was
no apparent increase in the retention volume of the 1:1 S-l/"minifilament"
incubation compared to that of putative "minifilament" alone. There were also no
apparent changes in the shape and width of the elution profile, (compare peak 1 in
fig. 4.12 with the peak 1 in fig. 4.3) unlike that observed in similar experiments with
rhodamine-phalloidin (see peak 1, fig. 4.8). These data are consistent with there
being no interaction between the putative "minifilament" and the S-1 head of
myosin, in the presence of ATP.
SDS-PAGE analysis of the elution profiles shown in fig. 4.12 appears to confirm this
observation. The SDS-polyacrylamide gel illustrated in fig. 4.13(A) shows the
protein components of the S-1 head elution profile. The gel below (fig. 4.13B) shows
the protein components of the 1:1 S-l/"minifilament" incubation elution profile. The
































Fig. 4.13. Myosin S-1 head does not bind to the putative "minifilament", in the presence
of ATP. (A) SDS-polyacrylamide gel showing the protein composition of the S-1 elution profile
(peak 2) from fig. 4.12. (B) SDS-polyacrylamide gel showing the protein composition of the 1:1
"GA3:D + S-1" incubation elution profile (peak 1) from fig. 4.12. "GA3:D + S-1": G:A2 ternary
complex and A:D binary complex were added together at a 1:1 molar ratio (6.0pM for each
complex) and incubated for 30min at room temperature, in ATP-F-Buffer; 0.2mM CaCI2.
Myosin S-1, in the same buffer was then added at a molar ratio of 1:1 (S-1 :"minifilament").
The final concentrations of G:A2, A:D and S-1 were 3.0|iM. This S-1:"minifilament" mixture
was then incubated for a further 30min at room temperature. Following the incubation the
mixture was concentrated and loaded onto an FPLC/Superose-12 size-exclusion column, pre-
equilibrated in ATP-F-Buffer; 0.2mM CaCI2. Preparation of the myosin S-1 head by papain
cleavage produces 5 polypeptide bands on SDS-polyacrylamide gels. The two at ~ 94kDa and
70kDa correspond to the polypeptides derived from the heavy chains (labelled S1-HC). Those
corresponding to the fragments derived from the light chains have Mr. between 14kDa and
30kDa (labelled S1-LC). Mr. of protein standards are given in kilodaltons. (SDS-PAGE was
performed as described in the methods).
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two separate chromatographic runs are directly aligned with each other. The S-1 head
does not appear to have shifted from its normal elution position. The peak fraction
for the elution of S-l is ~ 14. Comparison of the peak fraction positions of the
constituent myosin S-l polypeptides in fig. 4.13(A) and (B) suggests no shift in the
retention volume of S-l. The positions of the three proteins (gelsolin, actin and
DNasel) that constitute the putative "minifilament", with regard to the fractions they
appear in, also appear not to have changed. (Compare their positions in figs. 4.3B
and 4.14B).
The affinity of myosin for actin filaments increases dramatically in the absence of
ATP, and actin and the S-l head form a very tight rigor complex (Ka ~ 107 - 10s M"1
for acto-Sl, Marston and Weber, 1975; Margossian and Lowey, 1978). We have
attempted further experiments to analyse any binding of the S-l head to the putative
''minifilament" in the absence of ATP. The protocol used in the creation of a
nucleotide free solution is based on that described by Pollard et al (1992) and De la
Cruz and Pollard (1994) (see methods for details).
G:A2 ternary complex and A:D binary complex were added together at a 1:1 molar
ratio (6.0|iM for each complex) and incubated for 30min at room temperature, in
modified ATP-F-Buffer (5mM Tris, pH 8.0; 0.5mM DTT; 0.2mM CaCl2; 0.2mM
ATP; lOOmM KC1; 2mM MgCl2; 50nM ATP). Myosin S-l, in nucleotide-free-ATP-
F-Buffer (5mM Tris, pH 8.0; 0.5mM DTT; 0.2mM CaCl2; lOOmM KC1; 2mM
MgCl2), was then added at a molar ratio of 1:1 (S-l/"minifilament"). The final
concentrations of G:A2, A:D and S-l were ~ 3.0pM. Removal of free nucleotide
from this mixture was performed by gently mixing 25|il Dowex 1 beads (Bio-Rad,
AG1-X2, stored as a 50% slurry in a nucleotide-free ATP-F-Buffer) with the protein
solution, followed by an incubation of 5min at 4°C. (Dowex 1 is a strong anion
exchange resin and it binds free nucleotide very tightly). Following removal of the
Dowex 1 resin, the proteins mixture was incubated at room temperature for a further
30min, and then subjected to size-exclusion chromatography on an FPLC/Superose-
12 column, pre-equilibrated in nucleotide-free ATP-F-Buffer.
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This method of free nucleotide removal proved to be unsuccessful in our
experiments. We experienced a rapid and extensive protein denaturation upon
incubation with the Dowex 1 beads. Denaturation was observed as the appearance of
peaks, in A280nm monitored elution profiles from Superose-12 size-exclusion
chromatographic runs (performed on samples treated as described above) that were
indicative of denatured protein aggregates (data not shown). These denatured
aggregates frequently had elution volumes that overlapped with the non-denatured
protein complexes and made interpretation of the data almost impossible. The
amount of denaturation we observed was very preparation dependent but all of the
proteins in the incubation mixture (DNasel, gelsolin, actin and myosin S-l) appeared
to be affected to some degree. However, actin was by far the most predominantly
affected protein, with a loss of native protein from the incubation solution of between
~ 40 - 65%. SDS-PAGE analysis of such elution profiles produced a high degree of
band smearing and often showed evidence of loss of resolution probably due to the
presence of these denatured aggregates.





G:A2 ternary and A:D binary complexes were added together (1:1 molar ratio, at
3.0(iM) under polymerising conditions (lOOmM KC1; 2mM MgCl2 in the presence of
0.2mM CaC^) and complex formation analysed on size-exclusion columns. Our
results are consistent with G:A2 and A:D having associated together to form a
significantly larger species (in relation to G:A2). This putative capped-actin-
"minifilament" appears to have stoichiometry of G:A3:D (gelsolimactin.vDNasel).
We observed little evidence of complex formation on Native-PAGE. A possible
explanation for this may result from the harsh solution conditions and the rapid
changes in charge distribution experienced by the proteins and protein complexes
during such electrophoresis experiments (see section 4.3.2 for details), that may have
prevented and/or compromised any complex formation.
We performed experiments with rhodamine-phalloidin and the proteolytic myosin S-
1 head to specifically probe the actin monomers, within this putative "minifilament",
for filamentous conformation. Data from fluorescence enhancement experiments
performed with rhodamine-phalloidin, provides some evidence for the specific
binding of rhodamine-phalloidin to the putative "minifilament", with a Kj of ~
4.6pM.
Our results are consistent with there being no binding between the putative
"minifilament" and the myosin S-l head, in the presence of ATP (0.2mM). This may
be due to the reduced affinity of myosin for F-Actin in the presence of ATP, and not
solely due to the actin monomers lacking filamentous character. Experiments in the
absence of ATP proved to be problematic.
4
4.4.2. G:A2 and A:D associate to form a larger complex, consistent with the proposed
capped-"mini filament" model
Data from our size-exclusion experiments, performed on 1:1 molar ratio mixtures of
G:A2 and A:D (under polymerising conditions: lOOmM KC1; 2mM MgCl2; 0.2mM
CaCl2; 0.2mM ATP; 0.5mM DTT; 5mM Tris, pH 8.0; l.OmM NaN3), at
concentrations in excess (3.0pM for each complex) of the critical monomer
concentration of the pointed-end, seem to indicate the formation of a larger complex
(in relation to G:A2), with an apparent Mr. of ~ 271kDa. The stoichiometry of the
protein components within this larger complex was 1:3:1 (gelsolin:actin:DNaseI,
respectively). The apparent molecular weight and stoichiometry of this species is
consistent with the formation of the putative "minifilament" complex, most likely via
an actimactin association between the G:A2 ternary and the A:D binary complexes.
The dissociation constant for ATP-G-Actin binding to the pointed-end of a pre¬
formed actin filament is ~ 0.6 - 0.8|lM (Pollard, 1986). If we were simply adding a
further actin monomer (in the form of A:D binary complex) to the pointed-ends of
the monomers within the G:A2 complex we might have expected that any association
between the A:D and the G:A2 complexes (via an actimactin monomer association
occurring between the free ends of these two complexes), would have had a IQ of the
order of 0.6 - 0.8|itM, or even significantly weaker. Our results discussed in chapter 3
(see section 3.5) indicate the spatial orientation of the actin monomers within the
G:A2 ternary complex is different to that of the terminal monomers at the barbed-end
of filaments. Therefore, we are probably not dealing with a "true" pointed-end, with
regards to the addition of subsequent actin subunits onto the exposed pointed-ends of
the G:A2 ternary complex monomers.
However, the addition of a "third" actin monomer, in the form of A:D, may have
shifted the conformation of the monomers in G:A2 to be more like those in a
filament. Our results (see section 3.4) indicate that the A:D binary complex behaves
essentially as an actin monomer with regards to its interaction with gelsolin; the K<j
for binding of A:D by G:A is equivalent to the binding of G-Actin alone by G:A. The
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presence of DNasel bound at the pointed-end appears not to alter the crystal structure
of the monomer to any great extent; the structure of the monomer in the DNasel-
Actin complex (Kabsch et al, 1990) is the same as that in the Gl-Actin complex
(McLaughlin et al, 1993; see McLaughlin and Weeds, 1995 for review). The
complexed (A:D) monomer also does not appear to exhibit different actimactin
interactions with other actin monomers, with regards to its binding at the pointed-
ends of filaments, compared to those of uncomplexed G-Actin (Podolski et al, 1988;
Pope et al, 1991; Weber et al, 1994). Furthermore, the presence of the DNasel
molecule acts to prevent any further monomer addition at the pointed-end.
Thus, adding the "third" A:D monomer may have shifted the conformation of the
actin monomers within G:A2 to a more filamentous conformation, resulting in the
creation of a "capped-trimer" species, with the three actin subunits in an F-like
conformation; i.e. putative "minifilament".
There are multiple equilibrium interactions possible in such 1:1 mixtures of G:A2 and
A:D. As well as the proposed actimactin interaction between the G:A2 and A:D
complexes (giving rise to the formation of the putative "minifilament"), there is also
a possible exchange reaction. The apparent equivalence of the Kj values for the
formation of the GA:(A:D) and GiA? complexes (50nM and 39nM, respectively; see
section 3.4) implies that, at equilibrium in 1:1 molar ratio mixtures of G:A2 and A:D,
a significant amount of exchange of the actin monomer (bound at the EGTA site in
gelsolin, G4), for the A:D binary complex, would occur. Significant levels of
exchange occurring at this G4 actin-binding site has previously been demonstrated in
mixtures of NBD-Actin and unlabeled G:A2 ternary complex (Schoepper and
Wegner, 1991; Khaitlina and Flinssen, 1997). Such an exchange of G-Actin for A:D
would then result in the formation of significant amounts of the G:A2:D complex and
the corresponding amount of free G-Actin.
However, we did not observe any evidence of significant amounts of free G-Actin in
our size-exclusion experiments. During all of our chromatographic analysis,
conducted on 1:1 molar ratio incubation mixtures of G:A2 and A:D, we detected little
4-38
of either of the two individual complexes. The elution profiles obtained from such
gel-filtration experiments always contained a single sharp and relatively symmetrical
peak, with only a small trailing-edge. This trailing-edge (containing only very small
amounts of A:D binary complex) accounted for no more than ~ 10% of the total
protein partitioning on the column (see section 4.2.1). These profiles also all showed
a significantly shifted retention-volume, indicative of the formation of a larger
protein complex with a mean apparent Mr. of ~ 27 lkDa with a stoichiometry of 1:3:1
(gelsloin:actin:DNaseI, respectively). Furthermore, the peak-areas for this new
complex did not significantly change, in relation to the peak-areas obtained for the
individual G:A2 or A:D complexes alone. No peak broadening, that would suggested
the inefficient separation of the two smaller complexes (G:A2 and A:D) from each
other was observed. These profiles are indicative of the partitioning of a stable and
predominantly mono-disperse protein-complex species. This size-exclusion data is
consistent with the formation of a stable G:A3:D complex but alone not proof of a
putative "minifilament" complex.
These results suggest that the interaction between G:A2 and A:D is more stable than
one would have theoretically expected. They suggest that the majority of A:D was
bound to the pointed-ends of the monomers in the G:A2 complex and therefore that
the amount of exchange occurring was less than expected; i.e. the "minifilament" has
formed with a higher than expected stability.
For complex formation to occur the actimactin binding interaction between A:D to
G:A2 would have to have a fG below the critical concentration of the pointed-end (Kd
<0.6pM). The affinity even possibly approaches a value of similar magnitude to
those observed for the binding of A:D by G:A, (~ 50nM), to give the significant
amounts of "minifilament" (G:A3:D) we apparently observe at equilibrium, over the
formation of the G:A2:D complex via the exchange reaction. Our size-exclusion
elution profiles, indicating the formation of a larger (in relation to G:A2) and
predominantly mono-disperse complex, with a stoichiometry of 1:3:1
(gelsolin:actin3:DNaseI) for the peak components, are consistent with the formation
of the putative "minifilament".
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This is an unexpected result, but a significant one, that suggests that the actin:actin
interactions that occur between the G:A2 complex and the A:D complex, during the
formation of the "minifilament", are significantly stronger (and thus, may be
different) than the actimactin interactions that hold the filament together.
Further evidence for the formation of the "minifilament" comes from experiments
with rhodamine-phalloidin. Our data (see section 4.3.2) appear to indicate the
binding of rhodamine-phalloidin, an F-Actin specific binding molecule, to the
putative "minifilament". Incubation of rhodamine-phalloidin (3.0pM) with 1:1 molar
ratio mixtures of G:A2 and A:D (3.0|iM for each) resulted in a change in the way the
proteins partition during gel-filtration experiments. Although the apparent Mr. (~
271kDa) of the single peak, and the stoichiometry of the peak components (1:3:1
gelsolin:actin:DNaseI, respectively) did not change, (in relation to those experiments
performed in the absence of rhodamine-phalloidin), a slight leading-edge appeared in
these elution profiles. A small amount of rhodamine-phalloidin co-purified (~ 10 -
16% of the total added 3.0pM) with the proteins/protein complexes present within
these leading-edge fractions. Furthermore, the fractions of this leading-edge
contained increased amounts of all three proteins (gelsolin, actin and DNasel), with
unchanged stoichiometry, compared with the same fractions obtained from size-
exclusion experiments performed in the absence of rhodamine-phalloidin.
These data appeared to indicate a specific interaction between the putative
"minifilament" and rhodamine-phalloidin. We only observed these changes in the
presence of both G:A2 and A:D; Similar experiments with the two individual
complexes alone, showed no evidence of co-purification with rhodamine-phalloidin
or shifts in the elution profiles. The results were not inconsistent with the binding of
rhodamine-phalloidin, to a sub-population of the putative "minifilament". The
protein complex/es partitioning within the leading edge-fractions may have been
stabilised by the binding of the phalloidin molecule that then resulted in a
"stiffening" of the complex. This decrease in the flexibility of the putative complex
may then possibly have resulted in an increase in the apparent size or shape that this
species presents, with regards to the partitioning during gel-filtration
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chromatography. This binding interaction (rhodamine-phalloidin is an F-Actin
specific binding molecule) implies that the actin monomers within the protein
complex/es partitioning within these leading-edge fractions possess a filamentous
conformation. Or at least that the conformation is relatively flexible and could be
shifted more towards that of a filamentous conformation, by the binding of
rhodamine-phalloidin.
Using fluorescence enhancement experiments we have further characterised the
apparently specific binding of rhodamine-phalloidin to the putative "minifilament".
We only observed significant fluorescence enhancement in the presence of both G:A2
ternary complex and A:D binary complex (essentially no enhancement was observed
with either of the two smaller complexes - A:D or G:A2 - on their own, see section
4.3.2). Although the noise levels we observed were high, this enhancement further
suggested a specific interaction between the rhodamine-phalloidin and the new,
larger putative "minifilament" complex. The apparent Kd for rhodamine-phalloidin
binding to the putative "minifilament" species was ~ 4.6|iM. This Kd value is -100
fold lower than the binding of for rhodamine-phalloidin to actin filaments (Kd - 40 -
50nM; Huang et al, 1992; and see our own results described in section 4.3.1).
These results provide further, and again significant, evidence for the formation of a
putative "minifilament" complex, with the actin monomers within such a species
having filamentous-like conformation. The loss of binding affinity and the noisy
fluorescence signals we observed are probably not an unexpected feature of the
binding of rhodamine-phalloidin to such a protein complex that, after all, at best only
contains the minimal number of actin subunits (three) to bind phalloidin.
A refinement of the actin filament model in the presence of phalloidin (Lorenz, et al,
1993), coupled with other data, from biochemical cross-linking experiments
(Faulstich et al, 1993) and yeast point mutations that no longer bind to phalloidin
(Drubin et al, 1993), has suggested that the binding site for phalloidin lies at a
subunit interface between three actin subunits (see fig. 4.7). It is not difficult to
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envision why the very stereo-specific binding of phalloidin at this binding site on F-
Actin has the stabilising effects on actin filaments it does.
Although our "minifilament" model theoretically contains only a single rhodamine-
phalloidin binding site, this site in the "minifilament" is probably very much more
flexible and the very specific orientation required for the tight binding of phalloidin
is not as well maintained as in the more stable filament. The three monomers in the
putative "minifilament" are unlikely to experience the same strong co-operative
effects, arising from the further inter-molecular monomer:monomer interactions, that
contribute to the overall stability of the filament (Bremer et al, 1991). Furthermore,
due to the symmetry of the filament model (Holmes et al, 1990; Lorenz et al, 1993),
and the position of the putative phalloidin binding site at an interface between three
subunits (see fig. 4.7), the stoichiometry of rhodamine-phalloidin binding to F-Actin
is 1:1, phalloidimactin monomer (Huang et al, 1992; Cano et al, 1992; De la Cruz
and Pollard, 1994; and see also our results in section 4.3.1). Thus, over the whole
length of a filament each monomer contributes to three separate phalloidin binding
sites and thus would be braced by the stabilising interactions arising from these
interactions. Our putative "minifilament" model, at best with its single binding site,
even with the monomers oriented in a filamentous conformation, would lack these
additional co-operative stabilising interactions, arising from further phalloidin
binding sites over the whole actin filament.
A gelsolin-induced disruption of the actin:actin contacts that contribute to the
phalloidin binding site, may further explain the noisy fluorescence signals we
observed and also the markedly reduced affinity (~ 100 fold less than that for actin
filaments) of rhodamine-phalloidin for the "minifilament". Allen and Janmey (1994)
have reported that gelsolin causes a disruption of the rhodamine-phalloidin binding
site on F-Actin filaments. A gelsolin-induced loss of fluorescence enhancement,
following severing and capping of rhodamine-phalloidin saturated filaments, was
observed. This was explained by gelsolin causing a disarrangement in the normal
interactions of residues that were important in the formation of a tight rhodamine-
phalloidin binding site, and this caused a loss of affinity of rhodamine-phalloidin for
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the filaments. A disruption of these residues (or ones close by) is also probably a pre¬
requisite for severing, as several proteins that sever filaments either interfere with
(gelsolin) or compete for (ADF) the binding site of phalloidin (Maciver et al, 1991).
However, the fact that we observe the binding of rhodamine-phalloidin at all, and
detect a specific enhancement in the fluorescence intensity of rhodamine-phalloidin,
(only observed in the presence of both A:D and G:A2) is a significant result.
Rhodamine-phalloidin binding a pre-requisite for considering the actin monomers
within the G:A3:D complex possessing filamentous conformation; binding is F-Actin
specific.
Native-PAGE experiments provided little evidence of the formation of the putative
"minifilament". However, as we have already discussed (see section 4.2.2), the harsh
solution conditions and rapid changes in charge distributions experienced by the
proteins and protein complexes during such electrophoresis experiments, may
provide a possible explanation for why we did not observe any indication of
"minifilament" complex formation by this method.
Similarly, our size-exclusion experiments, in which we used the myosin S-l head to
probe the conformation of the actin monomers within the putative "minifilament",
showed no evidence of an interaction. These experiments were carried out in the
presence of ATP (~ 0.2mM). In the absence of ATP, actin and myosin form a very
tight complex (Ka ~ 107 - 108 M"1 for acto-Sl, Marston and Weber, 1975;
Margossian and Lowey, 1978; Sellers and Goodson, 1995). ATP binds rapidly to the
S-l head, as it does with myosin alone, and has the resultant effect of lowering the
affinity of actin for myosin to about 104 - 105 M"1 (Chalovich et al, 1984). The
presence of ATP may have resulted in any binding interaction, between the S-1 head
and the actin monomers within the putative "minifilament", being of such a low
affinity that we were unable to detect it during our size-exclusion experiments. In a
similar manner to the reduced affinity we observe for the binding of rhodamine-
phalloidin to the "minifilament", any increased flexibility of the actin monomers in
the "minifilament", compared to a filament, may have further reduced the affinity of
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the S-l. As described in section (4.3.3.1) our attempts to perform experiments in the
absence of ATP proved to be problematic and we have not pursued them further.
Nevertheless, our data do provide some evidence for the formation of a complex
formed by the actin-actin association between the G:A2 ternary complex and the A:D
binary complex. This putative "minifilament" appears to have a stoichiometry of
1:3:1 (gelsolin:actin3:DNaseI), and the actin monomers within the complex associate
with the F-Actin specific binding molecule rhodamine-phalloidin, with an apparent
Kd of ~ 4.6|iM. The stability of this complex also appears to be higher than one
would theoretically predict simply by the association of the actin monomers in A:D
and G:A2, further taking into account the apparent lack of filamentous-like
conformation of the monomers within G:A2 (see chapter 3).
A possible explanation for the increased stability of the putative "minifilament"
arises from a consideration of why gelsolin exhibits such tight barbed-end capping
activity. Very tight capping of the barbed-end (gelsolin has a Kcap of ~ lOpM, Selve
and Wegner 1986) can be achieved by the binding protein having a high on-rate and
a low off-rate. However, the on-rate for the capping protein cannot be greater than
the on-rate for actin monomer addition to the barbed-end as this appears to already
be approaching a diffusion-limited rate (Bonder and Mooseker, 1983; Pollard, 1983;
Frieden, 1985; Pollard and Cooper, 1986; Pollard, 1986; Sheterline et al, 1995).
Dissociation of the capping protein (from the barbed-end of the filament) can
proceed by two mechanisms; alone or complexed to the actin monomer. This
dissociation will be determined by the faster of the off-rates of these two dissociation
mechanisms. Kcap values that are lower than the Kd of the terminal actin monomer for
the barbed-end, (~ 0.1 |iM), imply that the off-rate of the actin monomer complexed
with the capping protein has a lower off-rate than an uncomplexed terminal actin
monomer.
This could be accomplished in two ways. One is that the capping molecule binds
tightly to two actin monomers and tethers them together (e.g. gelsolin, villin and
severin). Dissociation of the capping molecule complexed with two monomers, from
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the barbed-end of a filament (dissociation of actin-dimers), would involve the
breakage of more bonds than single monomer dissociation (Holmes et al, 1990;
Lorenz et al, 1993), and would thus be more energetically unfavourable. Such actin-
dimer dissociation could result in a decrease in the rate of dissociation from the
capped-end. The second method involves the capping protein inducing a subtle
conformational change in the structure of the terminal actin monomer/s bound to it.
This conformational change may then cause a change in the subunit:subunit
interactions that occur between the complexed monomer/s and the subsequent
monomers at the barbed-end of the filament. These altered interactions then cause a
reduction of the off-rate of the complexed actin monomer/s, from the barbed-end of
the filament. This could be accomplished by either a purely kinetic effect or by
strengthening the terminal actin-actin bond at the barbed-end of the filament (Weber
et al, 1991).
Some support for a gelsolin-induced conformational change in actin monomers, has
come from the work of Prochniewicz and co-workers (Prochniewicz et al, 1996).
They studied the effect of gelsolin on the rotational dynamics of capped actin
filaments, using time-resolved fluorescence anisotropy with erythrosin-
iodoacetamide-Cys-374 actin. Significant changes in the internal dynamics of the
whole filament were observed. These changes could not be explained simply by the
increase in the number of short length filaments by the severing and capping activity
of gelsolin, and they postulate that gelsolin had induced a subtle conformational
change in the actin monomers, that was translated along the entire length of the actin
filament (Prochniewicz et al, 1996). Similar reports indicating a co-operative
translation of filament-end-effects along the entire length of the actin filament have
also been described by other workers (Orlova and Egelman, 1995; Orlova et al, 1995;
Egelman and Orlova, 1995a/b).
Evidence of a similar nature has been reported by Weber et al (1991). G1 - 3 and G1
alone have Kcap values less than the monomer critical concentration of the barbed-
end (the Kcap for G1 is ~ 10 - 20nM). One explanation proposed for these low Kcap
values was a capping-protein-induced conformational change in the terminal
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complexed actin monomer that had resulted in an increased stability of the terminal
actin-actin monomer contacts at the barbed-end of the filament, i.e. G1 had
strengthened the longitudinal actin-actin interactions between the capped terminal
monomer and the barbed-end, resulting in a reduction of the off-rate of the Gl-
monomer complex.
Gelsolin (and to a lesser extent the G:A2 ternary complex) may possibly achieve its
extremely tight capping of the barbed-ends of filaments by a combination of the two
methods described above. If gelsolin is able to induce a conformational change in the
actin monomers bound to it, that then strengthens the longitudinal actin-actin
monomer contacts between the terminal gelsolin-bound monomers and any
subsequent monomers binding to the pointed ends of G:A2, it may provide an
explanation for the higher than expected stability of the "minifilament". i.e. gelsolin
has altered the conformation of the two monomers bound in ternary complex with it.
This re-arrangement then results in any subsequent monomer:monomer interactions,
between these gelsolin-bound monomers and say that of the A:D bound monomer,
being strengthened. In this manner, the off-rate of the A:D monomer may be reduced
(compared to the off-rate from the pointed-ends of filament), and the stability of the
putative "minifilament" increased.
However, even accounting for a gelsolin-induced strengthening of the terminal
longitudinal actimactin associations, the interactions that take place between the two
terminal gelsolin-bound actin monomers in G:A2, and the two monomers at the
barbed-end of the filament, are likely to be different, and more stable, than the actin-
actin interactions that may result in the formation of the putative "minifilament".
Capping of the barbed-end of a filament involves a dimer:dimer association between
the two monomers in G:A2 and the two terminal barbed-end subunits. One would
have expected that the formation of the putative "minifilament", occurring solely via
actimactin associations between the free barbed-end of the single monomer in A:D
and the free pointed-ends of the monomers in the G:A2 complex, to be significantly
less stable than the binding of G:A2 to a filament end. Furthermore, as our results
described in chapter 3 indicate the monomers in G:A2 are probably not oriented in a
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filamentous conformation, and we are not simply adding monomers to the pointed-
ends of already formed filaments, i.e. we would have predicted that the Kd for this
interaction would have been larger than the Kd for monomers binding to the pointed-
end (~ 0.6pM) of actin filaments. As described above, if this were the case we would
have expected to see a significant amount of uncomplexed A:D, G:A2 in our gel-
filtration experiments, to have experienced more problems with the exchange of actin
for A:D at the EGTA labile (G4) actin-binding site on gelsolin, and to have observed
little, if any, rhodamine-phalloidin binding.
This notion of a capping protein-induced conformational change in the complexed
actin subunits, that increases the stability of the terminal longitudinal actimactin
interactions may partially explain the high-affinity capping activity of gelsolin and
the barbed-end of actin filaments. However, an alternative model where gelsolin
forms a contact with a third actin monomer (via an interaction with the F-Actin
binding site in G2), up the longitudinal axis of the filament, is now emerging from a
body of work. This model seems to provide a better explanation for why the
"minifilament" might form, with a higher than expected stability, but it also provides
an insight as to why the orientation of actin monomers in the G:A2 ternary complex
may be non-filamentous. This model will be discussed in detail in chapter 6.
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4.5 Conclusion
Gel-filtration and fluorescence enhancement experiments provide evidence
consistent with our model for the formation of a capped-actin-"minifilament". This
complex appears to have formed from via an actimactin association between the
G:A2 ternary complex and the A:D binary complex. The actin monomer
conformation within this putative "minifilament" complex (G:A3:D) may be
relatively flexible, but the binding of rhodamine-phalloidin shifts it towards a more
filamentous-like and rigid conformation. A model where gelsolin forms a contact
with a third actin monomer (via an interaction with the F-Actin binding site in G2),
up the longitudinal axis of the filament is emerging from a body of work. This model
seems to provide an explanation for why the "minifilament" might form, with a
higher than expected stability, but it also provides an insight as to why the orientation
of actin monomers in the G:A2 ternary complex may be non-filamentous. This model
and the implications for the formation and stability of our putative "minifilament"
will be discussed in detail in chapter 6.
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5. T-cap-protein, a fragment of tensin spanning the sequence
containing "insertin", acts as a barbed-end-capper of actin
filaments.
5.1 Overview
In an attempt to resolve some of the problems, possibly associated with monomer
exchange at the EGTA labile actin-binding site (G4) on gelsolin, we proposed to use
an alternative protein as the barbed-end capping species in the analysis of the
"minifilament". This protein is a cloned polypeptide fragment derived from the
protein tensin, a component of focal adhesions. (We have termed this construct T-
cap-protein and its sequence spans amino acid residues R861 - A1223 of whole
tensin). T-cap-protein spans the region of tensin that contains the sequence of
"insertin", previously identified as a polypeptide possessing a controversial high-
affinity barbed-end capping activity. We have developed a novel purification
protocol that gives >85% final purity for T-cap-protein. We have studied its
interaction with filamentous actin. The results are consistent with T-cap-protein
having a tight barbed-end capping activity, with an apparent Kcap of ~ 6 - 8nM, but
with a non-"insertin-like" activity. We also report a novel F-Actin side-binding
activity for T-cap-protein, with an apparent IQ of ~ 10)itM. However, our results are
consistent with T-cap-protein showing no binding interaction with monomeric G-
actin, and therefore, it is not useful in the further analysis of the putative
"minifilament".
5.1.1 Introduction
Focal contacts (also called adhesion plaques or focal adhesions) are specialised areas
of the plasma membrane where cells attach to the underlying substratum (see section
1.4 for details). The protein tensin, originally identified in chicken gizzard extracts
(Wilkins and Lin, 1986), appears to be a prime candidate for the role of linking of the
actin cytoskeleton to the plasma membrane and the extra-cellular matrix (ECM).
Tensin is a large (~ 200kDa) actin cross-linking and capping protein that localises in
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the dense plaques of smooth muscle, the Z-line of cardiac muscle and focal
adhesions of fibroblasts (Bockholt et al, 1992). Three distinct actin-binding domains
have been identified within tensin; two N-terminal proximal domains (ABD-1, one
of which contains a region that shares homology with a consensus actin binding
sequence commonly found in cross-linking proteins; Matsudaira, 1991) and a central
ABD-2 domain, see fig. 5.1. In vitro binding experiments indicate that tensin
probably binds to the side of F-actin filaments via these ABD-1 domains (Lo et al,
1994c). The barbed-end capping of actin filaments is thought to occur via the















Fig. 5.1 Tensin has homology with a consensus actin-binding sequence. (A)
A schematic diagram of tensin, with the 3 proposed actin-binding domains
highlighted (2 ABD-1 domains and a ABD-2 domain), is illustrated above. The
sequence with very high identity to "insertin" (Wieght et al, 1992) is highlighted
below the tensin schematic. The position of the consensus actin-binding sequence,
located in the second ABD-1 domain (Lo et al, 1994a) is indicated by the black box
insert in the second ABD-1 domain. The high-affinity barbed-end capping domain
is indicated by the hatched box insert in ABD-2 (the sequence within this region is
not numbered due to a discrepancy in the residues of tensin actually involved in
the capping of the barbed-end; see Lo et al, 1994a/c and Chuang et al, 1995). (B)
Actin-binding consensus sequence found in the second ABD-1 domain in tensin.
The sequence illustrated is emerging as an F-actin binding consensus sequence.
This consensus sequence is usually found as a stretch of 25 amino acids
conserved within a 250 amino acid domain, commonly found in F-Actin cross-
linking domains e.g a-Actinin, filamin, spectrin, dystrophin, plastin/fibrin, APB-120
and APB-280 (Nagafuchi et al, 1991; Bresnick et al, 1991; Hartwig and
Kwiatkowski, 1991; Matsudaira, 1991; Van Troys et al, 1999). This region appears
to be essential for in vitro actin binding (Matsudaira, 1991). The numbering of
amino acids used is the same as that for the derived tensin sequence described by
Lo et al (1994a).
Tensin appears to be able to form parallel dimers by intermolecular interactions
involving sequences localised to the C-terminus (Lo et al, 1994a). The formation of a
tensin-dimer, via the C-terminus, would generate a U-shaped structure that could
both cross-link and cap two actin filaments. This would enable tensin to act as an
adapter, bridging the interactions between the ECM, the actin cytoskeleton and the
rest of the focal contact assembly (see fig. 1.3).
Wegner and co-workers (Schroer and Wegner, 1985; Ruhnau et al, 1989) have
previously described the purification and characterisation of a small polypeptide (20
- 80kDa) that that co-purified with vinculin. This polypeptide (which they termed
"insertin") exhibited barbed-end filament capping activity that retarded, but did not
completely, inhibit polymerisation (Ruhnau et al, 1989; Gaertner and Wegner, 1991).
Subsequent work has demonstrated that "insertin" shares a very high degree of
sequence identity to a stretch of amino acid sequence (R861 - A1223) from whole
tensin (Wieght et al, 1992; Lo et al, 1994a; Chuang et al, 1995; Teubner et al, 1998).
Northern blot analysis with tensin cDNA probes only detected a single mRNA
species of llkb in chick embryo fibroblasts (Davis et al, 1991). Furthermore, amino
acid sequence analysis of the derived sequence of tensin from chicken gizzard,
indicated the existence of 9 PEST regions (Chuang et al, 1995). PEST regions are
amino acid sequences that act as signals for rapid proteolysis, and are common in
many rapidly degraded proteins involved in signal transduction (Rogers at al, 1986;
Rechsteiner, 1990). Three of these PEST sequences surround the putative "insertin"
sequence in tensin (Chuang et al, 1995). This region also contains the high-affinity
barbed-end-capping region of tensin (Lo et al, 1994a/c; Chuang et al, 1995). Tensin
also shows a high sensitivity to the protease calpain II and both are localised to focal
contacts (Lo et al, 1994b), so it now seems highly likely that "insertin" is generated
by proteolytic degradation of the highly susceptible protein tensin.
A model in which "insertin" binds to one of the actin monomers at the barbed-end of
an actin filament, inhibiting polymerisation at this end, but still allowing monomer
insertion between the bound protein and the other actin subuint, has been proposed
(Ruhnau et al, 1989; Geartner and Wegner, 1991). Lo et al (1994c) provided a
5-3
similar monomer insertion model to explain the capping activities (Kcap ~ 20nM) of
their recombinant tensin, and several bacterially expressed fusion protein constructs
that span the sequences of tensin containing the high-affinity barbed-end capping
"insertin" domain.
This is in contrast to the findings of Chuang and colleagues (Chuang et al, 1995).
Using a set of bacterially expressed fusion proteins, again derived from the
sequences of whole tensin containing the high-affinity barbed-end capping "insertin"
domain. They report tight capping of the barbed-end (Kcap ~ 1 - 3nM). Furthermore,
no evidence of further monomer insertion was observed.
Both groups have also reported conflicting results with regard to the actual sequences
in the "insertin" domain in tensin, that are responsible for the tight capping of the
barbed-ends of actin filaments (Lo et al, 1994a/c; Chuang et al, 1995). Two of the
sequences reported for chicken cardiac tensin (GenBank accession No. L06662;
Chuang et al, 1995 and accession No. M96625; Lo et at, 1994a) show a variation in
the determination of the N-terminus and the initiation codon of the full-length
protein. The sequence reported by Lo et al (1994a) is missing the first 35 amino acids
and the alternative methionine initiation codon of the sequence reported by Chuang
et al (1995). These discrepancies are possibly artefacts of the cDNA synthesis and
cloning and have led to different residue numbering schemes. Thus, for reasons of
clarity, we state here that the numbering of the amino acid residues, used throughout,
is based on that scheme described by Lo et al (1994a).
We have cloned a fragment of chicken cardiac tensin (Mary Russell, unpublished
results). This construct spans amino acid residues R861 - A1223 of tensin and
contains the putative "insertin" sequence. We have expressed this fragment (here
termed T-cap-protein) in BL21 (DE3) E.coli and purified the full-length polypeptide.
Initially this protein was intended as a substitute for gelsolin, as the barbed-end
capping protein, in the further experimental analysis of the "minifilament". We have
analysed its interaction with actin filaments. Our results are consistent with the tight
capping of the barbed-ends of actin filaments, an apparent Kcap of ~ 6 - 8nM. Our
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data are also consistent with T-cap-protein showing no evidence of further monomer
addition at capped barbed-ends; i.e. no "insertin-like" activity. We further report that
this T-cap-protein construct appears to possess a novel F-Actin side-binding activity
with an apparent IQ of ~ lOpM. However, as is discussed in the proceeding sections,
we found no evidence of an interaction between the G-Actin monomer and T-cap-
protein. Thus, it appears that T-cap-protein was not a good alternative for gelsolin,
and was not of any use for the further analysis of the putative "minifilament".
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5.2 Purification of T-cap-protein.
5.2.1 Purification protocol
We have developed a novel purification protocol for T-cap-protein that gives >85%
purity. However, due to problems with severe proteolytic degradation, yields of pure
protein ranged from 0.2 - 3.0mg, (from 6 litres of original bacterial cell culture), in a
very preparation dependent manner.
5.2.1.1 Optimisation of expression
BL21(DE3) E.coli were successfully transformed with pMW172[T-cap-
protein/R861-A1223] (using the amino acid sequence numbering scheme of tensin as
described by Lo et al, 1994a; accession number M96625). Cells were grown in 2xTY
and the induction of synthesis of high levels of recombinant T-cap-protein was
obtained upon addition of IPTG to l.OmM. The appearance of a protein band that
migrates at approximately 46 - 48kDa on SDS-polyacrylamide gels corresponded to
the full- length recombinant T-cap-protein, see fig. 5.2(A). This apparent Mr. (46 -
48kDa) is significantly larger than the expected theoretical Mr. of ~ 38kDa.
Examination of the sequence of our protein construct indicated that it contains a
higher content of proline residues (14%, see fig. 5.3) as compared to the 5% average
of vertebrate proteins (Doolittle, 1986). The high proline content may contribute to
the apparent larger Mr. of T-cap-protein on SDS-polyacrylamide gels. Proteins with
a higher than average percentage of proline residues have previously been show to
have significantly larger than expected apparent Mr. values when analysed on SDS-
polyacrylamide gels (Olio and Maniatis, 1987).
Attempts were made to optimise the expression of the recombinant protein (see
optimisation protocol employed in the purification of DNasel, section 3.2.1.1.1, for
general protocol). However, rapid proteolytic degradation of the full-length T-cap-

















Fig. 5.2. SDS-PAGE analysis of induction of synthesis of recombinant T-cap-protein from
BL21(DE3)[pMW172/T-cap-protein/R861-A1223]. (A) SDS-polyacrylamide gel showing the high
levels of synthesis of the T-cap-protein from BL21(DE3)[pMW172/T-cap-protein/R861-A1223] by
addition of IPTG to 1.0mM. Lane a. pre-induction; b. 3hrs post IPTG addition.
BL21 (DE3)[pMW172/T-cap-protein/R861-A1223] in 100ml of 2xTY/AMP (50pg/ml) were grown at
37°C until the A600nm -0.6-1.0, and synthesis of the recombinant protein was induced by addition of
IPTG to 1.0mM. Cells were grown for a further 3hrs. 1.0ml aliquots from pre- and post-induction
conditions were taken and the resultant cell pellet was resuspended in 10Opil of 5 x SDS-sample
buffer (see methods) and boiled for 5mins. A 20pl sample was loaded onto the gel, following
centrifugation at 15,000 xg for 2min. Mr. of protein standards are given in kilodaltons. (B) SDS-
polyacrylamide gel showing the extensive proteolytic breakdown of the full-length T-cap-protein to
give a slightly smaller cleavage fragment as the major protein constituent (Mr. - 42kDa). Lane a.
Total cell extract, 3hrs post IPTG addition, post-lysis; b. Insoluble fraction, post lysis; c. Soluble
fraction, post lysis. The magnified image to the right of the gel shows the two protein bands, full-
length T-cap-protein and the major degradation fragment, from the box inset in lane c. The
increase in the relative amounts of the full-length and degraded T-cap-protein, when compared to
those in A, can clearly be seen. BL21(DE3)[pMW172/T-cap-protein/R861-A1223] in 100ml of
2xTY/AMP (50pg/ml) were grown at 37°C until the A600nm - 0.6, and synthesis of the recombinant
protein was induced by addition of IPTG to 1.0mM. Cells were grown for a further 3hrs and then a
5.0ml aliquot was resuspended in 20mM Bis-Tris, pH 6.1; 0.25mM EDTA; 5mM NaCI; 1mM NaN3;
1ml of bacterial cell extract protease inhibitor cocktail (Sigma), subjected to ultrasonication (3 x 20
sec bursts at 4°C) and the resulting cell lysate centrifuged at 18,000 xg (5min at 4°C). The extent of
proteolysis was analysed by SDS-PAGE. SDS-PAGE was performed as described in methods.
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protein was observed, even in the presence of excess of a cocktail of protease
inhibitors (~ 5x the normal recommended concentrations).
10 20 30 40 50 60
MRSFGTSVGT DPLAKPYSPG PLVPAARSTA EPDYTVHEYR ETYTPYSYQP VPEPRSYGSA
PASILPLSAS YSPAGSQQLL VSSPPSPTAP AQSQLPHKGL ESYEDLSRSG EEPLNLEGLV
AHRVAGVQSR EKSPEESTVP ARRRTPSDSH YEKSSPEPGS PRSPTVLSPE WSTIAANPG
GRPKEPHLHS YKEAFEEMES ASPSSLTSGG VRSPPGLAKT PLSALGLKPH NPADILLHPV
GELEGEAGAD SEEEPRSYVE SVARTATTGR AGNLPAAQPV GLEVPARNGA FGNSFTVPSP
VSTSSPIHSV DGASLRSYPS EGSPHGTVTP PHAVAETAYR SPMVSQTPSA HSSYQTSSPS
SFQA
*
Fig. 5.3. The amino acid sequence of full-length T-cap-protein[R861 -
A1223]. The proline (P) residues are highlighted in bold type. Out of a total of
364 residues 51 are proline, contributing 14% of the sequence. The underlined
portion indicates the sequence of the N-terminus, reported for the smaller
degradation fragment (see fig. 5.2B) following N-terminal sequencing. * denotes
the likely Endoproteinase Glu-C (or a bacterial enzyme with a similar specificity)
cleavage site (E336/T337, Teubner et al, 1998) for the proteolytic fragment. The
methionine (M) residue at the start of the sequence is derived from the bacterial
initiation codon within the pMW172 vector.
Fig. 5.2(B) shows the degradation of the full-length T-cap-protein, following cell
lysis. As a result of this degradation problem, it proved impractical to analyse the
relative amounts of protein present in the soluble and insoluble fractions in the
course of the optimisation procedure. The synthesis of T-cap-protein increased as a
function of time after induction with IPTG. After 3hrs the protein constituted ~ 6 -
9% of the total cellular protein prior to being subjected to lysis, as judged by
densiometric scanning of SDS-polyacrylamide gels lanes, similar to that shown in
fig. 5.2(A), lane b (data not shown). Therefore, cells were routinely induced for 3hrs
and then processed for purification as rapidly as possible. Although the severe
degradation hampered the optimisation process, we have developed a working
method that provides full-length T-cap-protein at >85% final purity.
5.2.1.2 Protein purification
BL21(DE3)[pMW172/T-cap-protein/R861-A1223] were grown at 37°C in
2xTY/AMP, and protein synthesis induced by the induction of IPTG to l.OmM. Cells
were grown for a further 3hrs and then harvested and processed for purification (see
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methods for protocol details). To minimise the extent of proteolytic degradation the
cells were processed as quickly as possible immediately after induction, always using
freshly transformed BL21(DE3) E.coli. Protease inhibitors were included (at ~ 5
times the normal working concentration) in all dialysis and chromatography buffers,
throughout the purification protocol.
Fig 5.4 shows the results of the DEAE-Sepharose anion-exchange chromatography
step. Bound proteins were eluted by a gradient of 5 - 300mM NaCl. Full-length T-
cap-protein elutes at ~ 60mM NaCl, see fig 5.4(A). A band that migrates at a slightly
lower Mr. than the full-length T-cap-protein, co-purifying with it (Mr. ~ 42kDa on
SDS-polyacrylamide gels), was always the major contaminant, see figs. 5.2(B) and
5.4(B).
We have purified this protein to >80% purity, utilising a similar protocol to that
employed in the purification of the full-length protein (data not shown). N-terminal
sequencing of this protein species gave the sequence, MRSFGT. This is identical to
the N-terminal sequence of full-length T-cap-protein suggesting that this smaller
species is proteolytically cleaved at the C-terminus (see fig. 5.3). Electro-spray mass
spectrometry analysis of this smaller protein species gave a corresponding mass, for
the major peak constituent, of 35236.0 Da. Together both pieces of information are
consistent with the full length protein having lost 28 amino acids from the C-
terminus, with a likely Glu-C cleavage site (or a bacterial protease with a similar
specificity) occurring between E336 and T337, see fig. 5.3. Our data is in agreement
with the Glu-C cleavage site reported by other workers (Teubner et al, 1998) at the
same (relative) position in whole tensin. A high susceptibility of tensin to proteolytic
degradation (especially for fusion proteins containing sequences that encompass the
putative "insertin" sequence, R861 to A1223), has been reported by others (Wieght
et al, 1992; Lo et al, 1994a/c; Chuang et al, 1995; Teubner et al, 1998). Thus, it




























Fig 5.4. DEAE-Sepharose chromatography of the recombinant T-cap-protein. (A) Abs280nn,
monitored elution profile from a DEAE-Sepharose column showing the elution of the full-length
T-cap-protein at ~ 60mM NaCI. (B) SDS-PAGE analysis of the elution profile in A. (SN50;
soluble fraction resulting from centrifugation of cell lysate at 50,000 xg). BL21(DE3)[pMW172/T-
cap-protein/R861-A1223] were grown at 37°C in 2xTY/AMP (50gg/ml) until A600nm ~ 0.6 - 1.0 and
protein synthesis induced by the addition of IPTG to 1 .OmM. Cells were grown for a further 3hrs
and then harvested by centrifugation at 3000 xg for 10 min at 4°C. Cells were lysed and
subjected to an overnight dialysis against 20mM Bis-Tris, pH 6.1; 0.25mM EDTA; 5mM NaCI;
1mM NaN3; 5ml of bacterial cell extract protease inhibitor cocktail (Sigma) per litre of dialysis
buffer. The soluble clarified fraction was then loaded onto a DEAE-Sepharose column (V, ~ 50
ml; 2.6cm x 9.5cm) pre-equilibrated in the same buffer. Bound proteins were eluted by a
gradient of 5 - 300mM NaCI, over 6 column volumes, and proteins detected by A280nm and
analysis by SDS-PAGE. Mr. of protein standards are given in kilodaltons. (SDS-PAGE and
chromatography were performed as described in methods).
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The relevant fractions, from the DEAE-Sepharose chromatography run, were pooled,
concentrated and subjected to an overnight dialysis against a 50mM MES, pH 5.5
buffer. Following dialysis, the soluble fraction was then loaded onto a cation-
exchange Mono-S/(30|jm) column. Fig. 5.5(A) shows a typical A28onm monitored
elution profile of the purification. T-cap-protein bound to the matrix (the theoretical
pi for full-length T-cap-protein is ~ 5.7) and elution was achieved with a 5 - lOOmM
NaCl gradient (see methods). Full-length T-cap-protein elutes at ~ 65mM NaCl.
Fig. 5.5(B) illustrates the analysis of the elution profile by SDS-PAGE. Some
success in partitioning full-length T-cap-protein from its major contaminants was
achieved on this column. The peak elution fraction of the degraded fragment was ~
F34, while that of the full-length protein was slightly later in the profile, peaking at ~
F36, see fig. 5.5(B). There is however, a high degree of overlap between the two
elution positions. Careful pooling of the relevant fractions at this stage was needed to
maximise the yield of full-length T-cap-protein. Relevant fractions were pooled,
concentrated and dialysed over night against a 50mM MES, pH 5.5 buffer (see
methods). Depending on the degree of severity of degradation and the corresponding
amounts of full-length T-cap-protein and fragment, several further rounds of Mono-
S/(30pm) cation-exchange chromatography, were frequently performed (data not
shown). These further stages were very preparation dependent and were not always
necessary.
The final ion-exchange chromatography step was always carried out on a HR 5/5
Mono-S/(15|im) column, attached to an FPLC. This semi-analytical column has a
highly uniform matrix-bed, due to the smaller 15|am diameter resin beads. This
provides higher band resolution, and when attached to an FPLC, chromatographic
runs can be performed with very fine and accurate control over the flow-rate and
gradient profile parameters (see methods for details).
Fig 5.6 shows the results obtained from such a chromatography step. T-cap-protein
bound to the resin and elution was achieved with a very shallow gradient of 60 -
















































Fig 5.5. Mono-S/(3<\im) chromatography of recombinant T-cap-protein. (A) Abs280nm monitored
elution profile from a Mono-S/(30pm) column showing elution of the full-length T-cap-protein at ~
65mM NaCI. (B) SDS-PAGE analysis of the elution profile in A. The first lane represents the
pooled fractions from the DEAE-Sepharose column. Relevant fractions from the DEAE-Sepharose
chromatography step were pooled and subjected to an over night dialysis against 50mM MES, pH
5.5; 0.25mM EDTA; 5mM NaCI; 1mM NaN3; 5ml of bacterial cell extract protease inhibitor cocktail
(Sigma) per litre of dialysis buffer. The dialysate was filtered through a 0.22pm filter and loaded
onto a Mono-S/(30pm) column (V, ~ 6.0ml; 1.6cm x 2.0cm), pre-equilibrated in the same buffer.
Elution of T-cap-protein from the resin was achieved with a 5mM - 100mM NaCI gradient, over 6
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Fig 5.6. HR 5/5 Mono-S/(15am)/FPLC chromatography of recombinant T-cap-protein. (A) Abs280nm
monitored elution profile from an HR 5/5 Mono-S/(15pm)/FPLC column showing elution of the full-
length T-cap-protein at ~ 65mM NaCI. (B) SDS-PAGE analysis of the elution profile in A. The first lane
represents the pooled fractions from the previous Mono-S/(30pm) column. Relevant fractions from the
previous Mono-S/(30pm) chromatography run were pooled and subjected to an over night dialysis
against 50mM MES, pH 5.5; 0.25mM EDTA; 5mM NaCI; 1mM NaN3; 5ml of bacterial cell extract
protease inhibitor cocktail (Sigma) per litre of dialysis buffer. The dialysate was filtered through a
0.22pm filter and loaded onto an HR 5/5 Mono-S/(15pm)/FPLC column (V, ~ 1.0ml; 1.0cm x 1.30cm),
pre-equilibrated in the same buffer. Elution of T-cap-protein from the resin was achieved with a
gradient of 60mM - 80mM NaCI, over 15 column volumes with a flow rate of 0.25ml.min'1. (SDS-PAGE
and chromatography were performed as described in methods).
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A280nm monitored elution profile, see fig. 5.6(A). Analysis of the protein components
of this elution profile, performed by SDS-PAGE, is illustrated in fig. 5.6(B). Full-
length T-cap-protein eluted at ~ 65mM NaCl (fraction 12) while the smaller
degraded fragment eluted earlier at ~ 62mM NaCl (fraction 8).
It is clear from the Mono-S cation-exchange chromatography that the pi of the major
contaminant (the smaller proteolytic fragment, Mr. ~ 42kDa on SDS-PAGE) and that
of full-length T-cap-protein are very close. Partition of these two protein species was
achieved, but the elution concentration of NaCl that separated them differed by only
~ 5mM, see fig. 5.6(A). The pi for the degraded fragment (assuming an intact N-
tcrminus and the loss of 28 amino acids from the C-terminus, via proteolysis at the
tryptic cleavage site, see fig. 5.3) is ~ 5.5. The difference in pi is only ~ 0.2 of a pEl
unit. This apparent closeness of pi values, coupled with problems associated with
rapid and extensive proteolysis, made purification very difficult and resulted in the
very variable yields. Typically, yields ranged from 0.2 - 3.0mg, from 6 litres of
original bacterial cell culture. This is in contrast to the relatively high initial levels of
expression obtained (~ 6 - 8mg.L_1) prior to cell lysis (see fig. 5.2 A).
Further purification was carried out by subjecting the relevant fractions from the HR
5/5 Mono-S/(15|im) column, to size-exclusion chromatography on an
FPLC/Superose-12 size-exclusion column. Fig. 5.7 illustrates the final purity
typically obtained for full-length T-cap-protein. Densiometric scanning of similar
SDS-polyacrylamide gel lanes gave a final purity for full-length T-cap-protein of
>85% (data not shown).
Fig 5.7 Final purity of full-length T-cap-protein obtained by a novel
purification protocol. SDS-polyacrylamide gel lane illustrating the final purity of
T-cap-protein. A final purity of >85% was obtained, as determined by
densiometric scans of similar gel lanes (data not shown). Mr. of protein
standards are given in kilodaltons. (SDS-PAGE and gel densitometry were












5.3 In vitro characterisation of full-length T-cap-protein's interaction with actin
5.3.1 Interaction of recombinant T-cap-protein with filamentous actin
As described before (see section 5.1.1) tensin has been previously shown to have
high-affinity capping activity, reflected in a Kcap for the barbed-end of actin filaments
in the nM range. There is however, a disagreement as to the "type" of capping
activity exhibited (see below). There is also disagreement as to which residues of
tensin are responsible for this barbed-end capping activity.
In summary: Lo et al (1994c) report a barbed-end capping affinity for whole tensin
of ~ 20nM (comparable to the Kcap of ~ 50nM, reported for "insertin" by Ruhnau et
al, 1989). Both whole tensin and several GST-tensin fusion constructs retarded but
did not completely inhibit barbed-end polymerisation, allowing for the insertion of
further actin monomers at the barbed-end, following capping ("insertin-like"
activity). This feature was illustrated by the protein having no effect on the long-term
steady-state critical monomer concentration ([Cc]) of F-Actin (measured after 24hr).
The residues important in this activity were located between amino acids T880 -
R989 (Lo et al, 1994c).
On the other hand, Chuang and colleagues (Chuang et al, 1995) have reported an
order of magnitude higher affinity (Kcap ~ 3nM), for capping of the barbed-end.
Furthermore, they also report a lack of "insertin-like" activity; their GST-tensin
fusion constructs (containing portions of the amino acid sequence that traverse the
"insertin" domain) affected the steady-state critical monomer concentration of F-
Actin, shifting it towards that of the pointed-end (0.6 - 0.8|lM). In further contrast to
Lo et al (1994c), they identified the residues between amino acids R989 - VI121 as
being important in the high affinity capping activity.
We have performed experiments to test our T-cap-protein construct (containing
residues R861 - A1223 from tensin) for tight capping of the barbed-end and also to
test its effect on the steady-state [Cc] values of F-Actin. We have also tested samples
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of the partially purified (~ 80% purity) degraded fragment for barbed-end capping
activity.
5.3.1.1 The effect of T-cap-protein on nucleated barbed-end actin polymerisation
We have determined the effect of our recombinant T-cap-protein on the initial rate of
nucleated actin polymerisation, under conditions (0.5|iM G-Actin, 20% pyrene
labelled, polymerised by the addition of KC1 and MgCl2 to lOOmM and 2mM,
respectively, in the presence of O.lpM F-Actin seeds) where monomer addition only
occurs at the barbed-end. The time course of polymerisation was followed by
measuring the increase in the fluorescence intensity of pyrene actin, which is directly
proportional to the incorporation of monomers into filaments. (See methods for
details of the protocol and see section 5.4 for an explanation of the kinetic
considerations).
Fig. 5.8 illustrates the effect of the addition of increasing amounts of full-length T-
cap-protein on the rate of nucleated actin polymerisation. It is clear that as the
concentration of T-cap-protein increases, the rate of polymerisation decreases
correspondingly. At high concentrations of T-cap-protein (~ 250nM and above) very
little, if any, polymerisation was observed. This approach to an initial polymerisation
rate of zero implies capping of the barbed-ends by T-cap-protein; polymerisation is
carried out under conditions that limit monomer addition to the barbed-end only.
Figs. 5.9(A) and (B) further illustrate the strong inhibitory effects of T-cap-protein
on nucleated polymerisation and show a graphical determination of the Kcap (the
concentration of capping protein that causes a 50% inhibition in the initial rate of
nucleated polymerisation). The initial polymerisation rates from the experiments
shown in fig. 5.8 were converted to units of nM.s"1 (see methods) and the percentage
of inhibition calculated, in relation to the initial rate of polymerisation in the absence
of T-cap-protein (that labelled as F-Actin in fig. 5.8).
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Fig 5.8. The effect of full-length T-cap-protein on nucleated actin
polymerisation. 0.5|iM G-actin (20% pyrene-labelled) was polymerised, in the
presence 0.1 pM F-Actin seeds and in the absence or presence of increasing
amounts of full-length T-cap-protein, by the addition of KCI and MgCI2 to 100mM
and 2mM, respectively. The time course of polymerisation was measured (at 20°C)
by following the increase in the fluorescence intensity of pyrene actin. The
excitation wavelength used was 366nm with an emission wavelength of 384nm,
with a 5nm slit for both. (Polymerisation assays were performed as described in
the methods).
As can be clearly seen from fig. 5.9(A) nM concentrations of T-cap-protein result in
extensive inhibition polymerisation, with the final level approaching complete
inhibition (100%). Under our assay conditions, polymerisation can only occur by the
addition of G-Actin monomers onto the free barbed-ends of the added F-Actin
nuclei. (The rate of spontaneous nucleation and subsequent polymerisation of 0.5mM
actin is negligible; Selve and Wegner, 1986; see also discussion). Capping of these
barbed-ends by T-cap-protein correspondingly reduces the number of free barbed-
ends onto which monomer can add, resulting in a reduction in the initial
polymerisation rate. This effect is clearly illustrated in fig. 5.8.
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Fig 5.9. Effect of full-length T-cap-protein on nucleated actin polymerisation.
(A) Inhibition of the rate of nucleated, barbed-end limited actin polymerisation by the
addition of increasing amounts of T-cap-protein. (B) Graphical determination of the
Kcap for T-cap-protein, derived from the values in A. Kcap is the dissociation constant
for T-cap-protein binding to the barbed-end of actin filaments, where this causes a
50% inhibition in the initial rate of polymerisation. Percentage inhibition values were
obtained from the experiments shown in fig. 5.8, and have been normalised to 1.0
for 100% inhibition. The initial rate of polymerisation was measured and the units of
fluorescence intensity units per second converted to give the rate of monomer
addition in nM.s"1, (calibrated from steady-state values). The solid line (in B) shows
a linear regression (R2 = 0.993), with the gradient corresponding to the Kcap; the
value is shown in the inset in B. (Polymerisation assay was performed as described
in methods).
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Fig. 5.9(B) shows the graphical determination of the Kcap. A value of ~ 5.2nM was
obtained for the Kcap of this particular T-cap-protein sample. The mean Kcap values
obtained for full-length T-cap-protein and for the degraded fragment were 6.9nM (±
3.1 SD, n=7) and 8.0nM (± 2.6 SD, n=6) respectively (see table 5.1). (The Kcap
values obtained for the degraded fragment were derived from a similar series of
assays to those described above and in fig. 5.8). These very low nM concentrations
of T-cap-protein (and the degraded fragment) that cause significant levels of
inhibition further suggest that inhibition of polymerisation is due to capping of the
barbed-end and not via the stoichiometric sequestration of monomers (see section
5.3.1.3).
Kcap T-cap-protein (nM) Kcap degraded T-cap-protein fragment








Mean = 6.9nM ± 3.1 (SD, n=7) Mean = 8.0nM ± 2.6 (SD, n=6)
Table 5.1 Range of Kcap values for full-length and degraded T-cap-protein. Values for
Kcap were calculated from data obtained from nucleated polymerisation experiments, similar
to those described in figs. 5.8, 5.9(A) and (B). (See methods for protocol details).
There is very little difference between the Kcap values obtained for full-length T-cap-
protein and those obtained for the degraded fragment (see table 5.1). The loss of the
28 amino acid residues from the C-terminus, likely due proteolysis (see section
5.2.1.2), appears to have no effect on the capping activity of this protein. These
residues (T337 - A364 from our T-cap-protein construct) therefore appear not to be
important for capping of the barbed-end of filaments. This is in agreement with both
Lo et al (1994c) and Chuang et al (1995), neither of whom, despite their conflicting
reports, has implicated these residues as being important in the high affinity capping
activity of tensin.
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5.3.1.2 The effect of full-length T-cap-protein on actin depolymerisation
We have also analysed the effect of full-length T-cap-protein on actin
depolymerisation. Fig. 5.10(A) shows the time course of actin depolymerisation
(induced by dilution of 3.0|iM F-actin - 20% pyrene labelled - to 0.5|iM with ATP-
G-Buffer) in the absence or presence of increasing amounts of full-length T-cap-
protein on (see methods for details). The loss of fluorescence intensity is directly
proportional to monomer dissociation from the ends of filaments. Under these low-
salt conditions actin filaments depolymerised completely, from both the pointed and
barbed-ends. The rate of depolymerisation is directly dependent on the number of
filament ends (both barbed and pointed) from which monomers are able to dissociate
(see discussion). Capping of the faster depolymerising barbed-ends will thus result in
very marked decreases in the initial rates of depolymerisation (under physiological
ionic conditions the ratio of the rate constants of monomer dissociation, from both
ends, k-b / k.p, is ~ 5 - 10; Pollard, 1986).
Fig. 5.10(A) clearly shows a steady decrease in the initial rate of depolymerisation as
the concentration of T-cap-protein in increases. In a similar manner to the
polymerisation experiments, a Kcap value of ~ 7.8nM was calculated for full-length
T-cap-protein (data not shown), in good agreement with the ~ 5 - 12nM values
obtained from analysis of nucleated polymerisation. Although the extent of
depolymerisation reached at the end of the time course (400 sec) was increasingly
reduced, as the concentration of added T-cap-protein increased, the final extent
reached was always the same (determined by measuring the fluorescence intensity
after ~ 4hrs). The intensity values measured, in all cases, were equal to that of 0.5|aM
G-Actin (20% pyrene labelled) indicating that depolymerisation had proceeded to
completion.
Further evidence of barbed-end capping activity of T-cap-protein can be seen in fig.
5.10(B). In these experiments, depolymerisation was performed by diluting 3.0pM F-
Actin (20% pyrene labelled) to 0.5|iM with ATP-F-Buffer (see methods for details).
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Fig. 5.10. Effect of full-length T-cap-protein on the rate and extent of actin
depolymerisation. (A) 3.0pM F-Actin (20% pyrene-labelled) was diluted to 0.5pM, into ATP-
G-Buffer, in the absence or presence of increasing amounts of full-length T-cap-protein. (B)
3.0p,M F-Actin (20% pyrene labelled) was diluted to 0.5|iM, into ATP-F-Buffer, in the absence
or presence of 30nM full-length T-cap-protein. The time course of depolymerisation (at 20°C)
was followed by measuring the decay of the fluorescence intensity of pyrene-actin. The
excitation wavelength was 366nm and the emission wavelength was 384nm, with a 5nm slit
for both. (Depolymerisation assay was performed as described in the methods).
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trailing-off to a new plateau level reflecting the attainment of a new steady-state (in
this instance, 0.5|iM total actin), where the concentration of [F-Actin] = [Actin]t0t —
[Cc]. The actin filaments at this concentration are experiencing loss of monomer
from the pointed-ends (we are below the critical concentration of the pointed-end;
0.6 - 0.8|iM) balanced by the addition of subunits to the barbed-end ([Cc]b ~ 0.1p,M),
with the net concentration of filaments remaining the same. i.e. the filaments are
undergoing treadmilling.
The time course of depolymerisation in the presence of 30nM T-cap-protein showed
a very different profile to that of F-actin alone (see fig. 5.10B). The initial
depolymerisation rate was much slower and a lower fluorescence intensity value was
reached at the end of the time course (400sec). Under these assay conditions the F-
Actin will depolymerise until it reaches a new steady-state, where the concentration
of F-Actin present at this new steady-state is determined by the concentration of free
monomer and by the ratio of free barbed and pointed-ends (especially the number of
free barbed-ends). Thus, increased capping of these faster growing barbed-ends, (in
this case by T-cap-protein), results in the new steady-state having increasingly
reduced F-Actin concentrations (reflected by lower fluorescence intensity signals,
directly proportional to the amount of F-Actin present, see fig. 5.10B). Eventually,
when all of the available barbed-ends are capped, complete depolymerisation will
occur (see discussion for details).
Our results are in agreement with those of Chuang et al (1995) who report a tight
Kcap (~ 1 - 5nM) and similar effects on nucleated, barbed-end limited polymerisation
and depolymerisation, with several of their GST-tensin fusion constructs (those
containing residues R989 - VI121).
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5.3.1.3 The effect of full-length T-cap-protein on the steady-state monomer critical
concentration
In an attempt to address the discrepancy in the "capping mode" of tensin (see section
5.3.1) we have conducted a series of extensive monomer critical concentration ([Cc])
assays in the presence of increasing amounts of full-length T-cap-protein. All protein
samples were incubated for 24hrs (at 20°C in the dark) to ensure that steady-state had
been reached (see methods for details).
Figs. 5.11(A), (B), (C), and (D) show the results from a typical [Cc] assay. The
steady-state critical monomer concentration increases with the amount of full-length
T-cap-protein added. Significant shifts were observed even with the addition of sub-
stoichiometric amounts of T-cap-protein. Fig. 5.12 graphically presents the data from
figs. 5.11(A) - (D), illustrating the shift in the steady-state critical monomer
concentration, from that of the barbed-end (~ 0.1pM) towards that of the pointed-end
(~ 0.74pM under these assay conditions).
Further evidence that the effects of T-cap-protein are due to its interaction with the
barbed-end and not due to monomer sequestration is provided by these data. The
apparent [Cc] values obtained in the presence of 500nM, 800nM and 1200nM T-cap-
protein are essentially identical (0.74pM, 0.72pM and 0.74pM, respectively), and
equal to that of the pointed-end. If T-cap-protein were acting by stoichiometrically
sequestering monomers, thus making them unavailable for polymerisation (similar to
the effects observed with DNasel, see appendix B) the [Cc] would be shifted by the
same corresponding concentration of monomers sequestered. If this was the case, at
high concentrations (e.g. 800nM and 1200nM) the steady-state critical concentration
would be equal to the [Cc] plus the [sequestered monomer] (which, assuming a 1:1
sequestration, is equal to the concentration of added T-cap-protein). i.e. [Cc] ~ 0.9pM
in the presence of 800nM T-cap-protein and [Cc] ~ 1.3pM in the presence of
1200nM T-cap-protein. However, as is clearly indicated by the approach to a plateau,
equal to the [Cc] of the pointed-end, (see fig. 5.12B), regardless of the addition of
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Fig. 5.11(A) and (B). Effect of full-length T-cap-protein on the steady-state actin
monomer critical concentration ([CJ). The table inset in each of the graphs gives the
[Cc] value obtained in each assay. Sub-critical points have been omitted for clarity, and
the solid lines are a linear regression of the data. (A) Closed squares indicate the
fluorescence intensity values for G-Actin alone; open squares, F-Actin alone; open
triangles, 2nM T-cap-protein; open circles, 5nM T-cap-protein. (B) Closed squares
indicate the fluorescence intensity values for G-Actin alone; open squares, F-Actin alone;
closed triangles, 10nM T-cap-protein; closed circles, 15nM T-cap-protein; open circles,
25nM T-cap-protein. Each point represents a separate incubation mixture. The
appropriate amount of T-cap-protein, in ATP-F-Buffer, was mixed with F-Actin (5%
pyrene labelled), and then incubated for 24hr, at 20°C in the dark. The fluorescence
intensity of each sample was then measured at 20°C. The excitation wavelength was
366nm, the emission wavelength was 384nm, with a 5nm slit width for both. (See









































Fig. 5.11(C) and (D). Effect of full-length T-cap-protein on the steady-state monomer
critical concentration of actin ([CJ). The table inset in each of the graphs gives the [Cc]
value obtained in each assay. Sub-critical points have been omitted for clarity, and the
solid lines are a linear regression of the data. (C) Closed squares indicate the fluorescence
intensity values for G-Actin alone; open squares, F-Actin alone; closed triangles, 30nM T-
cap-protein; closed circles, 40nM T-cap-protein; open circles, 60nM T6-protein. (D) Closed
squares indicate the fluorescence intensity values for G-Actin alone; open squares, F-Actin
alone; closed triangles, 100nM T-cap-protein; open triangles, 500nM T-cap-protein; closed
circles, 800nM T-cap-protein; open circles, 1200nM T-cap-protein. Each point represents a
separate incubation mixture. The appropriate amount of T-cap-protein, in ATP-F-Buffer,
was mixed with F-Actin (5% pyrene labelled), and then incubated for 24hr, at 20°C in the
dark. The fluorescence intensity of each sample was then measured at 20°C. The
excitation wavelength was 366nm, the emission wavelength was 384nm, with a 5nm slit
width for both. (See methods for protocol details).
5-25
20 40 60 80
nM T-cap-protein
100
200 400 600 800 1000 1200
nM T-cap-protein
Fig. 5.12. Full-length T-cap-protein shifts the steady-state critical monomer
concentration towards that of the pointed-end. (A) Plot of apparent [Cc] against
T-cap-protein concentration, up to 100nM (data obtained from fig. 5.11). (B) Similar
plot to that shown in A, with high concentrations of T-cap-protein (those above
100nM,) included. These graphs clearly indicate a shift towards the [Cc] of the
pointed-end (~ 0.74pM in this experiment) by addition of increasing amounts of T-
cap-protein.
The concentrations of T-cap-protein that produce the increase in the [Cc] are in good
agreement with the value of Kcap determined from polymerisation assay data. A 50%
increase in the initial [Cc] value is produced when 50% of the barbed-ends have been
capped; i.e. the Kcap value (Walsh et al, 1984; see discussion). The initial [Cc] is
0.1 l|iM and a 50% increase gives a figure of ~ 0.17|lM. The corresponding amount
of T-cap-protein that causes a 50% shift is ~ 5nM, see figs. 5.11(A) and 5.12(B).
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Our data is in agreement with the observations of Chuang et al (1995). These
workers have report a similar shift towards the critical concentration of the pointed-
end, upon addition of sub-stoichiometric amounts of several of their GST-tensin
constructs. We did not observe any evidence of an "insertin-like" activity; our assays
always illustrated significant shifts in the steady-state critical monomer
concentration, in samples containing nM concentrations of T-cap-protein.
5.3.1.4 Full-length T-cap-protein has an apparent novel filament side-binding activity
Three distinct actin-binding domains have been identified within tensin; two N-
terminal proximal ABD-1 domains and a central ABD-2 domain which our T-cap-
protein span (see fig. 5.1, and see Lo et al, 1994a; see Lo et al, 1994b and Taylor et
al, 1998 for reviews). The amino acid sequence within ABD-1, from L371 to N395
of whole tensin, shares homology with a consensus actin-binding sequence (see fig.
5.1) found in a-Actinin, filamin, spectrin, dystrophin, plastin/fibrin, APB-120 and
APB-280 (Nagafuchi et al, 1991; Bresnick et al, 1991; Hartwig and Kwiatkowski,
1991; Matsudaira, 1991). The two ABD-1 domains are most likely responsible for
the side-binding of tensin to F-actin. Lo et al (1994c) have reported that GST-tensin
fusion constructs, composed of amino acids 1 - 263 and 263 - 463, co-sediment with
actin filaments with dissociation constants in the sub-micro molar range (~ 0.5jlM).
The central ABD-2 domain (the region of tensin with very high sequence identity to
"insertin"), is responsible for the barbed-end capping activity. This has been
confirmed by our own experiments performed with T-cap-protein (R861 - A1223),
described in the preceding sections.
For the first time, we show evidence that ABD-2 also contains an F-Actin binding
site. We performed co-sedimentation assay analysis with our T-cap-protein construct
(containing the high-affinity ABD-2 barbed-end-capping domain) and our data seem
to suggest a novel F-Actin side-binding activity. Fig. 5.13 shows the results obtained
from an actin co-sedimentation assay, performed in the presence of increasing
amounts of full-length T-cap-protein (see methods for protocol details). It should be






















Fig. 5.13. Binding of recombinant T-cap-protein to the side of actin filaments. (A) SDS-
polyacrylamide gel (10%,w/v acrylamide) showing the amounts of T-cap-protein appearing in the
pellet and supernatant fractions following centrifugation at 386,000 xg for 15min (at 4°C), in the
absence of F-Actin. This is representative of the amount of insoluble T-cap-protein present; i.e. non¬
specific sedimentation. The corresponding amounts of G-Actin and F-Actin that appear in the in the
pellet and supernatant fractions, in the absence of T-cap-protein, are also shown. (B) SDS-
polyacrylamide gel (10%,w/v acrylamide) showing the results from an actin co-sedimentation assay
performed in the presence of increasing amounts of T-cap-protein. S/N denotes the supernatant
fraction; P, denotes the pellet fraction. 10jj.M Actin was used in all assays. (The co-sedimentation
assay was performed as described in the methods).
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calculated by analysing the percentage of total protein constituted by full-length T-
cap-protein. This was carried out due to the presence of a relatively high amount of
contaminants and/or degraded fragments in the T-cap-protein sample used, and was
calculated by densiometric scanning (data not shown) of the S/N fraction lane of the
62.5|iM T-cap-protein sample (see 5.13A).
As the amount of T-cap-protein increased (added to a constant 10|iM F-actin), a
concomitant increase in the amount of T-cap-protein co-sedimenting with F-Actin in
the pellet fraction was observed (see fig. 5.13B). This appears to be a specific
interaction with the sides actin filaments as essentially no T-cap-protein (the faint
band seen in the T-cap-protein supernatant fraction of fig. 5.13A represents ~ 1% of
the total) sediments in the absence of F-Actin.
Fig. 5.14 shows the binding curve obtained for the apparent specific association of T~
cap-protein with F-Actin. The approximate (see below) amount of T-cap-protein in
the pellet and supernatant fractions was obtained from densiometric analysis (see
methods) of the gel lanes shown in fig. 5.14(B). Least squares, non-linear regression
analysis of these data gives an apparent Kd of ~ 10|iM for this association, and the
Bmax value is ~ 8.0|LtM. This gives an apparent stoichiometry of between 1:2 and 1:1
for T-cap-protein:actin, respectively.
We were unable, however, to accurately determine the amounts of both T-cap-
protein and actin, present in the supernatant and pellet fractions. Several factors
contributed to this problem: the inability to achieve a high degree of separation
between G-Actin and T-cap-protein on SDS-polyacrylamide gels (due to the
closeness of the Mr. values, ~ 42kDa. for G-Actin compared to ~ 46 - 48kDa. for
full-length T-cap-protein), the lateral smudging of the bands in samples containing a
high concentration of T-cap-protein, and the existence of a significant amount of
degraded polypeptides in the T-cap-protein samples. A degraded fragment (or a
contaminant protein in the sample) migrates at a position such that it lies directly
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Fig. 5.14. Analysis of the apparent F-Actin side-binding activity of full-length
T-cap-protein. The figure shows a binding curve produced from densiometric
analysis of the co-sedimentation assay data shown in fig. 5.13. The solid line is a
non-linear least squares fit of the equation [T-cap-protein bound in F-Actin pellet] =
Bmax*[T-cap-protein]/([T-cap-protein]+Kd). The apparent Kd for this interaction is ~
10pM, with a Bmax value of - 8.0pM. (R = 0.998). This gives a stoichiometry of
between 1:2 and 1:1 for T-cap-protein:actin, respectively. (See methods for details
of the protocol).
A combination of these problems resulted in severe difficulties in obtaining distinct
and well-defined protein band-boundaries during the densiometric analysis (see
methods). Therefore, the integrated volume intensity values calculated for each of the
protein bands only very rough estimates. As we were also unable to obtain accurate
values for the amounts of actin present, in either the pellet or supernatant fractions,
the K<i and Bmax values obtained for T-cap-protein binding to F-Actin are inaccurate,
and contain high inherent errors. However, the general trend of an increased binding
of T-cap-protein to F-Actin (a novel feature) can clearly be seen in the pellet
fractions of fig. 5.13(B).
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5.3.2 Interaction with G-Actin
As we have described in the preceding sections, our T-cap-protein construct appears
to bind tightly (Kcap ~ 7 - 8nM) to the barbed-ends of actin filaments. Furthermore,
our results seem to suggest that capping of these ends takes place via simple barbed-
end capping rather than an "insertin-like" mechanism. We proposed to use T-cap-
protein as a replacement for gelsolin (as the barbed-end capping protein) in the
creation and further analysis of our putative "minifilament". This was in an attempt
to overcome the problems of possible monomer exchange (for the A:D binary
complex) at the EGTA labile site (G4) on gelsolin (see section 4.5). Furthermore, as
T-cap-protein is approximately half the size of gelsolin (Mr. ~ 38kDa compared to ~
82kDa for T-cap-protein and gelsolin, respectively) formation of the barbed-end cap
by this smaller protein in the analysis of the putative "minifilament", may reduce
competition with the surface of the putative "minifilament". This would also possibly
reduce the crystallographic problem of crystallisation and solving the structure of this
complex.
A pre-requisite for T-cap-protein, as a barbed-end capping protein in the creation of
the putative "minifilament", is that it is able to form tight, stable and easily purified
complexes with actin monomers. Such complex formation (analogous to the use of
the G:A2 ternary complex) would allow us to control the definition of the barbed-end
of the "minifilament". As described before (see chapter 4), the subsequent addition
of the A:D binary complex (capping and defining the pointed-end) may then result in
the formation of a putative "minifilament" complex. We therefore, initially tested for
any interaction between T-cap-protein and G-Actin monomers. Binding studies were
performed using size-exclusion chromatography and fluorescence enhancement
analysis with NBD-actin. However, the limiting factor in the scope of these
experiments was the small amount of pure (~ 85%) full-length T-cap-protein we
were able to routinely obtain. This has resulted in the extent and number of these
studies being severely limited (see below).
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T-cap-protein and G-actin were mixed together in ATP-G-Buffer, at a molar ratio of
1:1 (at a concentration of 3.0pM). Following a lhr incubation at room temperature
the protein mixture was subjected to size-exclusion on an FPLC/Superose-12
column, run in ATP-F-Buffer or lOOmM Tris, pH 8.0; ATP-G-Buffer (see below).
Fig. 5.15 shows the A2sonm monitored elution profile of such an incubation of T-cap-
protein and G-Actin, from an FPLC/Superose-12 column. The profile contains two,
relatively poorly resolved peaks. The retention volumes (see table 5.2) of the two
peaks correspond to the elution positions of the individual uncomplexed proteins; T-
cap-protein, peak (1) and G-Actin, peak (2). In four similar experiments we
conducted no shift in the retention volumes of either of the two proteins was
observed; the elution profiles always contained two peaks that corresponded to the
retention volumes of uncomplexed monomeric G-actin and that of uncomplexed full-
length T-cap-protein (see table 5.2).














Table 5.2. Retention volumes (ml) of G-Actin and full-length T-cap-protein. Data
obtained from FPLC/Superose-12 size-exclusion chromatography experiments. The value
given for the apparent Mr. is a mean value calculated from the calibration curve using the
corresponding mean retention volume. (See methods for details).
We did not observe any evidence of complex formation on Superose-12 columns run
in either lOOmM Tris, pH 8.0; ATP-G-Buffer or ATP-F-buffer, in the presence or
absence of Ca2+ ions (CaCl2 added to 0.2mM). The lOOmM Tris, pH 8.0; ATP-G-
Buffer is a buffer that contains no salt (i.e. KC1 or NaCl) but the ionic strength is
equivalent to that of ATP-F-Buffer. We used this buffer as a substitute for ATP-F-
Buffer to prevent any hydrophobic interactions between the partitioning proteins and
the Superose resin. It also prevents problems with actin polymerisation, that would
be caused by the addition of salt. It gives virtually identical values for protein
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Fig. 5.15. Full-length T-cap-protein does not bind to G-Actin. A280nm monitored elution profile of a
1:1 molar ratio incubation (in ATP-G-Buffer) of G-Actin and T-cap-protein (3.0pM for each protein),
following a 1 hr incubation at room temperature, from an FPLC/Superose-12 size-exclusion column,
run in 100mM Tris, pH 8.0; ATP-G-Buffer. The arrows mark the elution positions of (1); full-length T-
cap-protein and (2); G-Actin when chromatography was performed on the individual proteins alone.
No apparent shifts in the retention volumes, of either protein, were observed in samples containing a
mixture of the two proteins. (SDS-PAGE and chromatography were performed as described in
methods).
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The value obtained for the apparent Mr. of T-cap-protein is significantly larger than
the theoretical Mr. (64.5kDa compared to 38kDa, see table 5.2). A similar feature
was noticed during the analysis of full-length T-cap-protein with SDS-PAGE. The
value is close to that theoretically expected for a dimer of T-cap-protein (assuming
the protein has a compact globular shape). Full-length recombinant Tensin, from
which this T-cap-protein is derived, has been reported to dimerise in vitro (Lo et al,
1994a). However, the proposed dimerisation occurred via putative interactions
between amino acids in the C-terminus. Our T6-construct contains the amino acids
R861 - A1223 from tensin (based on the residue sequence numbering system of Lo
et al, 1994a). It does not contain the putative C-terminal residues involved in this
dimerisation process.
The relatively high proline content of our T-cap-protein (14%, see fig. 5.3) may
account for the larger apparent Mr. Proline has a more restricted set of allowable,
non-constrained bond angles than most other amino acid residues. The protein
molecule may have a distinctly non-globular hydrodynamic radius, as a direct result
of the steric constraints imposed on the protein by this high percentage of proline
residues, and this possibly explains its higher than expected apparent Mr. from size
exclusion experiments. Further evidence of the non-globular nature of the T-cap-
protein was illustrated by data obtained from NMR experiments. These data
suggested that the protein had very little secondary structure, and although not
completely unfolded, it had a very extended and open conformation (Paul
McLaughlin and Mary Russell, unpublished results). This observation may also
explain the severe proteolytic degradation observed with this protein. The more open
and extended conformation of the peptide backbone would theoretically present more
cleavage sites, and allow the proteolytic enzymes easier access to these sites than a
compact, folded globular domain would.
Similar results, reflecting no interaction between T-cap-protein and actin monomers,
were observed in experiments with NBD-Actin. The position of the covalently linked
fluorescent NBD probe, (coupled to lysine-373 of actin) exposed at the surface of
subdomain I, provides a method for reporting the binding of other proteins to G-
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Actin (see Bryan and Kurth, 1984; Weeds et al, 1986; Way et al, 1989 and see our
data described in chapter 3). The binding of other proteins to the barbed-ends of the
monomer/s, usually produces an enhancement in the fluorescence emission spectra of
NBD-Actin, due to a change in the solvent environment around the probe.
NBD-Actin and T-cap-protein were mixed together at a molar ratio of 1:1 (at a
concentration of 3.0|iM) in ATP-G-Buffer, and incubated for lhr at room
temperature. Following incubation the emission spectra (scanning from 500nm to
700nm, with an excitation wavelength of 475nm, and with a 5nm slit width for both)
was examined for any fluorescence enhancement. In two similar experiments we
observed no fluorescence enhancement, over that seen for 3.0p,M NBD-Actin alone
(data not shown).
We were unable to perform the numerous experiments needed to properly define any
possible interaction between our T-cap-protein and G-Actin. This was primarily due
to the very small amounts of pure, full-length T-cap-protein we could obtain, and the
length of time involved in the purification procedure, to even obtain these amounts.
As a result we have not pursued these experiments any further. However, our initial
results have suggested that there was no interaction between T-cap-protein and
monomeric G-Actin. No other evidence of an interaction between tensin, insertin or
any of the fusion proteins derived from tensin, and actin monomers, has been
reported in the literature.
Thus, we decided that T-cap-protein was not a good candidate for use as a substitute




We have developed a novel working protocol for the purification of our T-cap-
protein construct (a fragment of the protein tensin that spans the sequence containing
the high affinity barbed-end capping domain "insertin"). This protocol gives a final
purity of ~ 85% for the full-length T-cap-protein. Our experiments with the T-cap-
protein, a fragment derived from tensin (a protein localised to focal contacts),
indicate that it tightly caps the barbed-ends of filaments (Kcap ~ 7 - 8nM). The data
also indicate that T-cap-protein does not have any "insertin-like" activity; T-cap-
protein affects the long-term steady-state critical monomer concentration, shifting it
towards that of the pointed-end.
A pre-requisite the use of this T-cap-protein in the further analysis of the formation
of the "minifilament" is that it has the ability to form stable and easily purifiable
complexes with actin monomers (similar to A:D and G:A2). However, we did not
find any evidence of T-cap-protein binding to monomeric actin, and as a result, using
this protein as a substitute for gelsolin as the barbed-end-capping protein in the
further analysis of the "minifilament", was not a viable option. Interestingly
however, although this T-cap-protein still has function (high-affinity barbed-end
capping activity), in a similar manner to (3-thymosin, it appears to have little
secondary structure and lacks a compact folded core in solution (Czisch, et al, 1993);
at least as the isolated T-cap-protein fragment.
5.4.2 Kinetic considerations
A kinetic consideration of the data obtained from our polymerisation,
depolymerisation and steady-state critical concentration analysis experiments
(described in section 5.3.1), provides good evidence for the interaction of T-cap-
protein with the barbed-ends of actin filaments, and for the capping of these ends
taking place via a simple non "insertin-like" mechanism.
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During nucleated actin assembly, the rate of polymerisation d[F-Actin] / dt can be
described by the following relationship:
d[F-Actin] / dt = k+b-[G]-[endsb] + k+p-[G]-[endsp] - k.b-[endsb] - k.p-[endsp] +
spontaneous polymerisation (1),
where k+b is the rate constant of monomer addition to the barbed end, k+p is the rate
constant of monomer addition to the pointed end, [G] is the concentration of G-Actin,
[endsb] is the concentration of barbed-ends and [endsp] is the concentration of
pointed-ends.
If we consider only the initial rates, the loss of monomer from the filament ends can
be ignored as, under physiological ionic conditions, the typical ratio of the rate
constants for monomer addition, to both ends, k+b / k+p, is ~ 10, and the ratio of the
rate constants of monomer dissociation, from both ends, k.b/ k.p, is ~ 5 - 10 (Pollard,
1986; Sheterline et al, 1995). Our polymerisation assays were performed with 0.5pM
G-Actin (20% pyrene labelled), nucleated by the addition of O.lpM F-Actin seeds.
As a result we can also neglect any spontaneous polymerisation, from equation
(1). With actin concentrations below the critical concentration of the pointed-end (0.6
- 0.8pM) the rate of spontaneous polymerisation has been shown to be negligible
(Selve and Wegner, 1986). These workers reported that the rate of nucleation for
0.5pM actin was so low that essentially no polymerisation was observed for up to
2hrs (as observed by monitoring the increase in fluorescence intensity of pyrene
labelled actin). Furthermore, under these conditions (G-Actin concentration is below
the critical concentration for the pointed-end, 0.6 - 0.8pM) we can also neglect the
rates of polymerisation at the pointed-ends.
This gives the much simpler expression for the initial rate of nucleated
polymerisation:
d[F-Actin] / dt = k+b-[G]-[endsb] (2)
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We can calculate the initial rate of polymerisation, the term d[F-Actin] / dt, by
measuring the initial increase in the fluorescence intensity of pyrene-labelled actin,
directly from the linear portion of time courses of polymerisation (similar to those
illustrated in fig. 5.10). Conversion of the Fluorescence units.s"1, to units of monomer
addition in nM.s"1 can be performed by the following method:
d[F-Actin] / dt = (df / dt)-{[total actin] / (fF - fG)} (3),
where fF is the fluorescence of the pyrene-actin when it is all polymerised, fG is the
fluorescence when all the pyrene-actin is monomeric and df / dt is the time
dependent fluorescence, measured as the rate of change in fluorescence intensity
units (arbitrary units). Thus, we can calibrate df / dt (in units of AF.s"1) from the
mean values of fluorescence enhancement from a range of concentrations of pyrene
labelled G-Actin and F-Actin (corrected for the critical concentration), obtained from
critical concentration assays, to give d[F-actin] / dt in nM.s"1.
From equation (2) it is evident that the rate of addition of monomers to the barbed-
end is directly proportional to the concentration of free ends. An idea of the
concentration of the barbed-ends in such assays, [endSb], can be obtained from the
difference in the initial polymerisation rates observed with nuclei in the absence and
presence of nM concentrations of gelsolin (~ InM). Gelsolin binds to the barbed-
ends very tightly (Kd ~ lOpM, Selve and Wegner, 1986; Bryan et al, 1988), but at
these very low concentrations it has a negligible effect on the addition of monomers
to the pointed-end, or on the rate of nucleation (Selve and Wegner, 1986). When we
performed these calculations on control nucleated polymerisation experiments, in the
absence and presence of 0.5nM gelsolin, using the value of 5p,M"'.s"1 for k+b,
(Pollard, 1986), 0.8|lM actin (20% pyrene labelled) and 0.3|iM F-Actin nuclei the
concentration of free barbed-ends was ~ 0.08nM (data not shown). The significance
of this very low concentration of filament-ends is that the concentration of barbed-
ends is very much less than the amount of barbed-end binding protein added in our
experiments (in this case T-cap-protein). This means the vast majority of the capping
protein (T-cap-protein) remains free in the solution, uncomplexed with actin. This
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means we can make the assumption that the amount of free, uncomplexed T-cap-
protein is approximately equal to the total amount added, which simplifies the
estimate of the affinity for the barbed-end.
The concentration of free barbed-ends (on which the initial rate of nucleated
polymerisation is heavily dependent on, as described by equation 2) is dependent on
concentration of the barbed-end binding protein, and its affinity for the barbed-end of
the filament. Thus:
d[F-Actin] / dt = k+b-[G]-[free endsb] (2),
where the term [free endsb] is described by equation 4 below
[free endsb] = ([total barbed ends] * Kd) / ([Barbed binding protein] + Kd) (4),
where Kd is the equilibrium dissociation constant for binding of the protein to the
barbed end (i.e. the Kcap). As the concentration of barbed-ends is very much lower
than the concentration of added capping protein the amount of free capping protein is
approximately equal to the total added.
Simply put, under the experimental conditions described above, an increase in the
concentration of the barbed-end binding protein will result in a decrease in the
number of free barbed-ends. This in turn will result in a reduction of the initial rate of
nucleated polymerisation. When all of the barbed-ends are capped, the initial rate of
polymerisation will approach a rate of zero. The concentration that causes a 50%
reduction in the initial rate of polymerisation is equal to the Kcap. i.e. the
concentration of capping protein (in this case T-cap-protein) where 50% of the
barbed-ends are capped.
We routinely obtained nM Kcap values for our T-cap-protein construct, with the mean
value for full length T-cap-protein being 6.9nM (± 3.1 SD, n=7). Under our assay
conditions, any decrease in the initial rate of polymerisation most likely due to a
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reduction in the number of barbed-ends, as a direct result of the binding, and
subsequent inhibition of further monomer addition, of T-cap-protein.
A similar kinetic consideration of our results obtained from depolymerisation assays
and steady-state critical concentration analyses, also supports the notion of a tight
interaction with the barbed-end. Similarly to the situation with nucleated
polymerisation, if we consider only the initial rate of depolymerisation (regardless of
the solution conditions that are used to dilute the starting F-Actin concentration), this
rate is again heavily dependent on the concentration of free barbed-ends (due to the
differences in the rate constants). If, again, we consider only the initial rate we can
ignore the reverse reactions; furthermore, our assay conditions involve dilutions
below the critical concentration of the pointed-end so monomer addition at this end is
not going to occur.
Thus, equations 4 and 5 can be used to describe the initial rate of depolymerisation:
d[F-Actin] / dt = k.b*[free endsb] + k.p-[endsp] (5),
where the term [free endsb] is described by equation 4
[free endsb] = ([total barbed ends] * Kd) / ([Barbed binding protein] + Kd) (4)
Simply, as the concentration of barbed-end binding protein increases, the number of
free barbed-ends decreases. Capping of the faster depolymerising barbed-ends then
results in a reduction of the rate of polymerisation. However, unlike the situation that
exists for polymerisation (where complete capping of the barbed-ends approaches a
final zero level), when all of the barbed-ends are capped the final depolymerisation
rate will be solely that of monomer dissociation from the pointed-end (the term k.
p-[endsp]). Such behaviour was reflected in our results (see fig. 10A and B). Similar
Kcap values in the nM range (~ 8nM) were obtained in our depolymerisation
experiments, and these data further suggests a tight, stable interaction with the
barbed-end of the filament.
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At steady-state actin monomers are in equilibrium between the monomer pool and
actin filaments. Filaments at steady-state are treadmilling, with a net loss of
monomers from the pointed-end and net addition of monomer at the barbed-ends.
The net concentration of F-Actin and G-actin, at steady-state, remains constant.
Therefore, the steady-state concentration of F-Actin, at any given total actin
concentration, is determined by the concentration of free monomer and by the ratio
offree barbed and pointed-ends.
[F-Actin] = [Actin]tot - [Cc] (6),
where [Cc] is the steady-state critical monomer concentration, and is defined
by the relationship:
[Cc] = (k.b-[free-endsb] + k.p-[endsp]) / (k+b-[free-endsb] + k+p-[endsp]) (7)
Thus, following dilution (under polymerising conditions) of a given concentration of
F-Actin, as is described by equations 6 and 7, the new steady-state critical monomer
concentration is affected by the number of free barbed-ends. Stable, tight capping of
increasing numbers of barbed-ends (by a protein that does not allow any further
monomer addition after capping), has the effect of shifting the steady-state critical
monomer from a value close to that of the barbed-end (~ 0.1|iM) towards that of the
pointed-end (~ 0.6 - 0.8p.M).
The critical concentration is insensitive to a small extent of capping of the barbed-
end because the value for k+ at the barbed-end is much larger than at the pointed-end.
For example, modelled changes in the critical concentration (Walsh et al, 1984;
Selve and Wegner, 1986) have indicate that capping of ~ 90% all filaments at the
barbed-end is required for a ~ 50% shift towards the critical concentration of the
pointed-end. Only after the capping of 70% of the barbed-ends does the steady-state
critical concentration start to show sensitivity to the capping, i.e. relatively large
shifts in the values towards that of the pointed-end. Similarly, to produce a 50%
increase in the initial critical concentration, requires the capping of 50% of the
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barbed-ends, giving a value equal to the Kcap (Walsh et al, 1984). We observed
similar shifts in the steady-state critical concentration by the addition of nM
concentrations of T-cap-protein (see section 5.3.1.3). For example, an increase of ~
50% in the initial critical concentration, from ~ 0.11|iM to ~ 0.18pM, was brought
about by the presence of 5nM T-cap-protein. These Kcap values are comparable with
the values determined from the nucleated polymerisation experiments (~ 7 - 8nM).
In contrast to the high affinity for the barbed-end of filaments, the effect of T-cap-
protein on actin assembly and the steady-state monomer critical concentration is
consistent with there being no interaction between T-cap-protein and monomeric
actin. Preliminary results from size-exclusion and fluorescence enhancement
experiments (performed with NBD-Actin) appear to show no complex formation
between actin monomers and T-cap-protein (see section 5.3.1). This is in agreement
with other reports in the literature. No evidence has been reported for the binding of
actin monomers by tensin or the numerous sequence-deletion fusion proteins that
have been used to study the protein (Schroer and Wegner, 1985; Ruhnau et al, 1989;
Lo et al, 1994a/c; Chuang et al, 1995). The kinetic data also support this result; the
kinetic effects we observe occur via the interaction of T-cap-protein with the barbed-
end and not by monomer sequestration.
Equation (2) indicates that the free monomer concentration ([G]) also greatly
influences the initial rate of polymerisation (see above). Therefore, a reduction in the
free monomer concentration, due to sequestration by T-cap-protein, would also
produce a reduction in the initial rates of polymerisation. Our data however, do not
support this theory. Addition of sub-stoichiometric amounts of T-cap-protein causes
significant inhibition of both assembly and disassembly. Furthermore, the shift in the
steady-state critical monomer concentration reach a maximum level, that of the
pointed-end (~ 0.74p.M). Further addition of T-cap-protein, in excess of this
concentration, does not result in any further increase. The [Cc] in the presence of
500nM T-cap-protein is ~ 0.74|iM, while that in the presence of approximately 3
times this amount, 1200nM, is also 0.74p.M.
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5.5 Conclusion
Our data are consistent with the tight, stable capping of the barbed-end, by T-cap-
protein. Once bound no further monomer addition, by insertion of subunits between
the capping T-cap-protein and the barbed-end, was observed. Thus, our data do not
support the "insertin" mechanism of capping, proposed by Ruhnau et al (1989) and
Lo et al (1994c), but is in good agreement with similar data reported by Chuang and
colleagues (Chuang et al, 1995). Our T-cap-protein construct exhibits a capping
activity similar to that shown by gelsolin. However, gelsolin binds to the barbed-end
with a very much lower dissociation constant (Kcap ~ lOpM; Selve and Wegner,
1986). Gelsolin capping also involves the binding of two actin monomers at the
barbed-end (possible reasons for this very tight association are discussed in section
4.5). We have no evidence for the T-cap-protein binding two monomers at the
barbed-end, and have assumed throughout that only a single molecule of T-cap-
protein binding at the barbed-end was causing the effects we have observed.
Although our T-cap-protein is a tight barbed-end capping protein, its apparent lack of
any G-Actin binding activity precludes its usefulness as a substitute for gelsolin (as
the barbed-end capping molecule) in analysing the putative "minifilament".
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6. Final discussion and conclusions
6.1 Overview and summary
As we have already described, filamentous actin is not amenable to X-ray
crystallography because the polymer lengths are not homogenous. A best fit
orientation of the monomer crystal structure (Kabsch et al, 1990) to X-ray diffraction
data obtained from oriented actin gels has led to the construction of a model of the
filament (Holmes et al, 1990; Lorenz et al, 1993). The model is consistent with much
independent evidence for associations between the subunits (Mendelson and Morris,
1994) and it continues to be consistent with emerging evidence.
However, the maximum resolution of the fibre diffraction data is ~ 7 - 8A (Holmes et
al, 1990; Lorenz et al, 1993; Schmid et al, 1993), and although a unique solution was
found, the resolution of the experimental data were insufficient to allow further
refinement of the input model. Thus, we are far from understanding the contacts
between the actin monomers in the filament in atomic detail or the molecular details
of how the large numbers of actin binding proteins (e.g. gelsolin, myosin, a-Actinin)
interact with the filament.
We proposed a different approach in an attempt to try and resolve the resolution
problem of the current model; this was to create a capped-actin-"minifilament", with
a view to crystallographic studies. This species has a defined length and composition,
with the protein gelsolin capping the barbed-end, and the protein DNasel capping the
pointed-end. Both gelsolin (the G:A2 ternary complex, blocked at the barbed-end),
and DNasel (the A:D binary complex, blocked at the pointed-end) form separate,
stable and easily purified complexes with monomeric actin. Thus, we proposed to
add the A:D complex to the G:A2 complex (under polymerising conditions) and test
for any association between these two smaller species, resulting in the formation of a
putative "minifilament" complex with a stoichiometry G:A3:D, and hopefully with
the actin monomers oriented in a filamentous conformation (see fig. 4.1).
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The G:A2 ternary complex is a potent nucleator of actin polymerisation, but it is
unclear whether the actin monomers within this species are oriented in a filamentous
conformation (akin to the orientation of the terminal monomers at the barbed-end of
the filament), or are just held in close proximity to each other, in a more open, non-
filamentous conformation. The nucleating ability may just stem from the fact that
G:A2 reduces the entropy of nucleation (two monomers are held tightly in close
proximity to each other), and that it provides more ends for monomer addition during
polymerisation.
Kinetic and modelling evidence has indicated that two molecules of DNasel cannot
be bound to the pointed-end an actin filament (Weber at al, 1994). We have probed
the spatial orientation of the actin monomers in the G:A2 ternary complex, using the
binding of DNasel. Our results indicate that two DNasel molecules can be bound to
the pointed-ends of the actin monomers in the G:A2 complex. Furthermore, the
presence of DNasel does not appear to have any influence on the interaction between
the complexed monomer and gelsolin. Our results are consistent with the monomers
in G:A2 being held in a non-filamentous conformation (see chapter 3). Thus it would
seem that crystallising G:A2, and solving the complex's structure to atomic
resolution (by X-ray crystallography) would not provide us with an insight into the
atomic actimactin interactions between monomers oriented as they are in a filament.
Our experiments with the T-cap-protein, a fragment derived from tensin (a protein
localised to focal contacts), indicate that it tightly caps the barbed-ends of filaments
(Kcap ~ 7 - 8nM, see chapter 5). The data also indicate that T-cap-protein does not
have any "insertin-like" activity; T-cap-protein affects the steady-state critical
monomer concentration, shifting it towards that of the pointed-end. A pre-requisite
the use of this T-cap-protein in the further analysis of the formation of the
"minifilament" is that it has the ability to form stable and easily purifiable complexes
with actin monomers (similar to A:D and G:A2). However, we did not find any
evidence of T-cap-protein binding to monomeric actin, and as a result, using this
protein as a substitute for gelsolin as the barbed-end-capping protein in the further
analysis of the "minifilament", was not a viable option. Interestingly however,
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although this T-cap-protein still has function (high-affinity barbed-end capping
activity), in a similar manner to (3-thymosin, it appears to have little secondary
structure and lacks a compact folded core in solution (Czisch et al, 1993), at least as
the isolated T-cap-protein fragment.
Nevertheless, although the actin subunits in the G:A2 ternary complex appear to not
be oriented in a filamentous conformation, addition of a "third" actin monomer in the
form of the A:D binary complex (where the presence of DNasel blocks the pointed-
end and prevents any further monomer addition), to the G:A2 ternary complex may
shift the conformation towards a more filamentous one. Our results (described in
chapter 4) appear to indicate the formation of a stable putative "minifilament"
complex, formed by an association between the actin monomers in G:A2 and A:D,
with a stoichiometry of G:A3iD.
This "minifilament" complex binds to rhodamine-phalloidin, with an apparent Kd of
~ 4.6(tM, but not to the myosin S-l head (at least in the presence of ATP). The actin
monomers within this "minifilament" complex probably have some degree of
flexibility, but their conformation can be shifted towards one more like that of a
filament by the binding of rhodamine-phalloidin (an F-Actin specific binding
molecule).
Furthermore, the stability of this putative "minifilament" also appears to be higher
than one would predict. We would predict that the dissociation constant for the
binding of further monomers to the pointed-end of the G:A2 complex, to have been
close to the critical concentration for monomer addition to the pointed-ends of
filaments (K<i ~ 0.6 - 0.8jlM), or significantly higher (further taking into account the
apparent lack of filamentous character these G:A2 monomers possess). However, our
data seem to indicate that the "minifilament" complex is more stable than
theoretically predicted (see section 4.4.2).
A recent model (McGough et al, 1998; Puius et al, 2000; discussed below in section
6.2) proposes that, during capping, gelsolin is able to make a longitudinal contact
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with a third actin monomer up the long axis of the filament, in addition to the
contacts made by G1 and G4 with the two terminal barbed-end monomers, adjacent
to each other across the short-pitch helix (see fig. 6.2). This "three-subunit-contact"
model provides a rationale for the high stability of our putative "minifilament" and
also provides insight as to why the monomers in the G:A2 ternary complex may not
be oriented in a filamentous conformation.
Our experiments with the S-l head were carried out in the presence of ATP and the
lack of interaction between it and the putative "minifilament" may be a reflection of
the reduced affinity of myosin for F-Actin in the presence of ATP. The specific
binding of rhodamine-phalloidin (K<j ~ 4.6|i.M) to the "minifilament" suggests that
the three monomers have filamentous conformation (or at least that the addition of
rhodamine-phalloidin shifts the relatively flexible conformation of the monomers
within the "minifilament", to be more filamentous). The lack of any association
between the myosin S-l head and the "minifilament" may suggest that the actin
subunits do not possess a filamentous conformation. Further experimental analysis in
the absence of ATP still needs to be carried out. However, the "three-subunit-
contact" model may also provide an alternative explanation for why we might not
observe any binding of the S-l head to the "minifilament", regardless of whether the
actin monomers are oriented in a filamentous conformation or not, and regardless of
the absence or presence of ATP.
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6.2 A model where gelsolin makes a longitudinal contact with a third actin
monomers provides a possible explanation for the tight capping activity of
gelsolin. and also for why the putative "minifilament" species forms with a
higher than expected stability
6.2.1 Introduction to the "three-subunit-contact" model
It has been well established that there are three distinct actin-binding sites, unevenly
distributed, within the six-fold segmental repeat of gelsolin (G1 - 6), (see chapter 1
for details). Much of this work has been performed by studies on truncated forms of
whole gelsolin (following limited proteolysis or using expressed recombinant
constructs) and chimeric constructs (see Weeds and Maciver, 1993 and Sun et al,
1999 for reviews). These studies have proved invaluable for the elucidation of
gelsolins activity and function. However, they have also suggested that the molecular
details of the binding interaction between whole gelsolin and actin monomers (i.e.
formation of the G:A2 complex) and those between gelsolin and the barbed-end of an
actin filament (i.e. formation of the tight cap) may be quite different.
As discussed in section 4.4, whole gelsolin (and also its various constructs) may
cause a conformational change in the monomer complexed to it. This structural
rearrangement may then result in a strengthening of the terminal longitudinal
actin:actin bonds between the complexed actin and the barbed-end of the actin
filament. Although this provides a possible explanation for high affinity barbed-end
capping activity of gelsolin, the molecular details of the interaction between gelsolin
(or G:A2 ternary complex) and the terminal monomers at the barbed-end of a
filament, and those between G:A2 and the A:D complex (resulting in the formation of
the "minifilament"), are likely to be different. In the case of G:A2 binding to the
barbed-end of an already formed filament, one set of lateral and two sets of
longitudinal bonds form: in the case of G:A2 binding to A:D, only a single set of
longitudinal and lateral bonds form. Thus, despite the loss of a set of longitudinal
bonds the A:D binary complex still appears to bind more tightly than we would have
predicted for an actin monomer binding at the pointed-end of G:A2 (further taking
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into account the apparent lack of filamentous conformation possessed by the
monomers within this G:A2 ternary complex).
Although we could still explain the increased stability of the putative "minifilament"
(G:A3:D) complex by "action at a distance" (whereby a gelsolin induced
conformational change in the complexed monomer results in the strengthening of
further longitudinal actimactin contacts), the possibility remains that gelsolin may
make direct contact with additional monomers, longitudinally related to those bound
by the G1 and G4 domains, possibly with a different domain.
In the proceeding sections we discuss a "three-subunit-contact" model, along with
some of its shortcomings, and also discuss why this model provides a possible
explanation for the formation of our putative "minifilament" with a higher than
predicted stability. This "three-subunit-contact" model also suggests reasons for why
the spatial orientation of the monomers within the G:A2 ternary complex may be
non-filamentous and why the myosin S-l head binding site may not be available.
6.2,2 A "three-subunit-contact" model for the barbed-end gelsolin cap
The residues that are important in the binding of gelsolin to F-Actin (residues, 161 —
172 and 197 - 226 on plasma gelsolin, Sun et al, 1994) are all located within
segment 2 (G2) of gelsolin. Furthermore, residues 150 - 160 of G2 have been
implicated in providing some form of co-operative contribution to the potent
severing activity of G1 (Way et al, 1992). The importance of G2 - 3 for efficient
severing activity was confirmed in a chimeric construct containing the first segment
(analogous to G1 in gelsolin) from a related non-severing protein gCap39 and G2 - 3
of gelsolin (Yu et al, 1991). This chimera showed severing activity that was absent in
the native gCap39 protein. Another chimera containing the G1 domain from gelsolin
and the F-actin-binding domain of a-Actinin possessed severing and capping activity
not present in the native protein (Way et al, 1992). Furthermore, the domains from
gelsolin (G2 - 3) and the F-Actin-binding domains from a-Actinin appeared to
compete for a similarly oriented binding-site on the actin filament, each having a
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very similar affinity (Kd ~ 4jiM, Way et al, 1992). Data from EM images, consistent
with these observations, showed that actin filaments could be decorated with G2 - 6
(a construct that severs inefficiently), and indicate an apparent thickening of these
filaments, to almost double that of undecorated filaments (Way et al, 1989).
McGough and Way (1995) have produced a molecular model of an actin filament
capped at the barbed-end. This model proposes that the G1 - 3 cap would involve
two subunits related by the long-pitch of the filament (McGough and Way, 1995).
The orientation of G2 - 3 on the filament was modelled by analogy to the position of
the F-Actin-binding domains of a-Actinin on the filament (obtained from
reconstruction data from EM images of a-Actinin decorated filaments; McGough et
al, 1994), and by assuming that the G2 - 3 and aAl - 2 domains were competing for
a similarly positioned F-Actin-binding site on the filament (Way et al, 1992).
A recent helical reconstruction of cryo-EM images of actin filaments decorated with
the G2 - 6 construct (which possesses ~ 10% of the severing activity of whole
gelsolin, Way et al, 1989; Way et al, 1992) has provided more direct evidence for the
"three-subunit-contact" model (McGough et al, 1998). Three-dimensional
reconstruction of these decorated filaments indicates density located at a subunit
interface on the filament, bridging two longitudinally adjacent actin monomers (up
the long-axis of the filament), see fig. 6.1.
McGough et al (1998) suggest that the G2 - 3 domains of the G2 - 6 construct,
occupy the density located to the side of the filament. These domains appear to make
contacts with two different actin subunits longitudinally adjacent to each other along
the long axis of the filament. The orientation of the G2 - 3 domains on the filament
in this reconstruction was found to be similar to the orientation observed for the F-
Actin-binding domains of a-Actinin bound to actin filaments (obtained from a
similar EM reconstruction study; McGough et al, 1994). Although this analysis
seems to establish the general footprint of gelsolin on F-Actin, the resolution of this
reconstruction does not permit an unambiguous identification or orientation of the
G2 domain from gelsolin on the filament.
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Fig. 6.1. Cryo-EM structure of the G2 - 6 domains of gelsolin bound to
Actin in the presence of O.SmM CaCI2 (conditions that permit severing). The
side-on (left-hand image) and face-on (right-hand image) views of a three
dimensional reconstruction of an actin filament decorated with the inefficient
severing G2 - 6 construct (~ 10% severing activity of whole gelsolin, Way et al,
1989), as described by McGough et al (1998), are shown above. The density
attributed to domains G2 - 3 is coloured red, while that attributed to domains G4 -
6 is coloured green. The 2 longitudinally related actin subunits in the filament that
G2 - 3 interact with are marked A and C. The yellow asterisk indicates the G1
binding site on monomer A. The green asterisk indicates the G4 binding site
(between 50 and 100A away) located at the base of monomer D, proposed by
McGough et al (1998). However, our "minifilament" model (see figs. 4.1 and 6.2)
proposes a G4 binding site on monomer B, with G1 and G4 bound to monomers
adjacent to each other across the short pitch helix (monomers A and B). + ;
indicates the barbed-end of the filament, - end; indicates the pointed-end of the
filament. (The figure was reproduced from McGough et al, 1998).
However, further supportive evidence for a longitudinal interaction between the G2
domain of gelsolin and a third actin monomer has come from the recent work of
Puius et al (2000). These workers have constructed an atomic model of G2 and G1 in
complex with filamentous actin. They report the 1.75A crystal structure of domain 2
from severin (a gelsolin homologue from discoideum; Eichinger and
Schleicher, 1992). A structure based alignment of this severin domain 2 and other
gelsolin family domains implicated a number of residues in G2 that contributed to
the F-Actin binding surface. They assessed the involvement of these residues in the
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binding of G2 of gelsolin to filaments by making mutants. Two mutants (with
mutations in residues in or near to the long a-helix of G2, RRV168AAA and
RLK210AAA) had a lowered affinity for F-Actin; IQ ~ 36[lM and ~ 330|lM,
respectively, compared to ~ 7jiM for the wild-type G2 domain (Puius et al, 2000).
They suggest that the similarity of the structural fold of the various domains in
gelsolin (McLaughlin et al, 1993; Burtnick et al, 1997; Robinson et al, 1999), and the
position of these mutated residues in the G2 crystal structure, means that the long
helix in G2 was important for the binding of G2 to F-Actin. Residues in gelsolin
domain homologues which mediate side-binding activity have been suggested in
binding studies where peptides derived from residues in the long helix of G2 or of
villin domain 2 displayed a weak affinity for F-Actin (Van Troys et al, 1996; Van
Troys et al, 1997). This long helix in G2 was postulated to interact with actin
monomers in the filament, in a binding mode similar to that shown by G1 bound to
actin monomers (as described by McLaughlin et al, 1993). i.e. the G2 filament
binding-site is located in, or very close to, a cleft between subdomains I and III on
the actin monomer, in a similar orientation to the binding-site of Gl. (See fig. 1.8).
Therefore, Puius et al (2000) have constructed a model of the complex of F-Actin (as
described by Holmes et al, 1990) and domains Gl and G2 of gelsolin. This models
(see fig. 6.2) the interaction of the G2 domain with the filament by analogy to the
end-binding interaction of the Gl domain with the actin monomer (McLaughlin et al,
1993). This G2 orientation appears to agree with data from an immunochemical
study that defines a possible interface on the actin monomer, for the binding of
gelsolin to the side of actin filaments. This work has identified several regions of the
actin monomer, localised to actin subdomain I (residues 1-10 and 18 - 28), as being
important for the binding G2 to the sides of filaments (Feinberg et al, 1995). G:A2
ternary complexes were unable to react with an antibody raised to these N-terminal
residues (18 - 28) of the actin monomer, implying that this region was occluded
(possibly by G2) in gelsolimactin complexes, and was thus somehow close to or
actively involved in the binding interface between actin and gelsolin.
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In summary; the "three-subunit-contact" model (postulated by Way et al, 1992;
McGough and Way, 1995; McGough et al, 1998; Puius et al, 2000) proposes that G2
(the F-Actin binding domain) from gelsolin localises the protein to the sides of actin
filaments, and once bound it remains bound. In conjunction with the side-bound G2
- 3 domains, the G1 domain then severs, disrupting the actin:actin contacts between
actin subunits one monomer below (longitudinally, down the long axis of the
filament) that bound by G2. After severing G1 binds at the end of the filament in a
manner akin to that described by McLaughlin et al (1993). A large structural re¬
arrangement in the C-terminal half of the molecule then allows the second monomer-
binding domain (G4) to bind a second monomer, adjacent to that bound by G1
(across the short pitch helix). In this model, the formation of a tight cap (Kcap ~
lOpM; Selve and Wegner, 1986) at the barbed-end of the filament has the G2 domain
bound to a third actin monomer, longitudinally related up the long axis of the
filament, to the one bound by G1 (see fig. 6.2).
This model provides a possible explanation of why the gelsolin cap is so tight. Loss
of this "three-subunit-contact" cap would require the breakage of bonds from three
intimate gelsolin:actin associations; Gl, G2 and G4 are bound to three separate
monomers. In addition, binding may be very co-operative, adding additional stability
to the interactions. Furthermore, the loss of an actin-trimer species (dissociation of
gelsolin complexed to the three monomers it is bound to) from the barbed-ends of
filaments would require the breakage of many more bonds in the filament, than
would either monomer or dimer dissociation, and would be very energetically
unfavourable.
There are, however, criticisms of this model. Although it is clear that G2 localises
gelsolin to the filament and is important for efficient severing, the F-Actin-binding
domains from other proteins were only partially able to functionally replace the G2 -
3 domains from gelsolin. Capping by Gl - 3 is almost as efficient as whole gelsolin
(Way et al, 1989; Way et al, 1992) in contrast to the cap formed by the Gl:aAl - 2
hybrid; this cap was significantly less stable than that formed by Gl - 3 (Way et al,
1992). Furthermore, the severing activity of the hybrid was also reduced in
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comparison to G1 - 3 and whole gelsolin. The weakened Gl.ocAl - 2 hybrid capping
and severing activities suggest that the optimal interaction of G1 with the filament
and monomer binding site was not achieved, and imply that the F-Actin binding site




Fig. 6.2. "Three-subunit-contact" model of the putative "minifilament". A
schematic representation of a putative model of the capped-actin-"minifilament",
with stoichiometry of G:A3:D (gelsolin:actin3:DNasel), is shown. DNasel is
coloured grey, the three actin monomer subunits, oriented as described by the
Holmes filament model (Holmes et al, 1990), are coloured red, green and blue.
The G1 domain and a putatively positioned G4 domain - by analogy - are
shown, coloured yellow (oriented as described by McLaughlin et al, 1993). The
longitudinalG2 contact with the third actin monomer (complexed with DNasel,
here coloured green) is also shown, coloured cyan. The interaction of G2 with
this third actin monomer is modelled using a G1 like interaction, as described by
the model proposed by Puius et al (2000). The linker sequence between G1 and
G2 is not shown. The black spheres indicate the beginning (C-terminus of G1)
and end (N-terminus of G2) of this 10-residue linker. (The figure was created
using MOLSCRIPT; Kraulis, 1991).
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Further evidence for the differences in the localisation of the gelsolin and a-Actinin
F-Actin binding site on the filament, arises from the immunochemical analysis of the
definition of the possible F-Actin binding gelsolin:actin interface on the monomer
(Feinberg et al, 1995). While G2 - 3 did bind, a-Actinin showed no evidence of
binding to the peptide derived from residues 18 - 28 of actin. Although McGough et
al (1998) report that their reconstruction and difference mapping suggest that these
N-terminal residues lie outside the G2 - 3 binding site, the low resolution of their
EM reconstruction does not allow for the unambiguous assignment of the position of
these actin residues. However, this discrepancy may not be surprising as the N-
terminal residues of actin are thought to be relatively mobile (Kabsch et al, 1990;
McLaughlin et al, 1993). Furthermore, the conclusions drawn from this study
(Feinberg et al, 1995) should be tempered the fact that peptide fragments were used.
The actual three-dimensional conformation of these N-terminal residues in the folded
actin monomer, may not be at all representative of the conformation of the isolated
peptide fragments. Thus, the epitope/s presented by these peptides in isolation, may
be completely different to the epitope/s (and thus the three-dimensional
conformation) presented by the same region of the polypeptide chain in the native
monomer.
Some further objections to the interpretation of the orientation of the F-Actin-binding
domain of gelsolin (G2) on a third longitudinally translated actin monomer stem
from several anomalies observed during the analysis of the G2 - 6:F-Actin
micrographs. To achieve saturation of the actin filaments with G2 - 6 McGough et al
(1998) had to add a 4 - 5 molar excess of the construct. This resulted in the
micrographs of G2 - 6:F-Actin possessing lots of noise. In addition to the marked
length variations observed in the filaments in comparison to undecorated F-Actin
(explained by the slow severing of G2 - 6 during the processing time, giving rise to
many more shorter filaments) many of the G2 - 6:F-Actin filaments were also
"kinky" or curved. Furthermore, during analysis of the images, averaging of the data
was halted after eight filaments as it was apparent that further processing was
weakening the high radius features, that the authors attribute to the G4 - 6 domains
of gelsolin (McGough et al, 1998). Thus, it is possible that the very low level of
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resolution and the high levels of noise inherent in the data used to produce these EM
images, may have led to artefacts and the mis-assignment of the orientation of
gelsolin subunits, with regard to their interaction with the actin filament.
The loss of G1 (a requirement for efficient severing) may have resulted in G2 - 6
adopting an aberrant orientation on the filament. Indeed the change in the stmcture of
some of the filaments (many of the G2 - 6:F-Actin filaments were kinky or curved,
McGough et al, 1998) may reflect this aberrant conformational relationship between
the filaments and G2 - 6. The rapid severing activity of G1 (in whole gelsolin), and
the large structural re-arrangements that then result in G4 binding and subsequent
capping, may mean that the conformation of G2 - 3, observed by McGough et al
(1998), compared to whole gelsolin bound at the barbed-end, is significantly
different.
To allow G2 to bind to the monomer above (longitudinally related up the long axis of
the filament) that bound by Gl, Burtnick at al (1997) suggest that large and
energetically unfavourable re-orientations of the gelsolin structure would have to
take place. It is apparent that large scale conformational changes do occur during the
transition between the activation (by Ca2+ binding to several sites in the C-terminus)
and the actin binding, severing and capping activities of gelsolin (Patkowski et al,
1991; Burtnick et al, 1997; Pope et al, 1997; Robinson et al, 1999). However, the C-
terminus of Gl and the N-terminus of G2 are only connected by a relatively small
(10 residues) linker, unlike the longer ones observed between G2 and G3 (~ 20 - 30
residues) and the -40-50 residue linker between G3 and G4. It would seem difficult
for G2 to be able to make contact with the F-Actin-binding site on a longitudinally
adjacent monomer (adjacent to the one bound by Gl), as suggested by orientation of
the G2 - 3 domains in the model postulated by McGough and Way (1995) and
McGough et al (1998), without some considerable steric strain at the terminal
portions of these two domains. However, Puius et al (2000) suggest that the
orientation of the G2 domain (with a binding mode similar to the orientation of Gl)
in their model means that the 10-residue domain linker could span the 31A between
the C-terminus of Gl and the N-terminus of G2, without any significant steric strain.
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The crystal structure of inactivated gelsolin (Ca2+ free) determined by Burtnick and
co-workers (Burtnick et al, 1997) showed that all of the six domains (G1 - 6) of
gelsolin possess the same basic fold topology. This fold consists of a central five- or
six-stranded (3-sheet sandwiched between a 3.5 to 4.5 turn a-helix that runs roughly
parallel to the strands. Puius et al (2000) have suggested that residues within this
long a-helix are important for the binding of both G1 and G2 to the filament (with
G2 binding in a similar mode to that exhibited by G1 binding to the actin monomer,
as described by McLaughlin et al, 1993). However, if all of the domains possess the
same structural fold, why do the other domains from gelsolin not show similar
interaction with the filament? The variable length loops that connect the (3-sheets and
a-helixes in the core of the various domains (Burtnick et al, 1997), may somehow
ascribe positive or negative steric determinants for an end- or side-binding activity
for the six domains of gelsolin, as suggested by Puius et al (2000). Furthermore, the
amino acids that contribute to the formation of this a-helix in the other non-actin-
binding domains (G3, G5 and G6) may not possess the residues that "actively" allow
the others to bind to the actin-monomer. i.e. an apolar patch of hydrophobic residues
exposed on the surface of the long a-helix in G1 (centred around lie 103 in human
cytoplasmic gelsolin, see McLaughlin et al, 1993)
Despite the shortcomings of the "three-subunit-contact" model, it nevertheless
provides a good model for why gelsolin forms such a tight cap, why our putative
"minifilament" forms and also provides a rationale for why the monomers within
isolated G:A2 ternary complexes are not oriented in a filamentous conformation.
As our results appear to indicate (see chapter 3) the orientation of the actin
monomers within the G:A2 ternary complex is non-filamentous. They appear to have
some degree of flexibility, with gelsolin holding the monomers in close proximity to
one another. This non-filamentous subunit orientation may explain the slightly
different kinetics of nucleation exhibited by G:A2. Thus, in isolated G:A2 complexes
only the G1 and G4 binding sites are occupied with the monomers held in an open
non-filamentous conformation; the side-binding G2 site remains unoccupied. Once
the G:A2 complex has bound at the barbed-ends of filaments the strong cap is formed
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(and maintained) by the further association of G2 with a third actin monomer,
longitudinally related up the long axis of the filament to that bound by G1 (see fig.
6.2). This association then causes the monomers to adopt an F-like conformation.
These three monomer contacts (Gl, G2 and G4) provide the extra energy and
stability needed to form the very strong gelsolin cap.
A similar consideration of this "three-subunit-contact" model provides an
explanation for the apparently higher than expected stability of our
G:A3:D/"minifilament" complex (see chapter 4). The actin monomers in the isolated
G:Aa are not in a filamentous conformation, with the Gl and G4 monomer binding-
sites occupied, and the G2 filament-binding site unoccupied. However, upon addition
of A:D to G:A2, an end-to-end actimactin association between A:D and G:Ao,
enhanced by a third and possibly co-operative interaction between G2 and the actin
monomer in A:D, leads to the formation of the "minifilament" complex. In a similar
situation to the formation of a stable barbed-end cap, the third gelsolin:actin contact
(with the monomer capped at the pointed-end by DNasel) results in the increased
stability of the G:A3:D/ "minifilament" complex.
If this third G2 mediated gelsolimactin interaction leads to the stabilisation of the cap
and "minifilament" species why is the formation of gelsolin in complex with three
actin monomers (G:A3) not detected more often? Formation of the G:A3 complex
has been reported during the analysis of the native protein complexes formed
between gelsolin and actin, on a Native-PAGE system (Pharmacia PhastGel™
system) (Edgar, 1990), providing some supportive evidence for the "three-subunit-
contact" model.
Significant amounts of a complex, with an apparent stoichiometry of G:A3, was
observed in samples taken from incubations of gelsolin (purified from baby hamster
kidney cells; BHK gelsolin) with a large molar excess of G-Actin (ranging from 4:1
- 14:1, actimgelsolin). However, this species accounted for only ~ 10% of the total
complex formed. There is no evidence of the formation of G:A3 reported by
analytical gel-filtration chromatography, or by other methods, elsewhere in the
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literature. However, such experiments are not carried out routinely with the high
molar excess of actin needed to produce the complex on native-gels. Thus these
studies may not have detected the very small amounts (~ 10% of total) of G:A3
possibly forming. Edgar (1990) suggests that the formation of G:A3 may reflect the
simultaneous binding of three actin monomers (in a calcium regulated manner)
resulting in the occupation of all of the actin-binding sites in gelsolin (Gl, G2 and
G4), in an orientation that prevents further monomer addition at the pointed-end of
the G:A3 complex.
However, the fact that this complex has not been described elsewhere before, may
indicate that this G:A3 complex is an artefact of the gel-system used. Furthermore, as
the native-gel cannot be run under polymerising conditions (only the incubation is
carried out under these conditions) the details of formation of this putative G:A3
complex and its interaction with both G- and F-Actin cannot properly be assessed.
BHK gelsolin may also interact with actin in a different manner to that exhibited by
other forms of gelsolin, as has been reported by other workers (Bryan and Kurth,
1984; Weeds et al, 1986; Porte and Harricane, 1986; Laham et al, 1993; Laham et al,
1995). e.g. an apparent Mg2+ regulated actin monomer binding activity in pig plasma
gelsolin has been reported by Harris (1988).
During G:A2 nucleated polymerisation, the initial formation of a gelsolin-capped
trimer species, G:A3, by the addition of a third monomer onto the pointed ends of the
monomers in G:A2, resulting in the shift of the monomer conformation towards a
filamentous one, may account for the reduced lag-phase observed in such
experiments (see section 3.5 and 4.1). However, once this species has formed, with
the third monomer bound and stabilised by the interaction with the G2 domain of
gelsolin, polymerisation then takes place rapidly onto the pointed-end of the G:A3
species. Thus, G:A3 is rapidly consumed (as fast as the on-rate of monomers at the
pointed-ends takes place) and is thus not usually observed as a distinct molecular
species during experiments of this nature. However, in our "minifilament" the
presence of DNasel blocks the pointed-end of the putative "minifilament" (defining
that end of the complex), and would prevent any further monomer addition.
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Thus, the binding ofG2 to the third actin in the A:D complex, means that this species
is now stabilised (and blocked at both ends preventing any further monomer
addition) to such an extent that we are now able to isolate it.
A possible additional feature of this "three-subunit-contact" model is that the
interaction of the G2 domain from gelsolin with a third a monomer, longitudinally
related to that bound by Gl, may occlude the binding site for the myosin S-l on the
putative "minifilament" (see fig. 6.3).
Pointed-end
Barbed-end
Fig. 6.3. Model of the putative "minifilament" with the myosin S-1 head bound. A
schematic representation of a putative model of the capped-actin-"minifilament", with
stoichiometry of G:A3:D (gelsolin:actin3:DNasel), with the myosin S-1 head bound
(oriented as described by Rayment et al, 1993a/b) is shown. DNasel is coloured grey,
the three actin monomer subunits, oriented as described by the Holmes filament model
(Holmes et al, 1990), are coloured red, green and blue. Only segment 1 (G1) and a
putatively positioned segment 4 (G4) - by analogy - from gelsolin are shown, coloured
yellow. The S-1 head is coloured cyan. A comparison of this figure and the schematic
model for the proposed G2 contact with the third actin monomer capped by DNasel
(coloured green), shown in fig. 6.2, clearly shows the steric interference that this
interaction would have with the binding of the S-1 head. (The figure was created using
MOLSCRIPT; Kraulis, 1991).
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Each myosin head interacts with two actin monomers, the interaction occurring
across a longitudinal subunit interface, giving rise to primary and secondary binding
regions on both actin and myosin (Rayment et al, 1993a/b). The primary interaction
occurs with residues located in subdomain I of one actin monomer, with secondary
interactions occurring with subdomain II of the monomer directly below (see fig.
6.3).
Mutagenesis, cross-linking studies, peptide binding studies and modelling studies
have all implicated, amongst numerous others, the N-terminal residues 1 - 28 and the
C-terminal residues 341 - 375 of the actin monomer as being important for the
myosin interaction (see Sheterline et al, 1995 and Sellers and Goodson, 1995 for a
review of the residues involved in the acto-myosin contact site). This area of the
actin monomer is important in the binding of G1 (McLaughlin et al, 1993) and is
suggested to be a likely site in Puius et al's model for the binding of G2 to F-Actin
(Puius et al, 2000). Thus, even in the absence of ATP the S-l myosin head may not
bind to our putative "minifilament" due to an occlusion of its binding site on the
actin monomers by the longitudinal G2 domain contact with the A:D actin monomer.
Despite the lack of hard evidence for the Puius et al (2000) model, our "minfilament"
would allow a direct test of the hypothesis using the two mutants (RRV168AAA and
RLK210AAA, in the long helix of G2), that demonstrated a lowered affinity for F-
Actin. If the "minifilament" is indeed forming due to the stabilising effect of the G2
association with a third actin subunit (here complexed with DNasel), one would
predict that similar experiments with gelsolin mutants would show a marked loss of
stability of the putative "minifilament" species, as the association between the third
(A:D) actin and the mutant G2 (with reduced affinity) would be less stable. This loss
of G2 binding affinity would possibly result in the detection of significant amounts
of the two smaller complexes during size-exclusion experiments. Furthermore, the
loss of this third gelsolimactin contact, and its stabilising effects, would also possibly
result in the loss of the specific rhodamine-phalloidin binding (see section 4.3), as the




Although our experiments, provide evidence for the formation of a capped-actin-
"minifilament", of defined length and composition (most likely formed via an
actimactin association between the monomers in the G:A2 ternary complex and the
A:D binary complex), with a stoichiometry of G:A3:D (gelsolin:actin:DNaseI,
respectively), verification of the formation of our putative "minifilament" complex
by other complementary physical techniques would provide further evidence to
support our size-exclusion and rhodamine-phalloidin binding data. Several of these
methods include the use of alternative native-PAGE techniques, covalent cross-
linking, and possibly analytical ultra-centrifugation methods.
Although the native-gel system (adapted from Safer, 1989) used in the analysis of the
spatial orientation of the actin monomers in G:A2 proved to be ill-suited to the
analysis of the putative "minifilament", other native-PAGE techniques may possibly
be used to demonstrate the formation of the "minifilament". One possible method for
this is the adaptation of a Native-Blue electrophoresis technique for our purposes
(Schagger & von Jagow, 1991; Schagger et al, 1994). The procedure was developed
for the isolation of native membrane protein complexes, at a fixed pH of 7.5;
however it can also be applied to both acidic and basic water soluble proteins. This
system works on the basis of a "charge-shift" method, with the electrophoretic
mobility of the proteins determined by the negative charges of bound Coomassie dye.
The native gel is then followed by analysis in the second dimension using a Tricine-
SDS-PAGE protocol (Schagger & von Jagow, 1987). This native-gel system appears
to have a tolerance for the presence of salt in the sample and running buffers
(Schagger et al, 1994). Furthermore, the voltage, buffer conditions and gel running
times are all significantly different to those used in the system we have used, and
thus may allow the use of ionic solution conditions that are similar to F-conditions.
Cross-linking experiments may also provide a further method of verifying the
formation and stoichiometry of the putative "minifilament". We have performed
some preliminary covalent cross-linking experiments on the putative "minifilament"
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with the homo-bifunctional Sulfo-EGS reagent (reacts with primary amine, most
often lysine residues); however, our results were inconclusive (data not shown).
Nevertheless, further work needs to be carried out to fine-tune the solution conditions
required for the cross-linking reaction, and these experiments may provide some
useful complementary data for the formation of the "minifilament".
Our size-exclusion experiments performed in the presence of ATP, indicate no
binding between the S-l head and the "minifilament". The "three-subunit-contact"
model (discussed above, see section 6.2) provides a possible explanation for way we
may see no S-l binding to the minifilament (G2 occludes the S-l binding site on the
actin monomers within the minifilament), regardless of the presence or absence of
ATP. However, we have no direct evidence for this steric hindrance and further
experiments with the myosin S-l head, in the absence of ATP, still need to be
performed.
Our results (described in chapter 3) appear to indicate that the presence of DNasel
(bound at the pointed-end of the actin monomer in the A:D complex) has no effect on
the interaction between gelsolin and actin monomers. Furthermore, our results also
seem to indicate that the possible exchange reaction (of G-Actin for A:D binary
complex) occurring at the EGTA labile G4 monomer-binding site on gelsolin, creates
less of a problem than expected (due to the apparent increased stability of the
"minifilament"). Nevertheless, using a gelsolin construct that consists of two G1 - 3
domains in tandem (G1 - 3:G1 - 3), containing two tight (Kd ~ 5pM, Bryan, 1988)
G1 subunit binding sites, may increase the stability of the complex and reduce the
problems of exchange even further.
Other actin-binding proteins could be used to probe the conformation of the actin
"monomers" within our putative "minifilament" complex. Although the proposed
position of G2 in "three-subunit-contact" model may sterically occlude the binding
sites for several F-Actin specific binding proteins (e.g. a-Actinin, myosin) other
binding proteins may be found that are not (or less) affected by the orientation of the
G2 domain (e.g. tropomyosin). Such a binding interaction would provide further
6-20
evidence of "minifilament" formation, and also confirm the filamentous
conformation of the actin subunits implied by our rhodamine-phalloidin experiments.
The putative "minifilament" complex appears to stable enough to perform
crystallisation studies with; the complex can be stably re-chromatographed on
Superose-12 size-exclusion columns. Although we would have to be careful about
interpreting the structure, such an analysis of the putative "minifilament" would
hopefully show filamentous actin:actin contacts that could be used to build an atomic
resolution model of the actin filament.
6
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Appendix A
Assay for the long term storage of G-Actin in 1M Tris, pH 8.0; ATP-G-Buffer
solution
1M Tris. pH 8.0; ATP-G-Buffer
1M Tris, pH 8.0; 0.5mM DTT; 0.2mM CaCl2; 0.2mM ATP; l.OmM NaN3.
ATP-G-Buffer
5mM Tris, pH 8.0; 0.5mM DTT; 0.2mM CaCl2; 0.2mM ATP; l.OmM NaN3.
Pinder and co-workers (Pinder at al, 1995) have reported that high concentration Tris
buffer solutions could be used for the long-term storage (over 6 months), of G-Actin,
extracted from platelets. We have developed a protocol (adapted from those of
Spudich and Watt, 1971, and Pinder et al, 1995) for the extraction and purification of
G-Actin from rabbit muscle acetone powder (protocol details are described in the
methods). We have used the actin monomer critical concentration ([Cc]) assay (5%
pyrene labelled, see methods for details) to test the viability of 1M Tris, pH 8.0;
ATP-G-Buffer, at 4°C, for the long-term storage of extracted G-Actin. This is a well
documented and sensitive method for reporting the quality of monomeric actin, with
regards to its ability to undergo polymerisation. Prior to [Cc] assay and use in other
experiments the G-Actin was subjected to size-exclusion on an S200 column (Vt ~
135ml; 65cm x 1.6cm), in ATP-G-Buffer.
Fig. A.l shows the elution profile from a similar gel-filtration experiment. Freshly
prepared G-Actin always produced a similar profile. A slight leading-edge (arrow 1)
followed by a second large sharp peak (arrow 2) were commonly observed. The area
under peak 1 of the profile most likely contains an actin-dimer species (probably
formed via a disulphide bridge between the Cys-374 residue of one monomer and the
corresponding Cys-374 residue of the other) and also higher Mr. aggregates of


























Fig. A.1. S200 size-exclusion chromatography of G-Actin prepared using the 1M Tris, pH 8.0;
ATP-G-Buffer protocol. (A) A280nm monitored elution profile of a 2ml (~ Smg.ml'') sample of G-Actin,
extracted in1M Tris, pH 8.0; ATP-G-Buffer, from an S200 size-exclusion column (V, ~ 135ml; 65cm x
1.6cm), run in ATP-G-Buffer at 0.5ml.min"1. (B). SDS-PAGE analysis of the elution profile in A. The
arrows mark the elution positions of (1) actin dimer/denatured aggregates; (2) monomeric G-Actin.
The column was calibrated with the following protein standards: ferritin (Mr. = 443kDa), catalase
(232kDa), aldolase (158kDa), BSA (67kDa), ovalbumin (43kDa) and DNasel (29kDa). Plots of log10
Mr. against the retention volume for these proteins were linear within this range. The elution volumes
for peaks (1) and (2) corresponded to Mr. of 93kDa and 49kDa respectively. These values are in good
agreement with the theoretical Mr. (84kDa and 42kDa for the dimer and monomer species,
respectively). SDS-page was performed as described in the methods. ^_2
review). When pooling fractions of viable G-Actin care was taken to minimise the
overlap between these two areas.
Table A.l shows the [Cc] value taken from 10 different G-Actin preparations
following 1, 2, 3, 4 or 6 months storage in 1M Tris, pH 8.0; ATP-G-Buffer. The [Cc]
values for freshly prepared G-Actin compare favourably with those published by
others, where conventional methods of extraction and purification have been
employed in the preparation of G-Actin (Pollard, 1986; Sheterline et al, 1995). [Cc]
values for G-Actin, stored in 1M Tris, pH 8.0; ATP-G-Buffer for up to 4 months do
not increase significantly, and still compare favourably with those of freshly
prepared actin, see table A.l. After 4 months the actin started to deteriorate (as
judged by significant increases in the critical concentration).
However, the yield of high quality G-Actin obtained decreased steadily with time.
We routinely obtained yields of 12 - 15mg of G-actin (with [Cc] <0.15p.M) per gram
of acetone powder for fresh preparations. As can be seen from table A.l the yield
drops to ~ 40% after 3-4 months. The ratio of the relative amounts of dimer and
non-viable denatured aggregate species, to that of viable native G-Actin increased
with time. This was reflected by the peak areas at elution positions 1 and 2, in fig.
A.l, from S200 gel-filtration experiments performed on such samples, becoming
approximately equal.
Steady denaturation of the G-Actin monomer still appears to occur, but at a very
much reduced rate, in comparison to storage in ATP-G-Buffer. The high
concentration of Tris buffer salts appears to have a stabilising effect on the actin
monomer in solution, at 4°C.
We have used 1M Tris, pH 8.0: ATP-G-Buffer routinely for long-term G-Actin
storage due to the practicality of obtaining "good" actin with a relatively simple and
quick procedure. Other methods for the long-term storage of actin usually involve the
flash freezing of F-Actin aliquots in liquid nitrogen. However, although this method
allows for reasonable lengths of storage time and recovery, the processing time
A-3
(involving rounds of depolymerisation and size-exclusion chromatography under G-































































































Activity assay and long-term storage conditions for recombinant DNasel/lFl 13401
An actin critical concentration assay ([Cc]), performed in the presence of 0.5jxM
recombinant DNasel, was used as an assay for the relative activity of DNasel. The
amount of inactive protein was compensated for in subsequent experiments by the
further addition of the appropriate amount of protein so the final activity was 100%.
Fig. B.l shows the result from a typical [Cc] activity assay performed on a
preparation of newly purified DNasel.
Table B.l shows the results from various [Cc] activity assays performed on DNasel




Tris, pH 7.6; 2mM
CaCI2; 1mM NaN3,
stored at 4°C
Buffer A plus 20%
glycerol, stored
at -20°C





Length of storage Activity
Fresh 80 - 95% N/A N/A
1 month 80 - 95% 60 - 85% 50 - 80%
2 months 50 - 70% 60 - 85% 50 - 80%
3 months <25% 50 - 75% 50 - 75%
4 months N/A 50 - 75% 50 - 75%
5 months N/A 45 - 70% 50 - 70%
6 months N/A 40 - 65% 40 - 70%
Table B.1. Storage conditions for recombinant DNasel/[H134Q]. Actin critical monomer
concentration activity assays, in the presence of DNasel (0.5pM), were performed on a
variety of samples stored for differing lengths of time and under different conditions. Prior to
[Cc] assay protein samples were subjected to high-speed centrifugation and size-exclusion
on an S200 gel-filtration column (Vt ~ 135ml; 65cm x 1.6cm), run in ATP-G-Buffer at
0.5ml.min"1. ([Cc] assay was performed as described in methods).
Short term storage in Buffer A (see table B.l) was viable for 7 - 8 weeks. Longer-
term storage required the addition of a cyro-protectant (20% glycerol) and freezing at
-20°C or -70°C. Both conditions gave similar results however, the recovery yield of
active protein was very sample dependent.
B-l
|o.M Actin
Fig. B.1. Assay of recombinant DNasel/[H134Q] activity. Actin critical
concentration assay performed at 20°C (5% pyrene-labelled actin) in the
absence or presence of 0.5pM recombinant DNasel/[H134Q], The excitation
wavelength was 366nm, the emission wavelength was 384nm, with a 5nm
slit width for both. Closed squares represent actin incubated in ATP-G-
Buffer; open squares represent actin incubated in ATP-F-Buffer; triangles
represent actin incubated in ATP-F-Buffer, in the presence of 0.5pM DNasel.
DNasel binds stoichiometrically to the pointed ends of actin monomers (Kd ~
0.1 nM) resulting in its sequestration from the monomers pool available for
polymerisation. This results in an increase in the apparent [CJ; the increase
directly reflecting the amount of active DNasel present. In this example
activity is ~ 86% of the added 0.5pM. (0.58pM - 0.15pM = 0.43pM; 0.43/0.5 =
0.86). [Cc] assay was performed as described in methods.
